515 lines
No EOL
733 KiB
HTML
515 lines
No EOL
733 KiB
HTML
<?xml version="1.0" encoding="utf-8"?>
|
|
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
|
|
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
|
|
|
|
<head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
|
|
<!-- AppResources meta begin -->
|
|
<meta name="paf-app-resources" content="" />
|
|
<script type="text/javascript">var ncbi_startTime = new Date();</script>
|
|
|
|
<!-- AppResources meta end -->
|
|
|
|
<!-- TemplateResources meta begin -->
|
|
<meta name="paf_template" content="" />
|
|
|
|
<!-- TemplateResources meta end -->
|
|
|
|
<!-- Logger begin -->
|
|
<meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-toc" /><meta name="ncbi_acc" content="NBK5330" /><meta name="ncbi_domain" content="micad" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK5330/" /><meta name="ncbi_pagename" content="Molecular Imaging and Contrast Agent Database (MICAD) - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="toc" /><meta name="ncbi_app" content="bookshelf" />
|
|
<!-- Logger end -->
|
|
|
|
<title>Molecular Imaging and Contrast Agent Database (MICAD) - NCBI Bookshelf</title>
|
|
|
|
<!-- AppResources external_resources begin -->
|
|
<link rel="stylesheet" href="/core/jig/1.15.2/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.15.2/js/jig.min.js"></script>
|
|
|
|
<!-- AppResources external_resources end -->
|
|
|
|
<!-- Page meta begin -->
|
|
<meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_title" content="Molecular Imaging and Contrast Agent Database (MICAD)" /><meta name="citation_publisher" content="National Center for Biotechnology Information (US)" /><meta name="citation_date" content="2013" /><meta name="citation_pmid" content="20641179" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK5330/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Molecular Imaging and Contrast Agent Database (MICAD)" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="National Center for Biotechnology Information (US)" /><meta name="DC.Date" content="2013" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK5330/" /><meta name="description" content="The Molecular Imaging and Contrast Agent Database (MICAD) is an online source of scientific information regarding molecular imaging and contrast agents (under development, in clinical trials or commercially available for medical applications) that have in vivo data (animal or human) published in peer-reviewed scientific journals. MICAD is a key component of the “Molecular Libraries and Imaging” program of the National Institutes of Health (NIH) Common Fund (formerly NIH Roadmap), that encompasses a set of major inter-agency initiatives designed to accelerate medical research for disease detection, diagnosis and therapy. By linking programs in molecular imaging, molecular probes, and molecular libraries, the NIH Common Fund provides much needed support for the development of new, more specific therapies for a wide range of diseases such as cancers, Alzheimer's and Parkinson's diseases. MICAD is edited by a team of scientific editors and curators who are based at the National Library of Medicine, NIH, in Bethesda, Maryland. This program is under the guidance of a trans-NIH panel of experts in the field." /><meta name="og:title" content="Molecular Imaging and Contrast Agent Database (MICAD)" /><meta name="og:type" content="book" /><meta name="og:description" content="The Molecular Imaging and Contrast Agent Database (MICAD) is an online source of scientific information regarding molecular imaging and contrast agents (under development, in clinical trials or commercially available for medical applications) that have in vivo data (animal or human) published in peer-reviewed scientific journals. MICAD is a key component of the “Molecular Libraries and Imaging” program of the National Institutes of Health (NIH) Common Fund (formerly NIH Roadmap), that encompasses a set of major inter-agency initiatives designed to accelerate medical research for disease detection, diagnosis and therapy. By linking programs in molecular imaging, molecular probes, and molecular libraries, the NIH Common Fund provides much needed support for the development of new, more specific therapies for a wide range of diseases such as cancers, Alzheimer's and Parkinson's diseases. MICAD is edited by a team of scientific editors and curators who are based at the National Library of Medicine, NIH, in Bethesda, Maryland. This program is under the guidance of a trans-NIH panel of experts in the field." /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK5330/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-micad-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/micad/toc/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK5330/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.26/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace} .first-line-outdent .bk_ref {display: inline} </style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js?_=3.18"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.26/books.min.js"> </script><meta name="book-collection" content="NONE" />
|
|
|
|
<!-- Page meta end -->
|
|
<link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8C98017C9A87210000000000F900CB.m_13" />
|
|
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4216701/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/4207974/4206132/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/css/3411343/3882866.css" media="print" /></head>
|
|
<body class="book-toc">
|
|
<div class="grid">
|
|
<div class="col twelve_col nomargin shadow">
|
|
<!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
|
|
<div class="sysmessages">
|
|
<noscript>
|
|
<p class="nojs">
|
|
<strong>Warning:</strong>
|
|
The NCBI web site requires JavaScript to function.
|
|
<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
|
|
</p>
|
|
</noscript>
|
|
</div>
|
|
<!--/.sysmessage-->
|
|
<div class="wrap">
|
|
<div class="page">
|
|
<div class="top">
|
|
<div id="universal_header">
|
|
<section class="usa-banner">
|
|
<div class="usa-accordion">
|
|
<header class="usa-banner-header">
|
|
<div class="usa-grid usa-banner-inner">
|
|
<img src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/favicons/favicon-57.png" alt="U.S. flag" />
|
|
<p>An official website of the United States government</p>
|
|
<button class="non-usa-accordion-button usa-banner-button" aria-expanded="false" aria-controls="gov-banner-top" type="button">
|
|
<span class="usa-banner-button-text">Here's how you know</span>
|
|
</button>
|
|
</div>
|
|
</header>
|
|
<div class="usa-banner-content usa-grid usa-accordion-content" id="gov-banner-top" aria-hidden="true">
|
|
<div class="usa-banner-guidance-gov usa-width-one-half">
|
|
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-dot-gov.svg" alt="Dot gov" />
|
|
<div class="usa-media_block-body">
|
|
<p>
|
|
<strong>The .gov means it's official.</strong>
|
|
<br />
|
|
Federal government websites often end in .gov or .mil. Before
|
|
sharing sensitive information, make sure you're on a federal
|
|
government site.
|
|
</p>
|
|
</div>
|
|
</div>
|
|
<div class="usa-banner-guidance-ssl usa-width-one-half">
|
|
<img class="usa-banner-icon usa-media_block-img" src="https://www.ncbi.nlm.nih.gov/coreutils/uswds/img/icon-https.svg" alt="Https" />
|
|
<div class="usa-media_block-body">
|
|
<p>
|
|
<strong>The site is secure.</strong>
|
|
<br />
|
|
The <strong>https://</strong> ensures that you are connecting to the
|
|
official website and that any information you provide is encrypted
|
|
and transmitted securely.
|
|
</p>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
<div class="usa-overlay"></div>
|
|
<header class="ncbi-header" role="banner" data-section="Header">
|
|
|
|
<div class="usa-grid">
|
|
<div class="usa-width-one-whole">
|
|
|
|
<div class="ncbi-header__logo">
|
|
<a href="/" class="logo" aria-label="NCBI Logo" data-ga-action="click_image" data-ga-label="NIH NLM Logo">
|
|
<img src="https://www.ncbi.nlm.nih.gov/coreutils/nwds/img/logos/AgencyLogo.svg" alt="NIH NLM Logo" />
|
|
</a>
|
|
</div>
|
|
|
|
<div class="ncbi-header__account">
|
|
<a id="account_login" href="https://account.ncbi.nlm.nih.gov" class="usa-button header-button" style="display:none" data-ga-action="open_menu" data-ga-label="account_menu">Log in</a>
|
|
<button id="account_info" class="header-button" style="display:none" aria-controls="account_popup" type="button">
|
|
<span class="fa fa-user" aria-hidden="true">
|
|
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 24 24" width="20px" height="20px">
|
|
<g style="fill: #fff">
|
|
<ellipse cx="12" cy="8" rx="5" ry="6"></ellipse>
|
|
<path d="M21.8,19.1c-0.9-1.8-2.6-3.3-4.8-4.2c-0.6-0.2-1.3-0.2-1.8,0.1c-1,0.6-2,0.9-3.2,0.9s-2.2-0.3-3.2-0.9 C8.3,14.8,7.6,14.7,7,15c-2.2,0.9-3.9,2.4-4.8,4.2C1.5,20.5,2.6,22,4.1,22h15.8C21.4,22,22.5,20.5,21.8,19.1z"></path>
|
|
</g>
|
|
</svg>
|
|
</span>
|
|
<span class="username desktop-only" aria-hidden="true" id="uname_short"></span>
|
|
<span class="sr-only">Show account info</span>
|
|
</button>
|
|
</div>
|
|
|
|
<div class="ncbi-popup-anchor">
|
|
<div class="ncbi-popup account-popup" id="account_popup" aria-hidden="true">
|
|
<div class="ncbi-popup-head">
|
|
<button class="ncbi-close-button" data-ga-action="close_menu" data-ga-label="account_menu" type="button">
|
|
<span class="fa fa-times">
|
|
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 48 48" width="24px" height="24px">
|
|
<path d="M38 12.83l-2.83-2.83-11.17 11.17-11.17-11.17-2.83 2.83 11.17 11.17-11.17 11.17 2.83 2.83 11.17-11.17 11.17 11.17 2.83-2.83-11.17-11.17z"></path>
|
|
</svg>
|
|
</span>
|
|
<span class="usa-sr-only">Close</span></button>
|
|
<h4>Account</h4>
|
|
</div>
|
|
<div class="account-user-info">
|
|
Logged in as:<br />
|
|
<b><span class="username" id="uname_long">username</span></b>
|
|
</div>
|
|
<div class="account-links">
|
|
<ul class="usa-unstyled-list">
|
|
<li><a id="account_myncbi" href="/myncbi/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_myncbi">Dashboard</a></li>
|
|
<li><a id="account_pubs" href="/myncbi/collections/bibliography/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_pubs">Publications</a></li>
|
|
<li><a id="account_settings" href="/account/settings/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_settings">Account settings</a></li>
|
|
<li><a id="account_logout" href="/account/signout/" class="set-base-url" data-ga-action="click_menu_item" data-ga-label="account_logout">Log out</a></li>
|
|
</ul>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
</div>
|
|
</div>
|
|
</header>
|
|
<div role="navigation" aria-label="access keys">
|
|
<a id="nws_header_accesskey_0" href="https://www.ncbi.nlm.nih.gov/guide/browsers/#ncbi_accesskeys" class="usa-sr-only" accesskey="0" tabindex="-1">Access keys</a>
|
|
<a id="nws_header_accesskey_1" href="https://www.ncbi.nlm.nih.gov" class="usa-sr-only" accesskey="1" tabindex="-1">NCBI Homepage</a>
|
|
<a id="nws_header_accesskey_2" href="/myncbi/" class="set-base-url usa-sr-only" accesskey="2" tabindex="-1">MyNCBI Homepage</a>
|
|
<a id="nws_header_accesskey_3" href="#maincontent" class="usa-sr-only" accesskey="3" tabindex="-1">Main Content</a>
|
|
<a id="nws_header_accesskey_4" href="#" class="usa-sr-only" accesskey="4" tabindex="-1">Main Navigation</a>
|
|
</div>
|
|
<section data-section="Alerts">
|
|
<div class="ncbi-alerts-placeholder"></div>
|
|
</section>
|
|
</div>
|
|
<div class="header">
|
|
<div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
|
|
<div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" data-ac_dict="bookshelf-search">Books</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="nlmcatalog" class="last">NLM Catalog</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="protfam">Protein Family Models</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
|
|
<a href="/books/browse/">Browse Titles</a>
|
|
</li><li>
|
|
<a href="/books/advanced/">Advanced</a>
|
|
</li><li class="help">
|
|
<a href="/books/NBK3833/">Help</a>
|
|
</li><li class="disclaimer">
|
|
<a target="_blank" data-ga-category="literature_resources" data-ga-action="link_click" data-ga-label="disclaimer_link" href="https://www.ncbi.nlm.nih.gov/books/about/disclaimer/">Disclaimer</a>
|
|
</li></ul></div>
|
|
</div>
|
|
|
|
|
|
|
|
<!--<component id="Page" label="headcontent"/>-->
|
|
|
|
</div>
|
|
<div class="content">
|
|
<!-- site messages -->
|
|
<!-- Custom content 1 -->
|
|
<div class="col1">
|
|
|
|
</div>
|
|
|
|
<div class="container">
|
|
<div id="maincontent" class="content eight_col col">
|
|
<!-- Custom content in the left column above book nav -->
|
|
<div class="col2">
|
|
|
|
</div>
|
|
|
|
<!-- Book content -->
|
|
|
|
|
|
<!-- Custom content between navigation and content -->
|
|
<div class="col3">
|
|
|
|
</div>
|
|
|
|
<div class="source">
|
|
<div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p></div><div class="pagination bk_noprnt"><span class="inactive page_link prev">< Prev</span><a class="active page_link next" href="/books/n/micad/micad_book_info/" title="Next page in this title">Next ></a></div></div></div>
|
|
<div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/Book"><div class="meta-content fm-sec"><div class="iconblock whole_rhythm clearfix no_top_margin"><a href="http://www.ncbi.nlm.nih.gov/" title="National Center for Biotechnology Information (US)" class="img_link icnblk_img" ref="pagearea=logo&targetsite=external&targetcat=link&targettype=publisher"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-micad-lrg.png" alt="Cover of Molecular Imaging and Contrast Agent Database (MICAD)" /></a><div class="icnblk_cntnt"><h1 id="_NBK5330_"><span itemprop="name">Molecular Imaging and Contrast Agent Database (MICAD)</span></h1><div class="half_rhythm">Bethesda (MD): <a href="http://www.ncbi.nlm.nih.gov/" ref="pagearea=meta&targetsite=external&targetcat=link&targettype=publisher"><span itemprop="publisher">National Center for Biotechnology Information (US)</span></a>; 2004-<span itemprop="datePublished">2013</span>.</div><div class="half_rhythm"><ul class="inline_list"><li><span class="label"><a data-jig="ncbidialog" href="#_ncbi_dlg_cpyrght_NBK5330" data-jigconfig="modal:true">Copyright and
|
|
Permissions</a></span></li></ul></div><div id="_ncbi_dlg_cpyrght_NBK5330" style="display:none" title="Copyright and Permissions"><div>This publication is in the public domain. For more information, see the <a href="/books/about/copyright/">Bookshelf Copyright Notice</a>.</div></div><div class="bk_noprnt"><form method="get" action="/books/n/micad/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search this book" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search this book" submit="false" style="padding: 0.1em 0.4em;" /></div></form></div></div></div></div><div class="body-content whole_rhythm" itemprop="text"><div itemprop="description"><p>MICAD is a key component of the NIH Common Fund (formerly NIH Roadmap); it is developed by
|
|
the National Center for Biotechnology Information (NCBI), at the National Institutes of
|
|
Health (NIH). <a href="/books/n/micad/micad_book_info/">More about
|
|
MICAD »</a></p><p>After June 30 of 2013, new and revised chapters will no longer be uploaded to the MICAD
|
|
website. However, the current chapters remain available online.</p><p>1444 agents currently listed. Latest update: June 27, 2013.</p><p><b>MICAD available through PubMed:</b> MICAD chapters are now accessible through
|
|
PubMed. To retrieve a list of all MICAD records, query PubMed for <a href="https://www.ncbi.nlm.nih.gov/pubmed/?term=%22Molecular%20Imaging%20and%20Contrast%20Agent%20Database%20%28MICAD%29%22[book]" ref="pagearea=abstract&targetsite=external&targetcat=link&targettype=uri">"Molecular Imaging and Contrast Agent Database (MICAD)"[book].</a></p><p><b>FDA Approved Contrast Agents:</b> Download a <a href="/books/NBK5330/bin/fdaApprovedContrastAgents.xlsx">list of FDA approved contrast
|
|
agents</a> (Latest update: January 2013).</p><p><b>Molecular Imaging Probes and Contrast Agents List:</b> The MICAD staff has created
|
|
the <a href="/books/NBK5330/bin/MiCaList.xlsx">Molecular Imaging Probes and
|
|
Contrast Agents List</a> (MIP & CA List) by screening
|
|
the PubMed/MedLine databases and other appropriate sources of such information. Only agents
|
|
used in animal or human studies yielding in vivo data were selected for inclusion in the
|
|
list. Although great care has been taken to accurately present all and only those imaging
|
|
and contrast agents that fulfill the in vivo data criteria, this list is by no means
|
|
considered complete. No one imaging modality has been given preference over the others and
|
|
the omission of any agent(s) or the introduction of any errors in the list is purely
|
|
unintentional. The MIP & CA List is subject to the same copyright and disclaimers as the
|
|
rest of the MICAD content. Please read carefully the <a href="/About/disclaimer.html" ref="pagearea=abstract&targetsite=external&targetcat=link&targettype=uri">complete disclaimer
|
|
information</a> for MICAD before using the list. <a href="/books/NBK5330/bin/MiCaList.xlsx">
|
|
<b>Download the list</b></a> (Latest update: January 2013).</p></div><div><h2>Contents</h2><div class="bktoc_all_cntnr top align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div><ul id="toc_tllNBK5330_toc_micad_book_info" class="simple-list toc toc-toggle"><li class="half_rhythm" id="toc_itm_NBK5330_toc_micad_book_info"><a class="toc-item" href="/books/n/micad/micad_book_info/">About MICAD</a></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mri"><a class="toc-item" href="/books/n/micad/mri/">MRI</a><ul id="toc_lst_NBK5330_toc_mri" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos13c"><a class="toc-item" href="/books/n/micad/sos13c/">13C</a><ul id="toc_lst_NBK5330_toc_sos13c" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fumarate13C"><a class="toc-item" href="/books/n/micad/Fumarate13C/">Hyperpolarized [1,4-<sup>13</sup>C<sub>2</sub>]fumarate as an imaging agent of tumor cell death <i>in vivo</i></a><span class="small"> [<a href="/books/n/micad/Fumarate13C/pdf/">PDF Version</a>]</span><div>[1,4-<sup>13</sup>C<sub>2</sub>]Fumarate</div><div>Liang Shan.</div><div class="small">Created: January 15, 2010; Last Update: April 12, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DHA13C"><a class="toc-item" href="/books/n/micad/DHA13C/">Hyperpolarized [1-<sup>13</sup>C]dehydroascorbic acid</a><span class="small"> [<a href="/books/n/micad/DHA13C/pdf/">PDF Version</a>]</span><div>[1-<sup>13</sup>C]DHA</div><div>Kam Leung.</div><div class="small">Created: September 15, 2011; Last Update: December 15, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HP13CHEPP"><a class="toc-item" href="/books/n/micad/HP13CHEPP/">Hyperpolarized [<sup>13</sup>C]-2-hydroxyethylpropionate</a><span class="small"> [<a href="/books/n/micad/HP13CHEPP/pdf/">PDF Version</a>]</span><div>HP[<sup>13</sup>C]HEPP</div><div>Huiming Zhang.</div><div class="small">Created: January 31, 2008; Last Update: March 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bicarbonate13C"><a class="toc-item" href="/books/n/micad/Bicarbonate13C/">Hyperpolarized <sup>13</sup>C-labeled bicarbonate (H<sup>13</sup>CO<sub>3</sub><sup>-</sup>) for <i>in vivo</i> pH measurement with <sup>13</sup>C magnetic resonance spectroscopy</a><span class="small"> [<a href="/books/n/micad/Bicarbonate13C/pdf/">PDF Version</a>]</span><div>Hyperpolarized H<sup>13</sup>CO<sub>3</sub><sup>-</sup></div><div>Liang Shan.</div><div class="small">Created: January 25, 2010; Last Update: April 12, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HP13CPyr"><a class="toc-item" href="/books/n/micad/HP13CPyr/">Hyperpolarized sodium 1-[<sup>13</sup>C]pyruvate</a><span class="small"> [<a href="/books/n/micad/HP13CPyr/pdf/">PDF Version</a>]</span><div>HP[<sup>13</sup>C]Pyr</div><div>Huiming Zhang.</div><div class="small">Created: January 29, 2008; Last Update: February 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KIC13C"><a class="toc-item" href="/books/n/micad/KIC13C/">Hyperpolarized α-keto[1-<sup>13</sup>C]isocaproate as a <sup>13</sup>C magnetic resonance spectroscopic agent for profiling branched chain amino acid metabolism in tumors</a><span class="small"> [<a href="/books/n/micad/KIC13C/pdf/">PDF Version</a>]</span><div>[1-<sup>13</sup>C]KIC</div><div>Liang Shan.</div><div class="small">Created: January 15, 2010; Last Update: May 19, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos19f"><a class="toc-item" href="/books/n/micad/sos19f/">19F</a><ul id="toc_lst_NBK5330_toc_sos19f" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPOL"><a class="toc-item" href="/books/n/micad/FPOL/">6-Fluoropyridoxol</a><span class="small"> [<a href="/books/n/micad/FPOL/pdf/">PDF Version</a>]</span><div>6-FPOL</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 9, 2006; Last Update: March 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CS-1000"><a class="toc-item" href="/books/n/micad/CS-1000/">Aqueous colloidal nanoemulsion of perfluorocarbon polymers</a><span class="small"> [<a href="/books/n/micad/CS-1000/pdf/">PDF Version</a>]</span><div>CS-1000</div><div>Liang Shan.</div><div class="small">Created: February 24, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PFPE-DCs"><a class="toc-item" href="/books/n/micad/PFPE-DCs/">Perfluoro-15-crown-5 ether-labeled dendritic cells</a><span class="small"> [<a href="/books/n/micad/PFPE-DCs/pdf/">PDF Version</a>]</span><div>PFPE-DCs</div><div>Huiming Zhang.</div><div class="small">Created: August 1, 2008; Last Update: September 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PFPE-BTCs"><a class="toc-item" href="/books/n/micad/PFPE-BTCs/">Perfluoropolyethylene glycol–labeled BDC2.5 T cells</a><span class="small"> [<a href="/books/n/micad/PFPE-BTCs/pdf/">PDF Version</a>]</span><div>PFPE-BTCs</div><div>Huiming Zhang.</div><div class="small">Created: August 8, 2008; Last Update: September 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VCAM-1-PFC-19F"><a class="toc-item" href="/books/n/micad/VCAM-1-PFC-19F/">VHPKQHRGGSKGC-liquid perfluorocarbon nanoparticles</a><span class="small"> [<a href="/books/n/micad/VCAM-1-PFC-19F/pdf/">PDF Version</a>]</span><div>VCAM-1-targeted NPs</div><div>Kam Leung.</div><div class="small">Created: February 28, 2010; Last Update: April 1, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscu"><a class="toc-item" href="/books/n/micad/soscu/">Cu</a><ul id="toc_lst_NBK5330_toc_soscu" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au3Cu1NPs"><a class="toc-item" href="/books/n/micad/Au3Cu1NPs/">Au<sub>3</sub>Cu<sub>1</sub> Nanoparticles</a><span class="small"> [<a href="/books/n/micad/Au3Cu1NPs/pdf/">PDF Version</a>]</span><div>Au<sub>3</sub>Cu<sub>1</sub>-NPs</div><div>Kam Leung.</div><div class="small">Created: June 26, 2008; Last Update: August 18, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soseuropium"><a class="toc-item" href="/books/n/micad/soseuropium/">Europium</a><ul id="toc_lst_NBK5330_toc_soseuropium" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Eu-DOTA-OBZ2-Gly2"><a class="toc-item" href="/books/n/micad/Eu-DOTA-OBZ2-Gly2/">Eu-1,7-Bis(2-(methylene benzyloxy ether)-acetic acid) acetamide-4,10-bis(acetamidoacetic acid)-1,4,7,10- tetraazacyclododecane</a><span class="small"> [<a href="/books/n/micad/Eu-DOTA-OBZ2-Gly2/pdf/">PDF Version</a>]</span><div>Eu-DOTA-OBZ<sub>2</sub>-Gly<sub>2</sub></div><div>Mark Pagel and Kam Leung.</div><div class="small">Created: February 19, 2009; Last Update: March 10, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosfe"><a class="toc-item" href="/books/n/micad/sosfe/">Fe</a><ul id="toc_lst_NBK5330_toc_sosfe" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_BM3h-8C8"><a class="toc-item" href="/books/n/micad/BM3h-8C8/">BM3h-8C8 Mutant of the heme domain of the bacterial cytochrome P450-BM3 (<i>Bacillus megaterium</i>)</a><span class="small"> [<a href="/books/n/micad/BM3h-8C8/pdf/">PDF Version</a>]</span><div>BM3h-8C8</div><div>Liang Shan.</div><div class="small">Created: December 17, 2010; Last Update: January 18, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgadolinium"><a class="toc-item" href="/books/n/micad/sosgadolinium/">Gadolinium</a><ul id="toc_lst_NBK5330_toc_sosgadolinium" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Egadme"><a class="toc-item" href="/books/n/micad/Egadme/">(1-(2-(β-Galactopyranosyloxy)propyl)-4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane) gadolinium(III)</a><span class="small"> [<a href="/books/n/micad/Egadme/pdf/">PDF Version</a>]</span><div>EGadMe</div><div>Huiming Zhang.</div><div class="small">Created: January 14, 2008; Last Update: February 20, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd4peptide"><a class="toc-item" href="/books/n/micad/Gd4peptide/">(Gd-chelate)<sub>2</sub>-Phe-His-Cys-Pro(OH)-Tyr(2-Cl)-Asp-Leu-Cys-His-Ile-Leu-(Gd-chelate)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Gd4peptide/pdf/">PDF Version</a>]</span><div>4Gdpeptide</div><div>Huiming Zhang.</div><div class="small">Created: November 15, 2007; Last Update: January 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdAF"><a class="toc-item" href="/books/n/micad/GdAF/">[(Biotin-Ala-Ser-Lys-Lys-Pro-Lys-Arg-Asn-Ile-Lys-Ala)<sub>4</sub>-dendrimer]-streptavidin-[biotin-gadolinium 1,4,7-tris(carboxymethyl)-10-(2’-hydroxypropyl)-1,4,7,10-tetraazacyclododecane-loaded apoferritin] </a><span class="small"> [<a href="/books/n/micad/GdAF/pdf/">PDF Version</a>]</span><div>C3d-SA-GdAF</div><div>Huiming Zhang.</div><div class="small">Created: December 27, 2007; Last Update: February 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MotexafinGd"><a class="toc-item" href="/books/n/micad/MotexafinGd/">4,5-Diethyl-10,23-dimethyl-9,24-bis(3-hydroxypropyl)-16,-17-bis(3,hydroxypropyl)oxy-13,20,25,26,27—pentaazapentacyclo-[20.2.1.1<sup>3,6</sup>.1<sup>9,11</sup>.0<sup>14,19</sup>]heptacosa-3,5,8,10,12,14,16,18,20,22,24-undecaene gadolinium hydrates</a><span class="small"> [<a href="/books/n/micad/MotexafinGd/pdf/">PDF Version</a>]</span><div>MGd</div><div>Huiming Zhang.</div><div class="small">Created: December 6, 2007; Last Update: January 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiMetGdAlbu"><a class="toc-item" href="/books/n/micad/AntiMetGdAlbu/">Anti-c-Met monoclonal antibody linked to biotinylated bovine serum albumin and gadolinium</a><span class="small"> [<a href="/books/n/micad/AntiMetGdAlbu/pdf/">PDF Version</a>]</span><div>Anti-c-Met-Gd-albumin</div><div>Arvind Chopra.</div><div class="small">Created: December 4, 2008; Last Update: January 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdDTPAICAMAb"><a class="toc-item" href="/books/n/micad/GdDTPAICAMAb/">Anti-intercellular adhesion molecule 1 antibody–conjugated gadolinium diethylenetriaminepentaacetic acid</a><span class="small"> [<a href="/books/n/micad/GdDTPAICAMAb/pdf/">PDF Version</a>]</span><div>Gd-DTPA-anti-ICAM-1 antibody</div><div>The MICAD Research Team.</div><div class="small">Created: July 12, 2007; Last Update: August 13, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDA2-Gd-micelles"><a class="toc-item" href="/books/n/micad/MDA2-Gd-micelles/">Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody gadolinium-labeled micelles</a><span class="small"> [<a href="/books/n/micad/MDA2-Gd-micelles/pdf/">PDF Version</a>]</span><div>MDA2 micelles</div><div>Kam Leung.</div><div class="small">Created: August 15, 2009; Last Update: October 22, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anti-VEGF-PLA-PLL-G"><a class="toc-item" href="/books/n/micad/Anti-VEGF-PLA-PLL-G/">Anti-vascular endothelial growth factor polylactic acid-polyethylene glycol-poly-L-Lys/gadolinium-diethylenetriamine pentaacetic acid nanoparticles</a><span class="small"> [<a href="/books/n/micad/Anti-VEGF-PLA-PLL-G/pdf/">PDF Version</a>]</span><div>Anti-VEGF PLA-PEG-PLL-DTPA-Gd NPs</div><div>Kam Leung.</div><div class="small">Created: May 5, 2012; Last Update: July 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AvidinGd"><a class="toc-item" href="/books/n/micad/AvidinGd/">Avidin-gadolinium</a><span class="small"> [<a href="/books/n/micad/AvidinGd/pdf/">PDF Version</a>]</span><div>Avidin-Gd</div><div>Arvind Chopra.</div><div class="small">Created: December 1, 2008; Last Update: December 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BiotinBSAGd"><a class="toc-item" href="/books/n/micad/BiotinBSAGd/">Biotinylated bovine serum albumin linked to gadolinium diethylenetriaminepentaacetic acid</a><span class="small"> [<a href="/books/n/micad/BiotinBSAGd/pdf/">PDF Version</a>]</span><div>Biotin-BSA-GdDTPA</div><div>Arvind Chopra.</div><div class="small">Created: December 9, 2008; Last Update: December 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P866"><a class="toc-item" href="/books/n/micad/P866/">Dimeric Gd-tetraazacyclododecanetetraacetic acid-folate</a><span class="small"> [<a href="/books/n/micad/P866/pdf/">PDF Version</a>]</span><div>P866</div><div>Kam Leung.</div><div class="small">Created: January 17, 2009; Last Update: May 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EBDTPAGd"><a class="toc-item" href="/books/n/micad/EBDTPAGd/">Evans Blue-diethylenetriamine-<i>N,N,N”,N”</i>-pentaacetic acid-gadolinium </a><span class="small"> [<a href="/books/n/micad/EBDTPAGd/pdf/">PDF Version</a>]</span><div>EB-DTPA-Gd</div><div>Arvind Chopra.</div><div class="small">Created: October 25, 2007; Last Update: December 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P1133"><a class="toc-item" href="/books/n/micad/P1133/">Folate-polyethylene glycol-ultrasmall superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/P1133/pdf/">PDF Version</a>]</span><div>P1133</div><div>Kam Leung.</div><div class="small">Created: May 9, 2011; Last Update: July 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gadobenate"><a class="toc-item" href="/books/n/micad/Gadobenate/">Gadobenate</a><span class="small"> [<a href="/books/n/micad/Gadobenate/pdf/">PDF Version</a>]</span><div>Gd-BOPTA</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 28, 2005; Last Update: December 3, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gadobutrol"><a class="toc-item" href="/books/n/micad/Gadobutrol/">Gadobutrol</a><span class="small"> [<a href="/books/n/micad/Gadobutrol/pdf/">PDF Version</a>]</span><div>Gd-DO3A-butrol</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 15, 2006; Last Update: October 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cFlFlFK-DOTA-Gd"><a class="toc-item" href="/books/n/micad/cFlFlFK-DOTA-Gd/">Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-cinnamoyl-Phe-<span class="small-caps">D</span>-Leu-Phe-<span class="small-caps">D</span>-Leu-Phe-Lys-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/cFlFlFK-DOTA-Gd/pdf/">PDF Version</a>]</span><div>Gd-DOTA-cFlFlFK</div><div>Kam Leung.</div><div class="small">Created: May 1, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLT1-G3-DOTA-Gd"><a class="toc-item" href="/books/n/micad/CLT1-G3-DOTA-Gd/">Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)</a><span class="small"> [<a href="/books/n/micad/CLT1-G3-DOTA-Gd/pdf/">PDF Version</a>]</span><div>Gd-DOTA-G3-CLT1</div><div>Kam Leung.</div><div class="small">Created: October 1, 2012; Last Update: December 6, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLT1-dL-Gd-DOTA4"><a class="toc-item" href="/books/n/micad/CLT1-dL-Gd-DOTA4/">Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Lys-polyethylene glycol-CGLIIQKNEC (CLT1)</a><span class="small"> [<a href="/books/n/micad/CLT1-dL-Gd-DOTA4/pdf/">PDF Version</a>]</span><div>CLT1-dL-(Gd-DOTA)<sub>4</sub></div><div>Kam Leung.</div><div class="small">Created: September 15, 2012; Last Update: December 6, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CA-12"><a class="toc-item" href="/books/n/micad/CA-12/">Gadolinium-1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-icosahedral <i>closo</i>-borane<sub>12</sub> scaffold conjugated with Glu-{Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/CA-12/pdf/">PDF Version</a>]</span><div>CA-12</div><div>Kam Leung.</div><div class="small">Created: April 11, 2013; Last Update: May 30, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GDDOTA24CP"><a class="toc-item" href="/books/n/micad/GDDOTA24CP/">Gadolinium-1,4,7,10-tetraazacyclododecane-<i>N,N’,N’,N’”</i>-tetraacetic-monoamide-24-cascade-polymer</a><span class="small"> [<a href="/books/n/micad/GDDOTA24CP/pdf/">PDF Version</a>]</span><div>24GdDOTACP</div><div>Huiming Zhang.</div><div class="small">Created: October 17, 2007; Last Update: December 4, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P947"><a class="toc-item" href="/books/n/micad/P947/">Gadolinium-1,4,7,10-tetraazacyclododecane-<i>N</i>',<i>N</i>'',<i>N</i>''',<i>N</i>''''-tetraacetic acid-Gly-Pro-<span class="small-caps">D</span>-Leu-<span class="small-caps">D</span>-Ala-NHOH </a><span class="small"> [<a href="/books/n/micad/P947/pdf/">PDF Version</a>]</span><div>P947</div><div>Kam Leung.</div><div class="small">Created: December 15, 2008; Last Update: February 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PCA7-DOTA-Gd"><a class="toc-item" href="/books/n/micad/PCA7-DOTA-Gd/">Gadolinium-1,4,7,10-tetraazacyclododecane-<i>N</i>',<i>N</i>'',<i>N</i>''',<i>N</i>''''-tetraacetic acid-Pro-Leu-Ala-Leu-Lys-Arg-Asp-Arg </a><span class="small"> [<a href="/books/n/micad/PCA7-DOTA-Gd/pdf/">PDF Version</a>]</span><div>Gd-DOTA-PCA7</div><div>Kam Leung.</div><div class="small">Created: June 15, 2008; Last Update: July 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdC6Gln"><a class="toc-item" href="/books/n/micad/GdC6Gln/">Gadolinium 1-((11-<i>S</i>)-3,10-diaza-13-carboxamido-11-carboxy-2,9-dioxotridecyl)-<i>N,N’,N”</i>-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecane </a><span class="small"> [<a href="/books/n/micad/GdC6Gln/pdf/">PDF Version</a>]</span><div>Gd-DOTAMA-Gln</div><div>Huiming Zhang.</div><div class="small">Created: November 20, 2007; Last Update: January 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NGAL-Gd-Micelles"><a class="toc-item" href="/books/n/micad/NGAL-Gd-Micelles/">Gadolinium-anti-neutrophil gelatinase-associated lipocalin 2 24p3 antibody-conjugated micelles</a><span class="small"> [<a href="/books/n/micad/NGAL-Gd-Micelles/pdf/">PDF Version</a>]</span><div>NGAL/24p3-Targeted micelles</div><div>Kam Leung.</div><div class="small">Created: January 15, 2011; Last Update: June 16, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MPO-Gd"><a class="toc-item" href="/books/n/micad/MPO-Gd/">Gadolinium-<i>bis</i>-5-hydroxytriptamide-diethylenetriamine pentaacetic acid</a><span class="small"> [<a href="/books/n/micad/MPO-Gd/pdf/">PDF Version</a>]</span><div>Gd-<i>bis</i>-5-HT-DTPA</div><div>Arvind Chopra.</div><div class="small">Created: August 30, 2011; Last Update: October 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GDDTPA24CP"><a class="toc-item" href="/books/n/micad/GDDTPA24CP/">Gadolinium-diethylenetriamine pentaacetic acid-24-cascade-polymer</a><span class="small"> [<a href="/books/n/micad/GDDTPA24CP/pdf/">PDF Version</a>]</span><div>24GdDTPACP</div><div>Huiming Zhang.</div><div class="small">Created: October 2, 2007; Last Update: December 4, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DTPA-g-mimRGD"><a class="toc-item" href="/books/n/micad/Gd-DTPA-g-mimRGD/">Gadolinium diethylenetriamine pentaacetic acid-Arg-Gly-Asp peptidomimetic</a><span class="small"> [<a href="/books/n/micad/Gd-DTPA-g-mimRGD/pdf/">PDF Version</a>]</span><div>Gd-DTPA-g-mimRGD</div><div>Kam Leung.</div><div class="small">Created: June 15, 2008; Last Update: July 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CMAG-Gd"><a class="toc-item" href="/books/n/micad/CMAG-Gd/">Gadolinium-diethylenetriamine pentaacetic acid-carboxymethylarabinogalactan</a><span class="small"> [<a href="/books/n/micad/CMAG-Gd/pdf/">PDF Version</a>]</span><div>Gd-DTPA-CMAG-A<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: November 15, 2008; Last Update: January 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EP3533"><a class="toc-item" href="/books/n/micad/EP3533/">Gadolinium-diethylenetriamine pentaacetic acid-GKWHCTTKFPHHYCLY</a><span class="small"> [<a href="/books/n/micad/EP3533/pdf/">PDF Version</a>]</span><div>EP-3533</div><div>Kam Leung.</div><div class="small">Created: November 15, 2008; Last Update: January 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DTPA-g-R826"><a class="toc-item" href="/books/n/micad/Gd-DTPA-g-R826/">Gadolinium-Diethylenetriamine pentaacetic acid-Leu-Ile-Lys-Lys-Pro-Phe</a><span class="small"> [<a href="/books/n/micad/Gd-DTPA-g-R826/pdf/">PDF Version</a>]</span><div>Gd-DTPA-g-R826</div><div>Kam Leung.</div><div class="small">Created: October 26, 2009; Last Update: March 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DTPA-PLGA"><a class="toc-item" href="/books/n/micad/Gd-DTPA-PLGA/">Gadolinium-Diethylenetriamine pentaacetic acid-poly(lactic-co-glycolic acid) microbubbles</a><span class="small"> [<a href="/books/n/micad/Gd-DTPA-PLGA/pdf/">PDF Version</a>]</span><div>Gd-DTPA-PLGA</div><div>Kam Leung.</div><div class="small">Created: October 11, 2010; Last Update: December 9, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CA-9"><a class="toc-item" href="/books/n/micad/CA-9/">Gadolinium-diethylenetriamine tetraacetic acid-icosahedral <i>closo</i>-borane<sub>12</sub> scaffold</a><span class="small"> [<a href="/books/n/micad/CA-9/pdf/">PDF Version</a>]</span><div>CA-9</div><div>Kam Leung.</div><div class="small">Created: April 11, 2013; Last Update: May 30, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ProGlo"><a class="toc-item" href="/books/n/micad/ProGlo/">Gadolinium-Hexyl-1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid-progesterone</a><span class="small"> [<a href="/books/n/micad/ProGlo/pdf/">PDF Version</a>]</span><div>ProGlo</div><div>Kam Leung.</div><div class="small">Created: May 1, 2012; Last Update: August 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CB2R-Gd-Micelles"><a class="toc-item" href="/books/n/micad/CB2R-Gd-Micelles/">Gadolinium-HU-308-incorporated micelles</a><span class="small"> [<a href="/books/n/micad/CB2R-Gd-Micelles/pdf/">PDF Version</a>]</span><div>CB2R-Targeted micelles</div><div>Kam Leung.</div><div class="small">Created: March 15, 2011; Last Update: April 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd2O3SiO"><a class="toc-item" href="/books/n/micad/Gd2O3SiO/">Gadolinium-incorporated mesoporous silica nanoparticles</a><span class="small"> [<a href="/books/n/micad/Gd2O3SiO/pdf/">PDF Version</a>]</span><div>Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: July 11, 2011; Last Update: August 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DTPA-CLT1"><a class="toc-item" href="/books/n/micad/Gd-DTPA-CLT1/">Gadolinium-labeled diethylenetriamine pentaacetic acid-CGLIIQKNEC</a><span class="small"> [<a href="/books/n/micad/Gd-DTPA-CLT1/pdf/">PDF Version</a>]</span><div>Gd-DTPA-CLT1</div><div>Kam Leung.</div><div class="small">Created: July 15, 2009; Last Update: September 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_rHDL-P2A2"><a class="toc-item" href="/books/n/micad/rHDL-P2A2/">Gadolinium-reconstituted high-density liproprotein-[palmitoyl-WK(palmitoyl)G(LRKLRKRLLR)<sub>2</sub>-NH<sub>2</sub>] nanoparticles</a><span class="small"> [<a href="/books/n/micad/rHDL-P2A2/pdf/">PDF Version</a>]</span><div>rHDL-P2A2</div><div>Kam Leung.</div><div class="small">Created: August 15, 2009; Last Update: September 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DOTA-R832"><a class="toc-item" href="/books/n/micad/Gd-DOTA-R832/">Gadolinium-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys</a><span class="small"> [<a href="/books/n/micad/Gd-DOTA-R832/pdf/">PDF Version</a>]</span><div>Gd-DOTA-R832</div><div>Kam Leung.</div><div class="small">Created: October 29, 2009; Last Update: March 18, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdDOTAFolate"><a class="toc-item" href="/books/n/micad/GdDOTAFolate/">Gadolinium-tetraazacyclododecane tetraacetic acid coupled with folate <i>via</i> bis(aminoethyl)ethylene glycol linker</a><span class="small"> [<a href="/books/n/micad/GdDOTAFolate/pdf/">PDF Version</a>]</span><div>Gd.DOTA.Folate</div><div>Liang Shan.</div><div class="small">Created: March 12, 2011; Last Update: April 19, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gadoteridol"><a class="toc-item" href="/books/n/micad/Gadoteridol/">Gadoteridol Gd-HP-DO3A</a><span class="small"> [<a href="/books/n/micad/Gadoteridol/pdf/">PDF Version</a>]</span><div>Kenneth T. Cheng.</div><div class="small">Created: October 7, 2005; Last Update: November 5, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gadoversetamide"><a class="toc-item" href="/books/n/micad/Gadoversetamide/">GadoversetamideGd-DTPA-BMEA</a><span class="small"> [<a href="/books/n/micad/Gadoversetamide/pdf/">PDF Version</a>]</span><div>Kenneth T. Cheng.</div><div class="small">Created: November 7, 2007; Last Update: December 10, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-EOB-DTPA"><a class="toc-item" href="/books/n/micad/Gd-EOB-DTPA/">Gadoxetate</a><span class="small"> [<a href="/books/n/micad/Gd-EOB-DTPA/pdf/">PDF Version</a>]</span><div>Gd-EOB-DTPA</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 14, 2007; Last Update: April 10, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdC82"><a class="toc-item" href="/books/n/micad/GdC82/">Gd@C<sub>82</sub> Fullerenol </a><span class="small"> [<a href="/books/n/micad/GdC82/pdf/">PDF Version</a>]</span><div>Gd@C<sub>82</sub>(OH)<sub>40</sub></div><div>Huiming Zhang.</div><div class="small">Created: October 31, 2008; Last Update: December 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lipo-2C5-Gd"><a class="toc-item" href="/books/n/micad/Lipo-2C5-Gd/">Gd-Diethylenetriaminepentaacetic acid-polylysyl-N-glutaryl-phosphatidyl ethanolamine-2C5 liposomes</a><span class="small"> [<a href="/books/n/micad/Lipo-2C5-Gd/pdf/">PDF Version</a>]</span><div>Gd-DTPA-PLL-NGPE-2C5 liposomes</div><div>Kam Leung.</div><div class="small">Created: May 17, 2009; Last Update: June 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdAB42"><a class="toc-item" href="/books/n/micad/GdAB42/">Gd-DOTA-anti-Aβ42-F(ab’)<sub>2</sub>-antibody fragment (putrescine)<sub>n</sub></a><span class="small"> [<a href="/books/n/micad/GdAB42/pdf/">PDF Version</a>]</span><div>GdAβ42</div><div>Huiming Zhang.</div><div class="small">Created: November 7, 2008; Last Update: December 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P975"><a class="toc-item" href="/books/n/micad/P975/">Gd-DOTA-c(Cys-Arg-Gly-Asp-Cys)</a><span class="small"> [<a href="/books/n/micad/P975/pdf/">PDF Version</a>]</span><div>P975</div><div>Kam Leung.</div><div class="small">Created: June 27, 2010; Last Update: September 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdPCA2"><a class="toc-item" href="/books/n/micad/GdPCA2/">Gd-DOTA-G-NH(CH<sub>2</sub>)<sub>11</sub>CO-RSPAYYTAA-(CH<sub>2</sub>CH<sub>2</sub>O)<sub>8</sub>-R </a><span class="small"> [<a href="/books/n/micad/GdPCA2/pdf/">PDF Version</a>]</span><div>GdPCA2</div><div>Huiming Zhang.</div><div class="small">Created: December 22, 2008; Last Update: January 14, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdLPG"><a class="toc-item" href="/books/n/micad/GdLPG/">Gd-DTPA-Bz-poly(α,L-glutamic acid)</a><span class="small"> [<a href="/books/n/micad/GdLPG/pdf/">PDF Version</a>]</span><div>GdLPG</div><div>Huiming Zhang.</div><div class="small">Created: January 9, 2009; Last Update: January 26, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GDCEP"><a class="toc-item" href="/books/n/micad/GDCEP/">Gd-DTPA-Cystine diethyl ester copolymers</a><span class="small"> [<a href="/books/n/micad/GDCEP/pdf/">PDF Version</a>]</span><div>GDCEP</div><div>Kam Leung.</div><div class="small">Created: September 22, 2006; Last Update: November 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GCAC"><a class="toc-item" href="/books/n/micad/GCAC/">Gd-DTPA <span class="small-caps">l</span>-Cystine bisamide copolymers</a><span class="small"> [<a href="/books/n/micad/GCAC/pdf/">PDF Version</a>]</span><div>GCAC</div><div>Kenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.</div><div class="small">Created: November 8, 2007; Last Update: January 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GCIC"><a class="toc-item" href="/books/n/micad/GCIC/">Gd-DTPA <span class="small-caps">l</span>-Cystine bisisopropyl amide copolymers</a><span class="small"> [<a href="/books/n/micad/GCIC/pdf/">PDF Version</a>]</span><div>GCIC</div><div>Kenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.</div><div class="small">Created: February 7, 2008; Last Update: March 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GCPC"><a class="toc-item" href="/books/n/micad/GCPC/">Gd-DTPA <span class="small-caps">l</span>-Cystine bispropyl amide copolymers</a><span class="small"> [<a href="/books/n/micad/GCPC/pdf/">PDF Version</a>]</span><div>GCPC</div><div>Kenneth T. Cheng, Zheng-Rong Lu, and Todd Kaneshiro.</div><div class="small">Created: January 30, 2008; Last Update: February 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-DCCP16"><a class="toc-item" href="/books/n/micad/Gd-DCCP16/">GKVLAK–(Gadolinium-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid <i>t</i>-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL</a><span class="small"> [<a href="/books/n/micad/Gd-DCCP16/pdf/">PDF Version</a>]</span><div>Gd-DCCP16</div><div>Liang Shan.</div><div class="small">Created: March 29, 2011; Last Update: April 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GdAlbAnticMet"><a class="toc-item" href="/books/n/micad/GdAlbAnticMet/">Mouse anti-cMet monoclonal antibody linked to gadolinium diethylenetriamine pentaacetic acid conjugated to biotinylated bovine serum albumin</a><span class="small"> [<a href="/books/n/micad/GdAlbAnticMet/pdf/">PDF Version</a>]</span><div>Anti-c-Met-Gd-DTPA-albumin</div><div>Arvind Chopra.</div><div class="small">Created: September 15, 2009; Last Update: October 26, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEGPLysDOTAGd"><a class="toc-item" href="/books/n/micad/PEGPLysDOTAGd/">Poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid micelle</a><span class="small"> [<a href="/books/n/micad/PEGPLysDOTAGd/pdf/">PDF Version</a>]</span><div>PEG-P(Lys-DOTA-Gd)</div><div>Liang Shan.</div><div class="small">Created: May 31, 2011; Last Update: June 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PICmicelles"><a class="toc-item" href="/books/n/micad/PICmicelles/">Polyion complex micelles of poly(ethylene glycol)-b-poly(L-lysine)-gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-dextran sulfate</a><span class="small"> [<a href="/books/n/micad/PICmicelles/pdf/">PDF Version</a>]</span><div>PIC micelles</div><div>Liang Shan.</div><div class="small">Created: May 31, 2011; Last Update: June 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EPTA-Gd"><a class="toc-item" href="/books/n/micad/EPTA-Gd/">Pyridine-tetra-acetate-gadolinium(III) (PTA-Gd) conjugated to 17β-estradiol (EPTA-Gd) or tamoxifen (TPTA-Gd)</a><span class="small"> [<a href="/books/n/micad/EPTA-Gd/pdf/">PDF Version</a>]</span><div>EPTA-Gd; TPTA-Gd</div><div>Arvind Chopra.</div><div class="small">Created: January 23, 2012; Last Update: February 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-13-Gd-fullerene"><a class="toc-item" href="/books/n/micad/IL-13-Gd-fullerene/">TAMRA-IL-13-Conjugated functionalized gadolinium metallofullerene (Gd<sub>3</sub>N@C<sub>80</sub>(OH)<sub>-26</sub>(CH<sub>2</sub>CH<sub>2</sub>COOH)<sub>-16</sub>)</a><span class="small"> [<a href="/books/n/micad/IL-13-Gd-fullerene/pdf/">PDF Version</a>]</span><div>TAMRA-IL-13-f-Gd<sub>3</sub>N@C<sub>80</sub></div><div>Kam Leung.</div><div class="small">Created: September 4, 2011; Last Update: November 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-HSA-NP-Tf"><a class="toc-item" href="/books/n/micad/Gd-HSA-NP-Tf/">Transferrin-coated gadolinium-labeled human serum albumin nanoparticles</a><span class="small"> [<a href="/books/n/micad/Gd-HSA-NP-Tf/pdf/">PDF Version</a>]</span><div>Gd-HSA-Tf-NP</div><div>Arvind Chopra.</div><div class="small">Created: April 30, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd3NC80"><a class="toc-item" href="/books/n/micad/Gd3NC80/">Tri-gadolinium nitride PEGylated-hydroxylated endohedral metallofullerene</a><span class="small"> [<a href="/books/n/micad/Gd3NC80/pdf/">PDF Version</a>]</span><div>Gd<sub>3</sub>N@C<sub>80</sub>[DiPEG<sub>5000</sub>(OH)<sub>x</sub>]</div><div>Huiming Zhang.</div><div class="small">Created: October 28, 2008; Last Update: December 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_gadofosveset"><a class="toc-item" href="/books/n/micad/gadofosveset/">Trisodium-[(2-(R)-[(4,4-diphenylcyclohexyl)phosphono-oxymethyl]-diethylenetriaminepentaacetato)(aquo)gadolinium(III)Gadofosveset</a><span class="small"> [<a href="/books/n/micad/gadofosveset/pdf/">PDF Version</a>]</span><div>Huiming Zhang.</div><div class="small">Created: October 24, 2007; Last Update: January 3, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxide"><a class="toc-item" href="/books/n/micad/sosironoxide/">Iron oxide</a><ul id="toc_lst_NBK5330_toc_sosironoxide" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSCsSPIO_SiO2_NH2"><a class="toc-item" href="/books/n/micad/MSCsSPIO_SiO2_NH2/">Amine-modified silica-coated polyhedral superparamagnetic iron oxide nanoparticle–labeled rabbit bone marrow–derived mesenchymal stem cells</a><span class="small"> [<a href="/books/n/micad/MSCsSPIO_SiO2_NH2/pdf/">PDF Version</a>]</span><div>SPIO@SiO<sub>2</sub>-NH<sub>2</sub>-labeled MSCs</div><div>Liang Shan.</div><div class="small">Created: December 11, 2009; Last Update: January 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LIBS-MPIO"><a class="toc-item" href="/books/n/micad/LIBS-MPIO/">Anti-ligand–induced binding sites (LIBS) antibody conjugated to microparticles of iron oxide</a><span class="small"> [<a href="/books/n/micad/LIBS-MPIO/pdf/">PDF Version</a>]</span><div>LIBS-MPIOs</div><div>Kam Leung.</div><div class="small">Created: June 21, 2010; Last Update: September 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDA2-LSPIO"><a class="toc-item" href="/books/n/micad/MDA2-LSPIO/">Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/MDA2-LSPIO/pdf/">PDF Version</a>]</span><div>MDA2 LSPIOs</div><div>Kam Leung.</div><div class="small">Created: May 15, 2012; Last Update: August 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDA2-LUSPIO"><a class="toc-item" href="/books/n/micad/MDA2-LUSPIO/">Anti-malondialdehyde-modified low-density lipoprotein MDA2 monoclonal antibody–labeled lipid-coated ultra-small superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/MDA2-LUSPIO/pdf/">PDF Version</a>]</span><div>MDA2 LUSPIOs</div><div>Kam Leung.</div><div class="small">Created: May 10, 2012; Last Update: August 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VCAM-MPIO-Selectin"><a class="toc-item" href="/books/n/micad/VCAM-MPIO-Selectin/">Anti-vascular cell adhesion molecule antibody M/K-2.7 and anti-P-selectin antibody RB40.34 conjugated microparticles of iron oxide</a><span class="small"> [<a href="/books/n/micad/VCAM-MPIO-Selectin/pdf/">PDF Version</a>]</span><div>VCAM-MPIO-P-selectin</div><div>Kam Leung.</div><div class="small">Created: March 8, 2008; Last Update: April 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VCAM-MPIO"><a class="toc-item" href="/books/n/micad/VCAM-MPIO/">Anti-vascular cell adhesion molecule antibody M/K-2.7–conjugated microparticles of iron oxide</a><span class="small"> [<a href="/books/n/micad/VCAM-MPIO/pdf/">PDF Version</a>]</span><div>VCAM-MPIO</div><div>Kam Leung.</div><div class="small">Created: January 28, 2011; Last Update: April 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BaavibUSPIO"><a class="toc-item" href="/books/n/micad/BaavibUSPIO/">Avidin-coated baculoviral vectors-biotinylated ultra-small superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/BaavibUSPIO/pdf/">PDF Version</a>]</span><div>Baavi-bUSPIO</div><div>Huiming Zhang.</div><div class="small">Created: March 31, 2008; Last Update: April 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VSOPC184"><a class="toc-item" href="/books/n/micad/VSOPC184/">Citrate-coated (184<sup>th</sup> variant) very small superparamagnetic iron oxide particles</a><span class="small"> [<a href="/books/n/micad/VSOPC184/pdf/">PDF Version</a>]</span><div>VSOP-C184</div><div>The MICAD Research Team.</div><div class="small">Created: September 1, 2006; Last Update: September 27, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLIONRPV7"><a class="toc-item" href="/books/n/micad/CLIONRPV7/">CLIO-(H-2K<sup>d</sup>)-Lys-Tyr-Asp-Lys-Ala-Asp-Val-Phe-Leu</a><span class="small"> [<a href="/books/n/micad/CLIONRPV7/pdf/">PDF Version</a>]</span><div>CLIO-NRP-V7</div><div>Huiming Zhang.</div><div class="small">Created: August 15, 2008; Last Update: September 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CR2-Fc-SPIO"><a class="toc-item" href="/books/n/micad/CR2-Fc-SPIO/">Complement receptor type 2–conjugated superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/CR2-Fc-SPIO/pdf/">PDF Version</a>]</span><div>CR2-Fc-SPIO</div><div>Kam Leung.</div><div class="small">Created: July 23, 2010; Last Update: December 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLIO-Tat"><a class="toc-item" href="/books/n/micad/CLIO-Tat/">Cross-linked iron oxide–transactivator transcription</a><span class="small"> [<a href="/books/n/micad/CLIO-Tat/pdf/">PDF Version</a>]</span><div>CLIO-Tat</div><div>The MICAD Research Team.</div><div class="small">Created: July 18, 2006; Last Update: August 7, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyE-USPIO"><a class="toc-item" href="/books/n/micad/RGDyE-USPIO/">Cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Try-Glu) conjugated to ultrasmall superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/RGDyE-USPIO/pdf/">PDF Version</a>]</span><div>c(RGDyE)-USPIO</div><div>Kam Leung.</div><div class="small">Created: February 16, 2008; Last Update: April 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_YCCDOX"><a class="toc-item" href="/books/n/micad/YCCDOX/">Doxorubicin-loaded poly(ethylene oxide)-trimellitic anhydride chloride-folate superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/YCCDOX/pdf/">PDF Version</a>]</span><div>YCC-DOX</div><div>Arvind Chopra.</div><div class="small">Created: July 16, 2010; Last Update: September 23, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ferumoxide"><a class="toc-item" href="/books/n/micad/Ferumoxide/">Ferumoxides</a><span class="small"> [<a href="/books/n/micad/Ferumoxide/pdf/">PDF Version</a>]</span><div>SSPIO</div><div>Kam Leung.</div><div class="small">Created: November 1, 2004; Last Update: December 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ferumoxsil"><a class="toc-item" href="/books/n/micad/Ferumoxsil/">Ferumoxsil</a><span class="small"> [<a href="/books/n/micad/Ferumoxsil/pdf/">PDF Version</a>]</span><div>Large SPIO</div><div>Kam Leung.</div><div class="small">Created: November 1, 2004; Last Update: December 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ferumoxtran"><a class="toc-item" href="/books/n/micad/Ferumoxtran/">Ferumoxtran</a><span class="small"> [<a href="/books/n/micad/Ferumoxtran/pdf/">PDF Version</a>]</span><div>USPIO</div><div>Kam Leung.</div><div class="small">Created: November 1, 2004; Last Update: December 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FluidMAG-MSCs"><a class="toc-item" href="/books/n/micad/FluidMAG-MSCs/">FluidMAG iron nanoparticle-labeled mesenchymal stem cells for tracking cell homing to tumors</a><span class="small"> [<a href="/books/n/micad/FluidMAG-MSCs/pdf/">PDF Version</a>]</span><div>FluidMAG iron nanoparticle-labeled MSCs</div><div>Liang Shan.</div><div class="small">Created: December 23, 2009; Last Update: February 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CompositeNPs"><a class="toc-item" href="/books/n/micad/CompositeNPs/">Glycol chitosan/heparin-immobilized gold-deposited iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/CompositeNPs/pdf/">PDF Version</a>]</span><div>Composite NPs</div><div>Liang Shan.</div><div class="small">Created: July 28, 2011; Last Update: August 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLIO-H18"><a class="toc-item" href="/books/n/micad/CLIO-H18/">H18/7 F(ab’)<sub>2</sub> E-selectin monoclonal antibody conjugated to cross-linked iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/CLIO-H18/pdf/">PDF Version</a>]</span><div>CLIO-H18/7 F(ab’)<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: March 26, 2007; Last Update: April 20, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fn-Fe"><a class="toc-item" href="/books/n/micad/Fn-Fe/">Iron oxide–ferritin nanocages</a><span class="small"> [<a href="/books/n/micad/Fn-Fe/pdf/">PDF Version</a>]</span><div>Fn-Fe nanocages</div><div>Kam Leung.</div><div class="small">Created: June 4, 2011; Last Update: August 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SPIO_PLL"><a class="toc-item" href="/books/n/micad/SPIO_PLL/">Iron oxide nanoparticles-poly-L-lysine complex</a><span class="small"> [<a href="/books/n/micad/SPIO_PLL/pdf/">PDF Version</a>]</span><div>SPIO-PLL</div><div>Huiming Zhang.</div><div class="small">Created: February 20, 2008; Last Update: March 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fe3O4-Lf"><a class="toc-item" href="/books/n/micad/Fe3O4-Lf/">Lactoferrin-conjugated poly(ethylene glycol)-coated Fe<sub>3</sub>O<sub>4</sub> nanoparticles</a><span class="small"> [<a href="/books/n/micad/Fe3O4-Lf/pdf/">PDF Version</a>]</span><div>Fe<sub>3</sub>O<sub>4</sub>-Lf</div><div>Liang Shan.</div><div class="small">Created: September 25, 2012; Last Update: October 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lf-SPIONs"><a class="toc-item" href="/books/n/micad/Lf-SPIONs/">Lactoferrin-conjugated superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/Lf-SPIONs/pdf/">PDF Version</a>]</span><div>Lf-SPIONs</div><div>Liang Shan.</div><div class="small">Created: September 25, 2012; Last Update: October 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EpCAM-MB"><a class="toc-item" href="/books/n/micad/EpCAM-MB/">Magnetic iron microbeads coupled with HEA-125 monoclonal antibody against epithelial cell adhesion molecule</a><span class="small"> [<a href="/books/n/micad/EpCAM-MB/pdf/">PDF Version</a>]</span><div>EpCAM microbeads</div><div>Liang Shan.</div><div class="small">Created: February 24, 2011; Last Update: March 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MES-1-USPIO"><a class="toc-item" href="/books/n/micad/MES-1-USPIO/">MES-1 F(ab’)<sub>2</sub> E-selectin monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticle</a><span class="small"> [<a href="/books/n/micad/MES-1-USPIO/pdf/">PDF Version</a>]</span><div>MES-1-USPIO</div><div>Kam Leung.</div><div class="small">Created: February 8, 2007; Last Update: March 15, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A7-FMLMRI"><a class="toc-item" href="/books/n/micad/A7-FMLMRI/">Monoclonal antibody against antigen A7 coupled to ferromagnetic lignosite particles</a><span class="small"> [<a href="/books/n/micad/A7-FMLMRI/pdf/">PDF Version</a>]</span><div>A7-FML</div><div>Arvind Chopra.</div><div class="small">Created: November 20, 2008; Last Update: December 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEI2K-SPIO"><a class="toc-item" href="/books/n/micad/PEI2K-SPIO/"><i>N</i>-Alkyl-polyethylenimine 2 kDa–stabilized superparamagnetic iron oxide nanoparticles for MRI cell tracking</a><span class="small"> [<a href="/books/n/micad/PEI2K-SPIO/pdf/">PDF Version</a>]</span><div>Alkyl-PEI2k/SPIO</div><div>Liang Shan.</div><div class="small">Created: January 13, 2011; Last Update: February 22, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-OCT"><a class="toc-item" href="/books/n/micad/USPIO-OCT/">Octreotide conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticle</a><span class="small"> [<a href="/books/n/micad/USPIO-OCT/pdf/">PDF Version</a>]</span><div>USPIO-PEG-OCT</div><div>Kam Leung.</div><div class="small">Created: November 5, 2009; Last Update: February 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_OC183B2-USPIO"><a class="toc-item" href="/books/n/micad/OC183B2-USPIO/">Ovarian cancer antigen 183B2 monoclonal antibody conjugated to ultrasmall superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/OC183B2-USPIO/pdf/">PDF Version</a>]</span><div>OCMab183B2-USPIO</div><div>Kam Leung.</div><div class="small">Created: January 5, 2011; Last Update: April 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PDMAAm-Fe2O3-MSCs"><a class="toc-item" href="/books/n/micad/PDMAAm-Fe2O3-MSCs/">Poly(<i>N</i>,<i>N</i>-dimethylacrylamide)-coated maghemite nanoparticles for labeling and tracking mesenchymal stem cells</a><span class="small"> [<a href="/books/n/micad/PDMAAm-Fe2O3-MSCs/pdf/">PDF Version</a>]</span><div>PDMAAm-coated γ-Fe<sub>2</sub>O<sub>3</sub>-labeled MSCs</div><div>Liang Shan.</div><div class="small">Created: December 23, 2009; Last Update: February 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SPIO-PEG-FA"><a class="toc-item" href="/books/n/micad/SPIO-PEG-FA/">Polyethylene glycol–coated and folic acid–conjugated superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/SPIO-PEG-FA/pdf/">PDF Version</a>]</span><div>SPIO-PEG-FA</div><div>Liang Shan.</div><div class="small">Created: September 30, 2009; Last Update: November 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SapC-DOPS-IO"><a class="toc-item" href="/books/n/micad/SapC-DOPS-IO/">Saposin C-dioleylphosphatidylserine nanovesicles coupled with iron oxides</a><span class="small"> [<a href="/books/n/micad/SapC-DOPS-IO/pdf/">PDF Version</a>]</span><div>SapC-DOPS-IO</div><div>Liang Shan.</div><div class="small">Created: June 20, 2011; Last Update: July 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-PEG-sLeX"><a class="toc-item" href="/books/n/micad/USPIO-PEG-sLeX/">Sialy Lewis<sup>x</sup> mimetic conjugated to pegylated ultrasmall superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/USPIO-PEG-sLeX/pdf/">PDF Version</a>]</span><div>USPIO-PEG-sLeX</div><div>Kam Leung.</div><div class="small">Created: November 5, 2009; Last Update: February 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-g-sLex"><a class="toc-item" href="/books/n/micad/USPIO-g-sLex/">Sialy Lewis<sup>x</sup> mimetic conjugated to ultrasmall superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/USPIO-g-sLex/pdf/">PDF Version</a>]</span><div>USPIO-g-sLeX</div><div>Kam Leung.</div><div class="small">Created: March 5, 2007; Last Update: March 20, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ScFvEGFRIO"><a class="toc-item" href="/books/n/micad/ScFvEGFRIO/">Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to magnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/ScFvEGFRIO/pdf/">PDF Version</a>]</span><div>ScFvEGFR-IO</div><div>Arvind Chopra.</div><div class="small">Created: January 26, 2009; Last Update: March 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SPIO_alginate"><a class="toc-item" href="/books/n/micad/SPIO_alginate/">Superparamagnetic iron oxide nanoparticles (SPION) stabilized by alginate</a><span class="small"> [<a href="/books/n/micad/SPIO_alginate/pdf/">PDF Version</a>]</span><div>SPION-alginate</div><div>Liang Shan.</div><div class="small">Created: October 13, 2009; Last Update: November 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TCLSPIONAptDox"><a class="toc-item" href="/books/n/micad/TCLSPIONAptDox/">Thermally cross-linked superparamagnetic iron oxide nanoparticle-A10 RNA aptamer-doxorubicin conjugate</a><span class="small"> [<a href="/books/n/micad/TCLSPIONAptDox/pdf/">PDF Version</a>]</span><div>TCL-SPION-Apt(Dox)</div><div>Huiming Zhang.</div><div class="small">Created: August 29, 2008; Last Update: October 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEG-S-Au-SPIO"><a class="toc-item" href="/books/n/micad/PEG-S-Au-SPIO/">Thiol-modified poly(ethylene glycol)-conjugated gold/superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/PEG-S-Au-SPIO/pdf/">PDF Version</a>]</span><div>PEG-S-Au/SPIO</div><div>Kam Leung.</div><div class="small">Created: July 23, 2010; Last Update: December 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrasDexNP"><a class="toc-item" href="/books/n/micad/TrasDexNP/">Trastuzumab-dextran iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/TrasDexNP/pdf/">PDF Version</a>]</span><div>Trastuzumab-dextran NP</div><div>Arvind Chopra.</div><div class="small">Created: November 4, 2008; Last Update: December 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast-MnMEIO"><a class="toc-item" href="/books/n/micad/Trast-MnMEIO/">Trastuzumab-manganese–doped iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/Trast-MnMEIO/pdf/">PDF Version</a>]</span><div>Trastuzumab-MnMEIO nanoparticles</div><div>Kam Leung.</div><div class="small">Created: April 19, 2007; Last Update: May 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-CD20MAb"><a class="toc-item" href="/books/n/micad/USPIO-CD20MAb/">Ultrasmall superparamagnetic iron oxide-anti-CD20 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/USPIO-CD20MAb/pdf/">PDF Version</a>]</span><div>USPIO-anti-CD20 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 21, 2007; Last Update: February 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-R832"><a class="toc-item" href="/books/n/micad/USPIO-R832/">Ultrasmall superparamagnetic iron oxide-cyclo(Cys-Asn-Asn-Ser-Lys-Ser-His-Thr-Cys)</a><span class="small"> [<a href="/books/n/micad/USPIO-R832/pdf/">PDF Version</a>]</span><div>USPIO-R832</div><div>Kam Leung.</div><div class="small">Created: March 3, 2013; Last Update: May 9, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-R826"><a class="toc-item" href="/books/n/micad/USPIO-R826/">Ultrasmall superparamagnetic iron oxide-Leu-Ile-Lys-Lys-Pro-Phe</a><span class="small"> [<a href="/books/n/micad/USPIO-R826/pdf/">PDF Version</a>]</span><div>USPIO-R826</div><div>Kam Leung.</div><div class="small">Created: February 26, 2013; Last Update: May 16, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_USPIO-PHO"><a class="toc-item" href="/books/n/micad/USPIO-PHO/">Ultrasmall superparamagnetic iron oxide nanoparticles conjugated with Ile-Pro-Leu-Pro-Phe-Tyr-Asn</a><span class="small"> [<a href="/books/n/micad/USPIO-PHO/pdf/">PDF Version</a>]</span><div>USPIO-PHO</div><div>Kam Leung.</div><div class="small">Created: February 23, 2010; Last Update: March 25, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-PEG-IO"><a class="toc-item" href="/books/n/micad/Z342-PEG-IO/">Z<sub>HER2:342</sub> Affibody-polyethylene glycol-superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/Z342-PEG-IO/pdf/">PDF Version</a>]</span><div>IO-PEG-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: July 16, 2012; Last Update: October 18, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosmangansesferrite"><a class="toc-item" href="/books/n/micad/sosmangansesferrite/">Manganese ferrite</a><ul id="toc_lst_NBK5330_toc_sosmangansesferrite" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDA2-Mn-micelles"><a class="toc-item" href="/books/n/micad/MDA2-Mn-micelles/">Anti-malondialdehyde-modified low-density lipoprotein MDA2 murine monoclonal antibody manganese-micelles</a><span class="small"> [<a href="/books/n/micad/MDA2-Mn-micelles/pdf/">PDF Version</a>]</span><div>MDA2-Mn micelles</div><div>Kam Leung.</div><div class="small">Created: May 10, 2012; Last Update: August 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLT1-G3-DOTA-Mn"><a class="toc-item" href="/books/n/micad/CLT1-G3-DOTA-Mn/">Manganese(II)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-G3 nanoglobule-CGLIIQKNEC (CLT1)</a><span class="small"> [<a href="/books/n/micad/CLT1-G3-DOTA-Mn/pdf/">PDF Version</a>]</span><div>Mn-DOTA-G3-CLT1</div><div>Kam Leung.</div><div class="small">Created: September 15, 2012; Last Update: December 6, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF121rGel-MNPs"><a class="toc-item" href="/books/n/micad/VEGF121rGel-MNPs/">Vascular endothelial growth factor A isoform 121-gelonin fusion protein–conjugated manganese ferrite nanoparticles</a><span class="small"> [<a href="/books/n/micad/VEGF121rGel-MNPs/pdf/">PDF Version</a>]</span><div>VEGF<sub>121</sub>/rGel-MNPs</div><div>Liang Shan.</div><div class="small">Created: July 6, 2011; Last Update: August 17, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosnitroxide"><a class="toc-item" href="/books/n/micad/sosnitroxide/">Nitroxide</a><ul id="toc_lst_NBK5330_toc_sosnitroxide" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TEMPONE15N"><a class="toc-item" href="/books/n/micad/TEMPONE15N/"><sup>15</sup>N-Labeled 4-oxo-2,2,6,6-tetramethyl-piperidine-1-oxyl </a><span class="small"> [<a href="/books/n/micad/TEMPONE15N/pdf/">PDF Version</a>]</span><div>[<sup>15</sup>N]TEMPONE</div><div>Huiming Zhang.</div><div class="small">Created: April 30, 2008; Last Update: June 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Radical3CP"><a class="toc-item" href="/books/n/micad/Radical3CP/">3-Carbamoyl-2,2,5,5-tetramethyl-1-pyrrolidinyl-N-oxyl</a><span class="small"> [<a href="/books/n/micad/Radical3CP/pdf/">PDF Version</a>]</span><div>3CP</div><div>Huiming Zhang.</div><div class="small">Created: April 30, 2008; Last Update: June 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Radical3CxP"><a class="toc-item" href="/books/n/micad/Radical3CxP/">3-Carboxy-2,2,5,5-tetramethyl-pyrrolidinyl-N-oxyl</a><span class="small"> [<a href="/books/n/micad/Radical3CxP/pdf/">PDF Version</a>]</span><div>3CxP</div><div>Huiming Zhang.</div><div class="small">Created: April 30, 2008; Last Update: June 9, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos17O"><a class="toc-item" href="/books/n/micad/sos17O/">Nitroxide</a><ul id="toc_lst_NBK5330_toc_sos17O" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_H2O17"><a class="toc-item" href="/books/n/micad/H2O17/"><sup>17</sup>O-Labeled water</a><span class="small"> [<a href="/books/n/micad/H2O17/pdf/">PDF Version</a>]</span><div>H<sub>2</sub><sup>17</sup>O</div><div>Kam Leung.</div><div class="small">Created: May 27, 2010; Last Update: August 5, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Oxygen17"><a class="toc-item" href="/books/n/micad/Oxygen17/"><sup>17</sup>O-Oxygen</a><span class="small"> [<a href="/books/n/micad/Oxygen17/pdf/">PDF Version</a>]</span><div><sup>17</sup>O<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: May 17, 2010; Last Update: August 5, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sostm3"><a class="toc-item" href="/books/n/micad/sostm3/">Tm3+</a><ul id="toc_lst_NBK5330_toc_sostm3" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tm-DOTA-Gly"><a class="toc-item" href="/books/n/micad/Tm-DOTA-Gly/">Tm-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N</i>'',<i>N</i>'''-acetamidoacetic acid </a><span class="small"> [<a href="/books/n/micad/Tm-DOTA-Gly/pdf/">PDF Version</a>]</span><div>Tm-DOTA-Gly</div><div>Mark Pagel and Kam Leung.</div><div class="small">Created: February 19, 2009; Last Update: March 10, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosYb"><a class="toc-item" href="/books/n/micad/sosYb/">Yb</a><ul id="toc_lst_NBK5330_toc_sosYb" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_YbDO3AoAA"><a class="toc-item" href="/books/n/micad/YbDO3AoAA/">Ytterbium chelated to 1,4,7,10-tetraazacyclododecane-1,4,7-triacetic acid,10-orthoaminoanilide</a><span class="small"> [<a href="/books/n/micad/YbDO3AoAA/pdf/">PDF Version</a>]</span><div>Yb-DO3A-oAA</div><div>Mark Pagel and Arvind Chopra.</div><div class="small">Created: November 26, 2011; Last Update: January 5, 2012.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_multimodal"><a class="toc-item" href="/books/n/micad/multimodal/">Multimodal</a><ul id="toc_lst_NBK5330_toc_multimodal" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111in68ga"><a class="toc-item" href="/books/n/micad/sos111in68ga/">111In, 68Ga</a><ul id="toc_lst_NBK5330_toc_sos111in68ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHERmin111In68Ga"><a class="toc-item" href="/books/n/micad/ZHERmin111In68Ga/"><sup>111</sup>In/<sup>68</sup>Ga-Labeled anti-epidermal growth factor receptor, native chemical ligation cyclized Affibody Z<sub>HER2:342min</sub></a><span class="small"> [<a href="/books/n/micad/ZHERmin111In68Ga/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In/<sup>68</sup>Ga]Z<sub>HER2:342min</sub></div><div>Arvind Chopra.</div><div class="small">Created: April 3, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMG1-111In-68Ga"><a class="toc-item" href="/books/n/micad/cMG1-111In-68Ga/"><sup>111</sup>In/<sup>68</sup>Ga-Labeled DOTA-conjugated cyclo[γ-<span class="small-caps">d</span>-Glu-Ala-Tyr-<span class="small-caps">d</span>-Lys]-Trp-Met-Asp-Phe-NH<sub>2</sub> (cyclo-MG1), a minigastrin analog</a><span class="small"> [<a href="/books/n/micad/cMG1-111In-68Ga/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In/<sup>68</sup>Ga]-DOTA-cyclo-MG1</div><div>Arvind Chopra.</div><div class="small">Created: May 17, 2012; Last Update: July 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMG2-111In-68Ga"><a class="toc-item" href="/books/n/micad/cMG2-111In-68Ga/"><sup>111</sup>In/<sup>68</sup>Ga-Labeled DOTA conjugated cyclo[γ-<span class="small-caps">d</span>-Glu-Ala-Tyr-<span class="small-caps">d</span>-Lys]-Trp-Nle-Asp-Phe-NH<sub>2</sub> (cyclo-MG2), a minigastrin analog</a><span class="small"> [<a href="/books/n/micad/cMG2-111In-68Ga/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In/<sup>68</sup>Ga]-DOTA-cyclo-MG2</div><div>Arvind Chopra.</div><div class="small">Created: May 17, 2012; Last Update: July 26, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111incy5_5"><a class="toc-item" href="/books/n/micad/sos111incy5.5/">111In, Cy5.5</a><ul id="toc_lst_NBK5330_toc_sos111incy5_5" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-MSAP-RGD"><a class="toc-item" href="/books/n/micad/In111-MSAP-RGD/"><sup>111</sup>In-Labeled multifunctional single-attachment-point reagent-c[RGDfK]</a><span class="small"> [<a href="/books/n/micad/In111-MSAP-RGD/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-MSAP-RGD</div><div>Liang Shan.</div><div class="small">Created: July 13, 2012; Last Update: August 21, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111incy7"><a class="toc-item" href="/books/n/micad/sos111incy7/">111In, Cy7</a><ul id="toc_lst_NBK5330_toc_sos111incy7" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx-CCPM-111InCy7"><a class="toc-item" href="/books/n/micad/Anx-CCPM-111InCy7/"><sup>111</sup>In-Labeled annexin A5-polyethylene glycol–coated core-cross-linked polymeric micelle-Cy7</a><span class="small"> [<a href="/books/n/micad/Anx-CCPM-111InCy7/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-A5-CCPM</div><div>Kam Leung.</div><div class="small">Created: November 30, 2011; Last Update: January 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TNYL-CCPM-111InCy7"><a class="toc-item" href="/books/n/micad/TNYL-CCPM-111InCy7/"><sup>111</sup>In-Labeled-TNYLFSPNGPIARAW (TNYL-RAW)-polyethylene glycol–coated core-cross-linked polymeric micelle-Cy7</a><span class="small"> [<a href="/books/n/micad/TNYL-CCPM-111InCy7/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-TNYL-RAW-CCPM</div><div>Kam Leung.</div><div class="small">Created: September 18, 2011; Last Update: January 19, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111incyal5_5"><a class="toc-item" href="/books/n/micad/sos111incyal5.5/">111In, CyAL5.5</a><ul id="toc_lst_NBK5330_toc_sos111incyal5_5" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TZ14011-MSAP"><a class="toc-item" href="/books/n/micad/TZ14011-MSAP/"><sup>111</sup>In-Labeled Ac-TZ14011 peptide (a chemokine receptor 4 antagonist) conjugated to CyAL5.5 (a fluorescent dye) through a multifunctional single-attachment point (MSAP) reagent</a><span class="small"> [<a href="/books/n/micad/TZ14011-MSAP/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]Ac-TZ14011-MSAP</div><div>Arvind Chopra.</div><div class="small">Created: November 29, 2012; Last Update: December 27, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111inandirdye800"><a class="toc-item" href="/books/n/micad/sos111inandirdye800/">111In and IRDye800</a><ul id="toc_lst_NBK5330_toc_sos111inandirdye800" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-IRDye111In"><a class="toc-item" href="/books/n/micad/RGDfK-IRDye111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-benzyl-succinamido-Lys-IRDye800-c(Arg-Gly-Asp-D-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-IRDye111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-Bz-SA-Lys-IRDye800-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: October 4, 2008; Last Update: November 17, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111inandirdye800cw"><a class="toc-item" href="/books/n/micad/sos111inandirdye800cw/">111In and IRDye 800CW</a><ul id="toc_lst_NBK5330_toc_sos111inandirdye800cw" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IRDTras111In"><a class="toc-item" href="/books/n/micad/IRDTras111In/"><sup>111</sup>In-(Diethylenetriamine pentaacetic acid)<sub>n</sub>-trastuzumab-(IRDye 800CW)<sub>m</sub></a><span class="small"> [<a href="/books/n/micad/IRDTras111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-(DTPA)<sub>n</sub>-trastuzumab-(IRDye 800CW)<sub>m</sub></div><div>Arvind Chopra.</div><div class="small">Created: January 5, 2009; Last Update: April 5, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos123i124i"><a class="toc-item" href="/books/n/micad/sos123i124i/">123I, 124I</a><ul id="toc_lst_NBK5330_toc_sos123i124i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84minibody124I"><a class="toc-item" href="/books/n/micad/T84minibody124I/">Radioiodinated T84.66 minibody</a><span class="small"> [<a href="/books/n/micad/T84minibody124I/pdf/">PDF Version</a>]</span><div><sup>123/124</sup>I-T84.66 minibody</div><div>Kam Leung.</div><div class="small">Created: February 2, 2008; Last Update: April 3, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos124i125i"><a class="toc-item" href="/books/n/micad/sos124i125i/">124I, 125I</a><ul id="toc_lst_NBK5330_toc_sos124i125i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiFibril124I"><a class="toc-item" href="/books/n/micad/AntiFibril124I/"><sup>124</sup>I/<sup>125</sup>I-Fibril-reactive monoclonal antibody </a><span class="small"> [<a href="/books/n/micad/AntiFibril124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I/<sup>125</sup>I-11-1F4 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 7, 2006; Last Update: January 2, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos177lucypate"><a class="toc-item" href="/books/n/micad/sos177lucypate/">177Lu, cypate</a><ul id="toc_lst_NBK5330_toc_sos177lucypate" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_LuLS172"><a class="toc-item" href="/books/n/micad/LuLS172/"><sup>177</sup>Lu-DOTA-Tyr<sup>3</sup>-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LuLS172/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-LS172</div><div>Huiming Zhang.</div><div class="small">Created: March 20, 2008; Last Update: April 22, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cucy5_5"><a class="toc-item" href="/books/n/micad/sos64cucy5.5/">64Cu, Cy5.5</a><ul id="toc_lst_NBK5330_toc_sos64cucy5_5" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25D64CuCy55"><a class="toc-item" href="/books/n/micad/Knottin25D64CuCy55/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid-Lys(Cy5.5)-Gly-Gly-Tyr-knottin 2.5D</a><span class="small"> [<a href="/books/n/micad/Knottin25D64CuCy55/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA/Cy5.5-2.5D</div><div>Kam Leung.</div><div class="small">Created: September 28, 2010; Last Update: January 7, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PLGVR-BBQ-Cy55-64Cu"><a class="toc-item" href="/books/n/micad/PLGVR-BBQ-Cy55-64Cu/">BBQ650-Pro-Leu-Gly-Val-Arg-Lys(Cy5.5)-Glu-Lys(<sup>64</sup>Cu-DOTA)-OH</a><span class="small"> [<a href="/books/n/micad/PLGVR-BBQ-Cy55-64Cu/pdf/">PDF Version</a>]</span><div>BBQ650-PLGVR-K(Cy5.5)-E-K(<sup>64</sup>Cu-DOTA)-OH</div><div>Kam Leung.</div><div class="small">Created: January 6, 2013; Last Update: April 11, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGD4C-Fn-64Cu-Cy55"><a class="toc-item" href="/books/n/micad/RGD4C-Fn-64Cu-Cy55/">Cys-Asp-Cys-Arg-Gly-Asp-Cys-Phe-Cys/Cy5.5-Ferritin <sup>64</sup>Cu-loaded nanocages</a><span class="small"> [<a href="/books/n/micad/RGD4C-Fn-64Cu-Cy55/pdf/">PDF Version</a>]</span><div>RGD4C/Cy5.5-Fn-<sup>64</sup>Cu nanocages</div><div>Kam Leung.</div><div class="small">Created: June 23, 2011; Last Update: September 15, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cucypate"><a class="toc-item" href="/books/n/micad/sos64cucypate/">64Cu, cypate</a><ul id="toc_lst_NBK5330_toc_sos64cucypate" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CuLS172"><a class="toc-item" href="/books/n/micad/CuLS172/"><sup>64</sup>Cu-DOTA-Tyr<sup>3</sup>-c(Cys-Tyr-Trp-Lys-Thr-Cys)-Thr-Lys(cypate)-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/CuLS172/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-LS172</div><div>Huiming Zhang.</div><div class="small">Created: March 20, 2008; Last Update: April 21, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cuquantumdotqd705"><a class="toc-item" href="/books/n/micad/sos64cuquantumdotqd705/">64Cu, quantum dot (QD705)</a><ul id="toc_lst_NBK5330_toc_sos64cuquantumdotqd705" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CuQDVEGF"><a class="toc-item" href="/books/n/micad/CuQDVEGF/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-quantum dot-vascular endothelial growth factor </a><span class="small"> [<a href="/books/n/micad/CuQDVEGF/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-QD-VEGF</div><div>Huiming Zhang.</div><div class="small">Created: July 1, 2008; Last Update: August 12, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cuandacridine"><a class="toc-item" href="/books/n/micad/sos64cuandacridine/">64Cu and Acridine</a><ul id="toc_lst_NBK5330_toc_sos64cuandacridine" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_DO3AxyACR64Cu"><a class="toc-item" href="/books/n/micad/DO3AxyACR64Cu/"><sup>64</sup>Cu-Labeled 2,6-bis(dimethylamino)-10-(4-((4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclodo-decan-1-yl)methyl)benzyl)-acridin-10-ium</a><span class="small"> [<a href="/books/n/micad/DO3AxyACR64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]DO3A-xy-ACR</div><div>Arvind Chopra.</div><div class="small">Created: February 26, 2013; Last Update: April 11, 2013.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cuandirdye800"><a class="toc-item" href="/books/n/micad/sos64cuandirdye800/">64Cu and IRDye800</a><ul id="toc_lst_NBK5330_toc_sos64cuandirdye800" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bev-800CW-NOTA-64Cu"><a class="toc-item" href="/books/n/micad/Bev-800CW-NOTA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-<i>p</i>-isothiocyanatobenzyl-bevacizumab-IRDye 800CW</a><span class="small"> [<a href="/books/n/micad/Bev-800CW-NOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NOTA-Bev-800CW</div><div>Kam Leung.</div><div class="small">Created: December 7, 2012; Last Update: March 21, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mAb7CW80064Cu"><a class="toc-item" href="/books/n/micad/mAb7CW80064Cu/"><sup>64</sup>Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA)-conjugated IRDye 800CW (a near-infrared fluorescence dye) coupled to mAb7, an anti-epithelial cell adhesion molecule monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/mAb7CW80064Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]DOTA-IRDye 800CW-mAb7</div><div>Arvind Chopra.</div><div class="small">Created: March 5, 2013; Last Update: April 11, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CW800TRC10564Cu"><a class="toc-item" href="/books/n/micad/CW800TRC10564Cu/"><sup>64</sup>Cu-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody linked to near-infrared dye IRDye 800CW</a><span class="small"> [<a href="/books/n/micad/CW800TRC10564Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-NOTA-TRC105-800CW</div><div>Arvind Chopra.</div><div class="small">Created: March 23, 2012; Last Update: May 10, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cuandlrhodamine"><a class="toc-item" href="/books/n/micad/sos64cuandlrhodamine/">64Cu and LRhodamine</a><ul id="toc_lst_NBK5330_toc_sos64cuandlrhodamine" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_LRhodamine64Cu"><a class="toc-item" href="/books/n/micad/LRhodamine64Cu/"><sup>64</sup>Cu-Labeled DOTA-Lissamine Rhodamine B and derivatives</a><span class="small"> [<a href="/books/n/micad/LRhodamine64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]DOTA-LRB</div><div>Arvind Chopra.</div><div class="small">Created: January 16, 2013; Last Update: January 31, 2013.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cuandquantumdot"><a class="toc-item" href="/books/n/micad/sos64cuandquantumdot/">64Cu and quantum dot</a><ul id="toc_lst_NBK5330_toc_sos64cuandquantumdot" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-QD-64Cu"><a class="toc-item" href="/books/n/micad/RGDyK-QD-64Cu/"><sup>64</sup>Cu-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-quantum dot-c(Arg-Gly-Asp-<span class="small-caps">D</span>-Tyr-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDyK-QD-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-QD-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: March 1, 2008; Last Update: May 21, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos666768ga"><a class="toc-item" href="/books/n/micad/sos666768ga/">66/67/68Ga</a><ul id="toc_lst_NBK5330_toc_sos666768ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate-DF-Ga"><a class="toc-item" href="/books/n/micad/Folate-DF-Ga/"><sup>66/67/68</sup>Ga-γ-Deferoxamine-folate</a><span class="small"> [<a href="/books/n/micad/Folate-DF-Ga/pdf/">PDF Version</a>]</span><div><sup>66/67/68</sup>Ga-γ-DF-folate</div><div>Kam Leung.</div><div class="small">Created: September 14, 2006; Last Update: January 30, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos67ga68ga"><a class="toc-item" href="/books/n/micad/sos67ga68ga/">67Ga, 68Ga</a><ul id="toc_lst_NBK5330_toc_sos67ga68ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_NAPamide6768Ga"><a class="toc-item" href="/books/n/micad/NAPamide6768Ga/">[NIe<sup>4</sup>,Asp<sup>5</sup>,<span class="small-caps">d</span>-Phe<sup>7</sup>, <sup>67</sup>Ga/<sup>68</sup>Ga-1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-1,4,7,10-tetraacetic acid-Lys<sup>11</sup>]-α-MSH<sub>4-11</sub></a><span class="small"> [<a href="/books/n/micad/NAPamide6768Ga/pdf/">PDF Version</a>]</span><div><sup>67</sup>Ga/<sup>68</sup>Ga-DOTA-NAPamide</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 30, 2007; Last Update: November 19, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos89zrandirdye800CW"><a class="toc-item" href="/books/n/micad/sos89zrandirdye800CW/">89Zr and IRDye 800CW</a><ul id="toc_lst_NBK5330_toc_sos89zrandirdye800CW" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TRC10589Zr-800CW"><a class="toc-item" href="/books/n/micad/TRC10589Zr-800CW/"><sup>89</sup>Zr-Labeled anti-CD105 (endoglin) chimeric monoclonal antibody TRC105 linked to IRDye 800CW</a><span class="small"> [<a href="/books/n/micad/TRC10589Zr-800CW/pdf/">PDF Version</a>]</span><div> [<sup>89</sup>Zr]TRC105-IRDye800CW</div><div>Arvind Chopra.</div><div class="small">Created: January 23, 2013; Last Update: January 31, 2013.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos99mtciodine"><a class="toc-item" href="/books/n/micad/sos99mtciodine/">99mTc, iodine</a><ul id="toc_lst_NBK5330_toc_sos99mtciodine" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-G4-mPEG12"><a class="toc-item" href="/books/n/micad/Tc99m-G4-mPEG12/"><sup>99m</sup>Tc-Labeled acetylated, 2,3,5-triiodobenzoic acid- and diethylenetriamine pentaacetic acid-conjugated, and PEGylated ethylenediamine-core generation 4 polyamidoamine dendrimers</a><span class="small"> [<a href="/books/n/micad/Tc99m-G4-mPEG12/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-G4-[[[[Ac]-TIBA]-DTPA]-mPEG<sub>12</sub>]</div><div>Liang Shan.</div><div class="small">Created: March 5, 2012; Last Update: April 25, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor680gadolin"><a class="toc-item" href="/books/n/micad/sosalexafluor680gadolin/">Alexa Fluor 680, gadolinium</a><ul id="toc_lst_NBK5330_toc_sosalexafluor680gadolin" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TfLipCA"><a class="toc-item" href="/books/n/micad/TfLipCA/">Alexa Fluor 680-labeled transferrin-cationic (NBD-labeled DOPE-DOTAP) liposome-encapsulated gadopentetate dimeglumine complex</a><span class="small"> [<a href="/books/n/micad/TfLipCA/pdf/">PDF Version</a>]</span><div>Tf<sup>NIR</sup>-Lip<sup>NBD</sup>-CA complex</div><div>Kenneth T. Cheng, Paul C. Wang, and Liang Shan.</div><div class="small">Created: October 18, 2007; Last Update: December 17, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosaugadoliniumgd"><a class="toc-item" href="/books/n/micad/sosaugadoliniumgd/">Au, gadolinium (Gd)</a><ul id="toc_lst_NBK5330_toc_sosaugadoliniumgd" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-DTDTPA-Gd"><a class="toc-item" href="/books/n/micad/Au-DTDTPA-Gd/">Gold nanoparticles coated with dithiolated diethylenetriamine pentaacetic acid-gadolinium chelate</a><span class="small"> [<a href="/books/n/micad/Au-DTDTPA-Gd/pdf/">PDF Version</a>]</span><div>Au@DTDTPA-Gd<sub>50</sub></div><div>Liang Shan.</div><div class="small">Created: September 24, 2010; Last Update: November 17, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-GdL"><a class="toc-item" href="/books/n/micad/Au-GdL/">Gold nanoparticles functionalized with gadolinium-diethylenetriamine pentaacetic acid-cysteine conjugate</a><span class="small"> [<a href="/books/n/micad/Au-GdL/pdf/">PDF Version</a>]</span><div>Au@GdL</div><div>Liang Shan.</div><div class="small">Created: September 24, 2010; Last Update: November 17, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscy55gadoliniumgd"><a class="toc-item" href="/books/n/micad/soscy55gadoliniumgd/">Cy5.5, gadolinium (Gd)</a><ul id="toc_lst_NBK5330_toc_soscy55gadoliniumgd" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx-Micelles-Cy55"><a class="toc-item" href="/books/n/micad/Anx-Micelles-Cy55/">Annexin A5-Gd-micelles-Cy5.5</a><span class="small"> [<a href="/books/n/micad/Anx-Micelles-Cy55/pdf/">PDF Version</a>]</span><div>AnxA5-micelles</div><div>Kam Leung.</div><div class="small">Created: February 27, 2011; Last Update: April 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy5"><a class="toc-item" href="/books/n/micad/Cy5/">Cy5.5-Labeled and gadolinium-chelated chitosan nanoparticles</a><span class="small"> [<a href="/books/n/micad/Cy5/pdf/">PDF Version</a>]</span><div>Cy5.5-CNP-Gd(III)</div><div>Liang Shan.</div><div class="small">Created: September 2, 2010; Last Update: October 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLT1-G2-DOTA-Gd-Cy5"><a class="toc-item" href="/books/n/micad/CLT1-G2-DOTA-Gd-Cy5/">Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid monoamide-G2 nanoglobule-CGLIIQKNEC (CLT1)-Cy5</a><span class="small"> [<a href="/books/n/micad/CLT1-G2-DOTA-Gd-Cy5/pdf/">PDF Version</a>]</span><div>CLT1-G2-(Gd-DOTA-MA)-Cy5</div><div>Kam Leung.</div><div class="small">Created: April 21, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gd-G6-Cy55"><a class="toc-item" href="/books/n/micad/Gd-G6-Cy55/">Gadolinium-G6 dendrimer-Cy5.5</a><span class="small"> [<a href="/books/n/micad/Gd-G6-Cy55/pdf/">PDF Version</a>]</span><div>Gd-G6-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: June 19, 2009; Last Update: July 23, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscy55gadoliniumgdgoldau"><a class="toc-item" href="/books/n/micad/soscy55gadoliniumgdgoldau/">Cy5.5, gadolinium (Gd), gold (Au)</a><ul id="toc_lst_NBK5330_toc_soscy55gadoliniumgdgoldau" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-SiFluPaLCs"><a class="toc-item" href="/books/n/micad/Au-SiFluPaLCs/">Gold/silica nanoparticles with a near-infrared fluorescent and PEGylated paramagnetic lipid coating</a><span class="small"> [<a href="/books/n/micad/Au-SiFluPaLCs/pdf/">PDF Version</a>]</span><div>Au-SiFluPaLCs</div><div>Liang Shan.</div><div class="small">Created: May 23, 2011; Last Update: June 23, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soseuropiumperfluorocar"><a class="toc-item" href="/books/n/micad/soseuropiumperfluorocar/">Europium, perfluorocarbon</a><ul id="toc_lst_NBK5330_toc_soseuropiumperfluorocar" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Eupfc"><a class="toc-item" href="/books/n/micad/Eupfc/">Eu-chelate anti-fibrin antibody-conjugated perfluorocarbon nanoparticles</a><span class="small"> [<a href="/books/n/micad/Eupfc/pdf/">PDF Version</a>]</span><div>EuPFC</div><div>Huiming Zhang.</div><div class="small">Created: January 17, 2008; Last Update: February 20, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgadoliniumtexasred"><a class="toc-item" href="/books/n/micad/sosgadoliniumtexasred/">Gadolinium, Texas Red</a><ul id="toc_lst_NBK5330_toc_sosgadoliniumtexasred" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ICAM_ACPLs"><a class="toc-item" href="/books/n/micad/ICAM_ACPLs/">Anti-ICAM-1 antibody-conjugated paramagnetic liposomes</a><span class="small"> [<a href="/books/n/micad/ICAM_ACPLs/pdf/">PDF Version</a>]</span><div>Anti-ICAM ACPLs</div><div>Huiming Zhang.</div><div class="small">Created: January 3, 2008; Last Update: February 14, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgadoliniumgd3quantum"><a class="toc-item" href="/books/n/micad/sosgadoliniumgd3quantum/">Gadolinium (Gd3+), quantum dots (QDs)</a><ul id="toc_lst_NBK5330_toc_sosgadoliniumgd3quantum" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_cNGR-pQD"><a class="toc-item" href="/books/n/micad/cNGR-pQD/">Gadolinium-diethylenetriaminepentaacetic acid-cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-quantum dots</a><span class="small"> [<a href="/books/n/micad/cNGR-pQD/pdf/">PDF Version</a>]</span><div>cNGR-pQDs</div><div>Kam Leung.</div><div class="small">Created: January 15, 2009; Last Update: March 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Q-SiPaLCs"><a class="toc-item" href="/books/n/micad/Q-SiPaLCs/">PEGylated paramagnetic lipid-coated silica nanoparticles with a fluorescent quantum dot core</a><span class="small"> [<a href="/books/n/micad/Q-SiPaLCs/pdf/">PDF Version</a>]</span><div>Q-SiPaLCs</div><div>Liang Shan.</div><div class="small">Created: May 23, 2011; Last Update: June 23, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgoldnanoparticlescy55"><a class="toc-item" href="/books/n/micad/sosgoldnanoparticlescy55/">Gold nanoparticles, Cy5.5</a><ul id="toc_lst_NBK5330_toc_sosgoldnanoparticlescy55" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-GC-AuNPs"><a class="toc-item" href="/books/n/micad/MMP-GC-AuNPs/">Cy5.5-Containing matrix metalloproteinase (MMP) activatable peptide conjugated to glycol chitosan (GC)–coated gold nanoparticles (AuNPs)</a><span class="small"> [<a href="/books/n/micad/MMP-GC-AuNPs/pdf/">PDF Version</a>]</span><div>MMP-GC-AuNPs</div><div>Arvind Chopra.</div><div class="small">Created: March 6, 2012; Last Update: April 12, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosiasiohexolgdasgadoteridol"><a class="toc-item" href="/books/n/micad/sosiasiohexolgdasgadoteridol/">I (as iohexol); Gd (as gadoteridol)</a><ul id="toc_lst_NBK5330_toc_sosiasiohexolgdasgadoteridol" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEGlipo-IG"><a class="toc-item" href="/books/n/micad/PEGlipo-IG/">PEGylated liposome co-encapsulating iohexol and gadoteridol for multimodal CT and MR imaging</a><span class="small"> [<a href="/books/n/micad/PEGlipo-IG/pdf/">PDF Version</a>]</span><div>PEGlipo-IG-1</div><div>Jinzi Zheng, Christine Allen, David Jaffray, and Arvind Chopra.</div><div class="small">Created: July 29, 2011; Last Update: September 29, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosir783and111in"><a class="toc-item" href="/books/n/micad/sosir783and111in/">IR-783 and 111In</a><ul id="toc_lst_NBK5330_toc_sosir783and111in" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_DLIA-IL11R111In"><a class="toc-item" href="/books/n/micad/DLIA-IL11R111In/"><sup>111</sup>In-DTPA-Bz-NH-SA-K(IR-783-S-Ph-CO)-c(CGRRAGGSC)NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/DLIA-IL11R111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DLIA-IL11Rα</div><div>Kam Leung.</div><div class="small">Created: September 2, 2007; Last Update: November 6, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironGFP"><a class="toc-item" href="/books/n/micad/sosironGFP/">Iron, GFP</a><ul id="toc_lst_NBK5330_toc_sosironGFP" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lenti-myc-hFTH"><a class="toc-item" href="/books/n/micad/Lenti-myc-hFTH/">Bimodal lentiviral vector encoding myc-tagged human ferritin heavy chain and green fluorescent protein (GFP)</a><span class="small"> [<a href="/books/n/micad/Lenti-myc-hFTH/pdf/">PDF Version</a>]</span><div>Lenti-myc-hFTH</div><div>Liang Shan.</div><div class="small">Created: February 2, 2011; Last Update: March 9, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxide111in"><a class="toc-item" href="/books/n/micad/sosironoxide111in/">Iron oxide, 111In</a><ul id="toc_lst_NBK5330_toc_sosironoxide111in" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ChL6-SPIO-111In"><a class="toc-item" href="/books/n/micad/ChL6-SPIO-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-benzyl-ChL6-superparamagnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/ChL6-SPIO-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-Bz-ChL6-SPIO</div><div>Kam Leung.</div><div class="small">Created: August 8, 2008; Last Update: September 3, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxide124i"><a class="toc-item" href="/books/n/micad/sosironoxide124i/">Iron oxide, 124I</a><ul id="toc_lst_NBK5330_toc_sosironoxide124i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MnMEIO-SA-124I"><a class="toc-item" href="/books/n/micad/MnMEIO-SA-124I/"><sup>124</sup>I-Serum albumin-manganese-magnetism-engineered iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/MnMEIO-SA-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-SA-MnMEIO</div><div>Kam Leung.</div><div class="small">Created: February 1, 2009; Last Update: May 3, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxidecy55"><a class="toc-item" href="/books/n/micad/sosironoxidecy55/">Iron oxide, Cy5.5</a><ul id="toc_lst_NBK5330_toc_sosironoxidecy55" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx-CLIO-Cy55"><a class="toc-item" href="/books/n/micad/Anx-CLIO-Cy55/">Annexin V-cross-linked iron oxide-Cy5.5</a><span class="small"> [<a href="/books/n/micad/Anx-CLIO-Cy55/pdf/">PDF Version</a>]</span><div>AnxCLIO-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: July 27, 2006; Last Update: March 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VCAM-1-CLIO-Cy55"><a class="toc-item" href="/books/n/micad/VCAM-1-CLIO-Cy55/">Anti-vascular cell adhesion molecule monoclonal antibody M/K-2.7 conjugated cross-linked iron oxide-Cy5.5 nanoparticles</a><span class="small"> [<a href="/books/n/micad/VCAM-1-CLIO-Cy55/pdf/">PDF Version</a>]</span><div>VCAM-NP</div><div>Kam Leung.</div><div class="small">Created: October 1, 2007; Last Update: October 29, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLIO-Cy55"><a class="toc-item" href="/books/n/micad/CLIO-Cy55/">Cross-linked iron oxide-Cy5.5</a><span class="small"> [<a href="/books/n/micad/CLIO-Cy55/pdf/">PDF Version</a>]</span><div>CLIO-Cy5.5</div><div>The MICAD Research Team.</div><div class="small">Created: July 5, 2006; Last Update: July 21, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55_ATF_IO"><a class="toc-item" href="/books/n/micad/Cy55_ATF_IO/">Cy5.5-Amino-terminal fragment of urokinase-type plasminogen activator conjugated to magnetic iron oxide nanoparticles</a><span class="small"> [<a href="/books/n/micad/Cy55_ATF_IO/pdf/">PDF Version</a>]</span><div>Cy5.5-AFT-IO</div><div>Kam Leung.</div><div class="small">Created: October 7, 2009; Last Update: December 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_R4-SC-CLIO"><a class="toc-item" href="/books/n/micad/R4-SC-CLIO/">Cy5.5-Arg-Arg-Arg-Arg-crosslinked iron oxide nanoparticle</a><span class="small"> [<a href="/books/n/micad/R4-SC-CLIO/pdf/">PDF Version</a>]</span><div>
|
|
<b>Cy5.5-R4-SC-CLIO</b>
|
|
</div><div>Kam Leung.</div><div class="small">Created: May 16, 2005; Last Update: June 2, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cRGD-CLIO"><a class="toc-item" href="/books/n/micad/cRGD-CLIO/">Gly-Ser-Ser-Lys-(FITC)-Gly-Gly-Gly-Cys-Arg-Gly-Asp-Cys-CLIO-Cy5.5</a><span class="small"> [<a href="/books/n/micad/cRGD-CLIO/pdf/">PDF Version</a>]</span><div>cRGD-CLIO(Cy5.5)</div><div>Huiming Zhang.</div><div class="small">Created: December 17, 2007; Last Update: January 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_siGFPCLIO"><a class="toc-item" href="/books/n/micad/siGFPCLIO/">Green fluorescent protein specified small interfering RNA-cross-linked iron oxide nanoparticles-Cy5.5</a><span class="small"> [<a href="/books/n/micad/siGFPCLIO/pdf/">PDF Version</a>]</span><div>siGFP-CLIO-Cy5.5</div><div>Huiming Zhang.</div><div class="small">Created: April 17, 2008; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IPL-NP"><a class="toc-item" href="/books/n/micad/IPL-NP/">IPLVVPLGGSC(Cy5.5-Cross-linked iron oxide)K(Fitc)</a><span class="small"> [<a href="/books/n/micad/IPL-NP/pdf/">PDF Version</a>]</span><div>IPL-NP</div><div>Kam Leung.</div><div class="small">Created: August 10, 2008; Last Update: September 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KTLLPTP-CLIO-Cy55"><a class="toc-item" href="/books/n/micad/KTLLPTP-CLIO-Cy55/">Lys-Thr-Leu-Leu-Pro-Thr-Pro-cross-linked iron oxide-Cy5.5</a><span class="small"> [<a href="/books/n/micad/KTLLPTP-CLIO-Cy55/pdf/">PDF Version</a>]</span><div>PTP-CLIO-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: August 8, 2008; Last Update: February 22, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_siSurvivinCLIO"><a class="toc-item" href="/books/n/micad/siSurvivinCLIO/">Survivin specified small interfering RNA-CLIO-Cy5.5</a><span class="small"> [<a href="/books/n/micad/siSurvivinCLIO/pdf/">PDF Version</a>]</span><div>siSurvivin-CLIO-Cy5.5</div><div>Huiming Zhang.</div><div class="small">Created: April 17, 2008; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VINP-28NP"><a class="toc-item" href="/books/n/micad/VINP-28NP/">VCAM-1 internalizing peptide-28 nanoparticles</a><span class="small"> [<a href="/books/n/micad/VINP-28NP/pdf/">PDF Version</a>]</span><div>VINP-28 NP</div><div>Kam Leung.</div><div class="small">Created: September 29, 2007; Last Update: December 4, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxidecy55fitc"><a class="toc-item" href="/books/n/micad/sosironoxidecy55fitc/">Iron oxide, Cy5.5, FITC</a><ul id="toc_lst_NBK5330_toc_sosironoxidecy55fitc" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_BN-CLIO-Cy55"><a class="toc-item" href="/books/n/micad/BN-CLIO-Cy55/">Bombesin peptide conjugated–cross-linked iron oxide-Cy5.5</a><span class="small"> [<a href="/books/n/micad/BN-CLIO-Cy55/pdf/">PDF Version</a>]</span><div>BN-CLIO-Cy5.5</div><div>The MICAD Research Team.</div><div class="small">Created: August 1, 2006; Last Update: August 17, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLIO-EPPT"><a class="toc-item" href="/books/n/micad/CLIO-EPPT/">Cross-linked iron oxide–C-AHA-AREPPTRTFAYWGK(FITC)</a><span class="small"> [<a href="/books/n/micad/CLIO-EPPT/pdf/">PDF Version</a>]</span><div>CLIO-EPPT</div><div>The MICAD Research Team.</div><div class="small">Created: July 26, 2006; Last Update: August 14, 2006.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxidecy7"><a class="toc-item" href="/books/n/micad/sosironoxidecy7/">Iron oxide, Cy7</a><ul id="toc_lst_NBK5330_toc_sosironoxidecy7" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CREKA-SPIO"><a class="toc-item" href="/books/n/micad/CREKA-SPIO/">Cys-Arg-Glu-Lys-Ala-superparamagnetic iron oxide-Cy7 nanoparticles</a><span class="small"> [<a href="/books/n/micad/CREKA-SPIO/pdf/">PDF Version</a>]</span><div>CREKA-SPIO-Cy7</div><div>Kam Leung.</div><div class="small">Created: August 8, 2008; Last Update: October 15, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxideritc"><a class="toc-item" href="/books/n/micad/sosironoxideritc/">Iron oxides, RITC</a><ul id="toc_lst_NBK5330_toc_sosironoxideritc" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSCsMNPs_SiO2_RITC"><a class="toc-item" href="/books/n/micad/MSCsMNPs_SiO2_RITC/">Multimodal, rhodamine B isothiocyanate-incorporated, silica-coated magnetic nanoparticle–labeled human cord blood–derived mesenchymal stem cells for cell tracking</a><span class="small"> [<a href="/books/n/micad/MSCsMNPs_SiO2_RITC/pdf/">PDF Version</a>]</span><div>MNPs@SiO<sub>2</sub>(RITC)-labeled MSCs</div><div>Liang Shan.</div><div class="small">Created: December 11, 2009; Last Update: January 28, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosironoxidesvt68064cu"><a class="toc-item" href="/books/n/micad/sosironoxidesvt68064cu/">Iron oxides, VT680, 64Cu</a><ul id="toc_lst_NBK5330_toc_sosironoxidesvt68064cu" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_PASP_IO_cRGDyK64Cu"><a class="toc-item" href="/books/n/micad/PASP_IO_cRGDyK64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-iron oxide-c(RGDyK) nanoparticles</a><span class="small"> [<a href="/books/n/micad/PASP_IO_cRGDyK64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-IO-RGDyK</div><div>Kam Leung.</div><div class="small">Created: October 1, 2009; Last Update: December 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CuTNP"><a class="toc-item" href="/books/n/micad/CuTNP/"><sup>64</sup>Cu-DTPA-CLIO-VT680 </a><span class="small"> [<a href="/books/n/micad/CuTNP/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-TNP</div><div>Huiming Zhang.</div><div class="small">Created: February 8, 2008; Last Update: March 11, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosmicrospheres166ho"><a class="toc-item" href="/books/n/micad/sosmicrospheres166ho/">Microspheres, 166Ho</a><ul id="toc_lst_NBK5330_toc_sosmicrospheres166ho" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_PLLA-MS166Ho"><a class="toc-item" href="/books/n/micad/PLLA-MS166Ho/">[<sup>166</sup>Ho]-Loaded poly(L-lactic acid) microspheres</a><span class="small"> [<a href="/books/n/micad/PLLA-MS166Ho/pdf/">PDF Version</a>]</span><div> [<sup>166</sup>Ho]-PLLA-MS</div><div>Arvind Chopra.</div><div class="small">Created: August 19, 2010; Last Update: October 14, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosquantumdotgadolinium"><a class="toc-item" href="/books/n/micad/sosquantumdotgadolinium/">Quantum dot, gadolinium</a><ul id="toc_lst_NBK5330_toc_sosquantumdotgadolinium" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AnxA5-QD-Gd"><a class="toc-item" href="/books/n/micad/AnxA5-QD-Gd/">Annexin A5-quantum dot-DTPA-gadolinium</a><span class="small"> [<a href="/books/n/micad/AnxA5-QD-Gd/pdf/">PDF Version</a>]</span><div>AnxA5-QD-Gd</div><div>Kam Leung.</div><div class="small">Created: March 16, 2007; Last Update: March 27, 2008.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_optical"><a class="toc-item" href="/books/n/micad/optical/">Optical</a><ul id="toc_lst_NBK5330_toc_optical" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos5Carboxyfluorescein"><a class="toc-item" href="/books/n/micad/sos5Carboxyfluorescein/">5-Carboxy-fluorescein</a><ul id="toc_lst_NBK5330_toc_sos5Carboxyfluorescein" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_OcF"><a class="toc-item" href="/books/n/micad/OcF/">5-Carboxy-fluorescein-labeled octreotate</a><span class="small"> [<a href="/books/n/micad/OcF/pdf/">PDF Version</a>]</span><div>OcF</div><div>Liang Shan.</div><div class="small">Created: July 27, 2010; Last Update: August 16, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosa15"><a class="toc-item" href="/books/n/micad/sosa15/">A15</a><ul id="toc_lst_NBK5330_toc_sosa15" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_A15"><a class="toc-item" href="/books/n/micad/A15/">A15 (NIRF agent)</a><span class="small"> [<a href="/books/n/micad/A15/pdf/">PDF Version</a>]</span><div>The MICAD Research Team.</div><div class="small">Created: May 4, 2006; Last Update: May 30, 2006.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor488"><a class="toc-item" href="/books/n/micad/sosalexafluor488/">Alexa Fluor 488</a><ul id="toc_lst_NBK5330_toc_sosalexafluor488" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_LYVE-1-Alexa488"><a class="toc-item" href="/books/n/micad/LYVE-1-Alexa488/">AlexaFluor 488-conjugated antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1)</a><span class="small"> [<a href="/books/n/micad/LYVE-1-Alexa488/pdf/">PDF Version</a>]</span><div>Alexa488-Anti-LYVE-1</div><div>Kam Leung.</div><div class="small">Created: March 24, 2011; Last Update: July 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFluo4488CEA"><a class="toc-item" href="/books/n/micad/AFluo4488CEA/">Alexa Fluor 488–conjugated anti-carcinoembryonic antigen monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/AFluo4488CEA/pdf/">PDF Version</a>]</span><div>Alexa Fluor 488 anti-CEA MAb</div><div>Arvind Chopra.</div><div class="small">Created: August 11, 2008; Last Update: September 2, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor647"><a class="toc-item" href="/books/n/micad/sosalexafluor647/">Alexa Fluor 647</a><ul id="toc_lst_NBK5330_toc_sosalexafluor647" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TcapQ647"><a class="toc-item" href="/books/n/micad/TcapQ647/">Ac-rkkrrorrrGK(QSY21)DEVDAPC(Alexa Fluor 647)-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/TcapQ647/pdf/">PDF Version</a>]</span><div>T<sub>CAP</sub>Q<sub>647</sub></div><div>Kenneth T. Cheng and David Piwnica-Worms.</div><div class="small">Created: January 23, 2008; Last Update: April 22, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor680"><a class="toc-item" href="/books/n/micad/sosalexafluor680/">Alexa Fluor 680</a><ul id="toc_lst_NBK5330_toc_sosalexafluor680" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Alexa680-BSA"><a class="toc-item" href="/books/n/micad/Alexa680-BSA/">Alexa 680 conjugated to bovine serum albumin</a><span class="small"> [<a href="/books/n/micad/Alexa680-BSA/pdf/">PDF Version</a>]</span><div>Alexa680-BSA</div><div>Arvind Chopra.</div><div class="small">Created: March 8, 2012; Last Update: March 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bevacizumab680"><a class="toc-item" href="/books/n/micad/Bevacizumab680/">Alexa Fluor 680-Bevacizumab</a><span class="small"> [<a href="/books/n/micad/Bevacizumab680/pdf/">PDF Version</a>]</span><div>Alexa680-Bevacizumab</div><div>Kam Leung.</div><div class="small">Created: October 17, 2008; Last Update: December 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Alexafluor680BN"><a class="toc-item" href="/books/n/micad/Alexafluor680BN/">Alexa Fluor 680-glycylglycylglycine-bombesin[7-14]NH<sub>2</sub> peptide</a><span class="small"> [<a href="/books/n/micad/Alexafluor680BN/pdf/">PDF Version</a>]</span><div>Alexa Fluor 680-G-G-G-BN[7-14]NH<sub>2</sub></div><div>Kenneth T. Cheng, Charles J. Smith, Lixin Ma, Ping Yu, and Timothy J. Hoffman.</div><div class="small">Created: July 20, 2007; Last Update: August 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AF680-ProT"><a class="toc-item" href="/books/n/micad/AF680-ProT/">Alexa Fluor 680-NH-CO-CH<sub>2</sub>-S-CH<sub>2</sub>-Phe-Pro-Arg-CH<sub>2</sub>-prothrombin</a><span class="small"> [<a href="/books/n/micad/AF680-ProT/pdf/">PDF Version</a>]</span><div>AF680-ProT</div><div>Liang Shan.</div><div class="small">Created: March 15, 2012; Last Update: May 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ave1642Alexa680"><a class="toc-item" href="/books/n/micad/Ave1642Alexa680/">Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to Alexa 680</a><span class="small"> [<a href="/books/n/micad/Ave1642Alexa680/pdf/">PDF Version</a>]</span><div>AVE1642-Alexa 680</div><div>Arvind Chopra.</div><div class="small">Created: July 13, 2009; Last Update: August 4, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LLP2A-Alexa680"><a class="toc-item" href="/books/n/micad/LLP2A-Alexa680/">LLP2A-biotin-streptavidin-Alexa Fluor 680</a><span class="small"> [<a href="/books/n/micad/LLP2A-Alexa680/pdf/">PDF Version</a>]</span><div>LLP2A-SA-Alexa680</div><div>Kam Leung.</div><div class="small">Created: October 10, 2007; Last Update: December 4, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SQAFTra"><a class="toc-item" href="/books/n/micad/SQAFTra/">Self-quenching Alexa fluor 680 conjugated to trastuzumab</a><span class="small"> [<a href="/books/n/micad/SQAFTra/pdf/">PDF Version</a>]</span><div>Tra-Alexa680(SQ)</div><div>Arvind Chopra.</div><div class="small">Created: March 5, 2009; Last Update: April 6, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor700"><a class="toc-item" href="/books/n/micad/sosalexafluor700/">Alexa Fluor 700</a><ul id="toc_lst_NBK5330_toc_sosalexafluor700" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_A700-RAFT-RGD"><a class="toc-item" href="/books/n/micad/A700-RAFT-RGD/">AlexaFluor 700–Labeled regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-d-Phe-Lys)]<sub>4</sub></a><span class="small"> [<a href="/books/n/micad/A700-RAFT-RGD/pdf/">PDF Version</a>]</span><div>A700-RAFT-RGD</div><div>Liang Shan.</div><div class="small">Created: July 17, 2012; Last Update: August 29, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosalexafluor750"><a class="toc-item" href="/books/n/micad/sosalexafluor750/">Alexa Fluor 750</a><ul id="toc_lst_NBK5330_toc_sosalexafluor750" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-ABD-Alexa750"><a class="toc-item" href="/books/n/micad/Z342-ABD-Alexa750/">Alexa Fluor 750-albumin-binding domain-fused-(Z<sub>HER2:342</sub>)<sub>2</sub> Affibody</a><span class="small"> [<a href="/books/n/micad/Z342-ABD-Alexa750/pdf/">PDF Version</a>]</span><div>Alexa750-ABD-fused-(Z<sub>HER2:342</sub>)<sub>2</sub> Affibody</div><div>Kam Leung.</div><div class="small">Created: December 16, 2008; Last Update: April 4, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-Alexa750"><a class="toc-item" href="/books/n/micad/Z342-Alexa750/">Alexa Fluor 750-Z<sub>HER2:342</sub> Affibody</a><span class="small"> [<a href="/books/n/micad/Z342-Alexa750/pdf/">PDF Version</a>]</span><div>Alexa750-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: June 16, 2010; Last Update: March 16, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosaoi987"><a class="toc-item" href="/books/n/micad/sosaoi987/">AOI987</a><ul id="toc_lst_NBK5330_toc_sosaoi987" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AOI987"><a class="toc-item" href="/books/n/micad/AOI987/">AOI987</a><span class="small"> [<a href="/books/n/micad/AOI987/pdf/">PDF Version</a>]</span><div>The MICAD Research Team.</div><div class="small">Created: May 17, 2006; Last Update: June 15, 2006.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosau1"><a class="toc-item" href="/books/n/micad/sosau1/">Au</a><ul id="toc_lst_NBK5330_toc_sosau1" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-PEG-nanoshells"><a class="toc-item" href="/books/n/micad/Au-PEG-nanoshells/">Gold-polyethylene glycol nanoshells</a><span class="small"> [<a href="/books/n/micad/Au-PEG-nanoshells/pdf/">PDF Version</a>]</span><div>Au-PEG-nanoshells</div><div>Kam Leung.</div><div class="small">Created: May 26, 2008; Last Update: June 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AuNS-PEG-VCAM-1Ab"><a class="toc-item" href="/books/n/micad/AuNS-PEG-VCAM-1Ab/">Polyethylene glycol–coated gold nanoshells conjugated with anti-VCAM-1 antibody</a><span class="small"> [<a href="/books/n/micad/AuNS-PEG-VCAM-1Ab/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: February 28, 2013; Last Update: May 16, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AuNCs"><a class="toc-item" href="/books/n/micad/AuNCs/">Ultrasmall near-infrared gold nanoclusters</a><span class="small"> [<a href="/books/n/micad/AuNCs/pdf/">PDF Version</a>]</span><div>AuNCs</div><div>Kam Leung.</div><div class="small">Created: March 19, 2011; Last Update: June 2, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosbodipyfl"><a class="toc-item" href="/books/n/micad/sosbodipyfl/">BODIPY-FL</a><ul id="toc_lst_NBK5330_toc_sosbodipyfl" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cetuximab-BODIPY-FL"><a class="toc-item" href="/books/n/micad/Cetuximab-BODIPY-FL/">BODIPY-FL-neutravidin-biotin-Cetuximab</a><span class="small"> [<a href="/books/n/micad/Cetuximab-BODIPY-FL/pdf/">PDF Version</a>]</span><div>BODIPY-FL-Cetuximab</div><div>Kam Leung.</div><div class="small">Created: January 15, 2008; Last Update: February 25, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosbodipytmrx"><a class="toc-item" href="/books/n/micad/sosbodipytmrx/">BODIPY TMR-X</a><ul id="toc_lst_NBK5330_toc_sosbodipytmrx" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_GB117"><a class="toc-item" href="/books/n/micad/GB117/">Carbobenzoxy-capped Phe-Lys(BODIPY TMR-X-acyloxymethyl ketone(QSY7)</a><span class="small"> [<a href="/books/n/micad/GB117/pdf/">PDF Version</a>]</span><div>GB117</div><div>Liang Shan.</div><div class="small">Created: May 19, 2010; Last Update: May 25, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscellvuemaroon"><a class="toc-item" href="/books/n/micad/soscellvuemaroon/">CellVue Maroon</a><ul id="toc_lst_NBK5330_toc_soscellvuemaroon" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CVM-SapC-DOPS"><a class="toc-item" href="/books/n/micad/CVM-SapC-DOPS/">CellVue Maroon–labeled saposin C-dioleylphosphatidylserine nanovesicles</a><span class="small"> [<a href="/books/n/micad/CVM-SapC-DOPS/pdf/">PDF Version</a>]</span><div>CVM-SapC-DOPS</div><div>Liang Shan.</div><div class="small">Created: June 20, 2011; Last Update: July 18, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscy5"><a class="toc-item" href="/books/n/micad/soscy5/">Cy5</a><ul id="toc_lst_NBK5330_toc_soscy5" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_GB123"><a class="toc-item" href="/books/n/micad/GB123/">Carbobenzoxy-capped Phe-Lys(Cy5)-acyloxymethyl ketone</a><span class="small"> [<a href="/books/n/micad/GB123/pdf/">PDF Version</a>]</span><div>GB123</div><div>Liang Shan.</div><div class="small">Created: May 9, 2010; Last Update: May 25, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GB137"><a class="toc-item" href="/books/n/micad/GB137/">Cbz-Phe-Lys(Cy5)-methyl ketone-2,6,dimethylterephthalic amide-hexyl-QSY 21</a><span class="small"> [<a href="/books/n/micad/GB137/pdf/">PDF Version</a>]</span><div>GB137</div><div>Huiming Zhang.</div><div class="small">Created: November 24, 2008; Last Update: January 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AB50_Cy5"><a class="toc-item" href="/books/n/micad/AB50_Cy5/">Cy5-Glu-Pro-Asp-acyloxymethyl ketone</a><span class="small"> [<a href="/books/n/micad/AB50_Cy5/pdf/">PDF Version</a>]</span><div>Cy5-AB50</div><div>Kam Leung.</div><div class="small">Created: November 8, 2009; Last Update: December 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LP-1"><a class="toc-item" href="/books/n/micad/LP-1/">Cy5-labeled aza-peptidyl Pro-Asn epoxide</a><span class="small"> [<a href="/books/n/micad/LP-1/pdf/">PDF Version</a>]</span><div>LP-1</div><div>Liang Shan.</div><div class="small">Created: May 12, 2010; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CyRAFTRGD"><a class="toc-item" href="/books/n/micad/CyRAFTRGD/">Cy5-Regioselectively addressable functionalized template-[cyclo-(RGD-<span class="small-caps">d</span>-Phe-Lys)]<sub>4</sub> peptide </a><span class="small"> [<a href="/books/n/micad/CyRAFTRGD/pdf/">PDF Version</a>]</span><div>Cy5-RAFT-c(-RGDfK-)<sub>4</sub></div><div>Kenneth T. Cheng, Elisabeth Garanger, Veronique Josserand, Zhaohui Jin, Stephanie Foillard, Didier Boturyn, Pr Marie C. Favrot, Pascal Dumy, and Jean-Luc Coll.</div><div class="small">Created: October 9, 2007; Last Update: December 28, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_tAB50-Cy5"><a class="toc-item" href="/books/n/micad/tAB50-Cy5/">Cy5-Tat-Glu-Pro-Asp-acyloxymethyl ketone</a><span class="small"> [<a href="/books/n/micad/tAB50-Cy5/pdf/">PDF Version</a>]</span><div>tAB50-Cy5</div><div>Liang Shan.</div><div class="small">Created: May 19, 2010; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L36-Cy5-trimerbody"><a class="toc-item" href="/books/n/micad/L36-Cy5-trimerbody/">L36-Cy5 anti-laminin trimerbody</a><span class="small"> [<a href="/books/n/micad/L36-Cy5-trimerbody/pdf/">PDF Version</a>]</span><div>L36-Cy5 anti-laminin trimerbody</div><div>Liang Shan.</div><div class="small">Created: June 11, 2009; Last Update: August 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MFE23-trimerbody"><a class="toc-item" href="/books/n/micad/MFE23-trimerbody/">MFE23-Cy5 anti-carcinoembryonic antigen trimerbody</a><span class="small"> [<a href="/books/n/micad/MFE23-trimerbody/pdf/">PDF Version</a>]</span><div>MFE23-Cy5 anti-CEA trimerbody</div><div>Liang Shan.</div><div class="small">Created: June 11, 2009; Last Update: August 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EpoCy55"><a class="toc-item" href="/books/n/micad/EpoCy55/">Recombinant human erythropoietin coupled to near-infrared fluorescence dye Cy5.5</a><span class="small"> [<a href="/books/n/micad/EpoCy55/pdf/">PDF Version</a>]</span><div>Epo-Cy5.5</div><div>Arvind Chopra.</div><div class="small">Created: February 2, 2012; Last Update: February 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CyRAFTSSQ"><a class="toc-item" href="/books/n/micad/CyRAFTSSQ/">Self-quenched-regioselectively addressable functionalized template-[cyclo-(RGD-<span class="small-caps">d</span>-Phe-Lys)]<sub>4</sub> peptide-Cy5-fluorescence quencher QSY21</a><span class="small"> [<a href="/books/n/micad/CyRAFTSSQ/pdf/">PDF Version</a>]</span><div>RAFT-c(-RGDfK-)<sub>4</sub>-Cy5-SS-Q</div><div>Kenneth T. Cheng, Jesus Razkin, Veronique Josserand, Zhaohui Jin, Stephanie Foillard, Didier Boturyn, Pr Marie C. Favrot, Pascal Dumy, and Jean-Luc Coll.</div><div class="small">Created: October 31, 2007; Last Update: January 21, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscy55"><a class="toc-item" href="/books/n/micad/soscy55/">Cy5.5</a><ul id="toc_lst_NBK5330_toc_soscy55" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_LLP2A-6-Cy55"><a class="toc-item" href="/books/n/micad/LLP2A-6-Cy55/">2-(1E,3E,5E)-5-3-(R)-1-(1-(R)-2-(R)-2-[2-(4-(Benzo[d]thiazol-2-ylamino)phenyl)\acetamido]-6-(E)-3-(pyridin-3-yl)acrylamido)hexanamido)-5-carboxypentanamido)cyclohexyl)-27-carbamoyl-1,9,13,21,25,33-hexaoxo-5,17-dioxa-2,8,14,20,26,32-hexa-azaheptatriacontan-37-yl)-1,1-dimethyl-6,8-disulfonato-1H-benzo[e]indol-2(3H)-ylid-ene)penta-1,3-dienyl)-3-ethyl-1,1-dimethyl-1H-ben-zo[e]indolium-6,8-disulfonate</a><span class="small"> [<a href="/books/n/micad/LLP2A-6-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-LLP2A-6</div><div>Kam Leung.</div><div class="small">Created: June 10, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CTXCy55"><a class="toc-item" href="/books/n/micad/CTXCy55/">Chlorotoxin:Cy5.5</a><span class="small"> [<a href="/books/n/micad/CTXCy55/pdf/">PDF Version</a>]</span><div>CTX:Cy5.5</div><div>The MICAD Research Team.</div><div class="small">Created: July 23, 2007; Last Update: August 30, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PD156707-Cy55"><a class="toc-item" href="/books/n/micad/PD156707-Cy55/">Cy5.5-3-Benzo[1,3]dioxol-5-yl-5-hydroxy-5-(4-methoxyphenyl)-4-(3,4,5-trimethoxybenzyl)-5<i>H</i>-furan-2-one)</a><span class="small"> [<a href="/books/n/micad/PD156707-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-PD156707</div><div>Kam Leung.</div><div class="small">Created: August 12, 2009; Last Update: September 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGBP-8-Aoc-Cy55"><a class="toc-item" href="/books/n/micad/EGBP-8-Aoc-Cy55/">Cy5.5-8-Amino-octanoic acid-Ser-Cys-Pro-Pro-Trp-Gln-Glu-Trp-His-Asn-Phe-Met-Pro-Phe-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/EGBP-8-Aoc-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Aoc-EGBP</div><div>Kam Leung.</div><div class="small">Created: August 21, 2012; Last Update: November 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-Cy55"><a class="toc-item" href="/books/n/micad/Z1907-Cy55/">Cy5.5-Ac-Cys-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Z<sub>EGFR:1907</sub></div><div>Kam Leung.</div><div class="small">Created: June 21, 2012; Last Update: September 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PB-M7NIR"><a class="toc-item" href="/books/n/micad/PB-M7NIR/">Cy5.5-Aminohexanoic acid-RPLALWRS-aminohexanoic acid-C-G4-PAMAM-PEG-AF750</a><span class="small"> [<a href="/books/n/micad/PB-M7NIR/pdf/">PDF Version</a>]</span><div>PB-M7NIR</div><div>Kam Leung.</div><div class="small">Created: April 26, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy5-5AnnexinV"><a class="toc-item" href="/books/n/micad/Cy5-5AnnexinV/">Cy5.5-Annexin V</a><span class="small"> [<a href="/books/n/micad/Cy5-5AnnexinV/pdf/">PDF Version</a>]</span><div>The MICAD Research Team.</div><div class="small">Created: September 28, 2005; Last Update: October 31, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hAb47-Cy55"><a class="toc-item" href="/books/n/micad/hAb47-Cy55/">Cy5.5-Anti-ephrin receptor B4 (EphB4) humanized monoclonal antibody hAb47</a><span class="small"> [<a href="/books/n/micad/hAb47-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-hAb47</div><div>Kam Leung.</div><div class="small">Created: March 18, 2013; Last Update: May 9, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DGEA-Cy55"><a class="toc-item" href="/books/n/micad/DGEA-Cy55/">Cy5.5-Asp-Gly-Glu-Ala (DGEA)</a><span class="small"> [<a href="/books/n/micad/DGEA-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-DGEA</div><div>Kam Leung.</div><div class="small">Created: January 3, 2012; Last Update: April 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55-DGEAGK-R8-OH"><a class="toc-item" href="/books/n/micad/Cy55-DGEAGK-R8-OH/">Cy5.5-Asp-Gly-Glu-Ala-Gly-Lys-(Arg)<sub>8</sub>-OH</a><span class="small"> [<a href="/books/n/micad/Cy55-DGEAGK-R8-OH/pdf/">PDF Version</a>]</span><div>Cy5.5-DGEAGK(R8)-OH</div><div>Kam Leung.</div><div class="small">Created: January 6, 2012; Last Update: April 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-C6-Cy55"><a class="toc-item" href="/books/n/micad/MMP-C6-Cy55/">Cy5.5-c(Lys-Ala-His-Trp-Gly-Phe-Thr-Leu-Asp)NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/MMP-C6-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-C6</div><div>Kam Leung.</div><div class="small">Created: March 20, 2010; Last Update: April 15, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55Tat"><a class="toc-item" href="/books/n/micad/Cy55Tat/">Cy5.5-CGRRRQRRKKRG-Labeled T lymphocytes</a><span class="small"> [<a href="/books/n/micad/Cy55Tat/pdf/">PDF Version</a>]</span><div>Cy5.5-Tat-T cells</div><div>Huiming Zhang.</div><div class="small">Created: July 10, 2008; Last Update: August 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DC101-Cy55"><a class="toc-item" href="/books/n/micad/DC101-Cy55/">Cy5.5-Chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101</a><span class="small"> [<a href="/books/n/micad/DC101-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Chitosan-DC101</div><div>Kam Leung.</div><div class="small">Created: September 15, 2011; Last Update: December 15, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CetuximabCy55"><a class="toc-item" href="/books/n/micad/CetuximabCy55/">Cy5.5 conjugated anti-epidermal growth factor receptor monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/CetuximabCy55/pdf/">PDF Version</a>]</span><div>Cetuximab-Cy5.5</div><div>Arvind Chopra.</div><div class="small">Created: October 18, 2007; Last Update: November 1, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_C225Cy55"><a class="toc-item" href="/books/n/micad/C225Cy55/">Cy5.5-Conjugated anti-epidermal growth factor receptor monoclonal antibody C225</a><span class="small"> [<a href="/books/n/micad/C225Cy55/pdf/">PDF Version</a>]</span><div>C225-Cy5.5</div><div>Arvind Chopra.</div><div class="small">Created: April 14, 2009; Last Update: July 22, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CD31MAbCy55"><a class="toc-item" href="/books/n/micad/CD31MAbCy55/">Cy5.5-Conjugated anti-human CD31 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/CD31MAbCy55/pdf/">PDF Version</a>]</span><div>Cy5.5-anti-hCD31 MAb</div><div>Arvind Chopra.</div><div class="small">Created: December 15, 2008; Last Update: January 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55CNP"><a class="toc-item" href="/books/n/micad/Cy55CNP/">Cy5.5-Conjugated glycol chitosan-5β-cholanic acid nanoparticles</a><span class="small"> [<a href="/books/n/micad/Cy55CNP/pdf/">PDF Version</a>]</span><div>Cy5.5-CNPs</div><div>Arvind Chopra.</div><div class="small">Created: March 12, 2012; Last Update: May 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55MMPprobe"><a class="toc-item" href="/books/n/micad/Cy55MMPprobe/">Cy5.5-Conjugated matrix metalloproteinase cleavable peptide nanoprobe</a><span class="small"> [<a href="/books/n/micad/Cy55MMPprobe/pdf/">PDF Version</a>]</span><div>Cy5.5-MMP probe</div><div>Arvind Chopra.</div><div class="small">Created: March 19, 2012; Last Update: April 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GX1-Cy55"><a class="toc-item" href="/books/n/micad/GX1-Cy55/">Cy5.5-Cyclo(CGNSNPKSC)</a><span class="small"> [<a href="/books/n/micad/GX1-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-GX1</div><div>Kam Leung.</div><div class="small">Created: January 30, 2012; Last Update: May 3, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Endostatin-Cy55"><a class="toc-item" href="/books/n/micad/Endostatin-Cy55/">Cy5.5-Endostatin</a><span class="small"> [<a href="/books/n/micad/Endostatin-Cy55/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: May 8, 2006; Last Update: February 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGF-Cy55"><a class="toc-item" href="/books/n/micad/EGF-Cy55/">Cy5.5-Epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/EGF-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-EGF</div><div>Kam Leung.</div><div class="small">Created: July 15, 2006; Last Update: March 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fn-Cy55"><a class="toc-item" href="/books/n/micad/Fn-Cy55/">Cy5.5-Ferritin nanocages</a><span class="small"> [<a href="/books/n/micad/Fn-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Fn nanocages</div><div>Kam Leung.</div><div class="small">Created: June 4, 2011; Last Update: August 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-PL-MPEG-Cy55"><a class="toc-item" href="/books/n/micad/MMP-PL-MPEG-Cy55/">Cy5.5-GGPRQITAGK(Fitc)C-Poly-L-lysine-methoxypolyethylene glycol</a><span class="small"> [<a href="/books/n/micad/MMP-PL-MPEG-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-GGPRQITAGK(Fitc)C-PL-MPEG</div><div>Kam Leung.</div><div class="small">Created: October 10, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_uPA-PL-MPEG-Cy55"><a class="toc-item" href="/books/n/micad/uPA-PL-MPEG-Cy55/">Cy5.5-GGSGRSANAK(Fitc)C-poly-L-lysine-methoxy polyethylene glycol</a><span class="small"> [<a href="/books/n/micad/uPA-PL-MPEG-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-GGSGRSANAK(Fitc)C-PL-MPEG</div><div>Kam Leung.</div><div class="small">Created: January 5, 2009; Last Update: March 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CatK-PL-MPEG-Cy55"><a class="toc-item" href="/books/n/micad/CatK-PL-MPEG-Cy55/">Cy5.5-Gly-His-Pro-Gly-Gly-Pro-Gln-Gly-Lys(Fitc)-Cys-Poly-L-lysine-methoxypolyethylene glycol</a><span class="small"> [<a href="/books/n/micad/CatK-PL-MPEG-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-GHPGGPQK(Fitc)C-PL-MPEG</div><div>Kam Leung.</div><div class="small">Created: January 2, 2008; Last Update: January 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-FANP-Cy55"><a class="toc-item" href="/books/n/micad/MMP-FANP-Cy55/">Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-(TDOPA)<sub>3</sub>-flower-like gold–Fe<sub>3</sub>O<sub>4</sub> optical nanoparticles</a><span class="small"> [<a href="/books/n/micad/MMP-FANP-Cy55/pdf/">PDF Version</a>]</span><div>FANPs</div><div>Kam Leung.</div><div class="small">Created: October 6, 2011; Last Update: January 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-Cy55-Fn-BHQ"><a class="toc-item" href="/books/n/micad/MMP-Cy55-Fn-BHQ/">Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-Ferritin-black hole quencher-3 nanocages</a><span class="small"> [<a href="/books/n/micad/MMP-Cy55-Fn-BHQ/pdf/">PDF Version</a>]</span><div>C/B-Fn nanocages</div><div>Kam Leung.</div><div class="small">Created: June 21, 2011; Last Update: September 15, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-AuNP-Cy55"><a class="toc-item" href="/books/n/micad/MMP-AuNP-Cy55/">Cy5.5-Gly-Pro-Leu-Gly-Val-Arg-Gly-Cys-gold nanoparticles</a><span class="small"> [<a href="/books/n/micad/MMP-AuNP-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-MMP-AuNPs</div><div>Kam Leung.</div><div class="small">Created: April 26, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TIMP2-HSA-Cy55"><a class="toc-item" href="/books/n/micad/TIMP2-HSA-Cy55/">Cy5.5-Human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein</a><span class="small"> [<a href="/books/n/micad/TIMP2-HSA-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-HSA/TIMP-2</div><div>Kam Leung.</div><div class="small">Created: February 4, 2012; Last Update: May 31, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25DCy55"><a class="toc-item" href="/books/n/micad/Knottin25DCy55/">Cy5.5-Knottin 2.5D</a><span class="small"> [<a href="/books/n/micad/Knottin25DCy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Knottin 2.5D</div><div>Arvind Chopra.</div><div class="small">Created: March 26, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25FCy55"><a class="toc-item" href="/books/n/micad/Knottin25FCy55/">Cy5.5-Knottin 2.5F</a><span class="small"> [<a href="/books/n/micad/Knottin25FCy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Knottin 2.5F</div><div>Arvind Chopra.</div><div class="small">Created: March 26, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PHLIP-Cy5"><a class="toc-item" href="/books/n/micad/PHLIP-Cy5/">Cy5.5-labeled pH low insertion peptide (pHLIP)</a><span class="small"> [<a href="/books/n/micad/PHLIP-Cy5/pdf/">PDF Version</a>]</span><div>pHLIP-Cy5.5</div><div>Liang Shan.</div><div class="small">Created: August 8, 2009; Last Update: November 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AF489-Cy55"><a class="toc-item" href="/books/n/micad/AF489-Cy55/">Cy5.5-Polyethylene glycol-CGS25966 inhibitor of matrix metalloproteinases</a><span class="small"> [<a href="/books/n/micad/AF489-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-AF489</div><div>Kam Leung.</div><div class="small">Created: February 14, 2013; Last Update: May 9, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PL-MPEG-Cy55"><a class="toc-item" href="/books/n/micad/PL-MPEG-Cy55/">Cy5.5-Poly-L-lysine-methoxypolyethylene glycol</a><span class="small"> [<a href="/books/n/micad/PL-MPEG-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-PL-MPEG</div><div>Kam Leung.</div><div class="small">Created: November 10, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rituximab-Cy55"><a class="toc-item" href="/books/n/micad/Rituximab-Cy55/">Cy5.5-Rituximab</a><span class="small"> [<a href="/books/n/micad/Rituximab-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-RIT</div><div>Kam Leung.</div><div class="small">Created: March 10, 2009; Last Update: June 4, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-Cy55"><a class="toc-item" href="/books/n/micad/scVEGF-Cy55/">Cy5.5-Single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-scVEGF<sub>121</sub></div><div>Kam Leung.</div><div class="small">Created: February 17, 2008; Last Update: March 31, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast-Cy55"><a class="toc-item" href="/books/n/micad/Trast-Cy55/">Cy5.5-Trastuzumab</a><span class="small"> [<a href="/books/n/micad/Trast-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-Trast</div><div>Kam Leung.</div><div class="small">Created: June 15, 2006; Last Update: March 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-Cy55"><a class="toc-item" href="/books/n/micad/RGDyK-Cy55/">Cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Tyr-Lys)-Cy5.5</a><span class="small"> [<a href="/books/n/micad/RGDyK-Cy55/pdf/">PDF Version</a>]</span><div>RGD-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: December 27, 2004; Last Update: September 22, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CRGDC-GK-Cy55"><a class="toc-item" href="/books/n/micad/CRGDC-GK-Cy55/">Cyclo(Cys-Arg-Gly-Asp-Cys)-Gly-Lys-Cy5.5</a><span class="small"> [<a href="/books/n/micad/CRGDC-GK-Cy55/pdf/">PDF Version</a>]</span><div>c(CRGDC)-GK-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: October 17, 2011; Last Update: February 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cNGR-Cy55"><a class="toc-item" href="/books/n/micad/cNGR-Cy55/">Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys-Cy5.5</a><span class="small"> [<a href="/books/n/micad/cNGR-Cy55/pdf/">PDF Version</a>]</span><div>Cy5.5-cNGR</div><div>Kam Leung.</div><div class="small">Created: January 15, 2009; Last Update: March 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AP-HGC-NP-Cy55"><a class="toc-item" href="/books/n/micad/AP-HGC-NP-Cy55/">Cys-Arg-Lys-Arg-Leu-Asp-Arg-Asn-Cys-glycol chitosan-Cy5.5 nanoparticles</a><span class="small"> [<a href="/books/n/micad/AP-HGC-NP-Cy55/pdf/">PDF Version</a>]</span><div>AP-HGC-Cy5.5 NPs</div><div>Kam Leung.</div><div class="small">Created: April 15, 2009; Last Update: July 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_OA02-Cy55"><a class="toc-item" href="/books/n/micad/OA02-Cy55/"><span class="small-caps">D</span>-Cys-<span class="small-caps">D</span>-Asp-Gly-HCit-Gly-Pro-Gln-<span class="small-caps">D</span>-Cys-Ebes-Ebes-Lys-Cy5.5 </a><span class="small"> [<a href="/books/n/micad/OA02-Cy55/pdf/">PDF Version</a>]</span><div>OA02-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: September 6, 2007; Last Update: October 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_OA02-PEG-CA8-Cy55"><a class="toc-item" href="/books/n/micad/OA02-PEG-CA8-Cy55/"><span class="small-caps">D</span>-Cys-<span class="small-caps">D</span>-Asp-Gly-HCit-Gly-Pro-Gln-<span class="small-caps">D</span>-Cys-Ebes-Lys-polyethylene glycol-cholic acids-Cy5.5 telodendrimer nanoparticles</a><span class="small"> [<a href="/books/n/micad/OA02-PEG-CA8-Cy55/pdf/">PDF Version</a>]</span><div>OA02-PEG<sup>5k</sup>-CA<sub>8-</sub>Cy5.5 NPs</div><div>Kam Leung.</div><div class="small">Created: June 1, 2012; Last Update: September 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LXY1-Cy55"><a class="toc-item" href="/books/n/micad/LXY1-Cy55/"><span class="small-caps">D</span>-Cys-<span class="small-caps">D</span>-Asp-Gly-Leu-Gly-ProOH-Asn-<span class="small-caps">D</span>-Cys-biotin-streptavidin-Cy5.5</a><span class="small"> [<a href="/books/n/micad/LXY1-Cy55/pdf/">PDF Version</a>]</span><div>LXY1-biotin-SA-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: May 6, 2009; Last Update: June 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LXY2-Cy55"><a class="toc-item" href="/books/n/micad/LXY2-Cy55/"><span class="small-caps">D</span>-Cys-<span class="small-caps">D</span>-Asp-Gly-Tyr(3-NO<sub>2</sub>)-Gly-ProOH-Asn-<span class="small-caps">D</span>-Cys-biotin-streptavidin-Cy5.5</a><span class="small"> [<a href="/books/n/micad/LXY2-Cy55/pdf/">PDF Version</a>]</span><div>LXY2-biotin-SA-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: May 6, 2009; Last Update: June 8, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy55AFPQSY21"><a class="toc-item" href="/books/n/micad/Cy55AFPQSY21/">Fibroblast activation protein α–specific, near-infrared peptide probe (KGPGPNQC) linked to Cy5.5 and a quencher dye, QSY21</a><span class="small"> [<a href="/books/n/micad/Cy55AFPQSY21/pdf/">PDF Version</a>]</span><div>ANP<sub>FAP</sub></div><div>Arvind Chopra.</div><div class="small">Created: October 31, 2012; Last Update: November 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMBPAOCCy55"><a class="toc-item" href="/books/n/micad/cMBPAOCCy55/">Mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid conjugated to Cy5.5</a><span class="small"> [<a href="/books/n/micad/cMBPAOCCy55/pdf/">PDF Version</a>]</span><div>cMBP-AOC-Cy5.5</div><div>Arvind Chopra.</div><div class="small">Created: July 30, 2009; Last Update: September 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMBPGGGCy55"><a class="toc-item" href="/books/n/micad/cMBPGGGCy55/">Mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly conjugated to Cy5.5</a><span class="small"> [<a href="/books/n/micad/cMBPGGGCy55/pdf/">PDF Version</a>]</span><div>cMBP-GGG-Cy5.5</div><div>Arvind Chopra.</div><div class="small">Created: July 31, 2009; Last Update: September 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SLX-Lipo-Cy55"><a class="toc-item" href="/books/n/micad/SLX-Lipo-Cy55/">Sialyl-Lewis<sup>x</sup>-liposome-Cy5.5</a><span class="small"> [<a href="/books/n/micad/SLX-Lipo-Cy55/pdf/">PDF Version</a>]</span><div>SLX-Lipo-Cy5.5</div><div>Kam Leung.</div><div class="small">Created: April 28, 2009; Last Update: June 5, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscy7"><a class="toc-item" href="/books/n/micad/soscy7/">Cy7</a><ul id="toc_lst_NBK5330_toc_soscy7" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy7-3"><a class="toc-item" href="/books/n/micad/Cy7-3/">Cy7-(3<i>S</i>,7<i>S</i>)-26-Amino-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid</a><span class="small"> [<a href="/books/n/micad/Cy7-3/pdf/">PDF Version</a>]</span><div>Cy7-3</div><div>Kam Leung.</div><div class="small">Created: December 27, 2012; Last Update: April 4, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPA-Zn-Cy7"><a class="toc-item" href="/books/n/micad/DPA-Zn-Cy7/">Cy7-Bis-dipicolylamine-zinc</a><span class="small"> [<a href="/books/n/micad/DPA-Zn-Cy7/pdf/">PDF Version</a>]</span><div>Cy7-DPA-Zn</div><div>Kam Leung.</div><div class="small">Created: October 8, 2008; Last Update: November 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cFlFlFK-PEG-Cy7"><a class="toc-item" href="/books/n/micad/cFlFlFK-PEG-Cy7/">Cy7-Polyethylene glycol-cinnamoyl-Phe-<span class="small-caps">D</span>-Leu-Phe-<span class="small-caps">D</span>-Leu-Phe-Lys-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/cFlFlFK-PEG-Cy7/pdf/">PDF Version</a>]</span><div>Cy7-PEG-cFlFlFK</div><div>Kam Leung.</div><div class="small">Created: May 1, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cy7TetramericRGD"><a class="toc-item" href="/books/n/micad/Cy7TetramericRGD/">Cy7-Tetrameric arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/Cy7TetramericRGD/pdf/">PDF Version</a>]</span><div>Cy7-E{E[c(RGDyK)]<sub>2</sub>}<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: March 9, 2007; Last Update: May 13, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FTP11-Cy7"><a class="toc-item" href="/books/n/micad/FTP11-Cy7/">Cy7-Tyr-<span class="small-caps">d</span>-Glu-Cys-Hyp-Tyr(3-Cl)-Gly-Leu-Cys-Tyr-Ile-Gln-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/FTP11-Cy7/pdf/">PDF Version</a>]</span><div>Cy7-FTP11</div><div>Kam Leung.</div><div class="small">Created: April 27, 2013; Last Update: May 30, 2013.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soscypate"><a class="toc-item" href="/books/n/micad/soscypate/">Cypate</a><ul id="toc_lst_NBK5330_toc_soscypate" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cypate-2DG"><a class="toc-item" href="/books/n/micad/Cypate-2DG/">Cypate-2-Deoxy-<span class="small-caps">d</span>-glucose</a><span class="small"> [<a href="/books/n/micad/Cypate-2DG/pdf/">PDF Version</a>]</span><div>Cypate-2DG</div><div>Kam Leung.</div><div class="small">Created: August 18, 2012; Last Update: November 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cyp-GlcN"><a class="toc-item" href="/books/n/micad/cyp-GlcN/">cypate-<span class="small-caps">d</span>: -(+)-glucosamine (cyp-GlcN), and <span class="small-caps">d</span>: -(+)-glucosamine-cypate-<span class="small-caps">d</span>: -(+)-glucosamine (cyp-2GlcN)</a><span class="small"> [<a href="/books/n/micad/cyp-GlcN/pdf/">PDF Version</a>]</span><div>cyp-GlcN and cyp-2GlcN</div><div>Arvind Chopra.</div><div class="small">Created: August 8, 2012; Last Update: September 13, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cypate-GRD"><a class="toc-item" href="/books/n/micad/Cypate-GRD/">Cypate-Gly-Arg-Asp-Ser-Pro-Lys</a><span class="small"> [<a href="/books/n/micad/Cypate-GRD/pdf/">PDF Version</a>]</span><div>Cyp-GRDSPK</div><div>Kam Leung.</div><div class="small">Created: September 26, 2005; Last Update: October 12, 2005.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdid"><a class="toc-item" href="/books/n/micad/sosdid/">DiD</a><ul id="toc_lst_NBK5330_toc_sosdid" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_NK-92-scFvMOC31-DiD"><a class="toc-item" href="/books/n/micad/NK-92-scFvMOC31-DiD/">DiD-Labeled anti-EpCAM-directed NK-92-scFv(MOC31) zeta cells</a><span class="small"> [<a href="/books/n/micad/NK-92-scFvMOC31-DiD/pdf/">PDF Version</a>]</span><div>DiD-NK-92-scFv(MOC31) zeta cells</div><div>Kam Leung.</div><div class="small">Created: August 28, 2009; Last Update: September 30, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdir"><a class="toc-item" href="/books/n/micad/sosdir/">DiR</a><ul id="toc_lst_NBK5330_toc_sosdir" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_DiR-AsTNP"><a class="toc-item" href="/books/n/micad/DiR-AsTNP/">Indotricarbocyanine-loaded AS1411 DNA aptamer- and TGN peptide-modified poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles</a><span class="small"> [<a href="/books/n/micad/DiR-AsTNP/pdf/">PDF Version</a>]</span><div>DiR-AsTNP</div><div>Liang Shan.</div><div class="small">Created: August 10, 2012; Last Update: September 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MacrophagesDiR"><a class="toc-item" href="/books/n/micad/MacrophagesDiR/">Near-infrared fluorescence 1,1-dioctadecyl-3,3,3,3-tetramethylindotricarbocyanine iodide (DiR)-labeled macrophages for cell imaging</a><span class="small"> [<a href="/books/n/micad/MacrophagesDiR/pdf/">PDF Version</a>]</span><div>DiR-Labeled macrophages</div><div>Liang Shan.</div><div class="small">Created: December 11, 2009; Last Update: January 12, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdy675"><a class="toc-item" href="/books/n/micad/sosdy675/">DY675</a><ul id="toc_lst_NBK5330_toc_sosdy675" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_DY675-g7-PLGA-NPs"><a class="toc-item" href="/books/n/micad/DY675-g7-PLGA-NPs/">DY-675-<i>g7</i>-Poly(lactic-co-glycolic acid) nanoparticles</a><span class="small"> [<a href="/books/n/micad/DY675-g7-PLGA-NPs/pdf/">PDF Version</a>]</span><div>DY-<i>g7</i>-PLGA NPs</div><div>Kam Leung.</div><div class="small">Created: December 1, 2010; Last Update: March 3, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdy682"><a class="toc-item" href="/books/n/micad/sosdy682/">DY682</a><ul id="toc_lst_NBK5330_toc_sosdy682" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-ABD-DY682"><a class="toc-item" href="/books/n/micad/Z342-ABD-DY682/">DY-682-Albumin-binding domain-fused-Z<sub>HER2:342</sub> Affibody</a><span class="small"> [<a href="/books/n/micad/Z342-ABD-DY682/pdf/">PDF Version</a>]</span><div>DY-682-ABD-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: June 17, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdy750"><a class="toc-item" href="/books/n/micad/sosdy750/">DY750</a><ul id="toc_lst_NBK5330_toc_sosdy750" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MES-1-DyLight750"><a class="toc-item" href="/books/n/micad/MES-1-DyLight750/">DyLight 750-MES-1 E-selectin monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MES-1-DyLight750/pdf/">PDF Version</a>]</span><div>DyLight 750-MES-1</div><div>Kam Leung.</div><div class="small">Created: February 28, 2011; Last Update: June 1, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosfluorescein"><a class="toc-item" href="/books/n/micad/sosfluorescein/">Fluorescein</a><ul id="toc_lst_NBK5330_toc_sosfluorescein" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_FLSHSA"><a class="toc-item" href="/books/n/micad/FLSHSA/">Fluorescein-conjugated human serum albumin</a><span class="small"> [<a href="/books/n/micad/FLSHSA/pdf/">PDF Version</a>]</span><div>FLS-HSA</div><div>The MICAD Research Team.</div><div class="small">Created: July 26, 2007; Last Update: August 30, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosfluoresceinisothiocy"><a class="toc-item" href="/books/n/micad/sosfluoresceinisothiocy/">Fluorescein isothiocyanate (FITC)</a><ul id="toc_lst_NBK5330_toc_sosfluoresceinisothiocy" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_FITC-IAC"><a class="toc-item" href="/books/n/micad/FITC-IAC/">4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(<i>S</i>)-[<i>N</i>-3-amino-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine fluorescein thiourea </a><span class="small"> [<a href="/books/n/micad/FITC-IAC/pdf/">PDF Version</a>]</span><div>FITC-IAC</div><div>Kenneth T. Cheng, Narasimhan Danthi, and Jianwu Xie.</div><div class="small">Created: October 9, 2007; Last Update: January 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fluorescin-CLT"><a class="toc-item" href="/books/n/micad/Fluorescin-CLT/">Fluorescein-conjugated cyclic decapeptides, CGLIIQKNEC (CLT1) and CNAGESSKNC (CLT2)</a><span class="small"> [<a href="/books/n/micad/Fluorescin-CLT/pdf/">PDF Version</a>]</span><div>Fluorescent CLT peptides</div><div>Liang Shan.</div><div class="small">Created: July 28, 2011; Last Revision: August 28, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgreenfluorescencepro"><a class="toc-item" href="/books/n/micad/sosgreenfluorescencepro/">Green fluorescence protein</a><ul id="toc_lst_NBK5330_toc_sosgreenfluorescencepro" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AdE3EGFP"><a class="toc-item" href="/books/n/micad/AdE3EGFP/">Recombinant adenovirus with enhanced green fluorescent protein</a><span class="small"> [<a href="/books/n/micad/AdE3EGFP/pdf/">PDF Version</a>]</span><div>Ad-E3-EGFP</div><div>Arvind Chopra.</div><div class="small">Created: December 9, 2007; Last Update: January 2, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgreenfluorescencepro2"><a class="toc-item" href="/books/n/micad/sosgreenfluorescencepro2/">Green fluorescence protein (GFP), luciferin</a><ul id="toc_lst_NBK5330_toc_sosgreenfluorescencepro2" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TGL"><a class="toc-item" href="/books/n/micad/TGL/">HSV1-TK/GFP/Fluc</a><span class="small"> [<a href="/books/n/micad/TGL/pdf/">PDF Version</a>]</span><div>TGL</div><div>Huiming Zhang.</div><div class="small">Created: October 21, 2008; Last Update: December 1, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soshilytefluor647"><a class="toc-item" href="/books/n/micad/soshilytefluor647/">HiLyte Fluor 647</a><ul id="toc_lst_NBK5330_toc_soshilytefluor647" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_HHAuNPs"><a class="toc-item" href="/books/n/micad/HHAuNPs/">HiLyte Fluor 647-hyaluronic acid-gold nanoparticles</a><span class="small"> [<a href="/books/n/micad/HHAuNPs/pdf/">PDF Version</a>]</span><div>HHAuNPs</div><div>Kam Leung.</div><div class="small">Created: December 26, 2008; Last Update: February 24, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosianbd"><a class="toc-item" href="/books/n/micad/sosianbd/">IANBD</a><ul id="toc_lst_NBK5330_toc_sosianbd" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_pSIVAm"><a class="toc-item" href="/books/n/micad/pSIVAm/">Annexin B12 Cys101,Cys260-N,N'-dimethyl-N-(iodoacetyl)-N'-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)ethylenediamine</a><span class="small"> [<a href="/books/n/micad/pSIVAm/pdf/">PDF Version</a>]</span><div>pSIVA<sub>m</sub></div><div>Liang Shan.</div><div class="small">Created: May 22, 2010; Last Update: June 30, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosindocyaninegreen"><a class="toc-item" href="/books/n/micad/sosindocyaninegreen/">Indocyanine green</a><ul id="toc_lst_NBK5330_toc_sosindocyaninegreen" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anti-Sp17-ICG-Der02"><a class="toc-item" href="/books/n/micad/Anti-Sp17-ICG-Der02/">Anti-human sperm protein 17 monoclonal antibody-indocyanine green derivative 02</a><span class="small"> [<a href="/books/n/micad/Anti-Sp17-ICG-Der02/pdf/">PDF Version</a>]</span><div>Anti-Sp17-ICG-Der-02</div><div>Kam Leung.</div><div class="small">Created: September 8, 2012; Last Update: December 20, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-BSA-Folate-MPA"><a class="toc-item" href="/books/n/micad/Au-BSA-Folate-MPA/">Bovine serum albumin–stabilized gold nanoclusters conjugated with folate and indocyanine green derivative 02</a><span class="small"> [<a href="/books/n/micad/Au-BSA-Folate-MPA/pdf/">PDF Version</a>]</span><div>Au-FA-MPA</div><div>Kam Leung.</div><div class="small">Created: October 4, 2012; Last Update: January 24, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-BSA-Met-MPA"><a class="toc-item" href="/books/n/micad/Au-BSA-Met-MPA/">Bovine serum albumin–stabilized gold nanoclusters conjugated with <span class="small-caps">l</span>-methionine and indocyanine green derivative 02</a><span class="small"> [<a href="/books/n/micad/Au-BSA-Met-MPA/pdf/">PDF Version</a>]</span><div>Au-Met-MPA</div><div>Kam Leung.</div><div class="small">Created: October 1, 2012; Last Update: January 24, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DacICG"><a class="toc-item" href="/books/n/micad/DacICG/">Daclizumab complexed to near-infrared fluorophore indocyanine green</a><span class="small"> [<a href="/books/n/micad/DacICG/pdf/">PDF Version</a>]</span><div>Dac-ICG</div><div>Arvind Chopra.</div><div class="small">Created: February 17, 2009; Last Update: March 4, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FA-ICG-PLGA_NPs"><a class="toc-item" href="/books/n/micad/FA-ICG-PLGA_NPs/">Folic acid-indocyanine green-poly(<span class="small-caps">d</span>,<span class="small-caps">l</span>-lactide-coglycolide)-lipid nanoparticles</a><span class="small"> [<a href="/books/n/micad/FA-ICG-PLGA_NPs/pdf/">PDF Version</a>]</span><div>FA-ICG-PLGA-lipid NPs</div><div>Arvind Chopra.</div><div class="small">Created: August 30, 2012; Last Update: September 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ICG-Der-02-2DG"><a class="toc-item" href="/books/n/micad/ICG-Der-02-2DG/">Indocyanine green derivative 02-2-deoxy-<span class="small-caps">d</span>-glucose</a><span class="small"> [<a href="/books/n/micad/ICG-Der-02-2DG/pdf/">PDF Version</a>]</span><div>ICG-Der-02-2DG</div><div>Kam Leung.</div><div class="small">Created: September 17, 2012; Last Update: December 20, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cRGDyK2-ICG-Der-02"><a class="toc-item" href="/books/n/micad/cRGDyK2-ICG-Der-02/">Indocyanine green derivative 02-Glu-c(RGDyK)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/cRGDyK2-ICG-Der-02/pdf/">PDF Version</a>]</span><div>ICG-Der-02-c(RGDyK)<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: September 24, 2012; Last Update: December 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ICG-CPNP"><a class="toc-item" href="/books/n/micad/ICG-CPNP/">Indocyanine green–doped calcium phosphate nanoparticles</a><span class="small"> [<a href="/books/n/micad/ICG-CPNP/pdf/">PDF Version</a>]</span><div>ICG-CPNPs</div><div>Kam Leung.</div><div class="small">Created: March 17, 2010; Last Update: April 15, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ICG-PEG-Folate"><a class="toc-item" href="/books/n/micad/ICG-PEG-Folate/">Indocyanine green-polyethylene glycol-folate</a><span class="small"> [<a href="/books/n/micad/ICG-PEG-Folate/pdf/">PDF Version</a>]</span><div>fPI-01</div><div>Kam Leung.</div><div class="small">Created: January 19, 2011; Last Update: April 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Met-ICG-Der-02"><a class="toc-item" href="/books/n/micad/Met-ICG-Der-02/"><span class="small-caps">l</span>-Methyl-methionine-indocyanine green derivative 02</a><span class="small"> [<a href="/books/n/micad/Met-ICG-Der-02/pdf/">PDF Version</a>]</span><div>Met-ICG-Der-02</div><div>Kam Leung.</div><div class="small">Created: September 27, 2012; Last Update: December 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_J591-ICG"><a class="toc-item" href="/books/n/micad/J591-ICG/">Quenched indocyanine green-anti-prostate-specific membrane antigen antibody J591</a><span class="small"> [<a href="/books/n/micad/J591-ICG/pdf/">PDF Version</a>]</span><div>ICG-J591</div><div>Kam Leung.</div><div class="small">Created: December 8, 2011; Last Update: March 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TraICG"><a class="toc-item" href="/books/n/micad/TraICG/">Trastuzumab complexed to near-infrared fluorophore indocyanine green</a><span class="small"> [<a href="/books/n/micad/TraICG/pdf/">PDF Version</a>]</span><div>Tra-ICG</div><div>Arvind Chopra.</div><div class="small">Created: February 11, 2009; Last Update: March 4, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosindocyaninegreenandalexafluor680"><a class="toc-item" href="/books/n/micad/sosindocyaninegreenandalexafluor680/">Indocyanine green and Alexa Fluor680</a><ul id="toc_lst_NBK5330_toc_sosindocyaninegreenandalexafluor680" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Pan-Tra"><a class="toc-item" href="/books/n/micad/Pan-Tra/">Activatable Alexa Fluor680-conjugated panitumumab and indocyanine green-conjugated trastuzumab cocktail</a><span class="small"> [<a href="/books/n/micad/Pan-Tra/pdf/">PDF Version</a>]</span><div>Pan-Alexa680 and Tra-ICG cocktail</div><div>Liang Shan.</div><div class="small">Created: May 16, 2012; Last Update: July 10, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosir783"><a class="toc-item" href="/books/n/micad/sosir783/">IR-783</a><ul id="toc_lst_NBK5330_toc_sosir783" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IR783"><a class="toc-item" href="/books/n/micad/IR783/">2-[2-[2-Chloro-3-[2-[1,3-dihydro-3,3-dimethyl-1-(4-sulfobutyl)-2H-indol-2-ylidene]-ethylidene]-1-cyclohexen-1-yl]-ethenyl]-3,3-dimethyl-1-(4-sulfobutyl)-3H-indolium</a><span class="small"> [<a href="/books/n/micad/IR783/pdf/">PDF Version</a>]</span><div>IR-783</div><div>Kam Leung.</div><div class="small">Created: July 12, 2010; Last Update: October 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IR783-Hyaluronan"><a class="toc-item" href="/books/n/micad/IR783-Hyaluronan/">Hyaluronan conjugated with IR-783</a><span class="small"> [<a href="/books/n/micad/IR783-Hyaluronan/pdf/">PDF Version</a>]</span><div>IR783-HA</div><div>Kam Leung.</div><div class="small">Created: May 24, 2011; Last Update: July 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Glucosamine-IR783"><a class="toc-item" href="/books/n/micad/Glucosamine-IR783/">IR-783-Glucosamine</a><span class="small"> [<a href="/books/n/micad/Glucosamine-IR783/pdf/">PDF Version</a>]</span><div>IR-2</div><div>Kam Leung.</div><div class="small">Created: August 2, 2008; Last Update: May 11, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosir786"><a class="toc-item" href="/books/n/micad/sosir786/">IR-786</a><ul id="toc_lst_NBK5330_toc_sosir786" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Hoechst-IR786"><a class="toc-item" href="/books/n/micad/Hoechst-IR786/">Hoechst 33258-polyethylene glycol-IR-786</a><span class="small"> [<a href="/books/n/micad/Hoechst-IR786/pdf/">PDF Version</a>]</span><div>
|
|
<b>Hoechst-IR</b>
|
|
</div><div>Kam Leung.</div><div class="small">Created: September 29, 2011; Last Update: December 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IR-786"><a class="toc-item" href="/books/n/micad/IR-786/">IR-786 perchlorate</a><span class="small"> [<a href="/books/n/micad/IR-786/pdf/">PDF Version</a>]</span><div>IR-786</div><div>Kam Leung.</div><div class="small">Created: January 3, 2005; Last Update: October 5, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosir820"><a class="toc-item" href="/books/n/micad/sosir820/">IR-820</a><ul id="toc_lst_NBK5330_toc_sosir820" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ORMOSIL-NPs"><a class="toc-item" href="/books/n/micad/ORMOSIL-NPs/">Protoporphyrin IX and IR-820 fluorophore–encapsulated organically modified silica nanoparticles</a><span class="small"> [<a href="/books/n/micad/ORMOSIL-NPs/pdf/">PDF Version</a>]</span><div>PpIX/IR-820–doped ORMOSIL NPs</div><div>Liang Shan.</div><div class="small">Created: June 29, 2012; Last Update: August 7, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosir820andfitc"><a class="toc-item" href="/books/n/micad/sosir820andfitc/">IR-820 and FITC</a><ul id="toc_lst_NBK5330_toc_sosir820andfitc" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_BetaG-Trap"><a class="toc-item" href="/books/n/micad/BetaG-Trap/"><i>N</i>'-Fluorescein-<i>N</i>''-[4-<i>O</i>-(β-<span class="small-caps">d</span>-glucopyranuronic acid)-3-difluoromethylphenyl]-<i>S</i>-methylthiourea (FITC-TrapG) and <i>N</i>'-(p-aminophenyl)thioether of IR-820-<i>N</i>''-[4-<i>O</i>-(β-<span class="small-caps">d</span>-glucopyranuronic acid)-3-difluoromethylphenyl]-<i>S</i>-methylthiourea (NIR-TrapG)</a><span class="small"> [<a href="/books/n/micad/BetaG-Trap/pdf/">PDF Version</a>]</span><div>FITC-TrapG and NIR-TrapG</div><div>Arvind Chopra.</div><div class="small">Created: April 10, 2012; Last Update: May 10, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosirdye700dx"><a class="toc-item" href="/books/n/micad/sosirdye700dx/">IRDye700DX</a><ul id="toc_lst_NBK5330_toc_sosirdye700dx" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Annex700DX"><a class="toc-item" href="/books/n/micad/Annex700DX/">IRDye 700DX-Labeled annexin V</a><span class="small"> [<a href="/books/n/micad/Annex700DX/pdf/">PDF Version</a>]</span><div>NIR700-Annexin V</div><div>Arvind Chopra.</div><div class="small">Created: October 27, 2009; Last Update: December 17, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosirdye78"><a class="toc-item" href="/books/n/micad/sosirdye78/">IRDye78</a><ul id="toc_lst_NBK5330_toc_sosirdye78" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_GPI-78"><a class="toc-item" href="/books/n/micad/GPI-78/">GPI-78</a><span class="small"> [<a href="/books/n/micad/GPI-78/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: May 5, 2006; Last Update: August 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Pamidronate78"><a class="toc-item" href="/books/n/micad/Pamidronate78/">Pamidronate-IRDye78</a><span class="small"> [<a href="/books/n/micad/Pamidronate78/pdf/">PDF Version</a>]</span><div>PAM78</div><div>Kam Leung.</div><div class="small">Created: January 4, 2005; Last Update: January 5, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosirdye800cw"><a class="toc-item" href="/books/n/micad/sosirdye800cw/">IRDye 800CW</a><ul id="toc_lst_NBK5330_toc_sosirdye800cw" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF-Avib-SA800"><a class="toc-item" href="/books/n/micad/VEGF-Avib-SA800/">Biotinylated vascular endothelial growth factor<sub>121</sub>-Avi-streptavidin-IRDye800</a><span class="small"> [<a href="/books/n/micad/VEGF-Avib-SA800/pdf/">PDF Version</a>]</span><div>VEGF<sub>121</sub>-Avib-SA800</div><div>Kam Leung.</div><div class="small">Created: May 17, 2009; Last Update: July 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CD44v6Dye800CW"><a class="toc-item" href="/books/n/micad/CD44v6Dye800CW/">Humanized anti-CD44v6 monoclonal antibody labeled with IRDye800CW</a><span class="small"> [<a href="/books/n/micad/CD44v6Dye800CW/pdf/">PDF Version</a>]</span><div>Anti-CD44v6-IRDye800CW</div><div>Arvind Chopra.</div><div class="small">Created: May 20, 2013; Last Update: June 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_YC-27-IRDye800"><a class="toc-item" href="/books/n/micad/YC-27-IRDye800/">IRDye800-2-(3-{5-[7-(5-amino-1-carboxy-pentylcarbamoyl)-heptanoylamino]-1-carboxy-pentyl}-ureido)-pentanedioic acid</a><span class="small"> [<a href="/books/n/micad/YC-27-IRDye800/pdf/">PDF Version</a>]</span><div>YC-27</div><div>Kam Leung.</div><div class="small">Created: May 12, 2010; Last Update: July 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DG-IRDye800"><a class="toc-item" href="/books/n/micad/DG-IRDye800/">IRDye800-2-Deoxy-<span class="small-caps">D</span>-glucose</a><span class="small"> [<a href="/books/n/micad/DG-IRDye800/pdf/">PDF Version</a>]</span><div>IRDye800-2-DG</div><div>Kam Leung.</div><div class="small">Created: May 17, 2009; Last Update: July 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-ABD-IRDye800"><a class="toc-item" href="/books/n/micad/Z342-ABD-IRDye800/">IRDye 800-albumin-binding domain-fused-Z<sub>HER2:342</sub> Affibody</a><span class="small"> [<a href="/books/n/micad/Z342-ABD-IRDye800/pdf/">PDF Version</a>]</span><div>IRDye 800-ABD-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: March 16, 2011; Last Update: March 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Eaff-IRDye800"><a class="toc-item" href="/books/n/micad/Eaff-IRDye800/">IRDye 800-Anti–epidermal growth factor receptor Affibody</a><span class="small"> [<a href="/books/n/micad/Eaff-IRDye800/pdf/">PDF Version</a>]</span><div>Eaff800</div><div>Kam Leung.</div><div class="small">Created: June 17, 2010; Last Update: September 9, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Avas12a1-IRDye800"><a class="toc-item" href="/books/n/micad/Avas12a1-IRDye800/">IRDye800-Anti-vascular endothelial growth factor receptor-2 monoclonal antibody Avas12a1</a><span class="small"> [<a href="/books/n/micad/Avas12a1-IRDye800/pdf/">PDF Version</a>]</span><div>IRDye800-Avas12a1</div><div>Kam Leung.</div><div class="small">Created: February 17, 2010; Last Update: April 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TRC105-IRDye800"><a class="toc-item" href="/books/n/micad/TRC105-IRDye800/">IRDye800CW-anti-CD105 TRC105 chimeric monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/TRC105-IRDye800/pdf/">PDF Version</a>]</span><div>IRDye800CW-TRC105</div><div>Kam Leung.</div><div class="small">Created: December 1, 2011; Last Update: February 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IRDye800-7D12"><a class="toc-item" href="/books/n/micad/IRDye800-7D12/">IRDye 800CW-Anti-epidermal growth factor receptor nanobody 7D12</a><span class="small"> [<a href="/books/n/micad/IRDye800-7D12/pdf/">PDF Version</a>]</span><div>IRDye800CW-7D12</div><div>Kam Leung.</div><div class="small">Created: April 6, 2012; Last Update: July 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cABD-IRDye800"><a class="toc-item" href="/books/n/micad/cABD-IRDye800/">IRDye800CW-Cyclic albumin-binding domain (Ac-RLIEDICLPRWGCLWEDDK-NH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/cABD-IRDye800/pdf/">PDF Version</a>]</span><div>IRDye800-cABD</div><div>Kam Leung.</div><div class="small">Created: December 19, 2011; Last Update: March 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IRDye800CW-EGF"><a class="toc-item" href="/books/n/micad/IRDye800CW-EGF/">IRDye 800CW-Epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/IRDye800CW-EGF/pdf/">PDF Version</a>]</span><div>IRDye 800CW-EGF</div><div>Kam Leung.</div><div class="small">Created: January 19, 2007; Last Update: June 21, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HSA800"><a class="toc-item" href="/books/n/micad/HSA800/">IRDye 800CW-Human serum albumin</a><span class="small"> [<a href="/books/n/micad/HSA800/pdf/">PDF Version</a>]</span><div>HSA800</div><div>Kam Leung.</div><div class="small">Created: January 19, 2007; Last Update: May 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cys800CWiRGD"><a class="toc-item" href="/books/n/micad/Cys800CWiRGD/">Near-infrared Dye<sup>®</sup>800CW–conjugated disulfide-based cyclic RGD peptide c(CRGDKGPDC) and its DOTA analog</a><span class="small"> [<a href="/books/n/micad/Cys800CWiRGD/pdf/">PDF Version</a>]</span><div>Ac-Cys(IRDye800CW)-iRGD and DOTA-Cys(IRDye800CW)-iRGD</div><div>Arvind Chopra.</div><div class="small">Created: August 6, 2012; Last Update: August 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BChEIRDye800CW"><a class="toc-item" href="/books/n/micad/BChEIRDye800CW/">Near-infrared dye IRDye 800CW-labeled butyrylcholinesterase</a><span class="small"> [<a href="/books/n/micad/BChEIRDye800CW/pdf/">PDF Version</a>]</span><div>BChE-IRDye 800CW</div><div>Liang Shan.</div><div class="small">Created: October 20, 2009; Last Update: December 14, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosirisblue"><a class="toc-item" href="/books/n/micad/sosirisblue/">IRIS Blue</a><ul id="toc_lst_NBK5330_toc_sosirisblue" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_DCCP16-IRIS"><a class="toc-item" href="/books/n/micad/DCCP16-IRIS/">GKVLAK–(IRIS Blue-(1,4,7,10-tetraazacyclododecane-1,4,7-tris(acetic acid <i>t</i>-butyl ester)-10-acetic acid monoamide))–GGGGTVQQEL</a><span class="small"> [<a href="/books/n/micad/DCCP16-IRIS/pdf/">PDF Version</a>]</span><div>DCCP16-IRIS Blue</div><div>Liang Shan.</div><div class="small">Created: March 29, 2011; Last Update: April 26, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosluciferin"><a class="toc-item" href="/books/n/micad/sosluciferin/">Luciferin</a><ul id="toc_lst_NBK5330_toc_sosluciferin" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AdTSTAFluc"><a class="toc-item" href="/books/n/micad/AdTSTAFluc/"><i>Ad5</i>-(PSE-BC)-(GAL4-(VP16)<sub>2</sub>)-(GAL4)<sub>5</sub>-Fluc </a><span class="small"> [<a href="/books/n/micad/AdTSTAFluc/pdf/">PDF Version</a>]</span><div>AdTSTA-FL</div><div>Huiming Zhang.</div><div class="small">Created: December 5, 2008; Last Update: January 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GLuc"><a class="toc-item" href="/books/n/micad/GLuc/"><i>Gaussia princeps</i> luciferase </a><span class="small"> [<a href="/books/n/micad/GLuc/pdf/">PDF Version</a>]</span><div>hGLuc</div><div>Arvind Chopra.</div><div class="small">Created: January 31, 2008; Last Update: February 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IDMyoDNCFluc"><a class="toc-item" href="/books/n/micad/IDMyoDNCFluc/">Id protein-firefly luciferase N-fragment & firefly luciferase C-fragment-MyoD protein</a><span class="small"> [<a href="/books/n/micad/IDMyoDNCFluc/pdf/">PDF Version</a>]</span><div>Id-NFluc & CFluc-MyoD</div><div>Huiming Zhang.</div><div class="small">Created: September 24, 2008; Last Update: October 23, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FluorescentEcoli"><a class="toc-item" href="/books/n/micad/FluorescentEcoli/">Luciferase-expressing <i>Escherichia coli</i></a><span class="small"> [<a href="/books/n/micad/FluorescentEcoli/pdf/">PDF Version</a>]</span><div>pLux-expressing <i>E. coli</i></div><div>Arvind Chopra.</div><div class="small">Created: January 22, 2008; Last Update: February 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BARNCFluc"><a class="toc-item" href="/books/n/micad/BARNCFluc/">NFluc-FHA2-Aktpep-CFluc</a><span class="small"> [<a href="/books/n/micad/BARNCFluc/pdf/">PDF Version</a>]</span><div>BARNCFluc</div><div>Huiming Zhang.</div><div class="small">Created: November 14, 2008; Last Update: December 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hERNCRluc"><a class="toc-item" href="/books/n/micad/hERNCRluc/">NRluc-hER<sub>281-549</sub>-CRluc </a><span class="small"> [<a href="/books/n/micad/hERNCRluc/pdf/">PDF Version</a>]</span><div>hERNCRluc</div><div>Huiming Zhang.</div><div class="small">Created: December 29, 2008; Last Update: January 26, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DB18Rluc8"><a class="toc-item" href="/books/n/micad/DB18Rluc8/">T84.66 Anti-CEA diabody-GSTSGSGKPGSGEGSTSG-<i>Renilla</i> luciferase</a><span class="small"> [<a href="/books/n/micad/DB18Rluc8/pdf/">PDF Version</a>]</span><div>Db-18-Rluc8</div><div>Huiming Zhang.</div><div class="small">Created: September 18, 2008; Last Update: October 23, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosmalachitegreen"><a class="toc-item" href="/books/n/micad/sosmalachitegreen/">Malachite green</a><ul id="toc_lst_NBK5330_toc_sosmalachitegreen" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ScFvB10-AuNP-MGITC"><a class="toc-item" href="/books/n/micad/ScFvB10-AuNP-MGITC/">Malachite green-isothiocyanate-polyethylene glycol-gold nanoparticles conjugated with scFv anti-EGFR B10 antibody</a><span class="small"> [<a href="/books/n/micad/ScFvB10-AuNP-MGITC/pdf/">PDF Version</a>]</span><div>MGITC-AuNPs-scFvB10</div><div>Kam Leung.</div><div class="small">Created: February 26, 2008; Last Update: May 14, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosniad4"><a class="toc-item" href="/books/n/micad/sosniad4/">NIAD-4</a><ul id="toc_lst_NBK5330_toc_sosniad4" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_NIAD-4"><a class="toc-item" href="/books/n/micad/NIAD-4/">[[5'-(4-Hydroxyphenyl)[2,2’-bithiophen]-5-yl]methylene]-propanedinitrile NIAD-4</a><span class="small"> [<a href="/books/n/micad/NIAD-4/pdf/">PDF Version</a>]</span><div>Kenneth T. Cheng.</div><div class="small">Created: September 11, 2006; Last Update: November 8, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosnir2"><a class="toc-item" href="/books/n/micad/sosnir2/">NIR2</a><ul id="toc_lst_NBK5330_toc_sosnir2" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_LTVSPWY-PEG-CS"><a class="toc-item" href="/books/n/micad/LTVSPWY-PEG-CS/">LTVSPWY peptide–modified PEGylated chitosan magnetic nanoparticles</a><span class="small"> [<a href="/books/n/micad/LTVSPWY-PEG-CS/pdf/">PDF Version</a>]</span><div>LTVSPWY-PEG-CS NPs</div><div>Arvind Chopra.</div><div class="small">Created: September 7, 2012; Last Update: October 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NIR2-Folate"><a class="toc-item" href="/books/n/micad/NIR2-Folate/">NIR2-Folate</a><span class="small"> [<a href="/books/n/micad/NIR2-Folate/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: May 19, 2006; Last Update: May 30, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NPAPE-NPs"><a class="toc-item" href="/books/n/micad/NPAPE-NPs/">Pegylated bis(4-(<i>N</i>-(2-naphthyl)phenylamino)phenyl)-fumaronitrile (NPAPF) nanoparticles</a><span class="small"> [<a href="/books/n/micad/NPAPE-NPs/pdf/">PDF Version</a>]</span><div>NPAPF-PEG NPs</div><div>Arvind Chopra.</div><div class="small">Created: August 22, 2012; Last Update: September 27, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosoregongreen488"><a class="toc-item" href="/books/n/micad/sosoregongreen488/">Oregon Green 488</a><ul id="toc_lst_NBK5330_toc_sosoregongreen488" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cetuximab-OG"><a class="toc-item" href="/books/n/micad/Cetuximab-OG/">Cetuximab-Oregon Green 488</a><span class="small"> [<a href="/books/n/micad/Cetuximab-OG/pdf/">PDF Version</a>]</span><div>Cetuximab-OG</div><div>The MICAD Research Team.</div><div class="small">Created: August 22, 2007; Last Update: September 24, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CNA35OG"><a class="toc-item" href="/books/n/micad/CNA35OG/">Collagen-binding adhesion protein 35-Oregon Green 488</a><span class="small"> [<a href="/books/n/micad/CNA35OG/pdf/">PDF Version</a>]</span><div>CNA35-OG488</div><div>Kenneth T. Cheng and Marc A.M.J. Van Zandvoort.</div><div class="small">Created: December 11, 2007; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cNGR-OG488"><a class="toc-item" href="/books/n/micad/cNGR-OG488/">OG488-Cyclo(Cys-Asn-Gly-Arg-Cys)-Gly-Lys</a><span class="small"> [<a href="/books/n/micad/cNGR-OG488/pdf/">PDF Version</a>]</span><div>OG488-cNGR</div><div>Kam Leung.</div><div class="small">Created: January 15, 2009; Last Update: March 19, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sospyropheophorbidepyro"><a class="toc-item" href="/books/n/micad/sospyropheophorbidepyro/">Pyropheophorbide α (Pyro)</a><ul id="toc_lst_NBK5330_toc_sospyropheophorbidepyro" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_PPB"><a class="toc-item" href="/books/n/micad/PPB/">Pyro-Gly-Asp-Glu-Val-Asp-Gly-Ser-Gly-Lys(BHQ3)</a><span class="small"> [<a href="/books/n/micad/PPB/pdf/">PDF Version</a>]</span><div>PPB</div><div>Huiming Zhang.</div><div class="small">Created: May 22, 2008; Last Update: July 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PMB"><a class="toc-item" href="/books/n/micad/PMB/">Pyro-Gly-Pro-Leu-Gly-Leu-Ala-Arg-Lys(BHQ3)</a><span class="small"> [<a href="/books/n/micad/PMB/pdf/">PDF Version</a>]</span><div>PP<sub>MMP7</sub>B</div><div>Huiming Zhang.</div><div class="small">Created: May 22, 2008; Last Update: July 21, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosquantumdotqd"><a class="toc-item" href="/books/n/micad/sosquantumdotqd/">Quantum dot (QD)</a><ul id="toc_lst_NBK5330_toc_sosquantumdotqd" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFP-QD"><a class="toc-item" href="/books/n/micad/AFP-QD/">Anti-α-Fetoprotein antibody-quantum dots</a><span class="small"> [<a href="/books/n/micad/AFP-QD/pdf/">PDF Version</a>]</span><div>Anti-AFP-QDs</div><div>Kam Leung.</div><div class="small">Created: February 6, 2009; Last Update: February 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QD705RGD"><a class="toc-item" href="/books/n/micad/QD705RGD/">Arginine-glycine-aspartic acid peptide-labeled quantum dot 705</a><span class="small"> [<a href="/books/n/micad/QD705RGD/pdf/">PDF Version</a>]</span><div>QD705-RGD</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 1, 2006; Last Update: May 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGFQD"><a class="toc-item" href="/books/n/micad/EGFQD/">Epidermal growth factor conjugated to near-infrared fluorescent quantum dots</a><span class="small"> [<a href="/books/n/micad/EGFQD/pdf/">PDF Version</a>]</span><div>EGF-QD</div><div>Arvind Chopra.</div><div class="small">Created: February 2, 2009; Last Update: February 25, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ave1642QD"><a class="toc-item" href="/books/n/micad/Ave1642QD/">Humanized anti–type 1 insulin-like growth factor receptor monoclonal antibody conjugated to cadmium telluride quantum dots</a><span class="small"> [<a href="/books/n/micad/Ave1642QD/pdf/">PDF Version</a>]</span><div>AVE1642-QD</div><div>Arvind Chopra.</div><div class="small">Created: July 15, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSI-QD"><a class="toc-item" href="/books/n/micad/MSI-QD/">Ligand-conjugated, gold-doped CdHgTe quantum dots for multispectral imaging</a><span class="small"> [<a href="/books/n/micad/MSI-QD/pdf/">PDF Version</a>]</span><div>QD800-RGD, QD820-anti-CEACAM1, and QD840-anti-EGFR</div><div>Liang Shan.</div><div class="small">Created: October 23, 2012; Last Update: November 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QD800-EGFR-Ab"><a class="toc-item" href="/books/n/micad/QD800-EGFR-Ab/">QD800-Anti-epidermal growth factor receptor monoclonal antibody nanoparticles</a><span class="small"> [<a href="/books/n/micad/QD800-EGFR-Ab/pdf/">PDF Version</a>]</span><div>QD800-EGFR Ab</div><div>Kam Leung.</div><div class="small">Created: January 6, 2013; Last Update: April 4, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z342-PEG-QD800"><a class="toc-item" href="/books/n/micad/Z342-PEG-QD800/">QD800-Polyethylene glycol-Cys-Z<sub>HER2:342</sub> Affibody</a><span class="small"> [<a href="/books/n/micad/Z342-PEG-QD800/pdf/">PDF Version</a>]</span><div>QD800-PEG-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: July 20, 2012; Last Update: October 18, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Qd800-2154F12A4mAb"><a class="toc-item" href="/books/n/micad/Qd800-2154F12A4mAb/">Quantum dot 800-conjugated anti-Tn IgM 2154F12A4 murine monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Qd800-2154F12A4mAb/pdf/">PDF Version</a>]</span><div>Qdot 800-anti-Tn 2154F12A4 mAb</div><div>Liang Shan.</div><div class="small">Created: August 21, 2009; Last Update: October 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QD800-MPA"><a class="toc-item" href="/books/n/micad/QD800-MPA/">Quantum dot 800–mercaptopropionic acid</a><span class="small"> [<a href="/books/n/micad/QD800-MPA/pdf/">PDF Version</a>]</span><div>QD800-MPA</div><div>Kam Leung.</div><div class="small">Created: February 28, 2011; Last Update: May 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-PEG-QD800"><a class="toc-item" href="/books/n/micad/RGDyK-PEG-QD800/">Quantum dot800-poly(ethylene glycol)-c(Arg-Gly-Asp-<span class="small-caps">d</span>-Tyr-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDyK-PEG-QD800/pdf/">PDF Version</a>]</span><div>QD800-PEG-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: March 21, 2011; Last Update: June 16, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QD800-J591"><a class="toc-item" href="/books/n/micad/QD800-J591/">Quantum dot 800–prostate-specific membrane antigen antibody J591</a><span class="small"> [<a href="/books/n/micad/QD800-J591/pdf/">PDF Version</a>]</span><div>QD800-J591</div><div>Kam Leung.</div><div class="small">Created: February 28, 2011; Last Update: May 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QDAptDox"><a class="toc-item" href="/books/n/micad/QDAptDox/">Quantum dot-A10 RNA aptamer-doxorubicin conjugate</a><span class="small"> [<a href="/books/n/micad/QDAptDox/pdf/">PDF Version</a>]</span><div>QD-Apt(Dox)</div><div>Huiming Zhang.</div><div class="small">Created: August 25, 2008; Last Update: October 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_QD-PMSA"><a class="toc-item" href="/books/n/micad/QD-PMSA/">Quantum dot-prostate-specific membrane antigen antibody J591</a><span class="small"> [<a href="/books/n/micad/QD-PMSA/pdf/">PDF Version</a>]</span><div>QD655-J591</div><div>Kam Leung.</div><div class="small">Created: September 30, 2005; Last Update: February 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Q-LHD"><a class="toc-item" href="/books/n/micad/Q-LHD/">Quantum dots-deoxycholic acid (DOCA)-conjugated low molecular weight heparin (LMWH) nanoparticles</a><span class="small"> [<a href="/books/n/micad/Q-LHD/pdf/">PDF Version</a>]</span><div>Q-LHD</div><div>Kam Leung.</div><div class="small">Created: November 28, 2012; Last Update: February 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Qd-Trastuzumab"><a class="toc-item" href="/books/n/micad/Qd-Trastuzumab/">Quantum dot-trastuzumab</a><span class="small"> [<a href="/books/n/micad/Qd-Trastuzumab/pdf/">PDF Version</a>]</span><div>QT</div><div>Kam Leung.</div><div class="small">Created: March 1, 2007; Last Update: February 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ScFvEGFRQD"><a class="toc-item" href="/books/n/micad/ScFvEGFRQD/">Single-chain anti-epidermal growth factor receptor antibody fragment conjugated to functionalized quantum dots</a><span class="small"> [<a href="/books/n/micad/ScFvEGFRQD/pdf/">PDF Version</a>]</span><div>ScFvEGFR-QD</div><div>Arvind Chopra.</div><div class="small">Created: January 22, 2009; Last Update: March 11, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosrhodaminegreenrhodg"><a class="toc-item" href="/books/n/micad/sosrhodaminegreenrhodg/">Rhodamine green (RhodG)</a><ul id="toc_lst_NBK5330_toc_sosrhodaminegreenrhodg" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_GSA-RhodG"><a class="toc-item" href="/books/n/micad/GSA-RhodG/">Galactosyl serum albumin-rhodamine green</a><span class="small"> [<a href="/books/n/micad/GSA-RhodG/pdf/">PDF Version</a>]</span><div>GSA-RhodG</div><div>Kam Leung.</div><div class="small">Created: November 26, 2007; Last Update: January 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast-RhodG"><a class="toc-item" href="/books/n/micad/Trast-RhodG/">Trastuzumab-rhodamine green</a><span class="small"> [<a href="/books/n/micad/Trast-RhodG/pdf/">PDF Version</a>]</span><div>Trast-RhodG</div><div>Kam Leung.</div><div class="small">Created: January 19, 2008; Last Update: February 25, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosrhodaminex"><a class="toc-item" href="/books/n/micad/sosrhodaminex/">RhodamineX</a><ul id="toc_lst_NBK5330_toc_sosrhodaminex" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_GmSA-20ROX"><a class="toc-item" href="/books/n/micad/GmSA-20ROX/">Galactosamine-serum albumin-rhodamineX<sub>20</sub></a><span class="small"> [<a href="/books/n/micad/GmSA-20ROX/pdf/">PDF Version</a>]</span><div>GmSA-20ROX</div><div>Kam Leung.</div><div class="small">Created: December 10, 2007; Last Update: January 18, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sossidag"><a class="toc-item" href="/books/n/micad/sossidag/">SIDAG</a><ul id="toc_lst_NBK5330_toc_sossidag" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_SIDAG"><a class="toc-item" href="/books/n/micad/SIDAG/">1,1’-bis-(4-sulfobutyl)indotricarbocyanine-5,5’-dicarboxylic acid diglucamide monosodium salt</a><span class="small"> [<a href="/books/n/micad/SIDAG/pdf/">PDF Version</a>]</span><div>SIDAG</div><div>The MICAD Research Team.</div><div class="small">Created: June 1, 2006; Last Update: June 18, 2006.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sossinglewalledcarbonna"><a class="toc-item" href="/books/n/micad/sossinglewalledcarbonna/">Single-walled carbon nanotubes (SWNTs)</a><ul id="toc_lst_NBK5330_toc_sossinglewalledcarbonna" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDSWNTs"><a class="toc-item" href="/books/n/micad/RGDSWNTs/">Cyclic Arg-Gly-Asp-polyethyleneglycol-single-walled carbon nanotubes</a><span class="small"> [<a href="/books/n/micad/RGDSWNTs/pdf/">PDF Version</a>]</span><div>RGD-PEG-SWNTs</div><div>Huiming Zhang.</div><div class="small">Created: October 6, 2008; Last Update: November 17, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sostetramethyl6carboxyr"><a class="toc-item" href="/books/n/micad/sostetramethyl6carboxyr/">Tetramethyl-6-carboxyrhodamine</a><ul id="toc_lst_NBK5330_toc_sostetramethyl6carboxyr" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AvTMQ7"><a class="toc-item" href="/books/n/micad/AvTMQ7/">Avidin conjugated to tetramethyl-6-carboxyrhodamine-QSY<sup>®</sup>7</a><span class="small"> [<a href="/books/n/micad/AvTMQ7/pdf/">PDF Version</a>]</span><div>Av-TM-Q7</div><div>Arvind Chopra.</div><div class="small">Created: February 20, 2009; Last Update: April 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrazTMQ7"><a class="toc-item" href="/books/n/micad/TrazTMQ7/">Trastuzumab conjugated to tetramethyl-6-carboxyrhodamine-QSY<sup>®</sup>7</a><span class="small"> [<a href="/books/n/micad/TrazTMQ7/pdf/">PDF Version</a>]</span><div>Traz-TM-Q7</div><div>Arvind Chopra.</div><div class="small">Created: March 2, 2009; Last Update: April 6, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sostetramethyrhodamine"><a class="toc-item" href="/books/n/micad/sostetramethyrhodamine/">Tetramethylrhodamine</a><ul id="toc_lst_NBK5330_toc_sostetramethyrhodamine" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-PEG-TMR"><a class="toc-item" href="/books/n/micad/MMP-PEG-TMR/">Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-Lys-Lys-tetramethylrhodamine</a><span class="small"> [<a href="/books/n/micad/MMP-PEG-TMR/pdf/">PDF Version</a>]</span><div>PEG-peptide-TMR</div><div>Kam Leung.</div><div class="small">Created: February 6, 2012; Last Update: May 10, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosTHK-265"><a class="toc-item" href="/books/n/micad/sosTHK-265/">THK-265</a><ul id="toc_lst_NBK5330_toc_sosTHK-265" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_THK-265"><a class="toc-item" href="/books/n/micad/THK-265/">5-(2<i>E</i>,4<i>E</i>)-5-(6-hydroxy-4-oxo-2-thioxo-1,2,3,4-tetrahydroxy-5 pyrimidinyl)-2,4-pentadienylidene-2-thioxodihydro-4,6(1<i>H</i>,5<i>H</i>)-pyrimidinedione</a><span class="small"> [<a href="/books/n/micad/THK-265/pdf/">PDF Version</a>]</span><div>THK-265</div><div>Kam Leung.</div><div class="small">Created: July 1, 2012; Last Update: October 25, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sostoto3"><a class="toc-item" href="/books/n/micad/sostoto3/">TOTO-3</a><ul id="toc_lst_NBK5330_toc_sostoto3" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TOTO-3"><a class="toc-item" href="/books/n/micad/TOTO-3/">Quinolinium, 1,1'-[1,3-propanediylbis[(dimethyliminio)-3,1-propanediyl]]bis[4-[3-(3-methyl-2(3<i>H</i>)-benzothiazolylidene)-1-propen-1-yl]-,iodide (1:4)</a><span class="small"> [<a href="/books/n/micad/TOTO-3/pdf/">PDF Version</a>]</span><div>TOTO-3</div><div>Liang Shan.</div><div class="small">Created: April 2, 2012; Last Update: May 2, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosVT750"><a class="toc-item" href="/books/n/micad/sosVT750/">VivoTag 750</a><ul id="toc_lst_NBK5330_toc_sosVT750" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_E4X12-VT750"><a class="toc-item" href="/books/n/micad/E4X12-VT750/">VivoTag-S 750-(<i>S</i>)-2-amino-4-pentynoic acid<sup>12</sup>-exendin-4</a><span class="small"> [<a href="/books/n/micad/E4X12-VT750/pdf/">PDF Version</a>]</span><div>E4<sub>X12</sub>-VT750</div><div>Kam Leung.</div><div class="small">Created: November 1, 2011; Last Update: January 5, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosvivotags680"><a class="toc-item" href="/books/n/micad/sosvivotags680/">VivoTag-S680</a><ul id="toc_lst_NBK5330_toc_sosvivotags680" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MamAb-VT680"><a class="toc-item" href="/books/n/micad/MamAb-VT680/">VivoTag-S 680-anti-human mammaglobin-A monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MamAb-VT680/pdf/">PDF Version</a>]</span><div>MamAb-680</div><div>Kam Leung.</div><div class="small">Created: May 19, 2011; Last Update: July 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IntegriSense"><a class="toc-item" href="/books/n/micad/IntegriSense/">VivoTag-S680–conjugated 3-aminomethyl α<sub>v</sub>β<sub>3</sub> antagonist derivative for fluorescence molecular tomography of tumors</a><span class="small"> [<a href="/books/n/micad/IntegriSense/pdf/">PDF Version</a>]</span><div>IntegriSense</div><div>Liang Shan.</div><div class="small">Created: January 6, 2010; Last Update: May 19, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosvm315"><a class="toc-item" href="/books/n/micad/sosvm315/">VM315</a><ul id="toc_lst_NBK5330_toc_sosvm315" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_VM315"><a class="toc-item" href="/books/n/micad/VM315/">3,3-Diphenylpropylamido-indocyanine sulfonamide</a><span class="small"> [<a href="/books/n/micad/VM315/pdf/">PDF Version</a>]</span><div>VM315</div><div>Milind Rajopadhye.</div><div class="small">Created: December 13, 2006; Last Update: January 26, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_soszw8001"><a class="toc-item" href="/books/n/micad/soszw8001/">ZW800-1</a><ul id="toc_lst_NBK5330_toc_soszw8001" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZW800-1"><a class="toc-item" href="/books/n/micad/ZW800-1/">ZW800-1, a zwitterionic near-infrared fluorophore, and its cyclic RGD peptide derivative cyclo-(RGDyK)-ZW800-1</a><span class="small"> [<a href="/books/n/micad/ZW800-1/pdf/">PDF Version</a>]</span><div>ZW800-1 and cRGD-ZW800-1</div><div>Arvind Chopra.</div><div class="small">Created: February 12, 2013; Last Update: February 28, 2013.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_pet"><a class="toc-item" href="/books/n/micad/pet/">PET</a><ul id="toc_lst_NBK5330_toc_pet" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos11c"><a class="toc-item" href="/books/n/micad/sos11c/">11C</a><ul id="toc_lst_NBK5330_toc_sos11c" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CB1-12a-11C"><a class="toc-item" href="/books/n/micad/CB1-12a-11C/">(-)-3-(4-Chlorophenyl)-<i>N</i>'-[(4-[<sup>11</sup>C]cyanophenyl)sulfonyl]-4-phenyl-4,5-dihydro-1<i>H</i>-pyrazole-1-carboxamidine</a><span class="small"> [<a href="/books/n/micad/CB1-12a-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]CB1-(-)-12a</div><div>Kam Leung.</div><div class="small">Created: December 16, 2008; Last Update: January 2, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GR103545-11C"><a class="toc-item" href="/books/n/micad/GR103545-11C/">(<i>-</i>)-4-[<sup>11</sup>C]Methoxycarbonyl-2-[(1-pyrrolidinylmethyl]-1-[(3,4-dichlorophenyl)acetyl]-piperidine</a><span class="small"> [<a href="/books/n/micad/GR103545-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]GR103545</div><div>Kam Leung.</div><div class="small">Created: May 21, 2006; Last Update: March 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NPA11C"><a class="toc-item" href="/books/n/micad/NPA11C/">(-)-<i>N</i>-[<sup>11</sup>C]Propyl-norapomorphine</a><span class="small"> [<a href="/books/n/micad/NPA11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]NPA</div><div>Kam Leung.</div><div class="small">Created: April 6, 2006; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZYY-339-11C"><a class="toc-item" href="/books/n/micad/ZYY-339-11C/">(+/-)-2-(<i>N</i>-Cyclohexylethyl-<i>N</i>-[<sup>11</sup>C]propyl)amino-5-hydroxytetralin </a><span class="small"> [<a href="/books/n/micad/ZYY-339-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]ZYY-339</div><div>Kam Leung.</div><div class="small">Created: August 16, 2006; Last Update: February 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PPHT11C"><a class="toc-item" href="/books/n/micad/PPHT11C/">(+/-)-2-(<i>N</i>-Phenethyl-<i>N</i>-1'-[<sup>11</sup>C]propyl)amino-5-hydroxytetralin </a><span class="small"> [<a href="/books/n/micad/PPHT11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PPHT</div><div>Kam Leung.</div><div class="small">Created: August 16, 2006; Last Update: February 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CP99994C11"><a class="toc-item" href="/books/n/micad/CP99994C11/">(+)-(2<i>S</i>,3<i>S</i>)-3-(2-[<sup>11</sup>C]Methoxybenzylamino)-2-phenylpiperidine </a><span class="small"> [<a href="/books/n/micad/CP99994C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]CP-99,994</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 14, 2006; Last Update: January 23, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NNC112-11C"><a class="toc-item" href="/books/n/micad/NNC112-11C/">(+)-8-Chloro-5-(7-benzofuranyl)-7-hydroxy-3-[<sup>11</sup>C]methyl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepine</a><span class="small"> [<a href="/books/n/micad/NNC112-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]NNC 112</div><div>Kam Leung.</div><div class="small">Created: March 17, 2006; Last Update: January 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PMV11C"><a class="toc-item" href="/books/n/micad/PMV11C/">(+)-<i>p-</i>[<sup>11</sup>C]Methylvesamicolphenoxy)</a><span class="small"> [<a href="/books/n/micad/PMV11C/pdf/">PDF Version</a>]</span><div>(+)-[<sup>11</sup>C]PMV</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 12, 2006; Last Update: January 23, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LY2428703-11C"><a class="toc-item" href="/books/n/micad/LY2428703-11C/">(1<i>R</i>,2<i>R</i>)-<i>N</i>-(3-(4-[<sup>11</sup>C]Methoxyphenyl)-4-methylisothiazol-5-yl)-2-methylcyclopropane-carboxamide</a><span class="small"> [<a href="/books/n/micad/LY2428703-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]LY2428703</div><div>Kam Leung.</div><div class="small">Created: January 18, 2013; Last Update: April 11, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEO-11C"><a class="toc-item" href="/books/n/micad/PEO-11C/">(20<i>R)</i>-4,5-α-Epoxy-17-methyl-3-hydroxy-6-[<sup>11</sup>C]methoxy-α,17-dimethyl-α-(2-phenylethyl)-6,14-ethenomorphinan-7-methanol</a><span class="small"> [<a href="/books/n/micad/PEO-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]PEO</div><div>Kam Leung.</div><div class="small">Created: October 24, 2009; Last Update: March 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RHM-1-11C"><a class="toc-item" href="/books/n/micad/RHM-1-11C/">(2-<i>methoxy</i>-<sup>11</sup>C)-<i>N</i>-(4-(3,4-Dihydro-6,7-dimethoxy-isoquinolin-2(1<i>H</i>)-yl)butyl)-5-methylbenzamide </a><span class="small"> [<a href="/books/n/micad/RHM-1-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]RHM-1</div><div>Kam Leung.</div><div class="small">Created: July 31, 2006; Last Update: May 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GR203040C11"><a class="toc-item" href="/books/n/micad/GR203040C11/">(2<i>S</i>,3<i>S</i>)-(2-[<sup>11</sup>C]Methoxy-5-tetrazol-1-ylbenzyl)(2-phenylpiperidin-3-yl)amine</a><span class="small"> [<a href="/books/n/micad/GR203040C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]GR203040</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 30, 2006; Last Update: February 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MENET-1-11C"><a class="toc-item" href="/books/n/micad/MENET-1-11C/">(2<i>S</i>,3<i>S</i>)-2-[α-(2-[<sup>11</sup>C]Methylphenoxy)phenylmethyl]morpholine</a><span class="small"> [<a href="/books/n/micad/MENET-1-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MENET-1</div><div>Kam Leung.</div><div class="small">Created: February 9, 2009; Last Update: May 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GR205171C11"><a class="toc-item" href="/books/n/micad/GR205171C11/">(2<i>S</i>,3<i>S</i>)-<i>N</i>-[[2-[<sup>11</sup>C]Methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenyl-piperidin-3-amine</a><span class="small"> [<a href="/books/n/micad/GR205171C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]GR205171</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 19, 2006; Last Update: April 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JNJ-16567083-11C"><a class="toc-item" href="/books/n/micad/JNJ-16567083-11C/">(3-Ethyl-2-[<sup>11</sup>C]methyl-6-quinolinyl)(cis-4-methoxycyclohexyl)methanone</a><span class="small"> [<a href="/books/n/micad/JNJ-16567083-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]JNJ-16567083</div><div>Kam Leung.</div><div class="small">Created: November 15, 2012; Last Update: March 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMePPEP11C"><a class="toc-item" href="/books/n/micad/FMePPEP11C/">(3<i>R</i>,5<i>R</i>)-3-((<i>R</i>)-1-(4-Fluorophenyl)ethylamino)-5-(3-[<sup>11</sup>C]methoxyphenyl)-1-(4-trifluoromethylphenyl)pyrrolidin-2-one</a><span class="small"> [<a href="/books/n/micad/FMePPEP11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]FMePPEP</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 6, 2010; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MePPEP11C"><a class="toc-item" href="/books/n/micad/MePPEP11C/">(3<i>R</i>,5<i>R</i>)-5-(3-[<sup>11</sup>C]Methoxy-phenyl)-3-((<i>R</i>)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one</a><span class="small"> [<a href="/books/n/micad/MePPEP11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]MePPEP</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 6, 2010; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Mirtazapine11C"><a class="toc-item" href="/books/n/micad/Mirtazapine11C/">(<i>R,S</i>)-1,2,3,4,10,14b-Hexahydro-2-[<sup>11</sup>C]methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine</a><span class="small"> [<a href="/books/n/micad/Mirtazapine11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Mirtazapine</div><div>Kam Leung.</div><div class="small">Created: March 9, 2006; Last Update: March 27, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPAT11C"><a class="toc-item" href="/books/n/micad/DPAT11C/">(<i>R</i>,<i>S</i>)-2-(<i>N</i>-Propyl-<i>N</i>-1'-[<sup>11</sup>C]-propyl)amino-5-hydroxytetralin</a><span class="small"> [<a href="/books/n/micad/DPAT11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]-5-OH-DPAT</div><div>Kam Leung.</div><div class="small">Created: August 26, 2006; Last Update: February 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cl-NPA11C"><a class="toc-item" href="/books/n/micad/Cl-NPA11C/">(<i>R</i>)-(-)-2-Chloro-<i>N</i>-[1-<sup>11</sup>C-propyl]<i>n</i>-propylnorapomorphine</a><span class="small"> [<a href="/books/n/micad/Cl-NPA11C/pdf/">PDF Version</a>]</span><div>2-Cl-[<sup>11</sup>C]-(-)-NPA</div><div>Kam Leung.</div><div class="small">Created: October 24, 2010; Last Update: December 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SCH23390"><a class="toc-item" href="/books/n/micad/SCH23390/">(<i>R</i>)-(+)-8-Chloro-2,3,4,5-tetrahydro-3-[<sup>11</sup>C]methyl-5-phenyl-1<i>H</i>-3-benzazepin-7-ol ([<sup>11</sup>C]SCH 23390)</a><span class="small"> [<a href="/books/n/micad/SCH23390/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SCH 23390</div><div>Kam Leung.</div><div class="small">Created: November 22, 2005; Last Update: January 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RWAY11C"><a class="toc-item" href="/books/n/micad/RWAY11C/"><i>(R)</i>-2,3,4,5,6,7-Hexahydro-1-[4-[1-[4-(2-[<sup>11</sup>C]methoxyphenyl)piperazinyl]]-2-phenylbutyryl]-1<i>H</i>-azepine</a><span class="small"> [<a href="/books/n/micad/RWAY11C/pdf/">PDF Version</a>]</span><div>(<i>R</i>)-[<sup>11</sup>C]RWAY</div><div>Kam Leung.</div><div class="small">Created: September 2, 2007; Last Update: October 22, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MNPA11C"><a class="toc-item" href="/books/n/micad/MNPA11C/">(<i>R</i>)-2-[<sup>11</sup>C]Methoxy-<i>N</i>-<i>n</i>-propylnorapomorphine</a><span class="small"> [<a href="/books/n/micad/MNPA11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MNPA</div><div>Kam Leung.</div><div class="small">Created: April 11, 2006; Last Update: February 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MRB11C"><a class="toc-item" href="/books/n/micad/MRB11C/">(<i>S</i>,<i>S</i>)-[<sup>11</sup>C]Methylreboxetine</a><span class="small"> [<a href="/books/n/micad/MRB11C/pdf/">PDF Version</a>]</span><div>(<i>S</i>,<i>S</i>)-[<sup>11</sup>C]MRB</div><div>The MICAD Research Team.</div><div class="small">Created: April 19, 2006; Last Update: May 8, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_WC-98-11C"><a class="toc-item" href="/books/n/micad/WC-98-11C/">(<i>S</i>)-1-(4–2-[<sup>11</sup>C]Methoxybenzyl)-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1<i>H</i>-indole-2,3-dione</a><span class="small"> [<a href="/books/n/micad/WC-98-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]<b>WC-98</b></div><div>Kam Leung.</div><div class="small">Created: September 1, 2009; Last Update: September 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SL25C11"><a class="toc-item" href="/books/n/micad/SL25C11/"> (S)-5-Methoxymethyl-3-[6-(4,4,4-trifluorobutoxy)benzo[<i>d</i>]isoxazol-3-yl]-oxazolidin-2-[<sup>11</sup>C]one</a><span class="small"> [<a href="/books/n/micad/SL25C11/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]SL25.1188</div><div>Kam Leung.</div><div class="small">Created: May 22, 2010; Last Update: July 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Vorozole11C"><a class="toc-item" href="/books/n/micad/Vorozole11C/">(<i>S</i>)-6-[(4-Chlorophenyl)(1<i>H</i>-1,2,4-triazol-1-yl)methyl]-1-[<sup>11</sup>C]methyl-1<i>H</i>-benzotriazole</a><span class="small"> [<a href="/books/n/micad/Vorozole11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Vorozole</div><div>Kam Leung.</div><div class="small">Created: May 8, 2009; Last Update: July 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FLB457-11C"><a class="toc-item" href="/books/n/micad/FLB457-11C/"><i>(S</i>)-<i>N</i>-(1-Ethyl-2-pyrrolidinyl)methyl)-5-bromo-2-[<sup>11</sup>C]methoxy-3-methoxybenzamide</a><span class="small"> [<a href="/books/n/micad/FLB457-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]FLB 457</div><div>Kam Leung.</div><div class="small">Created: April 11, 2006; Last Update: October 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PHNO11C"><a class="toc-item" href="/books/n/micad/PHNO11C/">[<sup>11</sup>C](+)-4-<i>N</i>-Propyl-,3,4a,5,6,10b-hexahydro-2<i>H</i>-naphth[1,2-<i>b</i>][1,4]-oxazin-9-ol</a><span class="small"> [<a href="/books/n/micad/PHNO11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C](+)-PHNO</div><div>Kam Leung.</div><div class="small">Created: May 2, 2006; Last Update: October 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Befloxatone11C"><a class="toc-item" href="/books/n/micad/Befloxatone11C/">[<sup>11</sup>C](5<i>R</i>)-5-(Methoxymethyl)-3-[4-[(3<i>R</i>)-4,4,4-trifluoro-3-hydroxybutoxy]phenyl]-2-oxazolidinone </a><span class="small"> [<a href="/books/n/micad/Befloxatone11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Befloxatone</div><div>Kam Leung.</div><div class="small">Created: July 15, 2006; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GSK21508311C"><a class="toc-item" href="/books/n/micad/GSK21508311C/">[<sup>11</sup>C]-[<i>N</i>-Methyl]3-[(3-fluorophenyl)sulfonyl]-8-(4-methyl-1-piperazinyl)quinoline</a><span class="small"> [<a href="/books/n/micad/GSK21508311C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]-GSK215083</div><div>Arvind Chopra.</div><div class="small">Created: February 6, 2012; Last Update: April 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AL43811C"><a class="toc-item" href="/books/n/micad/AL43811C/">[<sup>11</sup>C]10-Methoxy-5-(2-propenyl)-2,5-dihydro-2,2,4-trimethyl-1H-[1]benzopyrano[3,4-f]quinoline</a><span class="small"> [<a href="/books/n/micad/AL43811C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AL-348</div><div>Arvind Chopra.</div><div class="small">Created: January 13, 2009; Last Update: April 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFE11C"><a class="toc-item" href="/books/n/micad/AFE11C/">[<sup>11</sup>C]2-(2-((Dimethylamino)methyl)phenylthio)-5-(2-fluoroethyl)phenylamine</a><span class="small"> [<a href="/books/n/micad/AFE11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AFE</div><div>The MICAD Research Team.</div><div class="small">Created: February 15, 2006; Last Update: March 7, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFM11C"><a class="toc-item" href="/books/n/micad/AFM11C/">[<sup>11</sup>C]2-(2-(Dimethylaminomethyl)phenylthio)-5-fluoromethylphenylamine</a><span class="small"> [<a href="/books/n/micad/AFM11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AFM</div><div>The MICAD Research Team.</div><div class="small">Created: February 7, 2006; Last Update: February 14, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BF227-11C"><a class="toc-item" href="/books/n/micad/BF227-11C/">[<sup>11</sup>C]2-(2-[2-Dimethylaminothiazol-5-yl]ethenyl)-6-(2-[fluoro]ethoxy)benzoxazole</a><span class="small"> [<a href="/books/n/micad/BF227-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]BF-227</div><div>Kam Leung.</div><div class="small">Created: May 18, 2007; Last Update: August 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PJ34C11"><a class="toc-item" href="/books/n/micad/PJ34C11/">[<sup>11</sup>C]2-(Dimethylamino)-N-(5,6-dihydro-6-oxophenanthridin-2-yl)acetamide</a><span class="small"> [<a href="/books/n/micad/PJ34C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PJ34</div><div>The MICAD Research Team.</div><div class="small">Created: March 31, 2006; Last Update: March 31, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFA11C"><a class="toc-item" href="/books/n/micad/AFA11C/">[<sup>11</sup>C]2-2-(Dimethylaminomethyl)phenylthio)-5-fluorophenylamine</a><span class="small"> [<a href="/books/n/micad/AFA11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AFA</div><div>The MICAD Research Team.</div><div class="small">Created: January 25, 2006; Last Update: February 14, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SB1311C"><a class="toc-item" href="/books/n/micad/SB1311C/">[<sup>11</sup>C]4-<i>N-</i>Methylamino-4´-hydroxystilbene</a><span class="small"> [<a href="/books/n/micad/SB1311C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SB-13</div><div>The MICAD Research Team.</div><div class="small">Created: February 27, 2005; Last Update: March 3, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_benzofuranderivativ"><a class="toc-item" href="/books/n/micad/benzofuranderivativ/">[<sup>11</sup>C]5-Hydroxy-2-(4-methyaminophenyl)benzofuran</a><span class="small"> [<a href="/books/n/micad/benzofuranderivativ/pdf/">PDF Version</a>]</span><div>The MICAD Research Team.</div><div class="small">Created: October 7, 2006; Last Update: October 16, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Acetate11C"><a class="toc-item" href="/books/n/micad/Acetate11C/">[<sup>11</sup>C]Acetate</a><span class="small"> [<a href="/books/n/micad/Acetate11C/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: December 8, 2005; Last Update: May 19, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Acetoacetate11C"><a class="toc-item" href="/books/n/micad/Acetoacetate11C/">[<sup>11</sup>C]Acetoacetate </a><span class="small"> [<a href="/books/n/micad/Acetoacetate11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]ACAC</div><div>Kam Leung.</div><div class="small">Created: October 18, 2008; Last Update: November 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Carfentanil11C"><a class="toc-item" href="/books/n/micad/Carfentanil11C/">[<sup>11</sup>C]Carfentanil</a><span class="small"> [<a href="/books/n/micad/Carfentanil11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]CFN</div><div>Kam Leung.</div><div class="small">Created: March 24, 2007; Last Update: February 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Choline11C"><a class="toc-item" href="/books/n/micad/Choline11C/">[<sup>11</sup>C]Choline</a><span class="small"> [<a href="/books/n/micad/Choline11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]CH</div><div>Kam Leung.</div><div class="small">Created: October 1, 2004; Last Update: February 7, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gly-Sar11C"><a class="toc-item" href="/books/n/micad/Gly-Sar11C/">[<sup>11</sup>C]Glycylsarcosine</a><span class="small"> [<a href="/books/n/micad/Gly-Sar11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Gly-Sar</div><div>Kam Leung.</div><div class="small">Created: September 21, 2008; Last Update: November 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mHED11C"><a class="toc-item" href="/books/n/micad/mHED11C/">[<sup>11</sup>C]<i>meta</i>-Hydroxyephedrine</a><span class="small"> [<a href="/books/n/micad/mHED11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]mHED</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 19, 2006; Last Update: June 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LY2181308-11C"><a class="toc-item" href="/books/n/micad/LY2181308-11C/">[<sup>11</sup>C]Methylated LY2181308</a><span class="small"> [<a href="/books/n/micad/LY2181308-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]LY2181308</div><div>Kam Leung.</div><div class="small">Created: January 27, 2011; Last Update: April 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HOMADAM11C"><a class="toc-item" href="/books/n/micad/HOMADAM11C/">[<sup>11</sup>C]<i>N</i>,<i>N</i>-Dimethyl-2-(2´-amino-4´-hydroxymethylphenylthio)benzylamine</a><span class="small"> [<a href="/books/n/micad/HOMADAM11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]HOMADAM</div><div>The MICAD Research Team.</div><div class="small">Created: January 10, 2005; Last Update: February 27, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DASB11C"><a class="toc-item" href="/books/n/micad/DASB11C/">[<sup>11</sup>C]<i>N</i>,<i>N</i>-Dimethyl-2-(2-amino-4-cyanophenylthio)benzylamine </a><span class="small"> [<a href="/books/n/micad/DASB11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]DASB</div><div>Kam Leung.</div><div class="small">Created: May 18, 2005; Last Update: June 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Erlotinib11C"><a class="toc-item" href="/books/n/micad/Erlotinib11C/">[<sup>11</sup>C]<i>N</i>-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine</a><span class="small"> [<a href="/books/n/micad/Erlotinib11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Erlotinib</div><div>Liang Shan.</div><div class="small">Created: May 18, 2009; Last Update: June 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR7-11C"><a class="toc-item" href="/books/n/micad/PBR7-11C/">[<sup>11</sup>C]<i>N</i>-Methyl-<i>N</i>-phenyl-[2-(4-chlorophenyl)-6,8-dichloroimidazo[1,2-<i>a</i>]pyridin-3-yl]acetamide</a><span class="small"> [<a href="/books/n/micad/PBR7-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]PBR7</div><div>Kam Leung.</div><div class="small">Created: October 8, 2008; Last Update: December 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NE11C"><a class="toc-item" href="/books/n/micad/NE11C/">[<sup>11</sup>C]Norepinephrine</a><span class="small"> [<a href="/books/n/micad/NE11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]NE</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 14, 2006; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HydroxyPG11C"><a class="toc-item" href="/books/n/micad/HydroxyPG11C/">[<sup>11</sup>C]-<i>p</i>-Hydroxyphenethylguanidine </a><span class="small"> [<a href="/books/n/micad/HydroxyPG11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]-<i>p</i>-hydroxy-PG</div><div>Kenneth T. Cheng, David M. Raffel, and Yong-Woon Jung.</div><div class="small">Created: January 18, 2007; Last Update: February 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TPMP11C"><a class="toc-item" href="/books/n/micad/TPMP11C/">[<sup>11</sup>C]Triphenylmethylphosphonium</a><span class="small"> [<a href="/books/n/micad/TPMP11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]TPMP</div><div>Kam Leung.</div><div class="small">Created: September 21, 2006; Last Update: April 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HX4-18F"><a class="toc-item" href="/books/n/micad/HX4-18F/">[<sup>18</sup>F]-3-Fluoro-2-(4-((2-nitro-1<i>H</i>-imidazol-1-yl)methyl)-1<i>H</i>-1,2,3-triazol-1-yl)propan-1-ol</a><span class="small"> [<a href="/books/n/micad/HX4-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-HX4</div><div>Arvind Chopra.</div><div class="small">Created: August 16, 2010; Last Update: September 23, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MPDX11C"><a class="toc-item" href="/books/n/micad/MPDX11C/">[1-<i>methyl</i>-<sup>11</sup>C]8-Dicyclopropylmethyl-1-methyl-3-propylxanthine</a><span class="small"> [<a href="/books/n/micad/MPDX11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MPDX</div><div>Kam Leung.</div><div class="small">Created: February 10, 2006; Last Update: July 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KW-6002-11C"><a class="toc-item" href="/books/n/micad/KW-6002-11C/">[4-<i>O</i>-<i>methyl</i>-<sup>11</sup>C]-8-[(<i>E</i>)-2-(3,4-Dimethoxyphenyl)ethenyl]-1,3-diethyl-7-methylpurine-2,6-dione</a><span class="small"> [<a href="/books/n/micad/KW-6002-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]KW-6002</div><div>Kam Leung.</div><div class="small">Created: September 9, 2008; Last Update: October 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPN11C"><a class="toc-item" href="/books/n/micad/DPN11C/">[6-<i>O</i>-<i>methyl</i>-<sup>11</sup>C]Diprenorphine</a><span class="small"> [<a href="/books/n/micad/DPN11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]DPN</div><div>Kam Leung.</div><div class="small">Created: May 24, 2006; Last Update: May 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TMSX11C"><a class="toc-item" href="/books/n/micad/TMSX11C/">[7-<i>methyl</i>-<sup>11</sup>C]-(<i>E</i>)-8-(3,4,5-Trimethoxystyryl)-1,3,7-trimethylxanthine</a><span class="small"> [<a href="/books/n/micad/TMSX11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]TMSX</div><div>Kam Leung.</div><div class="small">Created: February 17, 2006; Last Update: July 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JWAY11C"><a class="toc-item" href="/books/n/micad/JWAY11C/">[<i>carbonyl</i>-<sup>11</sup>C](<i>R</i>,<i>S</i>)-(<i>N</i>-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)(2-methylethyl)))-<i>N</i>-pyridinyl)cyclohexanecarboxamide</a><span class="small"> [<a href="/books/n/micad/JWAY11C/pdf/">PDF Version</a>]</span><div>[<i>carbonyl</i>-<sup>11</sup>C](<i>R</i>,<i>S</i>)-JWAY</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 16, 2006; Last Update: February 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LY2795050-11C"><a class="toc-item" href="/books/n/micad/LY2795050-11C/">[<i>Carbonyl</i>-<sup>11</sup>C](S)-3-chloro-4-(4-((2-(pyridine-3-yl)pyrrolidin-1-yl)methyl)phenoxy)benzamide</a><span class="small"> [<a href="/books/n/micad/LY2795050-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]LY2795050</div><div>Kam Leung.</div><div class="small">Created: March 21, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Carbonyl11C-WAY"><a class="toc-item" href="/books/n/micad/Carbonyl11C-WAY/">[<i>Carbonyl</i>-<sup>11</sup>C]<i>N</i>-(2-(1-(4-(2-Methoxyphenyl)-piperazinyl)ethyl)-<i>N</i>-pyridinyl)cyclohexanecarboxamide</a><span class="small"> [<a href="/books/n/micad/Carbonyl11C-WAY/pdf/">PDF Version</a>]</span><div>[<i>Carbonyl</i>-<sup>11</sup>C]WAY 100635</div><div>The MICAD Research Team.</div><div class="small">Created: November 11, 2005; Last Update: February 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PipISB11C"><a class="toc-item" href="/books/n/micad/PipISB11C/">[<i>Carbonyl</i>-<sup>11</sup>C]-<i>N</i>-(4-Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide</a><span class="small"> [<a href="/books/n/micad/PipISB11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]PipISB</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 18, 2010; Last Update: October 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MethylImatinib11C"><a class="toc-item" href="/books/n/micad/MethylImatinib11C/">[<i>N</i>-<sup>11</sup>C-<i>methyl</i>]-[4-[(4-Methyl-1-piperazinyl)methyl]-<i>N</i>-[4-methyl-3-[[4-(3-pyridyl)-2-pyrimidinyl]amino]phenyl]benzamide </a><span class="small"> [<a href="/books/n/micad/MethylImatinib11C/pdf/">PDF Version</a>]</span><div>[<i>N</i>-<sup>11</sup>C-<i>methyl</i>]Imatinib</div><div>Arvind Chopra.</div><div class="small">Created: May 30, 2007; Last Update: June 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_COrg34850"><a class="toc-item" href="/books/n/micad/COrg34850/">[<i>N</i>-Methyl-<sup>11</sup>C]-(11β17α)-11-[4-(dimethylamino)phenyl]-17-hydroxy-21-[4-(methylsulfonyl)phenyl]-19-norpregna-4,9-dien-20-yn-3-one</a><span class="small"> [<a href="/books/n/micad/COrg34850/pdf/">PDF Version</a>]</span><div>[<i>N</i>-Methyl-<sup>11</sup>C]Org 34850</div><div>Arvind Chopra.</div><div class="small">Created: January 7, 2009; Last Update: April 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Loperamide11C"><a class="toc-item" href="/books/n/micad/Loperamide11C/">[<i>N</i>-<i>methyl</i>-<sup>11</sup>C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-<i>N</i>-dimethyl-butanamide </a><span class="small"> [<a href="/books/n/micad/Loperamide11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Lop</div><div>Kam Leung.</div><div class="small">Created: December 23, 2008; Last Update: February 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_dLop11C"><a class="toc-item" href="/books/n/micad/dLop11C/">[<i>N</i>-<i>methyl</i>-<sup>11</sup>C]4-(4-(4-Chlorophenyl)-4-hydroxypiperidin-1-yl)-2,2-diphenyl-N-methyl-butanamide</a><span class="small"> [<a href="/books/n/micad/dLop11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]dLop</div><div>Kam Leung.</div><div class="small">Created: May 2, 2009; Last Update: December 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PD153035-11C"><a class="toc-item" href="/books/n/micad/PD153035-11C/">[<i>O</i>-<sup>11</sup>C-<i>methyl</i>]4-<i>N</i>-(3-Bromoanilino)-6,7-dimethoxyquinazoline</a><span class="small"> [<a href="/books/n/micad/PD153035-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PD153035</div><div>Kam Leung.</div><div class="small">Created: May 6, 2009; Last Update: July 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP11C"><a class="toc-item" href="/books/n/micad/MMP11C/">[O-<i>methyl</i>-<sup>11</sup>C]2-(4-(4-(2-Methoxyphenyl)piperazin-1-yl)butyl)-4-methyl-1,2,4-triazine-3,5(2<i>H</i>,4<i>H</i>)dione</a><span class="small"> [<a href="/books/n/micad/MMP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MMP (CUMI-101)</div><div>Kam Leung.</div><div class="small">Created: September 4, 2007; Last Update: June 20, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MPT11C"><a class="toc-item" href="/books/n/micad/MPT11C/">[<i>O</i>-methyl-<sup>11</sup>C]2-{4-[4-(7-Methoxynaphthalen-1-yl)piperazin-1-yl]butyl}-4-methyl-2<i>H</i>-[1,2,4]triazine-3,5-dione</a><span class="small"> [<a href="/books/n/micad/MPT11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MPT</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 30, 2007; Last Update: February 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MeS-IMPY11C"><a class="toc-item" href="/books/n/micad/MeS-IMPY11C/">[<i>S</i>-<i>methyl</i>-<sup>11</sup>C]<i>N</i>,<i>N</i>-Dimethyl-4-(6-(methylthio)imidazo[1,2-<i>a</i>]pyridine-2-yl)aniline</a><span class="small"> [<a href="/books/n/micad/MeS-IMPY11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MeS-IMPY</div><div>Kam Leung.</div><div class="small">Created: October 6, 2007; Last Update: November 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SA4503C11"><a class="toc-item" href="/books/n/micad/SA4503C11/">1-([4-methoxy-<sup>11</sup>C]-3,4-Dimethoxyphenethyl)-4-(3-phenylpropyl)piperazinephenoxy)</a><span class="small"> [<a href="/books/n/micad/SA4503C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SA4503</div><div>Kenneth T. Cheng.</div><div class="small">Created: June 30, 2006; Last Update: February 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SA5845C11"><a class="toc-item" href="/books/n/micad/SA5845C11/">1-([4-methoxy-<sup>11</sup>C]3,4-Dimethoxyphenethyl)-4-[3-(4-fluorophenyl)propyl]piperazine</a><span class="small"> [<a href="/books/n/micad/SA5845C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SA5845</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 21, 2006; Last Update: May 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Metomidate11C"><a class="toc-item" href="/books/n/micad/Metomidate11C/">1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid [11C]methyl ester</a><span class="small"> [<a href="/books/n/micad/Metomidate11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MTO</div><div>Kam Leung.</div><div class="small">Created: June 10, 2005; Last Update: July 18, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JHU76609-11C"><a class="toc-item" href="/books/n/micad/JHU76609-11C/">1-(2,4-Dichlorophenyl)-4-cyano-5-(4-[<sup>11</sup>C]methoxyphenyl)-<i>N</i>-(pyrrolidin-1-yl)-1<i>H</i>-pyrazole-3-carboxamide</a><span class="small"> [<a href="/books/n/micad/JHU76609-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]JHU76609</div><div>Kam Leung.</div><div class="small">Created: June 25, 2010; Last Update: August 26, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PK11195-11C"><a class="toc-item" href="/books/n/micad/PK11195-11C/">1-(2-Chlorophenyl)-<i>N</i>-[<sup>11</sup>C]methyl-<i>N</i>-(1-methylpropyl)-3-isoquinoline carboxamide</a><span class="small"> [<a href="/books/n/micad/PK11195-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PK11195</div><div>Kam Leung.</div><div class="small">Created: January 6, 2006; Last Update: February 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SA6298C11"><a class="toc-item" href="/books/n/micad/SA6298C11/">1-(3,4-[<sup>11</sup>C]Dimethoxyphenethyl)-4-[3-(3,4-dichlorophenyl)propyl]piperazinephenoxy)</a><span class="small"> [<a href="/books/n/micad/SA6298C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SA6298</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 28, 2006; Last Update: May 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Papaverine11C"><a class="toc-item" href="/books/n/micad/Papaverine11C/">1-(3-[<sup>11</sup>C]Methoxy-4-methoxybenzyl)-6,7-dimethoxyisoquinoline</a><span class="small"> [<a href="/books/n/micad/Papaverine11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Papaverine</div><div>Kam Leung.</div><div class="small">Created: December 12, 2010; Last Update: March 2, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Carvedilol11C"><a class="toc-item" href="/books/n/micad/Carvedilol11C/">1-(9<i>H</i>-Carbazol-4-yloxy)-3-(2-(2-[<sup>11</sup>C]methoxyphenoxy)ethylamino)-propan-2-ol</a><span class="small"> [<a href="/books/n/micad/Carvedilol11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Carvedilol</div><div>Kam Leung.</div><div class="small">Created: December 30, 2005; Last Update: February 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_C11-13"><a class="toc-item" href="/books/n/micad/C11-13/">1-(Benzofuran-2-ylmethyl)-4-(4-[<sup>11</sup>C]methoxybenzyl)piperazine</a><span class="small"> [<a href="/books/n/micad/C11-13/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]13</div><div>Liang Shan.</div><div class="small">Created: May 10, 2012; Last Update: June 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AA11C"><a class="toc-item" href="/books/n/micad/AA11C/">1-[<sup>11</sup>C]Arachidonic acid </a><span class="small"> [<a href="/books/n/micad/AA11C/pdf/">PDF Version</a>]</span><div>1-[<sup>11</sup>C]AA</div><div>Arvind Chopra.</div><div class="small">Created: December 29, 2008; Last Update: January 14, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PMP11C"><a class="toc-item" href="/books/n/micad/PMP11C/">1-[<sup>11</sup>C]Methylpiperidin-4-yl propionate</a><span class="small"> [<a href="/books/n/micad/PMP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PMP</div><div>Kam Leung.</div><div class="small">Created: May 1, 2006; Last Update: February 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MP4B11C"><a class="toc-item" href="/books/n/micad/MP4B11C/">1-<sup>11</sup>C-Methyl-4-piperidinyl <i>n</i>-butyrate</a><span class="small"> [<a href="/books/n/micad/MP4B11C/pdf/">PDF Version</a>]</span><div><sup>11</sup>C-MP4B</div><div>Liang Shan.</div><div class="small">Created: October 20, 2009; Last Update: December 14, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHER2342ST11C68Ga"><a class="toc-item" href="/books/n/micad/ZHER2342ST11C68Ga/"><sup>11</sup>C/<sup>68</sup>Ga-Labeled sel-tagged anti-epidermal growth factor receptor 2 affibody Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/ZHER2342ST11C68Ga/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C/<sup>68</sup>Ga]Z<sub>HER2:342</sub>-ST</div><div>Arvind Chopra.</div><div class="small">Created: October 2, 2012; Last Update: October 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Dtaxe11C"><a class="toc-item" href="/books/n/micad/Dtaxe11C/"><sup>11</sup>C-Labeled 1,7β,10β-trihydroxy-9-oxo-5β,20-epoxytax-11-ene-2α,4,13α-triyl 4-acetate 2-benzoate 13-{(2<i>R</i>,3S)-3-[(tert-butoxycarbonyl)amino]-2-hydroxy-3-phenylpropanoate}</a><span class="small"> [<a href="/books/n/micad/Dtaxe11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]-Docetaxel</div><div>Arvind Chopra.</div><div class="small">Created: July 22, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GSK189254C11"><a class="toc-item" href="/books/n/micad/GSK189254C11/"><sup>11</sup>C-Labeled 6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1<i>H</i>-3-benzazepin-7-yl)oxy]-<i>N</i>-methyl-3-pyridinecarboxamide hydrochloride</a><span class="small"> [<a href="/books/n/micad/GSK189254C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]GSK189254</div><div>Arvind Chopra.</div><div class="small">Created: December 11, 2009; Last Revision: July 14, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GSK93114511C"><a class="toc-item" href="/books/n/micad/GSK93114511C/"><sup>11</sup>C-Labeled GSK931145</a><span class="small"> [<a href="/books/n/micad/GSK93114511C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]GSK931145</div><div>Arvind Chopra.</div><div class="small">Created: March 2, 2012; Last Update: April 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_INH11C"><a class="toc-item" href="/books/n/micad/INH11C/"><sup>11</sup>C-Labeled isoniazid</a><span class="small"> [<a href="/books/n/micad/INH11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]INH</div><div>Liang Shan.</div><div class="small">Created: August 2, 2010; Last Update: October 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PZA11C"><a class="toc-item" href="/books/n/micad/PZA11C/"><sup>11</sup>C-Labeled pyrazinamide</a><span class="small"> [<a href="/books/n/micad/PZA11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PZA</div><div>Liang Shan.</div><div class="small">Created: August 2, 2010; Last Update: October 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rhodamine123-11C"><a class="toc-item" href="/books/n/micad/Rhodamine123-11C/"><sup>11</sup>C-Labeled rhodamine-123</a><span class="small"> [<a href="/books/n/micad/Rhodamine123-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]Rhodamine-123</div><div>Arvind Chopra.</div><div class="small">Created: November 19, 2012; Last Update: December 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RIF11C"><a class="toc-item" href="/books/n/micad/RIF11C/"><sup>11</sup>C-Labeled rifampicin</a><span class="small"> [<a href="/books/n/micad/RIF11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]RIF</div><div>Liang Shan.</div><div class="small">Created: August 2, 2010; Last Update: September 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Telmisartan11C"><a class="toc-item" href="/books/n/micad/Telmisartan11C/"><sup>11</sup>C-Labeled Telmisartan, an angiotensin II type 1 receptor antagonist</a><span class="small"> [<a href="/books/n/micad/Telmisartan11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]Telmisartan</div><div>Arvind Chopra.</div><div class="small">Created: July 30, 2012; Last Update: August 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PHEN11C"><a class="toc-item" href="/books/n/micad/PHEN11C/">1<i>R</i>-[<sup>11</sup>C]Phenylephrine</a><span class="small"> [<a href="/books/n/micad/PHEN11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PHEN</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 25, 2006; Last Update: March 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A-836339-11C"><a class="toc-item" href="/books/n/micad/A-836339-11C/">2,2,3,3-Tetramethylcyclopropanecarboxylic acid [3-(2-[<sup>11</sup>C]methoxyethyl)-4,5-dimethyl-3H-thiazol-(2<i>Z</i>)-ylidene]amide</a><span class="small"> [<a href="/books/n/micad/A-836339-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]A-836339</div><div>Kam Leung.</div><div class="small">Created: December 6, 2010; Last Update: January 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_M-MPEP11C"><a class="toc-item" href="/books/n/micad/M-MPEP11C/">2-(2-(3-[<sup>11</sup>C]Methoxyphenyl)ethynyl)pyridine </a><span class="small"> [<a href="/books/n/micad/M-MPEP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]M-MPEP</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 16, 2008; Last Update: February 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_M-PEPy11C"><a class="toc-item" href="/books/n/micad/M-PEPy11C/">2-(2-(5-[<sup>11</sup>C]Methoxypyridin-3-yl)ethynyl)pyridine</a><span class="small"> [<a href="/books/n/micad/M-PEPy11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]M-PEPy</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 7, 2008; Last Update: March 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Metrazoline-11C"><a class="toc-item" href="/books/n/micad/Metrazoline-11C/">2-(2-[[<i>O</i>-<sup>11</sup>C]Tolyl)vinyl]-4,5-dihydro-1<i>H</i>-imidazole</a><span class="small"> [<a href="/books/n/micad/Metrazoline-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Metrazoline</div><div>Kam Leung.</div><div class="small">Created: February 24, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Verapamil11C"><a class="toc-item" href="/books/n/micad/Verapamil11C/">2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-[<sup>11</sup>C]methyl-amino]-2-propan-2-yl-pentanenitrile</a><span class="small"> [<a href="/books/n/micad/Verapamil11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Verapamil</div><div>Kam Leung.</div><div class="small">Created: December 20, 2005; Last Update: February 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FTIMD-11C"><a class="toc-item" href="/books/n/micad/FTIMD-11C/"><i>2</i>-(3-Fluoro-[4-<sup>11</sup>C]tolyl)-4,5-dihydro-1<i>H</i>-imidazole</a><span class="small"> [<a href="/books/n/micad/FTIMD-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]FTIMD</div><div>Kam Leung.</div><div class="small">Created: February 19, 2012; Last Update: May 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CIMBI-36-11C"><a class="toc-item" href="/books/n/micad/CIMBI-36-11C/">2-(4-Bromo-2,5-dimethoxyphenyl)-<i>N</i>-(2-[<sup>11</sup>C]methoxybenzyl)ethanamine</a><span class="small"> [<a href="/books/n/micad/CIMBI-36-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]CIMBI-36</div><div>Kam Leung.</div><div class="small">Created: February 18, 2011; Last Update: March 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CIMBI-5-11C"><a class="toc-item" href="/books/n/micad/CIMBI-5-11C/">2-(4-Iodo-2,5-dimethoxyphenyl)-<i>N</i>-(2-[<sup>11</sup>C]methoxybenzyl)ethanamine</a><span class="small"> [<a href="/books/n/micad/CIMBI-5-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]CIMBI-5</div><div>Kam Leung.</div><div class="small">Created: January 18, 2011; Last Update: March 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A-844606-11C"><a class="toc-item" href="/books/n/micad/A-844606-11C/">2-(5-[<sup>11</sup>C]Methyl-hexahydro-pyrrolo[3,4-c]pyrrol-2-yl)-xanthene-9-one</a><span class="small"> [<a href="/books/n/micad/A-844606-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]A-844606</div><div>Kam Leung.</div><div class="small">Created: October 12, 2010; Last Update: January 19, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A752274-11C"><a class="toc-item" href="/books/n/micad/A752274-11C/">2-(6-[<sup>11</sup>C]Methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-7-(6-methyl-3,6-diazabicyclo[3.2.0]heptan-3-yl)-9H-fluoren-9-one</a><span class="small"> [<a href="/books/n/micad/A752274-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]A-752274</div><div>Arvind Chopra.</div><div class="small">Created: April 9, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A-582941-11C"><a class="toc-item" href="/books/n/micad/A-582941-11C/">2-[<sup>11</sup>C]Methyl-5-[6-phenylpyridazine-3-yl]octahydropyrrolo[3,4-c]pyrrole</a><span class="small"> [<a href="/books/n/micad/A-582941-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]A-582941</div><div>Kam Leung.</div><div class="small">Created: October 12, 2010; Last Update: January 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MPEP11C"><a class="toc-item" href="/books/n/micad/MPEP11C/">2-[<sup>11</sup>C]Methyl-6-(2-phenylethynyl)pyridine </a><span class="small"> [<a href="/books/n/micad/MPEP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MPEP</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 15, 2007; Last Update: February 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TEIMD-11C"><a class="toc-item" href="/books/n/micad/TEIMD-11C/"><i>2</i>-[2-([<i>O</i>-<sup>11</sup>C]Tolyl)ethyl]-4,5-dihydro-1<i>H</i>-imidazole</a><span class="small"> [<a href="/books/n/micad/TEIMD-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]TEIMD</div><div>Kam Leung.</div><div class="small">Created: February 22, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MeES11C"><a class="toc-item" href="/books/n/micad/MeES11C/">2-[<i>methyl</i>-<sup>11</sup>C]Methoxyestradiol </a><span class="small"> [<a href="/books/n/micad/MeES11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]2-ME</div><div>Kam Leung.</div><div class="small">Created: September 28, 2007; Last Update: December 4, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KR31173-11C"><a class="toc-item" href="/books/n/micad/KR31173-11C/">2-Butyl-5-[<sup>11</sup>C]methoxymethyl-6-(1-oxopyridin-2-yl)-3-[[2'-(1<i>H</i>-tetrazol-5-yl)biphenyl-4-yl]methyl]-3<i>H</i>-imidazo[4,5-b]pyridine</a><span class="small"> [<a href="/books/n/micad/KR31173-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]KR31173</div><div>Kam Leung.</div><div class="small">Created: May 12, 2006; Last Update: March 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SA12311Ca"><a class="toc-item" href="/books/n/micad/SA12311Ca/">2-chloro-<i>N</i>-((<i>S</i>)-((<i>S</i>)-1-[<sup>11</sup>C]methylpiperidine-2-yl)(thiophen-3-yl)methyl)-3-(trifluoromethyl)benzamide ([<sup>11</sup>C]SA1) and derivatives</a><span class="small"> [<a href="/books/n/micad/SA12311Ca/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]SA1, [<sup>11</sup>C]SA2, and [<sup>11</sup>C]SA3</div><div>Arvind Chopra.</div><div class="small">Created: February 14, 2012; Last Update: May 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DTBZ11C"><a class="toc-item" href="/books/n/micad/DTBZ11C/">2-Hydroxy-3-isobutyl-9-[<sup>11</sup>C]methoxy-10-methoxy-1,2,3,4,6,7,-hexahydro-11b<i>H</i>-bezo[α]-quinolizine</a><span class="small"> [<a href="/books/n/micad/DTBZ11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]DTBZ</div><div>Kam Leung.</div><div class="small">Created: March 17, 2006; Last Update: October 27, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mZIENT11C"><a class="toc-item" href="/books/n/micad/mZIENT11C/">2β-Carbo[<sup>11</sup>C]methoxy-3β-(3´-((<i>Z</i>)-2-iodoethenyl)phenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/mZIENT11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]<i>m</i>ZIENT</div><div>Jeffrey Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_pZIENT11C"><a class="toc-item" href="/books/n/micad/pZIENT11C/">2β-Carbo[<sup>11</sup>C]methoxy-3β-(4´-((<i>Z</i>)-2-iodoethenyl)phenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/pZIENT11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]<i>p</i>ZIENT</div><div>Jeffrey Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMAU11C"><a class="toc-item" href="/books/n/micad/FMAU11C/">2’-Fluoro-5-([<sup>11</sup>C]-methyl)-1-β-D-arabinofuranosyluracil </a><span class="small"> [<a href="/books/n/micad/FMAU11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]FMAU</div><div>Arvind Chopra.</div><div class="small">Created: January 2, 2008; Last Update: January 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABP688-11C"><a class="toc-item" href="/books/n/micad/ABP688-11C/">3-(6-Methyl-pyridin-2-ylethynyl)-cyclohex-2-enone-<i>O</i>-<sup>11</sup>C-methyl-oxime </a><span class="small"> [<a href="/books/n/micad/ABP688-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]ABP688</div><div>Kenneth T. Cheng.</div><div class="small">Created: April 27, 2006; Last Update: April 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SU11274-11C"><a class="toc-item" href="/books/n/micad/SU11274-11C/">3-[3,5-Dimethyl-4-(4-[<sup>11</sup>C]methylpiperazinecarbonyl)-1<i>H</i>-pyrrol-2-ylmethylene]-2-oxo-2,3-dihydro-1<i>H</i>-indole-5-sulfonic acid (3-chlorophenyl)methylamide</a><span class="small"> [<a href="/books/n/micad/SU11274-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SU11274</div><div>Kam Leung.</div><div class="small">Created: April 17, 2010; Last Update: March 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR6a-11C"><a class="toc-item" href="/books/n/micad/PBR6a-11C/">3-Fluoromethyl-<i>N</i>-[<sup>11</sup>C]methyl-4-phenyl-<i>N</i>-(phenylmethyl)quinoline-2-carboxamide </a><span class="small"> [<a href="/books/n/micad/PBR6a-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PBR6a</div><div>Kam Leung.</div><div class="small">Created: August 9, 2007; Last Update: September 17, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NMSP11C"><a class="toc-item" href="/books/n/micad/NMSP11C/">3-<i>N</i>-[<sup>11</sup>C]Methylspiperone</a><span class="small"> [<a href="/books/n/micad/NMSP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]NMSP</div><div>Kam Leung.</div><div class="small">Created: November 3, 2005; Last Update: October 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rolipram11C"><a class="toc-item" href="/books/n/micad/Rolipram11C/">4-(3-Cyclopentoxy-4-[<sup>11</sup>C]methoxy-phenyl)pyrrolidin-2-one </a><span class="small"> [<a href="/books/n/micad/Rolipram11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]Rolipram</div><div>Kam Leung.</div><div class="small">Created: January 12, 2006; Last Update: January 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CHIBA-1001-11C"><a class="toc-item" href="/books/n/micad/CHIBA-1001-11C/">4-[<sup>11</sup>C]Methylphenyl-1,4-diazabicyclo[3.2.2]nonane-4-carboxylate</a><span class="small"> [<a href="/books/n/micad/CHIBA-1001-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]CHIBA-1001</div><div>Kam Leung.</div><div class="small">Created: December 12, 2008; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AcL703-11C"><a class="toc-item" href="/books/n/micad/AcL703-11C/">4-Acetoxy-7-chloro-3-(3-(-4-[<sup>11</sup>C]methoxybenzyl)phenyl)-2(1<i>H</i>)-quinolone</a><span class="small"> [<a href="/books/n/micad/AcL703-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AcL703,717</div><div>Kam Leung.</div><div class="small">Created: May 8, 2009; Last Update: June 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JHU75528-11C"><a class="toc-item" href="/books/n/micad/JHU75528-11C/">4-Cyano-1-(2,4-dichlorophenyl)-5-(4-[<sup>11</sup>C]methoxyphenyl)-<i>N</i>-(piperidin-1-yl)-1<i>H</i>-pyrazole-3-carboxamide</a><span class="small"> [<a href="/books/n/micad/JHU75528-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]JHU75528</div><div>Kam Leung.</div><div class="small">Created: February 16, 2007; Last Update: March 5, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PIBana11C"><a class="toc-item" href="/books/n/micad/PIBana11C/">4-Hydroxy-, 5-hydroxy-, and 7-hydroxy- analogs of 6-hydroxy-2-(4’-[<sup>11</sup>C]methylaminophenyl)-1,3-benzothiazole</a><span class="small"> [<a href="/books/n/micad/PIBana11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]6a, [<sup>11</sup>C]6b, and [<sup>11</sup>C]6c</div><div>Arvind Chopra.</div><div class="small">Created: December 8, 2009; Last Update: January 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A833834-11C"><a class="toc-item" href="/books/n/micad/A833834-11C/">5-(6-(5-[<sup>11</sup>C]methylhexahydropyrrolo[3,4-c]pyrrol-2(1H)-yl)pyridazin-3-yl)-1H-indole</a><span class="small"> [<a href="/books/n/micad/A833834-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]A-833834</div><div>Arvind Chopra.</div><div class="small">Created: April 9, 2013; Last Update: June 27, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SCH442416-11C"><a class="toc-item" href="/books/n/micad/SCH442416-11C/">5-Amino-7-(3-(4-[<sup>11</sup>C]methoxy)phenylpropyl)-2-(2-furyl)pyrazolo[4,3-<i>e</i>]-1,2,4-triazolo[1,5-<i>c</i>]pyrimidine </a><span class="small"> [<a href="/books/n/micad/SCH442416-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]SCH442416</div><div>Kam Leung.</div><div class="small">Created: July 7, 2007; Last Update: July 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AZ10419369-11C"><a class="toc-item" href="/books/n/micad/AZ10419369-11C/">5-Methyl-8-(4-[<sup>11</sup>C]methyl-piperazin-1-yl)-4-oxo-4<i>H</i>-chromene-2-carboxylic acid (4-morpholin-4-yl-phenyl)-amide</a><span class="small"> [<a href="/books/n/micad/AZ10419369-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AZ10419369</div><div>Kam Leung.</div><div class="small">Created: May 4, 2009; Last Update: July 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MC-266-11C"><a class="toc-item" href="/books/n/micad/MC-266-11C/">6,7-Dimethoxy-2-[3-(5-[<sup>11</sup>C]methoxy-1,2,3,4-tetrahydro-naphthalen-1-yl)-propyl]-1,2,3,4-tetrahydro-isoquinoline</a><span class="small"> [<a href="/books/n/micad/MC-266-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]MC-266</div><div>Kam Leung.</div><div class="small">Created: June 24, 2010; Last Update: September 15, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P-gp-6-11C"><a class="toc-item" href="/books/n/micad/P-gp-6-11C/">6,7-Dimethoxy-2-{3-[4-[<sup>11</sup>C]methoxy-3,4-dihydro-2<i>H</i>-naphthalen-(1<i>E</i>)-ylidene]-propyl}-1,2,3,4-tetrahydro-isoquinoline</a><span class="small"> [<a href="/books/n/micad/P-gp-6-11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]6</div><div>Kam Leung.</div><div class="small">Created: June 24, 2010; Last Update: September 15, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CURB-11C"><a class="toc-item" href="/books/n/micad/CURB-11C/">6-Hydroxy-[1,1'-biphenyl]-3-yl-cyclohexyl-[<sup>11</sup>C-<i>carbonyl</i>]carbamate</a><span class="small"> [<a href="/books/n/micad/CURB-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]CURB</div><div>Kam Leung.</div><div class="small">Created: October 24, 2012; Last Update: March 21, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Harmine11C"><a class="toc-item" href="/books/n/micad/Harmine11C/">7-[ <sup>11</sup>C]Methox<i>y</i>-1-methyl-9<i>H</i>-[3,4-<i>b</i>]indole</a><span class="small"> [<a href="/books/n/micad/Harmine11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]HAR</div><div>Kam Leung.</div><div class="small">Created: June 23, 2006; Last Update: March 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LBT-999-11C"><a class="toc-item" href="/books/n/micad/LBT-999-11C/">8-((<i>E</i>)-4-Fluoro-but-2-enyl)-3β-p-tolyl-8-aza-bicyclo[3.2.1]octane-2β-carboxylic acid [<sup>11</sup>C]methyl ester</a><span class="small"> [<a href="/books/n/micad/LBT-999-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]LBT-999</div><div>Kam Leung.</div><div class="small">Created: December 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_URB597-1-11C"><a class="toc-item" href="/books/n/micad/URB597-1-11C/">Biphenyl-3-yl-4-[<sup>11</sup>C]methoxyphenylcarbamate</a><span class="small"> [<a href="/books/n/micad/URB597-1-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]URB597-1</div><div>Kam Leung.</div><div class="small">Created: December 18, 2012; Last Update: February 21, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMTP-11C"><a class="toc-item" href="/books/n/micad/MMTP-11C/">Dimethylamino-3(4-[<sup>11</sup>C]methoxyphenyl)-3<i>H</i>-pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-4-one</a><span class="small"> [<a href="/books/n/micad/MMTP-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MMTP</div><div>Kam Leung.</div><div class="small">Created: December 5, 2012; Last Update: February 21, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMZ11C"><a class="toc-item" href="/books/n/micad/FMZ11C/">Ethyl 8-fluoro-5-[<sup>11</sup>C]methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate</a><span class="small"> [<a href="/books/n/micad/FMZ11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]FMZ</div><div>Arvind Chopra.</div><div class="small">Created: April 28, 2008; Last Update: June 10, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L-5-Glutamine-11C"><a class="toc-item" href="/books/n/micad/L-5-Glutamine-11C/"><i><span class="small-caps">L</span></i>-[5-<sup>11</sup>C]-Glutamine</a><span class="small"> [<a href="/books/n/micad/L-5-Glutamine-11C/pdf/">PDF Version</a>]</span><div><i><span class="small-caps">L</span></i>-[5-<sup>11</sup>C]-Gln</div><div>Kam Leung.</div><div class="small">Created: January 7, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MET11C"><a class="toc-item" href="/books/n/micad/MET11C/"><span class="small-caps">l</span>-[<i>methyl</i>-<sup>11</sup>C]Methionine</a><span class="small"> [<a href="/books/n/micad/MET11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MET</div><div>Kam Leung.</div><div class="small">Created: September 15, 2005; Last Update: December 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DST11C"><a class="toc-item" href="/books/n/micad/DST11C/">Methyl-[<sup>11</sup>C]-4'-thiothymidine</a><span class="small"> [<a href="/books/n/micad/DST11C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]-4DST</div><div>Arvind Chopra.</div><div class="small">Created: August 1, 2011; Last Update: September 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPA713C11"><a class="toc-item" href="/books/n/micad/DPA713C11/"><i>N</i>,<i>N</i>-Diethyl-2-2(2-(4-[<sup>11</sup>C]methoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-<i>a</i>)pyrimidin-3-yl)-acetamide</a><span class="small"> [<a href="/books/n/micad/DPA713C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]DPA-713</div><div>Elisabeth Lutanie and Kam Leung.</div><div class="small">Created: April 19, 2006; Last Update: March 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DAA1106-11C"><a class="toc-item" href="/books/n/micad/DAA1106-11C/"><i>N</i>-(2-[<sup>11</sup>C],5-Dimethoxybenzyl)-<i>N</i>-(5-fluoro-2-phenoxyphenyl)acetamide </a><span class="small"> [<a href="/books/n/micad/DAA1106-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]DAA1106</div><div>Kam Leung.</div><div class="small">Created: January 30, 2006; Last Update: January 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ITMM-11C"><a class="toc-item" href="/books/n/micad/ITMM-11C/"><i>N</i>-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-4-[<sup>11</sup>C]methoxy-<i>N</i>-methylbenzamide</a><span class="small"> [<a href="/books/n/micad/ITMM-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]ITMM</div><div>Kam Leung.</div><div class="small">Created: February 14, 2013; Last Update: May 2, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ITDM-11C"><a class="toc-item" href="/books/n/micad/ITDM-11C/"><i>N</i>-(4-(6-(Isopropylamino)pyrimidin-4-yl)-1,3-thiazol-2-yl)-<i>N</i>-methyl-4-[<sup>11</sup>C]methylbenzamide</a><span class="small"> [<a href="/books/n/micad/ITDM-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]ITDM</div><div>Kam Leung.</div><div class="small">Created: February 19, 2013; Last Update: May 2, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MetSch225336C11"><a class="toc-item" href="/books/n/micad/MetSch225336C11/"><i>N</i>-[(1s)-1-[4-[[4-methoxy-2-[(4-[<sup>11</sup>C]methoxyphenyl)sulfonyl]-phenyl]sulfonyl]phenyl]ethyl]methanesulfonamide</a><span class="small"> [<a href="/books/n/micad/MetSch225336C11/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]Methoxy-Sch225336</div><div>Arvind Chopra.</div><div class="small">Created: May 12, 2010; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L-159884-11C"><a class="toc-item" href="/books/n/micad/L-159884-11C/"><i>N</i>-[[4'-[(2-Ethyl-5,7-dimethyl-3<i>H</i>-imidazo[4,5-b]pyridine-3-yl)methyl][1,1'-biphenyl]-2-yl]sul-fonyl]-4-[<sup>11</sup>C]methoxybenzamide</a><span class="small"> [<a href="/books/n/micad/L-159884-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]L-159,884</div><div>Kam Leung.</div><div class="small">Created: May 17, 2006; Last Update: March 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDDP11C"><a class="toc-item" href="/books/n/micad/MDDP11C/"><i>N</i>-[<sup>11</sup>C]Methyl-3-[[(dimethylamino)carbonyl]oxy]-2-(2’,2’-diphenylpropionoxymethyl)pyridinium</a><span class="small"> [<a href="/books/n/micad/MDDP11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MDDP</div><div>The MICAD Research Team.</div><div class="small">Created: June 24, 2006; Last Update: July 25, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MP4A11C"><a class="toc-item" href="/books/n/micad/MP4A11C/"><i>N</i>-[<sup>11</sup>C]Methylpiperidin-4-yl acetate</a><span class="small"> [<a href="/books/n/micad/MP4A11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MP4A</div><div>Kam Leung.</div><div class="small">Created: April 19, 2006; Last Update: February 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_D4-7-11C"><a class="toc-item" href="/books/n/micad/D4-7-11C/"><i>N</i>-[2-[4-(3-Cyanopyridin-2-yl)piperazin-1-yl]ethyl]-3-[<sup>11</sup>C]methoxybenzamide</a><span class="small"> [<a href="/books/n/micad/D4-7-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]7</div><div>Kam Leung.</div><div class="small">Created: May 5, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DCMC11C"><a class="toc-item" href="/books/n/micad/DCMC11C/"><i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-Dicarboxypropyl]carbamoyl]-<i>S</i>-[<sup>11</sup>C]methyl-L-cysteine</a><span class="small"> [<a href="/books/n/micad/DCMC11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]DCMC</div><div>Arvind Chopra.</div><div class="small">Created: March 1, 2007; Last Update: December 6, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MeNTI-11C"><a class="toc-item" href="/books/n/micad/MeNTI-11C/"><i>N</i>1’-([<sup>11</sup>C]Methyl)naltrindole</a><span class="small"> [<a href="/books/n/micad/MeNTI-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MeNTI</div><div>Kam Leung.</div><div class="small">Created: April 12, 2007; Last Update: May 8, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GB67-11C"><a class="toc-item" href="/books/n/micad/GB67-11C/"><i>N</i>2-{6-[(4-Amino-6,7-dimethoxy-2-quinazolinyl)(methyl)amino]hexyl}-<i>N</i>2-[<sup><i>11</i></sup>C]methyl-2-furamide</a><span class="small"> [<a href="/books/n/micad/GB67-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]GB67</div><div>Kam Leung.</div><div class="small">Created: February 2, 2006; Last Update: February 27, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PR04MZ11C"><a class="toc-item" href="/books/n/micad/PR04MZ11C/"><i>N</i>-4-Fluorobut-2-yn-1-yl-2β-carbo-[<sup>11</sup>C]methoxy-3β-phenyltropane</a><span class="small"> [<a href="/books/n/micad/PR04MZ11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PR04.MZ</div><div>Kam Leung.</div><div class="small">Created: August 8, 2011; Last Update: November 3, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR28-11C"><a class="toc-item" href="/books/n/micad/PBR28-11C/"><i>N</i>-Acetyl-<i>N</i>-(2-[<sup>11</sup>C]methoxybenzyl)-2-phenoxy-5-pyridinamine</a><span class="small"> [<a href="/books/n/micad/PBR28-11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]PBR28</div><div>Kam Leung.</div><div class="small">Created: June 12, 2007; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AC5216C11"><a class="toc-item" href="/books/n/micad/AC5216C11/"><i>N</i>-Benzyl-<i>N</i>-ethyl -2-(7-[<sup>11</sup>C]-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide</a><span class="small"> [<a href="/books/n/micad/AC5216C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]AC-5216</div><div>Kazuhiko Yanamoto and Ming-Rong Zhang.</div><div class="small">Created: December 4, 2007; Last Update: December 31, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PIB11C"><a class="toc-item" href="/books/n/micad/PIB11C/">N-Methyl-[<sup>11</sup>C]-2-(4'-methylaminophenyl)-6-hydroxybenzothiasole</a><span class="small"> [<a href="/books/n/micad/PIB11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]6-OH-BTA-1 or [<sup>11</sup>C]PIB</div><div>Kam Leung.</div><div class="small">Created: July 11, 2005; Last Update: July 25, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MC11311C"><a class="toc-item" href="/books/n/micad/MC11311C/">O-[<sup>11</sup>C]methyl derivative of 6,7-dimethoxy-2-(4-methoxy-biphenyl-4-yl-methyl)-1,2,3,4-tetrahydro-isoquinoline</a><span class="small"> [<a href="/books/n/micad/MC11311C/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]MC113</div><div>Arvind Chopra.</div><div class="small">Created: November 5, 2012; Last Update: January 31, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EPI11C"><a class="toc-item" href="/books/n/micad/EPI11C/"><i>R</i>-(−)-[<sup>11</sup>C]Epinephrine</a><span class="small"> [<a href="/books/n/micad/EPI11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]EPI</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 28, 2006; Last Update: March 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MCYS11C"><a class="toc-item" href="/books/n/micad/MCYS11C/"><i><span class="small-caps">S</span></i>-[<sup>11</sup>C]Methyl-<span class="small-caps">L</span>-cysteine</a><span class="small"> [<a href="/books/n/micad/MCYS11C/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C]MCYS</div><div>Kam Leung.</div><div class="small">Created: March 11, 2012; Last Update: June 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CGP12388-11C"><a class="toc-item" href="/books/n/micad/CGP12388-11C/"><i>S</i>-4-(3-([<sup>11</sup>C]Isopropylamino)-2-hydroxypropoxy)-2<i>H</i>-benzimidazol-2-one</a><span class="small"> [<a href="/books/n/micad/CGP12388-11C/pdf/">PDF Version</a>]</span><div><i>S</i>-[<sup>11</sup>C]CGP 12388</div><div>Kam Leung.</div><div class="small">Created: January 20, 2006; Last Update: February 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_McN5652C11"><a class="toc-item" href="/books/n/micad/McN5652C11/"><i>trans-</i>(+)-1,2,3,5,6,10b-Hexahydro-6-(4-([<sup>11</sup>C]methylthio)-phenyl)pyrrolo-(2,1-a)-isoquinoline</a><span class="small"> [<a href="/books/n/micad/McN5652C11/pdf/">PDF Version</a>]</span><div>[<sup>11</sup>C](+)McN5652</div><div>The MICAD Research Team.</div><div class="small">Created: March 7, 2006; Last Update: April 12, 2006.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos124i"><a class="toc-item" href="/books/n/micad/sos124i/">124I</a><ul id="toc_lst_NBK5330_toc_sos124i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IAZG124I"><a class="toc-item" href="/books/n/micad/IAZG124I/">[<sup>124</sup>I]Iodo-azomycin-galactoside </a><span class="small"> [<a href="/books/n/micad/IAZG124I/pdf/">PDF Version</a>]</span><div>[<sup>124</sup>I]IAZG</div><div>Kam Leung.</div><div class="small">Created: November 22, 2007; Last Update: January 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ApoPep-1RadIdo"><a class="toc-item" href="/books/n/micad/ApoPep-1RadIdo/"><sup>124/131</sup>I-Labeled apoptosis-targeting peptide-1 (ApoPep-1)</a><span class="small"> [<a href="/books/n/micad/ApoPep-1RadIdo/pdf/">PDF Version</a>]</span><div> [<sup>124/131</sup>I]-ApoPep-1</div><div>Arvind Chopra.</div><div class="small">Created: November 8, 2011; Last Update: December 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiCD20Mb124I"><a class="toc-item" href="/books/n/micad/AntiCD20Mb124I/"><sup>124</sup>I/<sup>64</sup>Cu-Labeled anti-CD20 minibody</a><span class="small"> [<a href="/books/n/micad/AntiCD20Mb124I/pdf/">PDF Version</a>]</span><div>[<sup>124</sup>I/<sup>64</sup>Cu]Anti-CD20 ScFv-C<sub>H</sub>3 dimer</div><div>Arvind Chopra.</div><div class="small">Created: October 13, 2009; Last Update: November 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx5I124"><a class="toc-item" href="/books/n/micad/Anx5I124/"><sup>124</sup>I-Annexin V</a><span class="small"> [<a href="/books/n/micad/Anx5I124/pdf/">PDF Version</a>]</span><div>Kenneth T. Cheng.</div><div class="small">Created: July 20, 2006; Last Update: January 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_U36-124I"><a class="toc-item" href="/books/n/micad/U36-124I/"><sup>124</sup>I-Anti-CD44v6 chimeric monoclonal antibody U36</a><span class="small"> [<a href="/books/n/micad/U36-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-cMAb U36</div><div>Kam Leung.</div><div class="small">Created: October 5, 2007; Last Update: November 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_bm2B3-Db8-124I"><a class="toc-item" href="/books/n/micad/bm2B3-Db8-124I/"><sup>124</sup>I-Anti–prostate stem-cell antigen back-mutated 2B3 diabody</a><span class="small"> [<a href="/books/n/micad/bm2B3-Db8-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-bm2B3-Db8</div><div>Kam Leung.</div><div class="small">Created: May 25, 2010; Last Update: August 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Minibody2B3-124I"><a class="toc-item" href="/books/n/micad/Minibody2B3-124I/"><sup>124</sup>I-Anti-PSCA 2B3 minibody</a><span class="small"> [<a href="/books/n/micad/Minibody2B3-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-2B3</div><div>Kam Leung.</div><div class="small">Created: March 25, 2009; Last Update: May 13, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250-124I"><a class="toc-item" href="/books/n/micad/cG250-124I/"><sup>124</sup>I-Chimeric monoclonal antibody G250</a><span class="small"> [<a href="/books/n/micad/cG250-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-cG250</div><div>Kam Leung.</div><div class="small">Created: April 22, 2010; Last Update: May 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LYVE-1-124I"><a class="toc-item" href="/books/n/micad/LYVE-1-124I/"><sup>124</sup>I-Labeled antibody against lymphatic vessel endothelial hyaluronan receptor-1 (LYVE-1)</a><span class="small"> [<a href="/books/n/micad/LYVE-1-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-Anti-LYVE-1</div><div>Kam Leung.</div><div class="small">Created: March 22, 2011; Last Update: July 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiCD20scFv124I"><a class="toc-item" href="/books/n/micad/AntiCD20scFv124I/"><sup>124</sup>I-Labeled anti-CD20 scFv-sc fragment</a><span class="small"> [<a href="/books/n/micad/AntiCD20scFv124I/pdf/">PDF Version</a>]</span><div>[<sup>124</sup>I]Anti-CD20 scFv-sc DM</div><div>Arvind Chopra.</div><div class="small">Created: October 13, 2009; Last Update: November 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_C65Diabody124I"><a class="toc-item" href="/books/n/micad/C65Diabody124I/"><sup>124</sup>I-Labeled anti-HER2-specific C6.5 diabody</a><span class="small"> [<a href="/books/n/micad/C65Diabody124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-C6.5db</div><div>Kam Leung.</div><div class="small">Created: May 22, 2011; Last Update: August 4, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A11-124I"><a class="toc-item" href="/books/n/micad/A11-124I/"><sup>124</sup>I-Labeled anti-prostate stem cell antigen affinity-matured A11 minibody</a><span class="small"> [<a href="/books/n/micad/A11-124I/pdf/">PDF Version</a>]</span><div><sup>124</sup>I-A11</div><div>Liang Shan.</div><div class="small">Created: June 23, 2010; Last Update: July 19, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HuCC49DCH2124I"><a class="toc-item" href="/books/n/micad/HuCC49DCH2124I/"><sup>124</sup>I-Labeled humanized CH2-domain-deleted anti-tumor-associated glycoprotein-72 (TAG-72) monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/HuCC49DCH2124I/pdf/">PDF Version</a>]</span><div> [<sup>124</sup>I]-HuCC49deltaC<sub>H</sub>2</div><div>Arvind Chopra.</div><div class="small">Created: September 22, 2011; Last Update: October 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMPR4ch806-124I"><a class="toc-item" href="/books/n/micad/IMPR4ch806-124I/"><sup>124</sup>I-Labeled residulizing ligand IMP-R4 conjugated chimeric monoclonal antibody ch806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/IMPR4ch806-124I/pdf/">PDF Version</a>]</span><div> [<sup>124</sup>I]-IMP-R4-ch806</div><div>Arvind Chopra.</div><div class="small">Created: June 26, 2010; Last Update: August 5, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FIAU"><a class="toc-item" href="/books/n/micad/FIAU/">2'-Fluoro-2'-deoxy-5'-[<sup>123/124/125/131</sup>I]iodo-1β-<span class="small-caps">d</span>-arabinofuranosyluracil</a><span class="small"> [<a href="/books/n/micad/FIAU/pdf/">PDF Version</a>]</span><div>[<sup>123/124/125/131</sup>I]FIAU</div><div>Kam Leung.</div><div class="small">Created: February 1, 2005; Last Update: February 9, 2005.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos13n"><a class="toc-item" href="/books/n/micad/sos13n/">13N</a><ul id="toc_lst_NBK5330_toc_sos13n" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AmmoniaN13"><a class="toc-item" href="/books/n/micad/AmmoniaN13/">[<sup>13</sup>N]Ammonia</a><span class="small"> [<a href="/books/n/micad/AmmoniaN13/pdf/">PDF Version</a>]</span><div>[<sup>13</sup>N]NH<sub>3</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: December 5, 2005; Last Update: December 4, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos149tb152tb155tb161tb"><a class="toc-item" href="/books/n/micad/sos149tb152tb155tb161tb/">149Tb, 152Tb, 155Tb, 161Tb</a><ul id="toc_lst_NBK5330_toc_sos149tb152tb155tb161tb" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_cm09149-161Tb"><a class="toc-item" href="/books/n/micad/cm09149-161Tb/">[<sup>149/152/155/161</sup>Tb]-Labeled DOTA-folate conjugated to an albumin-binding entity</a><span class="small"> [<a href="/books/n/micad/cm09149-161Tb/pdf/">PDF Version</a>]</span><div> [<sup>149/152/155/161</sup>Tb]cm09</div><div>Arvind Chopra.</div><div class="small">Created: December 3, 2012; Last Update: December 27, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos18f"><a class="toc-item" href="/books/n/micad/sos18f/">18F</a><ul id="toc_lst_NBK5330_toc_sos18f" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_nAChR6c-18F"><a class="toc-item" href="/books/n/micad/nAChR6c-18F/">(-)-7-Methyl-2-<i>exo</i>-[3'-(6-[<sup>18</sup>F]fluoropyridin-2-yl)-5'-pyridinyl]-7-azabicyclo[2.2.1]heptane</a><span class="small"> [<a href="/books/n/micad/nAChR6c-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F](-)-6c</div><div>Kam Leung.</div><div class="small">Created: April 12, 2009; Last Update: April 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FP-DTBZ18F"><a class="toc-item" href="/books/n/micad/FP-DTBZ18F/">(+)-2-Hydroxy-3-isobutyl-9-(3-[<sup>18</sup>F]fluoropropoxy)-10-methoxy-1,2,3,4,6,7-hexahydro-11<i>bH</i>-benzo[<i>a</i>]quinolizine</a><span class="small"> [<a href="/books/n/micad/FP-DTBZ18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FP-(+)-DTBZ</div><div>Kam Leung.</div><div class="small">Created: February 12, 2007; Last Update: October 14, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PR17MZ18F"><a class="toc-item" href="/books/n/micad/PR17MZ18F/"> (1<i>R</i>,2<i>S</i>,3<i>S</i>,5<i>S</i>)-Methyl-8-{[(1<i>S</i>,2<i>S</i>)-2-([<sup>18</sup>F]fluoromethyl)cyclopropyl]methyl}-3-phenyl-8-azabicyclo[3.2.1]octane-2-carboxylate</a><span class="small"> [<a href="/books/n/micad/PR17MZ18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PR17.MZ</div><div>Kam Leung.</div><div class="small">Created: July 12, 2011; Last Update: December 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FE-PEO-18F"><a class="toc-item" href="/books/n/micad/FE-PEO-18F/">(20<i>R</i>)-4,5-α-Epoxy-6-(2-[<sup>18</sup>F])fluoroethoxy)-3-hydroxy-α,17-dimethyl-α-(2-phenyleth-1-yl)-6,14-ethenomorphinan-7-methanol</a><span class="small"> [<a href="/books/n/micad/FE-PEO-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FE-PEO</div><div>Kam Leung.</div><div class="small">Created: February 24, 2013; Last Update: April 25, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEPEP18F"><a class="toc-item" href="/books/n/micad/FEPEP18F/">(3<i>R</i>,5<i>R</i>)-5-(3-(2-[<sup>18</sup>F]Fluoroethoxy)phenyl)-3-((<i>R</i>)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one</a><span class="small"> [<a href="/books/n/micad/FEPEP18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FEPEP</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 6, 2010; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMPEP-d2-18F"><a class="toc-item" href="/books/n/micad/FMPEP-d2-18F/">(3<i>R</i>,5<i>R</i>)-5-(3-[<sup>18</sup>F]Fluoromethoxy-<i>d</i><sub>2</sub>)phenyl)-3-((<i>R</i>)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one</a><span class="small"> [<a href="/books/n/micad/FMPEP-d2-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FMPEP-<i>d</i><sub>2</sub></div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 6, 2010; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMPEP18F"><a class="toc-item" href="/books/n/micad/FMPEP18F/">(3<i>R</i>,5<i>R</i>)-5-(3-[<sup>18</sup>F]Fluoromethoxy-phenyl)-3-((<i>R</i>)-1-phenyl-ethylamino)-1-(4-trifluoromethyl-phenyl)-pyrrolidin-2-one</a><span class="small"> [<a href="/books/n/micad/FMPEP18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FMPEP</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 6, 2010; Last Update: October 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FSPG18F"><a class="toc-item" href="/books/n/micad/FSPG18F/">(4<i>S</i>)-4-(3-[<sup>18</sup>F]Fluoropropyl)-<span class="small-caps">l</span>-glutamate</a><span class="small"> [<a href="/books/n/micad/FSPG18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FSPG</div><div>Arvind Chopra.</div><div class="small">Created: March 20, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Styrylpyridine18F"><a class="toc-item" href="/books/n/micad/Styrylpyridine18F/">(<i>E</i>)-2-(2-(2-(2-[<sup>18</sup>F]Fluoroethoxy)ethoxy)ethoxy)-5-(4-dimethylaminostyryl)-pyridine</a><span class="small"> [<a href="/books/n/micad/Styrylpyridine18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPEGN3-Styrylpyridine</div><div>Kam Leung.</div><div class="small">Created: February 2, 2007; Last Update: March 5, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPEG-chalcone-18F"><a class="toc-item" href="/books/n/micad/FPEG-chalcone-18F/">(<i>E</i>)-3-(4-(Dimethylamino)phenyl)-1-(4-(2-(([<sup>18</sup>F]fluoroethoxy)ethoxy)ethoxy)phenyl)-2-propen-1-one</a><span class="small"> [<a href="/books/n/micad/FPEG-chalcone-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]7c</div><div>Kam Leung.</div><div class="small">Created: July 11, 2010; Last Update: October 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDEGPECO-18F"><a class="toc-item" href="/books/n/micad/FDEGPECO-18F/">(<i>E</i>)-3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-<i>O</i>-2-(2-[<sup>18</sup>F]fluoroethoxy)ethyl oxime</a><span class="small"> [<a href="/books/n/micad/FDEGPECO-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDEGPECO</div><div>Kam Leung.</div><div class="small">Created: June 5, 2011; Last Update: September 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AV-45-18F"><a class="toc-item" href="/books/n/micad/AV-45-18F/">(<i>E</i>)-4-(2-(6-(2-(2-(2-([<sup>18</sup>F]-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)-<i>N</i>-methylbenzenamine</a><span class="small"> [<a href="/books/n/micad/AV-45-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]AV-45</div><div>Kam Leung.</div><div class="small">Created: February 11, 2010; Last Update: December 9, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPPAT18F"><a class="toc-item" href="/books/n/micad/FPPAT18F/">(<i>R</i>,<i>S</i>)-2-(<i>N</i>-Propyl-<i>N</i>-5'-[<sup>18</sup>F]fluoropentyl)amino-5-hydroxytetralin</a><span class="small"> [<a href="/books/n/micad/FPPAT18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-5-OH-FPPAT</div><div>Kam Leung.</div><div class="small">Created: August 27, 2006; Last Update: February 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FACPC18F"><a class="toc-item" href="/books/n/micad/FACPC18F/"><i>(R,S)-anti</i>-1-Amino-2-[<sup>18</sup>F]fluorocyclopentyl-1-carboxylic acid</a><span class="small"> [<a href="/books/n/micad/FACPC18F/pdf/">PDF Version</a>]</span><div><i>anti</i>-2-[<sup>18</sup>F]FACPC</div><div>Kam Leung.</div><div class="small">Created: November 18, 2010; Last Update: February 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-1f18F"><a class="toc-item" href="/books/n/micad/MMP-1f18F/">(<i>R</i>)-2-(<i>N</i>-Benzyl-4-(2-[<sup>18</sup>F]fluoroethoxy)phenylsulfonamido)-<i>N</i>-hydroxy-3-methylbutanamide</a><span class="small"> [<a href="/books/n/micad/MMP-1f18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]1f</div><div>Kam Leung.</div><div class="small">Created: March 10, 2008; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FAMP18F"><a class="toc-item" href="/books/n/micad/FAMP18F/">(<i>R</i>)-2-Amino-3-[<sup>18</sup>F]fluoro-2-methylpropanoic acid</a><span class="small"> [<a href="/books/n/micad/FAMP18F/pdf/">PDF Version</a>]</span><div> (<i>R</i>)-[<sup>18</sup>F]FAMP</div><div>Kam Leung.</div><div class="small">Created: May 18, 2010; Last Update: July 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MeFAMP18F"><a class="toc-item" href="/books/n/micad/MeFAMP18F/">(<i>R</i>)-3-[<sup>18</sup>F]Fluoro-2-methyl-2-<i>N</i>-(methylamino)propanoic acid</a><span class="small"> [<a href="/books/n/micad/MeFAMP18F/pdf/">PDF Version</a>]</span><div> (<i>R</i>)-[<sup>18</sup>F]<i>N</i>MeFAMP</div><div>Kam Leung.</div><div class="small">Created: May 18, 2010; Last Update: July 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMeNER18FD2"><a class="toc-item" href="/books/n/micad/FMeNER18FD2/">(<i>S,S</i>)-2-(α-(2-[<sup>18</sup>F]Fluoro[<sup>2</sup>H<sub>2</sub>]methoxyphenoxy)phenoxy)benzyl)morpholine</a><span class="small"> [<a href="/books/n/micad/FMeNER18FD2/pdf/">PDF Version</a>]</span><div>(<i>S,S</i>)-[<sup>18</sup>F]FMeNER-D<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: May 5, 2006; Last Update: March 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FRB-D4F18"><a class="toc-item" href="/books/n/micad/FRB-D4F18/">(<i>S</i>,<i>S</i>)-2-[α-(2-(2-[<sup>18</sup>F]Fluoro[<sup>2</sup>H<sub>4</sub>]ethoxy)phenoxy)benzyl]morpholine</a><span class="small"> [<a href="/books/n/micad/FRB-D4F18/pdf/">PDF Version</a>]</span><div>(<i>S</i>,<i>S</i>)-[<sup>18</sup>F]FRB-D<sub>4</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: September 14, 2006; Last Update: January 23, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FRB18F"><a class="toc-item" href="/books/n/micad/FRB18F/">(<i>S</i>,<i>S</i>)-2-[α-(2-(2-[<sup>18</sup>F]Fluoroethoxy)phenoxy)benzyl]morpholine</a><span class="small"> [<a href="/books/n/micad/FRB18F/pdf/">PDF Version</a>]</span><div>(<i>S</i>,<i>S</i>)-[<sup>18</sup>F]FRB</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 9, 2006; Last Update: January 23, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Isatin-15-18F"><a class="toc-item" href="/books/n/micad/Isatin-15-18F/">(<i>S</i>)-1-((1-(2-[<sup>18</sup>F]Fluoroethyl)-1<i>H</i>-[1,2,3]-triazol-4-yl)methyl)-5-(2-4-difluorophenoxymethyl-pyrrolidine-1-sulfonyl)isatin</a><span class="small"> [<a href="/books/n/micad/Isatin-15-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]<b>Isatin-15</b></div><div>Kam Leung.</div><div class="small">Created: August 28, 2009; Last Update: September 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CbR2-18F"><a class="toc-item" href="/books/n/micad/CbR2-18F/">(<i>S</i>)-1-(4-(2-[<sup>18</sup>F]Fluoroethoxy)benzyl)-5-[1-(2-methoxymethyl-pyrrolidinyl)sulfonyl]-1<i>H</i>-indole-2,3-dione</a><span class="small"> [<a href="/books/n/micad/CbR2-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]CbR<b>2</b></div><div>Kam Leung.</div><div class="small">Created: June 29, 2007; Last Update: February 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_S-18F-4"><a class="toc-item" href="/books/n/micad/S-18F-4/"> (<i>S</i>)-2-Amino-3-[1-(2-[<sup>18</sup>F]fluoroethyl)-1<i>H</i>-[1,2,3]triazol-4-yl]propanoic acid</a><span class="small"> [<a href="/books/n/micad/S-18F-4/pdf/">PDF Version</a>]</span><div>(<i>S</i>)-[<sup>18</sup>F]4</div><div>Kam Leung.</div><div class="small">Created: July 7, 2011; Last Update: October 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fallypride18F"><a class="toc-item" href="/books/n/micad/Fallypride18F/"><i>(S)-N</i>-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[<sup>18</sup>F]fluoropropyl)-2,3-dimethoxybenzamide </a><span class="small"> [<a href="/books/n/micad/Fallypride18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Fallypride</div><div>Kam Leung.</div><div class="small">Created: November 29, 2005; Last Update: January 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DMFP18F"><a class="toc-item" href="/books/n/micad/DMFP18F/"><i>(S)-N</i>-((1-Allyl-2-pyrrolidinyl)methyl)-5-(3-[<sup>18</sup>F]fluoropropyl)-2-methoxybenzamide </a><span class="small"> [<a href="/books/n/micad/DMFP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]DMFP</div><div>Kam Leung.</div><div class="small">Created: August 3, 2006; Last Update: May 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SFE18F"><a class="toc-item" href="/books/n/micad/SFE18F/">[<sup>18</sup>F]1-(2-Fluoroethyl)-4-[(4-cyanophenoxy)methyl]piperidine</a><span class="small"> [<a href="/books/n/micad/SFE18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]SFE</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 1, 2006; Last Update: February 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPS18F"><a class="toc-item" href="/books/n/micad/FPS18F/">[<sup>18</sup>F]1-(3-Fluoropropyl)-4-[(4-cyanophenoxy)methyl]piperidine</a><span class="small"> [<a href="/books/n/micad/FPS18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPS</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 18, 2006; Last Update: December 20, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EF3-18F"><a class="toc-item" href="/books/n/micad/EF3-18F/">[<sup>18</sup>F]-2-(2-Nitroimidazol-1<i>H</i>-yl)-(3,3,3-trifluoropropyl)acetamide</a><span class="small"> [<a href="/books/n/micad/EF3-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]EF3</div><div>Kam Leung.</div><div class="small">Created: September 10, 2007; Last Update: October 22, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fluoroproxyfan18F"><a class="toc-item" href="/books/n/micad/Fluoroproxyfan18F/">[<sup>18</sup>F]3-(1<i>H</i>-Imidazol-4-yl)propyl-4-fluorobenzyl ether</a><span class="small"> [<a href="/books/n/micad/Fluoroproxyfan18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Fluoroproxyfan</div><div>Kam Leung.</div><div class="small">Created: December 3, 2007; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F-MTEB18F"><a class="toc-item" href="/books/n/micad/F-MTEB18F/">[<sup>18</sup>F]3-Fluoro-5-[(2-methyl-1,3-thiazol-4-yl)ethynyl]benzonitrile</a><span class="small"> [<a href="/books/n/micad/F-MTEB18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]F-MTEB</div><div>The MICAD Research Team.</div><div class="small">Created: July 12, 2006; Last Update: July 24, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F-PEB18F"><a class="toc-item" href="/books/n/micad/F-PEB18F/">[<sup>18</sup>F]3-Fluoro-5-[(pyridin-3-yl)ethynyl]benzonitrile </a><span class="small"> [<a href="/books/n/micad/F-PEB18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]F-PEB</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 22, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEatSUPPY18F"><a class="toc-item" href="/books/n/micad/FEatSUPPY18F/">[<sup>18</sup>F]-5-(2-fluoroethyl)2,4-diethyl-3-(ethylsulfanylcarbonyl)-6-phenylpyridine-5-carboxylate</a><span class="small"> [<a href="/books/n/micad/FEatSUPPY18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FE@SUPPY</div><div>Arvind Chopra.</div><div class="small">Created: December 26, 2007; Last Update: December 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZW_104_18F"><a class="toc-item" href="/books/n/micad/ZW_104_18F/">[<sup>18</sup>F]5-(6-Fluorohexyn-1-yl)-3-[2(<i>S</i>)-2-azetidinylmethoxy]pyridine</a><span class="small"> [<a href="/books/n/micad/ZW_104_18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]ZW-104</div><div>Kam Leung.</div><div class="small">Created: November 12, 2009; Last Update: January 14, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_iNOS-9-18F"><a class="toc-item" href="/books/n/micad/iNOS-9-18F/">[<sup>18</sup>F]6-(2-Fluoropropyl)-4-methyl-pyridin-2-amine</a><span class="small"> [<a href="/books/n/micad/iNOS-9-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]iNOS-9</div><div>Kam Leung.</div><div class="small">Created: August 11, 2009; Last Update: September 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_OMFD18F"><a class="toc-item" href="/books/n/micad/OMFD18F/">[18F]6-fluoro-3-O-methyl-L-3,4-dihydroxyphenylalanine</a><span class="small"> [<a href="/books/n/micad/OMFD18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]OMFD</div><div>Arvind Chopra.</div><div class="small">Created: December 13, 2007; Last Update: January 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NAPamide18F"><a class="toc-item" href="/books/n/micad/NAPamide18F/">[<sup>18</sup>F]FB-(Ac-NIe-Asp-His-<span class="small-caps">d</span>-Phe-Arg-Trp-Gly-Lys-NH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/NAPamide18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-NAPamide</div><div>Kenneth T. Cheng, Sam Gambhir, and Zhen Cheng.</div><div class="small">Created: August 2, 2007; Last Update: August 10, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18FPRGD4"><a class="toc-item" href="/books/n/micad/F18FPRGD4/">[<sup>18</sup>F]FB-NH-mini-PEG-E{E[c(RGDyK)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/F18FPRGD4/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPRGD4</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 20, 2008; Last Update: March 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Choline-D4-18F"><a class="toc-item" href="/books/n/micad/Choline-D4-18F/">[<sup>18</sup>F]Fluoro-[1,2-<sup>2</sup>H<sub>4</sub>]choline</a><span class="small"> [<a href="/books/n/micad/Choline-D4-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]12c</div><div>Kam Leung.</div><div class="small">Created: March 1, 2011; Last Update: June 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDG"><a class="toc-item" href="/books/n/micad/FDG/">[<sup>18</sup>F]Fluoro-2-deoxy-2-<span class="small-caps">D</span>-glucose</a><span class="small"> [<a href="/books/n/micad/FDG/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDG</div><div>Kam Leung.</div><div class="small">Created: October 1, 2004; Last Update: January 12, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-5"><a class="toc-item" href="/books/n/micad/F18-5/">[<sup>18</sup>F]-Fluoro-2-deoxy-<span class="small-caps">d</span>-glucose-folate</a><span class="small"> [<a href="/books/n/micad/F18-5/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-5</div><div>Liang Shan.</div><div class="small">Created: October 1, 2012; Last Update: October 31, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Leptin18F"><a class="toc-item" href="/books/n/micad/Leptin18F/">[<sup>18</sup>F]Fluorobenzaldehyde-leptin</a><span class="small"> [<a href="/books/n/micad/Leptin18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBA-Leptin</div><div>Kam Leung.</div><div class="small">Created: November 6, 2008; Last Update: December 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TLP4V18F"><a class="toc-item" href="/books/n/micad/TLP4V18F/">[<sup>18</sup>F]Fluorobenzoyl-((VHPKQHRGGSY)<sub>2</sub>K)<sub>2</sub>KK</a><span class="small"> [<a href="/books/n/micad/TLP4V18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]4V</div><div>Kam Leung.</div><div class="small">Created: June 29, 2010; Last Update: September 30, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-FB-Cys-Db"><a class="toc-item" href="/books/n/micad/F18-FB-Cys-Db/">[<sup>18</sup>F]Fluorobenzoyl anti-HER2 Cys-diabody</a><span class="small"> [<a href="/books/n/micad/F18-FB-Cys-Db/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-Cys-Db</div><div>Liang Shan.</div><div class="small">Created: October 31, 2012; Last Update: November 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDPEG18F"><a class="toc-item" href="/books/n/micad/RGDPEG18F/">[<sup>18</sup>F]Fluorobenzoyl-PEGylated cyclic arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/RGDPEG18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-PEG-c(RGDyK)</div><div>Kenneth T. Cheng and Peter S. Conti.</div><div class="small">Created: June 11, 2008; Last Update: July 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-cRGDyK-18F"><a class="toc-item" href="/books/n/micad/BBN-cRGDyK-18F/">[<sup>18</sup>F]Fluorobenzyl-bombesin[7-14]-c(RGDyK)</a><span class="small"> [<a href="/books/n/micad/BBN-cRGDyK-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-BBN-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: October 26, 2008; Last Update: December 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-RGDy-PEG3-18F"><a class="toc-item" href="/books/n/micad/BBN-RGDy-PEG3-18F/">[<sup>18</sup>F]Fluorobenzyl-PEG<sub>3</sub>-Glu-c(RGDyK)-bombesin[7-14]</a><span class="small"> [<a href="/books/n/micad/BBN-RGDy-PEG3-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-PEG<sub>3</sub>-Glu-RGD-BBN</div><div>Kam Leung.</div><div class="small">Created: April 26, 2009; Last Update: July 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Choline18F"><a class="toc-item" href="/books/n/micad/Choline18F/">[<sup>18</sup>F]Fluorocholine</a><span class="small"> [<a href="/books/n/micad/Choline18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FCH</div><div>Kam Leung.</div><div class="small">Created: October 4, 2004; Last Update: February 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDP18F-liposomes"><a class="toc-item" href="/books/n/micad/FDP18F-liposomes/">[<sup>18</sup>F]Fluorodipalmitin-labeled liposomes</a><span class="small"> [<a href="/books/n/micad/FDP18F-liposomes/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDP-liposomes</div><div>Kam Leung.</div><div class="small">Created: May 12, 2008; Last Update: May 29, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FETNIM"><a class="toc-item" href="/books/n/micad/FETNIM/">[<sup>18</sup>F]Fluoroerythronitroimidazole</a><span class="small"> [<a href="/books/n/micad/FETNIM/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FETNIM</div><div>The MICAD Research Team.</div><div class="small">Created: September 10, 2005; Last Update: February 6, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FETA"><a class="toc-item" href="/books/n/micad/FETA/">[<sup>18</sup>F]Fluoroetanidazole</a><span class="small"> [<a href="/books/n/micad/FETA/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FETA</div><div>The MICAD Research Team.</div><div class="small">Created: September 28, 2005; Last Update: October 19, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FECh18F"><a class="toc-item" href="/books/n/micad/FECh18F/">[<sup>18</sup>F]Fluoroethylcholine</a><span class="small"> [<a href="/books/n/micad/FECh18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FECh</div><div>Kam Leung.</div><div class="small">Created: March 1, 2011; Last Update: June 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-1ra-18F"><a class="toc-item" href="/books/n/micad/IL-1ra-18F/">[<sup>18</sup>F]Fluoroethyl-recombinant human interlukin-1 receptor antagonist</a><span class="small"> [<a href="/books/n/micad/IL-1ra-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]IL-1ra</div><div>Kam Leung.</div><div class="small">Created: April 28, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DFMT18F"><a class="toc-item" href="/books/n/micad/DFMT18F/">[<sup>18</sup>F]Fluoromethyl-<span class="small-caps">d</span>-tyrosine</a><span class="small"> [<a href="/books/n/micad/DFMT18F/pdf/">PDF Version</a>]</span><div><span class="small-caps">d</span>-[<sup>18</sup>F]FMT</div><div>Arvind Chopra.</div><div class="small">Created: May 7, 2009; Last Update: June 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMISO"><a class="toc-item" href="/books/n/micad/FMISO/">[<sup>18</sup>F]Fluoromisonidazole</a><span class="small"> [<a href="/books/n/micad/FMISO/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FMISO</div><div>The MICAD Research Team.</div><div class="small">Created: July 18, 2005; Last Update: August 15, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPTP18F"><a class="toc-item" href="/books/n/micad/FPTP18F/">[<sup>18</sup>F]Fluoropropyl-Tanaproget</a><span class="small"> [<a href="/books/n/micad/FPTP18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FPTP</div><div>Kam Leung.</div><div class="small">Created: October 6, 2010; Last Update: December 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-9"><a class="toc-item" href="/books/n/micad/F18-9/">[<sup>18</sup>F]-Labeled (<i>R</i>)-(2-(2-(2-methylpyrrolidin-1-yl)ethyl)benzofuran-5-yl)(4-fluorophenyl)-methanone</a><span class="small"> [<a href="/books/n/micad/F18-9/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]9</div><div>Liang Shan.</div><div class="small">Created: August 24, 2012; Last Update: September 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-6"><a class="toc-item" href="/books/n/micad/F18-6/">[<sup>18</sup>F]<i>N</i>-(2-benzofuranylmethyl)-<i>N</i>'-[4-(2-fluoroethoxy)benzyl]piperazine</a><span class="small"> [<a href="/books/n/micad/F18-6/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]6</div><div>Liang Shan.</div><div class="small">Created: May 10, 2012; Last Update: June 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SKI-249380-18F"><a class="toc-item" href="/books/n/micad/SKI-249380-18F/">[<sup>18</sup>F]-<i>N</i>-(2-Chloro-6-methylphenyl)-2-(6-(4-(2-fluoroethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide</a><span class="small"> [<a href="/books/n/micad/SKI-249380-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]SKI-249380</div><div>Kam Leung.</div><div class="small">Created: August 30, 2008; Last Update: October 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ML04-18F"><a class="toc-item" href="/books/n/micad/ML04-18F/">[<sup>18</sup>F]-<i>N</i>-{4-[(4,5-Dichloro-2-fluorophenyl)amino]quinazoline-6-yl}-dimethylamine-butylamide</a><span class="small"> [<a href="/books/n/micad/ML04-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]ML04</div><div>Arvind Chopra.</div><div class="small">Created: June 26, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NCFHEB18F"><a class="toc-item" href="/books/n/micad/NCFHEB18F/">[<sup>18</sup>F]Norchloro-fluoro-homoepibatidine </a><span class="small"> [<a href="/books/n/micad/NCFHEB18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]NCFHEB</div><div>Kam Leung.</div><div class="small">Created: August 12, 2008; Last Update: August 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SB20967018F"><a class="toc-item" href="/books/n/micad/SB20967018F/">[<sup>18</sup>F]SB209670</a><span class="small"> [<a href="/books/n/micad/SB20967018F/pdf/">PDF Version</a>]</span><div>The MICAD Research Team.</div><div class="small">Created: March 17, 2007; Last Update: March 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Y1-973-18F"><a class="toc-item" href="/books/n/micad/Y1-973-18F/">[<sup>18</sup>F]Y1-973</a><span class="small"> [<a href="/books/n/micad/Y1-973-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Y1-973</div><div>Kam Leung.</div><div class="small">Created: October 30, 2012; Last Update: February 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate18F"><a class="toc-item" href="/books/n/micad/Folate18F/">[<sup>18</sup>F]α/γ-Fluorobenzylamine-folate</a><span class="small"> [<a href="/books/n/micad/Folate18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]α/γ-FBA-folate</div><div>Kam Leung.</div><div class="small">Created: July 12, 2006; Last Update: August 7, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SPA-RQ18F"><a class="toc-item" href="/books/n/micad/SPA-RQ18F/">[2-[<sup>18</sup>F]Fluoromethoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]([2<i>S</i>,3<i>S</i>]2-phenyl-piperidin-3-yl)-amine</a><span class="small"> [<a href="/books/n/micad/SPA-RQ18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]SPA-RQ</div><div>The MICAD Research Team.</div><div class="small">Created: June 21, 2006; Last Update: July 10, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_D4-3d-18F"><a class="toc-item" href="/books/n/micad/D4-3d-18F/">1-(2,3-Dihydrobenzo[<i>b</i>][1,4]dioxin-6-yl)-4-((6-[<sup>18</sup>F]fluoropyridin-3-yl)methyl)piperazine</a><span class="small"> [<a href="/books/n/micad/D4-3d-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]3d</div><div>Kam Leung.</div><div class="small">Created: May 10, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FAC-18F"><a class="toc-item" href="/books/n/micad/FAC-18F/">1-(2'-Deoxy-2'-[<sup>18</sup>F]fluoroarabinofuranosyl)cytosine</a><span class="small"> [<a href="/books/n/micad/FAC-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FAC</div><div>Kam Leung.</div><div class="small">Created: December 18, 2010; Last Update: March 9, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-FIAC"><a class="toc-item" href="/books/n/micad/F18-FIAC/">1-(2'-Deoxy-2'-[<sup>18</sup>F]fluoro-β-<span class="small-caps">d</span>-arabinofuranosyl)-5-iodocytosine</a><span class="small"> [<a href="/books/n/micad/F18-FIAC/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-FIAC</div><div>Liang Shan.</div><div class="small">Created: March 19, 2012; Last Update: April 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPIT-18F"><a class="toc-item" href="/books/n/micad/FPIT-18F/">1-(2-[<sup>18</sup>F]Fluoro-3-pyridyl)-4-(2-isopropyl-1-oxo-isoindoline-5-yl)-5-methyl-1H-1,2,3-triazole</a><span class="small"> [<a href="/books/n/micad/FPIT-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPIT</div><div>Kam Leung.</div><div class="small">Created: November 15, 2012; Last Update: March 7, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MK-1312-18F"><a class="toc-item" href="/books/n/micad/MK-1312-18F/">1-(2-[<sup>18</sup>F]Fluoro-3-pyridyl)-4-(2-propyl-1-oxo-isoindoline-5-yl)-5-methyl-1<i>H</i>-1,2,3-triazole</a><span class="small"> [<a href="/books/n/micad/MK-1312-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]MK-1312</div><div>Kam Leung.</div><div class="small">Created: November 8, 2012; Last Update: March 7, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-2FP3"><a class="toc-item" href="/books/n/micad/F18-2FP3/">1-(2-{(2R)-1-[(2-[<sup>18</sup>F]Fluorophenyl)sulfonyl]pyrrolidin-2-yl}ethyl)-4-methylpiperidine</a><span class="small"> [<a href="/books/n/micad/F18-2FP3/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-2FP3</div><div>Kam Leung.</div><div class="small">Created: July 20, 2012; Last Update: November 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMAU18F"><a class="toc-item" href="/books/n/micad/FMAU18F/">1-(2’-Deoxy-2’-[<sup>18</sup>F]-fluoro-β-D-arabinofuranosyl)thymine</a><span class="small"> [<a href="/books/n/micad/FMAU18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FMAU</div><div>Arvind Chopra.</div><div class="small">Created: January 9, 2008; Last Update: February 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FE18F-SA4503"><a class="toc-item" href="/books/n/micad/FE18F-SA4503/">1-(4-[<sup>18</sup>F]Fluoroethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine</a><span class="small"> [<a href="/books/n/micad/FE18F-SA4503/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FE-SA4503</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 5, 2006; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SA4503FM18F"><a class="toc-item" href="/books/n/micad/SA4503FM18F/">1-(4-[<sup>18</sup>F]Fluoromethoxy-3-methoxyphenethyl)-4-(3-phenylpropyl)piperazine</a><span class="small"> [<a href="/books/n/micad/SA4503FM18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FM-SA4503</div><div>Kenneth T. Cheng.</div><div class="small">Created: June 7, 2007; Last Update: February 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FAZA18F"><a class="toc-item" href="/books/n/micad/FAZA18F/">1-(5-[<sup>18</sup>F]Fluoro-5-deoxy-α-<span class="small-caps">D</span>-arabinofuranosyl)-2-nitroimidazole</a><span class="small"> [<a href="/books/n/micad/FAZA18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FAZA</div><div>Kam Leung.</div><div class="small">Created: July 19, 2005; Last Update: December 27, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SteP218F"><a class="toc-item" href="/books/n/micad/SteP218F/">1-[<sup>18</sup>F]Fluoro-3,6-dioxatetracosane </a><span class="small"> [<a href="/books/n/micad/SteP218F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]SteP2</div><div>Arvind Chopra.</div><div class="small">Created: March 31, 2009; Last Update: May 20, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_WC-II-89-18F"><a class="toc-item" href="/books/n/micad/WC-II-89-18F/">1-[4-(2-[<sup>18</sup>F]Fluoroethoxy)-benzyl]-5-(2-phenoxymethyl-pyrrolidine-1-sulfonyl)-1<i>H</i>-indole-2,3-dione</a><span class="small"> [<a href="/books/n/micad/WC-II-89-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]<b>WC-II-89</b></div><div>Kam Leung.</div><div class="small">Created: June 28, 2007; Last Update: February 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Curcumin18F"><a class="toc-item" href="/books/n/micad/Curcumin18F/">1-[4-(3-[<sup>18</sup>F]Fluoropropoxy)-3-methoxyphenyl]-5-hydroxy-7-(4-hydroxy-3-methoxyphenyl)-1,4,6-heptatrien-3-one</a><span class="small"> [<a href="/books/n/micad/Curcumin18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Fluoropropyl-substituted curcumin</div><div>The MICAD Research Team.</div><div class="small">Created: October 17, 2006; Last Update: October 24, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBzBMS18F"><a class="toc-item" href="/books/n/micad/FBzBMS18F/"><sup>11</sup>C-BMS-5p and <sup>18</sup>F-FBzBMS: radiolabeled analogs of BMS-207940, a potent and selective antagonist of endothelin receptor subtype A</a><span class="small"> [<a href="/books/n/micad/FBzBMS18F/pdf/">PDF Version</a>]</span><div> [<sup>11</sup>C]-BMS-5p and [<sup>18</sup>F]FBzBMS</div><div>Arvind Chopra.</div><div class="small">Created: March 12, 2013; Last Update: June 27, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FES"><a class="toc-item" href="/books/n/micad/FES/">16α-[<sup>18</sup>F]Fluoro-17β-estradiol</a><span class="small"> [<a href="/books/n/micad/FES/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FES</div><div>Kam Leung.</div><div class="small">Created: December 6, 2004; Last Update: June 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FTO-18F"><a class="toc-item" href="/books/n/micad/FTO-18F/">18-[<sup>18</sup>F]Fluoro-4-thia-oleate</a><span class="small"> [<a href="/books/n/micad/FTO-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FTO</div><div>Kam Leung.</div><div class="small">Created: September 15, 2010; Last Update: December 22, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FTP-18F"><a class="toc-item" href="/books/n/micad/FTP-18F/">18-[<sup>18</sup>F]Fluoro-4-thia-palmitate</a><span class="small"> [<a href="/books/n/micad/FTP-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FTP</div><div>Kam Leung.</div><div class="small">Created: October 15, 2010; Last Update: December 22, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Gln18F"><a class="toc-item" href="/books/n/micad/Gln18F/"><sup>18</sup>F-(<i>2S</i>,<i>4R</i>)4-fluoroglutamine</a><span class="small"> [<a href="/books/n/micad/Gln18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]4-FGln</div><div>Arvind Chopra.</div><div class="small">Created: December 15, 2011; Last Update: January 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-2395-NOTA-18F"><a class="toc-item" href="/books/n/micad/Z-2395-NOTA-18F/"><sup>18</sup>F-1,4,7-Triazacyclononane-1,4,7-triacetic acid-10-maleimidoethylacetamide-Affibody Z<sub>HER2:2395</sub></a><span class="small"> [<a href="/books/n/micad/Z-2395-NOTA-18F/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-NOTA-Z<sub>HER2:2395</sub></div><div>Kam Leung.</div><div class="small">Created: January 16, 2012; Last Update: March 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18MEL050"><a class="toc-item" href="/books/n/micad/F18MEL050/"><sup>18</sup>F-6-Fluoro-N-[2-(diethylamino)ethyl]pyridine-3-carboxamide</a><span class="small"> [<a href="/books/n/micad/F18MEL050/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-MEL050</div><div>Liang Shan.</div><div class="small">Created: August 5, 2011; Last Update: September 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-FET-AG-TOCA"><a class="toc-item" href="/books/n/micad/F18-FET-AG-TOCA/"><sup>18</sup>F-Fluoroethyl triazole-βAG-[(<span class="small-caps">d</span>)-Phe<sup>1</sup>-c(Cys<sup>2</sup>-Tyr<sup>3</sup>-(<span class="small-caps">d</span>)-Trp<sup>4</sup>-Lys<sup>5</sup>-Thr<sup>6</sup>-Cys<sup>7</sup>)Thr<sup>8</sup>]</a><span class="small"> [<a href="/books/n/micad/F18-FET-AG-TOCA/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-FET-βAG-TOCA</div><div>Liang Shan.</div><div class="small">Created: March 7, 2012; Last Update: March 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-FPHBF1"><a class="toc-item" href="/books/n/micad/F18-FPHBF1/"><sup>18</sup>F-Labeled 4-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-<i>N</i>,<i>N</i>-dimethylbenzenamine</a><span class="small"> [<a href="/books/n/micad/F18-FPHBF1/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPHBF-1</div><div>Liang Shan.</div><div class="small">Created: January 2, 2012; Last Update: March 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-FPYBF1"><a class="toc-item" href="/books/n/micad/F18-FPYBF1/"><sup>18</sup>F-Labeled 5-(5-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-<i>N</i>,<i>N</i>-dimethylpyridin-2-amine</a><span class="small"> [<a href="/books/n/micad/F18-FPYBF1/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPYBF-1</div><div>Liang Shan.</div><div class="small">Created: January 2, 2012; Last Update: March 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFPB_18F"><a class="toc-item" href="/books/n/micad/AFPB_18F/"><sup>18</sup>F-Labeled 6-amino-2-(4’-fluorophenyl)-1,3-benzothiazole and other derivatives</a><span class="small"> [<a href="/books/n/micad/AFPB_18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]2</div><div>Arvind Chopra.</div><div class="small">Created: November 23, 2009; Last Update: January 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MFPB_18F"><a class="toc-item" href="/books/n/micad/MFPB_18F/"><sup>18</sup>F-Labeled 6-methyl-2-(4’-fluorophenyl)-1,3-benzothiazole</a><span class="small"> [<a href="/books/n/micad/MFPB_18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]5</div><div>Arvind Chopra.</div><div class="small">Created: December 4, 2009; Last Update: January 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHER2342-18F"><a class="toc-item" href="/books/n/micad/ZHER2342-18F/"><sup>18</sup>F-Labeled Cys-Z<sub>HER2:342</sub>, an anti-epidermal growth factor receptor-2 Affibody</a><span class="small"> [<a href="/books/n/micad/ZHER2342-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Cys-Z<sub>HER2:342</sub></div><div>Arvind Chopra.</div><div class="small">Created: July 3, 2012; Last Update: August 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exe9-3918F"><a class="toc-item" href="/books/n/micad/Exe9-3918F/"><sup>18</sup>F-Labeled exendin(9-39)</a><span class="small"> [<a href="/books/n/micad/Exe9-3918F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]Ex(9-39)</div><div>Arvind Chopra.</div><div class="small">Created: February 9, 2012; Last Update: May 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-8a-c"><a class="toc-item" href="/books/n/micad/F18-8a-c/"><sup>18</sup>F-Labeled fluoropegylated 6-fluoroethoxy-4'-dimethylaminoflavone, 6-(2-(2-fluoro-ethoxy)-ethoxy)-4'-dimethylaminoflavone, and 6-(2-(2-(2-fluoro-ethoxy)-ethoxy)ethoxy)-4'-dimethylaminoflavone</a><span class="small"> [<a href="/books/n/micad/F18-8a-c/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]8(a–c)</div><div>Liang Shan.</div><div class="small">Created: November 30, 2011; Last Update: December 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18_3f"><a class="toc-item" href="/books/n/micad/F18_3f/"><sup>18</sup>F-Labeled <i>N</i>-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)butyl)-2-(2-[<sup>18</sup>F]-fluoroethoxy)-5-iodo-3-methoxybenzamide</a><span class="small"> [<a href="/books/n/micad/F18_3f/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]3f</div><div>Arvind Chopra.</div><div class="small">Created: November 18, 2009; Last Update: January 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18_3c"><a class="toc-item" href="/books/n/micad/F18_3c/"><sup>18</sup>F-Labeled <i>N</i>-(4-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1<i>H</i>)-yl)butyl)-2-(2-fluoroethoxy)-5-methylbenzamide</a><span class="small"> [<a href="/books/n/micad/F18_3c/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]3c</div><div>Arvind Chopra.</div><div class="small">Created: November 18, 2009; Last Update: January 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-2ZHER2-477"><a class="toc-item" href="/books/n/micad/F18-2ZHER2-477/"><sup>18</sup>F-Labeled N-(4-fluorobenzylidene)oxime-dimeric (Z<sub>HER2:477</sub>)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/F18-2ZHER2-477/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-FBO-(Z<sub>HER2:477</sub>)<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: November 2, 2011; Last Update: January 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-ZHER2-477"><a class="toc-item" href="/books/n/micad/F18-ZHER2-477/"><sup>18</sup>F-Labeled N-(4-fluorobenzylidene)oxime-monomeric Z<sub>HER2:477</sub></a><span class="small"> [<a href="/books/n/micad/F18-ZHER2-477/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-FBO-Z<sub>HER2:477</sub></div><div>Liang Shan.</div><div class="small">Created: November 2, 2011; Last Update: January 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-MUT-DS"><a class="toc-item" href="/books/n/micad/F18-MUT-DS/"><sup>18</sup>F-Labeled N-(4-fluorobenzylidene)oxime-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH<sub>2</sub> with a disulfide bridge between the two homoC</a><span class="small"> [<a href="/books/n/micad/F18-MUT-DS/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-FBO-MUT-DS</div><div>Liang Shan.</div><div class="small">Created: November 15, 2011; Last Update: January 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NGA18F"><a class="toc-item" href="/books/n/micad/NGA18F/"><sup>18</sup>F-Labeled neogalactosylalbumin</a><span class="small"> [<a href="/books/n/micad/NGA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FNGA</div><div>Arvind Chopra.</div><div class="small">Created: October 19, 2009; Last Update: November 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBAvas12a1MB18F"><a class="toc-item" href="/books/n/micad/FBAvas12a1MB18F/"><sup>18</sup>F-Labeled <i>N</i>-succinimidyl-4-fluorobenzoate–conjugated rat anti-mouse vascular endothelial growth factor receptor 2 monoclonal antibody linked to microbubbles</a><span class="small"> [<a href="/books/n/micad/FBAvas12a1MB18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-4SFB-Avas12a1 MB</div><div>Arvind Chopra.</div><div class="small">Created: November 14, 2011; Last Update: March 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lactosome18F"><a class="toc-item" href="/books/n/micad/Lactosome18F/"><sup>18</sup>F-Labeled poly(L-lactic acid)-<i>block</i>-poly(sarcosine) lactosome, a polymer micelle</a><span class="small"> [<a href="/books/n/micad/Lactosome18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Lactosome</div><div>Arvind Chopra.</div><div class="small">Created: April 5, 2013; Last Update: May 2, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-4-TTCO-18F"><a class="toc-item" href="/books/n/micad/Exendin-4-TTCO-18F/"><sup>18</sup>F-Tetrazine-<i>trans</i>-cyclooctene-Cys<sup>40</sup>-exendin-4</a><span class="small"> [<a href="/books/n/micad/Exendin-4-TTCO-18F/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-TTCO-Cys<sup>40</sup>-exendin-4</div><div>Kam Leung.</div><div class="small">Created: February 18, 2013; Last Update: April 25, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scyllo-Inositol18F"><a class="toc-item" href="/books/n/micad/scyllo-Inositol18F/">1-Deoxy-1-[<sup>18</sup>F]fluoro-<i>scyllo</i>-inositol</a><span class="small"> [<a href="/books/n/micad/scyllo-Inositol18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-<i>scyllo</i>-Inositol</div><div>Kam Leung.</div><div class="small">Created: December 7, 2011; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEAnGA18F"><a class="toc-item" href="/books/n/micad/FEAnGA18F/">1-<i>O</i>-(4-(2-[<sup>18</sup>F]Fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-<i>O</i>-β-<span class="small-caps">d</span>-glucopyronuronate</a><span class="small"> [<a href="/books/n/micad/FEAnGA18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FEAnGA</div><div>Arvind Chopra.</div><div class="small">Created: March 28, 2012; Last Update: April 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FFAU18F"><a class="toc-item" href="/books/n/micad/FFAU18F/">2´-Deoxy-2´-[<sup>18</sup>F]fluoro-5-fluoro-1-β-D-arabinofuranosyluracil </a><span class="small"> [<a href="/books/n/micad/FFAU18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FFAU</div><div>The MICAD Research Team.</div><div class="small">Created: October 3, 2006; Last Update: October 16, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FAA18F"><a class="toc-item" href="/books/n/micad/FAA18F/">2'-Deoxy-2'-[<sup>18</sup>F]fluoro-1-β-<span class="small-caps">D</span>-arabinofuranosyl-adenine </a><span class="small"> [<a href="/books/n/micad/FAA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FAA</div><div>Kam Leung.</div><div class="small">Created: September 11, 2007; Last Update: October 29, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ACF18F"><a class="toc-item" href="/books/n/micad/ACF18F/">2-((2-Amino-4-chloro-5-[<sup>18</sup>F]fluorophenyl)thio)-<i>N,N</i>-dimethylbenzenmethanamine</a><span class="small"> [<a href="/books/n/micad/ACF18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]ACF</div><div>The MICAD Research Team.</div><div class="small">Created: February 13, 2006; Last Update: February 27, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPhEP18F"><a class="toc-item" href="/books/n/micad/FPhEP18F/">2-(+/-)-2-<i>exo</i>-(2'-[<sup>18</sup>F]Fluoro-3'-phenyl-pyridin-5'-yl)-7-azabicyclo[2.2.1]heptane</a><span class="small"> [<a href="/books/n/micad/FPhEP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPhEP</div><div>Kam Leung.</div><div class="small">Created: October 6, 2006; Last Update: December 4, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDDNP18F"><a class="toc-item" href="/books/n/micad/FDDNP18F/">2-(1-{6-[(2-[<sup>18</sup>F]Fluoroethyl)(methyl)amino]-2-naphthyl}ethylidene)malononitrile</a><span class="small"> [<a href="/books/n/micad/FDDNP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDDNP</div><div>Kam Leung.</div><div class="small">Created: July 25, 2005; Last Update: June 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SERT-1-18F"><a class="toc-item" href="/books/n/micad/SERT-1-18F/">2-(2'-((Dimethylamino)methyl)-4'-(3-[<sup>18</sup>F]fluoropropoxy)-phenylthio)benzenamine</a><span class="small"> [<a href="/books/n/micad/SERT-1-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]SERT-1</div><div>Kam Leung.</div><div class="small">Created: September 24, 2008; Last Update: December 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AV-138-18F"><a class="toc-item" href="/books/n/micad/AV-138-18F/">2-(2-(2-(4-((4-(Methylamino)phenyl)ethynyl)phenoxy)ethoxy)[<sup>18</sup>F]fluoroethoxy)ethyl-4-methylbenzenamine</a><span class="small"> [<a href="/books/n/micad/AV-138-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]AV-138</div><div>Kam Leung.</div><div class="small">Created: May 11, 2011; Last Update: July 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NEFT18F"><a class="toc-item" href="/books/n/micad/NEFT18F/">2-(2-Nitro-1<i>H</i>-imidazol-1-yl)ethyl 2-[<sup>18</sup>F]fluoroacetate</a><span class="small"> [<a href="/books/n/micad/NEFT18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]NEFT</div><div>Kam Leung.</div><div class="small">Created: July 19, 2011; Last Update: October 13, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EF5"><a class="toc-item" href="/books/n/micad/EF5/">2-(2-Nitro-1<i>H</i>-imidazol-1-yl)-<i>N</i>-(2,2,3,3,3-[<sup>18</sup>F]pentafluoropropyl)-acetamide</a><span class="small"> [<a href="/books/n/micad/EF5/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]EF5</div><div>The MICAD Research Team.</div><div class="small">Created: November 8, 2005; Last Update: December 31, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EF-mono"><a class="toc-item" href="/books/n/micad/EF-mono/">2-(2-Nitroimidazol-1<i>H</i>-yl)-(3-[<sup>18</sup>F]fluoropropyl)acetamide</a><span class="small"> [<a href="/books/n/micad/EF-mono/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]EF1</div><div>The MICAD Research Team.</div><div class="small">Created: November 5, 2005; Last Update: November 17, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-DCFPyL"><a class="toc-item" href="/books/n/micad/F18-DCFPyL/">2-(3-{1-Carboxy-5-[(6-[<sup>18</sup>F]fluoro-pyridine-3-carbonyl)-amino]-pentyl}-ureido)-pentanedioic acid</a><span class="small"> [<a href="/books/n/micad/F18-DCFPyL/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]DCFPyL</div><div>Liang Shan.</div><div class="small">Created: November 10, 2012; Last Update: December 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T808-18F"><a class="toc-item" href="/books/n/micad/T808-18F/">2-(4-(2-[<sup>18</sup>F]Fluoroethyl)piperidin-1-yl)benzo[4,5]imidazo[1,2-a]pyrimidine</a><span class="small"> [<a href="/books/n/micad/T808-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]T808</div><div>Kam Leung.</div><div class="small">Created: September 27, 2012; Last Update: December 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RP1005-18F"><a class="toc-item" href="/books/n/micad/RP1005-18F/">2-(4-(4-[<sup>18</sup>F]Fluoro-butyl)-benzylsulfanyl)-3-methyl-chromen-4-one</a><span class="small"> [<a href="/books/n/micad/RP1005-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]RP1005</div><div>Kam Leung.</div><div class="small">Created: June 15, 2011; Last Update: January 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_THK523-18F"><a class="toc-item" href="/books/n/micad/THK523-18F/">2-(4-Aminophenyl)-6-(2-([<sup>18</sup>F]fluoroethoxy))quinoline</a><span class="small"> [<a href="/books/n/micad/THK523-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]THK523</div><div>Kam Leung.</div><div class="small">Created: June 27, 2011; Last Update: September 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ML1018F"><a class="toc-item" href="/books/n/micad/ML1018F/">2-(5-[<sup>18</sup>F]Fluoro-pentyl)-2-methyl-malonic acid (ML-10)</a><span class="small"> [<a href="/books/n/micad/ML1018F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]ML-10</div><div>Arvind Chopra.</div><div class="small">Created: August 15, 2012; Last Update: September 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR111-18F"><a class="toc-item" href="/books/n/micad/PBR111-18F/">2-(6-Chloro-2-(4-(3-[<sup>18</sup>F]fluoropropoxy)phenyl)imidazo[1,2-<i>a</i>]pyridin-3-yl)-<i>N</i>,<i>N</i>-diethylacetamide</a><span class="small"> [<a href="/books/n/micad/PBR111-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PBR111</div><div>Kam Leung.</div><div class="small">Created: December 6, 2008; Last Update: March 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FCP18F"><a class="toc-item" href="/books/n/micad/FCP18F/">2-[(2-chloro-2’-<sup>18</sup>F-fluorodiethyl)amino]-2H-1,3,2-oxazaphosphorinane-2-oxide</a><span class="small"> [<a href="/books/n/micad/FCP18F/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-F-CP</div><div>Arvind Chopra.</div><div class="small">Created: December 21, 2007; Last Update: January 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate218F"><a class="toc-item" href="/books/n/micad/Folate218F/">2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{<i>N</i>-[(2-[18F]-fluoro(4-pyridyl))carbonylamino] carbamoyl}butanoic acid</a><span class="small"> [<a href="/books/n/micad/Folate218F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Folate-2</div><div>Arvind Chopra.</div><div class="small">Created: November 16, 2011; Last Update: December 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate118F"><a class="toc-item" href="/books/n/micad/Folate118F/">2-[(4-{[(2-amino-4-oxohydropteridin-7yl)methyl]amino}phenyl) carbonylamino]-4-{<i>N</i>-[(4-[<sup>18</sup>F]-fluorophenyl)carbonylamino] carbamoyl}butanoic acid</a><span class="small"> [<a href="/books/n/micad/Folate118F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Folate-1</div><div>Arvind Chopra.</div><div class="small">Created: November 16, 2011; Last Update: December 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nifene18F"><a class="toc-item" href="/books/n/micad/Nifene18F/">2-[<sup>18</sup>F]Fluoro-3-[2-((<i>S</i>)-3-pyrrolinyl)methoxy]pyridine </a><span class="small"> [<a href="/books/n/micad/Nifene18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Nifene</div><div>Kam Leung.</div><div class="small">Created: September 6, 2006; Last Update: October 2, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A85380-2-18F"><a class="toc-item" href="/books/n/micad/A85380-2-18F/">2-[<sup>18</sup>F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine</a><span class="small"> [<a href="/books/n/micad/A85380-2-18F/pdf/">PDF Version</a>]</span><div>2-[<sup>18</sup>F]FA</div><div>Kam Leung.</div><div class="small">Created: June 23, 2006; Last Update: April 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fluoroacetate18F"><a class="toc-item" href="/books/n/micad/Fluoroacetate18F/">2-[<sup>18</sup>F]Fluoroacetate</a><span class="small"> [<a href="/books/n/micad/Fluoroacetate18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FAC</div><div>Kam Leung.</div><div class="small">Created: March 22, 2007; Last Update: June 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NEFA18F"><a class="toc-item" href="/books/n/micad/NEFA18F/">2-[<sup>18</sup>F]Fluoro-<i>N</i>-(2-(2-nitro-1<i>H</i>-imidazol-1-yl)ethyl)acetamide</a><span class="small"> [<a href="/books/n/micad/NEFA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]NEFA</div><div>Kam Leung.</div><div class="small">Created: July 19, 2011; Last Update: October 13, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_OSP-1-FP18F"><a class="toc-item" href="/books/n/micad/OSP-1-FP18F/">2-[<sup>18</sup>F]Fluoropropionyl-osteosarcoma–specific peptide-1 (ASGALSPSRLDT)</a><span class="small"> [<a href="/books/n/micad/OSP-1-FP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FP-OSP-1</div><div>Kam Leung.</div><div class="small">Created: September 23, 2010; Last Update: January 7, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MTX9-18F"><a class="toc-item" href="/books/n/micad/MTX9-18F/">2-[<sup>18</sup>F]Fluoropyridine-4-carbohydrazide-methotrexate</a><span class="small"> [<a href="/books/n/micad/MTX9-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Folate-MTX-9</div><div>Arvind Chopra.</div><div class="small">Created: November 16, 2011; Last Update: December 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MC-1-18F"><a class="toc-item" href="/books/n/micad/MC-1-18F/">2-[4-(4-[<sup>18</sup>F]Fluorobutyl)benzylsulfanyl]-3-methylchromene-4-one</a><span class="small"> [<a href="/books/n/micad/MC-1-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]10</div><div>Kam Leung.</div><div class="small">Created: December 15, 2007; Last Update: January 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Flutemetamol18F"><a class="toc-item" href="/books/n/micad/Flutemetamol18F/">2-{3-[<sup>18</sup>F]Fluoro-4-(methylamino)phenyl}-1,3-benzothiazol-6-ol</a><span class="small"> [<a href="/books/n/micad/Flutemetamol18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]Flutemetamol</div><div>Arvind Chopra.</div><div class="small">Created: November 14, 2012; Last Update: December 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JNJ41510417-18F"><a class="toc-item" href="/books/n/micad/JNJ41510417-18F/">2-{4-[-Pyridin-4-yl-1-(2-[<sup>18</sup>F]fluoro-ethyl)-1<i>H</i>-pyrazol-3-yl]-phenoxymethyl}-quinoline</a><span class="small"> [<a href="/books/n/micad/JNJ41510417-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]JNJ41510417</div><div>Kam Leung.</div><div class="small">Created: December 20, 2010; Last Update: March 2, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDS18F"><a class="toc-item" href="/books/n/micad/FDS18F/">2-Deoxy-2-[<sup>18</sup>F]fluorosorbitol </a><span class="small"> [<a href="/books/n/micad/FDS18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDS</div><div>Arvind Chopra.</div><div class="small">Created: January 14, 2008; Last Update: February 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BMS-747158-02"><a class="toc-item" href="/books/n/micad/BMS-747158-02/">2-<i>tert</i>-Butyl-4-chloro-5-[4-(2-[<sup>18</sup>F]fluoroethoxymethyl)-benzyloxy]-2<i>H</i>-pyridazin-3-one</a><span class="small"> [<a href="/books/n/micad/BMS-747158-02/pdf/">PDF Version</a>]</span><div>BMS-747158-02</div><div>Kam Leung.</div><div class="small">Created: December 15, 2007; Last Update: January 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MC1-27-18F"><a class="toc-item" href="/books/n/micad/MC1-27-18F/">2-<i>tert</i>-Butyl-4-chloro-5-[4-(2-[<sup>18</sup>F]fluoro-ethoxymethyl)-benzyloxy]-3-(2<i>H</i>)-pyridazinone</a><span class="small"> [<a href="/books/n/micad/MC1-27-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]MC1-27</div><div>Kam Leung.</div><div class="small">Created: May 15, 2010; Last Update: July 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RP1004-18F"><a class="toc-item" href="/books/n/micad/RP1004-18F/">2-<i>tert</i>-Butyl-4-chloro-5-[4-(4-[<sup>18</sup>F]fluoro-butyl)-benzyloxy]-2<i>H</i>-pyridazin-3-one</a><span class="small"> [<a href="/books/n/micad/RP1004-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]RP1004</div><div>Kam Leung.</div><div class="small">Created: June 15, 2010; Last Update: August 26, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEmZIENT18F"><a class="toc-item" href="/books/n/micad/FEmZIENT18F/">2β-Carbo(2-[<sup>18</sup>F]fluoroethoxy)-3β-(3´-((<i>Z</i>)-2-iodoethenyl)phenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/FEmZIENT18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FE<i>m</i>ZIENT</div><div>Jeffrey Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEpZIENT18F"><a class="toc-item" href="/books/n/micad/FEpZIENT18F/">2β-Carbo(2-[<sup>18</sup>F]fluoroethoxy)-3β-(4´-((<i>Z</i>)-2-iodoethenyl)phenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/FEpZIENT18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FE<i>p</i>ZIENT</div><div>Jeffrey Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FECNT18F"><a class="toc-item" href="/books/n/micad/FECNT18F/">2β-Carbomethoxy-3β-(4-chlorophenyl)-8-(2-[<sup>18</sup>F]fluoroethyl)nortropane </a><span class="small"> [<a href="/books/n/micad/FECNT18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FECNT</div><div>Kam Leung.</div><div class="small">Created: October 27, 2005; Last Update: January 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FFMZ"><a class="toc-item" href="/books/n/micad/FFMZ/">2’-[<sup>18</sup>F]Fluoroflumazenil</a><span class="small"> [<a href="/books/n/micad/FFMZ/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FFMZ</div><div>The MICAD Research Team.</div><div class="small">Created: December 19, 2005; Last Update: December 17, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate-2-18F"><a class="toc-item" href="/books/n/micad/Folate-2-18F/">2’-[<sup>18</sup>F]Fluorofolic acid</a><span class="small"> [<a href="/books/n/micad/Folate-2-18F/pdf/">PDF Version</a>]</span><div>2’-[<sup>18</sup>F]FFA</div><div>Kam Leung.</div><div class="small">Created: December 6, 2010; Last Update: March 9, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate-Aza-18F"><a class="toc-item" href="/books/n/micad/Folate-Aza-18F/">3'-Aza-2'-[<sup>18</sup>F]fluorofolic acid</a><span class="small"> [<a href="/books/n/micad/Folate-Aza-18F/pdf/">PDF Version</a>]</span><div>3'-Aza-2'-[<sup>18</sup>F]FFA</div><div>Kam Leung.</div><div class="small">Created: April 6, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FXA18F"><a class="toc-item" href="/books/n/micad/FXA18F/">3'-Deoxy-3'-[<sup>18</sup>F]fluoro-1-β-<span class="small-caps">D</span>-xylofuranosyl-adenine</a><span class="small"> [<a href="/books/n/micad/FXA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FXA</div><div>Kam Leung.</div><div class="small">Created: September 11, 2007; Last Update: October 29, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fluorothymidine18F"><a class="toc-item" href="/books/n/micad/Fluorothymidine18F/">3'-Deoxy-3'-[<sup>18</sup>F]fluorothymidine</a><span class="small"> [<a href="/books/n/micad/Fluorothymidine18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FLT</div><div>Kam Leung.</div><div class="small">Created: October 1, 2004; Last Update: January 15, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nifrolene-18F"><a class="toc-item" href="/books/n/micad/Nifrolene-18F/">3-(2-(S)-3,4-Dehydropyrrolinyl methoxy)-5-(3'-[<sup>18</sup>F]fluoropropyl)pyridine</a><span class="small"> [<a href="/books/n/micad/Nifrolene-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Nifrolene</div><div>Kam Leung.</div><div class="small">Created: March 18, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FP-TZTP"><a class="toc-item" href="/books/n/micad/FP-TZTP/">3-(3-(3-[<sup>18</sup>F]Flouropropyl)thio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine</a><span class="small"> [<a href="/books/n/micad/FP-TZTP/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FP-TZTP</div><div>Kam Leung.</div><div class="small">Created: May 25, 2005; Last Update: June 6, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMTP18F"><a class="toc-item" href="/books/n/micad/FMTP18F/">3-(4-[<sup>18</sup>F]Fluorobenzyl)-8-methoxy-1,2,3,4 tetrahydrochromeno[3,4-c]pyridin-5-one</a><span class="small"> [<a href="/books/n/micad/FMTP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FMTP</div><div>Kam Leung.</div><div class="small">Created: December 5, 2005; Last Update: February 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FE-DABP688-18F"><a class="toc-item" href="/books/n/micad/FE-DABP688-18F/">3-(Pyridin-2-ylethynyl)-cyclohex-2-enone-<i>O</i>-[<sup>18</sup>F]fluoroethyl-oxime</a><span class="small"> [<a href="/books/n/micad/FE-DABP688-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FE-DABP688</div><div>Kam Leung.</div><div class="small">Created: December 3, 2007; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Altanserin18F"><a class="toc-item" href="/books/n/micad/Altanserin18F/">3-[2-[4-(4-[<sup>18</sup>F]Fluorobenzoyl)-1-piperidyl]ethyl]-2-sulfanyl-3<i>H</i>-quinazolin-4-one </a><span class="small"> [<a href="/books/n/micad/Altanserin18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Altanserin</div><div>Kam Leung.</div><div class="small">Created: December 8, 2005; Last Update: May 29, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PPARGammaLigand18F"><a class="toc-item" href="/books/n/micad/PPARGammaLigand18F/">3-{4-[2-[Benzoxazol-2-yl-methylamino]ethoxy]phenyl}-2-(2-[<sup>18</sup>F]fluoroethoxy)propionic acid</a><span class="small"> [<a href="/books/n/micad/PPARGammaLigand18F/pdf/">PDF Version</a>]</span><div>Compound [<sup>18</sup>F]22</div><div>The MICAD Research Team.</div><div class="small">Created: April 2, 2007; Last Update: May 15, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F13714-18F"><a class="toc-item" href="/books/n/micad/F13714-18F/">3-Chloro-4-[<sup>18</sup>F]fluorophenyl-(4-fluoro-4-[[((5-methyl-4-methylamino-pyridin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F13714)</a><span class="small"> [<a href="/books/n/micad/F13714-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]F13714</div><div>Kam Leung.</div><div class="small">Created: June 24, 2012; Last Update: October 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F15599-18F"><a class="toc-item" href="/books/n/micad/F15599-18F/">3-Chloro-4-[<sup>18</sup>F]fluorophenyl-(4-fluoro-4-[[(5-methyl-pyrimidin-2-ylmethyl)-amino]-methyl]-piperidin-1-yl)methanone (F15599)</a><span class="small"> [<a href="/books/n/micad/F15599-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]F15599</div><div>Kam Leung.</div><div class="small">Created: June 20, 2012; Last Update: October 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BAY86-4367-18F"><a class="toc-item" href="/books/n/micad/BAY86-4367-18F/">3-Cyano-4-[<sup>18</sup>F]fluoro-benzoyl-Ala(SO<sub>3</sub>H)-Ala(SO<sub>3</sub>H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BAY86-4367-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]BAY 86-4367</div><div>Kam Leung.</div><div class="small">Created: June 5, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-7b"><a class="toc-item" href="/books/n/micad/F18-7b/">3-Cyano-4-[<sup>18</sup>F]fluoro-benzoyl-Ala(SO<sub>3</sub>H)-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/F18-7b/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]7b</div><div>Liang Shan.</div><div class="small">Created: December 20, 2010; Last Update: January 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-6b"><a class="toc-item" href="/books/n/micad/F18-6b/">3-Cyano-4-[<sup>18</sup>F]fluoro-benzoyl-Arg-Ava-Gln-Trp-Ala-Val-NMeGly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/F18-6b/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]6b</div><div>Liang Shan.</div><div class="small">Created: December 20, 2010; Last Update: January 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FESP18F"><a class="toc-item" href="/books/n/micad/FESP18F/">3-<i>N</i>-(2-[<sup>18</sup>F]Fluoroethyl)spiperone</a><span class="small"> [<a href="/books/n/micad/FESP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FESP</div><div>Kam Leung.</div><div class="small">Created: October 7, 2005; Last Update: January 18, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEatCIT18F"><a class="toc-item" href="/books/n/micad/FEatCIT18F/">3-β-(4-Iodophenyl)tropane-2-β-carboxylic acid 2-[<sup>18</sup>F]fluoroethyl ester </a><span class="small"> [<a href="/books/n/micad/FEatCIT18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FE@CIT</div><div>Kam Leung.</div><div class="small">Created: August 11, 2008; Last Update: September 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FES-M-4F-18F"><a class="toc-item" href="/books/n/micad/FES-M-4F-18F/">4,16α-[16α-<sup>18</sup>F]Difluoro-11β-methoxyestradiol</a><span class="small"> [<a href="/books/n/micad/FES-M-4F-18F/pdf/">PDF Version</a>]</span><div>4F-M[<sup>18</sup>F]FES</div><div>Kam Leung.</div><div class="small">Created: August 6, 2009; Last Update: September 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPWAY18F"><a class="toc-item" href="/books/n/micad/FPWAY18F/">4-(2´-Methoxyphenyl)-1-[2´-(<i>N</i>-2´´-1,3 pyrimidino)-<i>p</i>-[<sup>18</sup>F]fluorobenzamido]ethylpiperazine</a><span class="small"> [<a href="/books/n/micad/FPWAY18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPWAY</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 1, 2005; Last Update: June 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_p-MPPF18F"><a class="toc-item" href="/books/n/micad/p-MPPF18F/">4-(2´-Methoxyphenyl)-1-[2´-(<i>N</i>-2´´-pyridinyl)-<i>p</i>-[<sup>18</sup>F]fluorobenzamido]ethylpiperazine</a><span class="small"> [<a href="/books/n/micad/p-MPPF18F/pdf/">PDF Version</a>]</span><div><i>p</i>-[<sup>18</sup>F]MPPF</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 20, 2005; Last Update: March 10, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RP1003-18F"><a class="toc-item" href="/books/n/micad/RP1003-18F/">4-(2-(4-(4-[<sup>18</sup>F]Fluoro-butyl)-phenyl)ethoxy) quinazoline</a><span class="small"> [<a href="/books/n/micad/RP1003-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]RP1003</div><div>Kam Leung.</div><div class="small">Created: June 15, 2011; Last Update: January 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PF-9811-18F"><a class="toc-item" href="/books/n/micad/PF-9811-18F/">4-(3-((5-(2-[<sup>18</sup>F]Fluoroethoxy)pyridine-2-yl)oxy)benzylidene)-<i>N</i>-(pyridazin-3-yl)piperidine-1-carboxamide</a><span class="small"> [<a href="/books/n/micad/PF-9811-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PF-9811</div><div>Kam Leung.</div><div class="small">Created: October 20, 2012; Last Update: February 7, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FCAP18F"><a class="toc-item" href="/books/n/micad/FCAP18F/">4-[<sup>18</sup>F]Fluoro-2-D-methyl-3-mercaptopropanoyl-L-proline </a><span class="small"> [<a href="/books/n/micad/FCAP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FCAP</div><div>Arvind Chopra.</div><div class="small">Created: March 8, 2007; Last Update: January 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MTX8-18F"><a class="toc-item" href="/books/n/micad/MTX8-18F/">4-[<sup>18</sup>F]Fluorobenzenecarbohydrazide-methotrexate</a><span class="small"> [<a href="/books/n/micad/MTX8-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-Folate-MTX-8</div><div>Arvind Chopra.</div><div class="small">Created: November 16, 2011; Last Update: December 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AnnexinV18F"><a class="toc-item" href="/books/n/micad/AnnexinV18F/">4-[<sup>18</sup>F]Fluorobenzoyl-annexin V</a><span class="small"> [<a href="/books/n/micad/AnnexinV18F/pdf/">PDF Version</a>]</span><div>4-[<sup>18</sup>F]FBA</div><div>Kam Leung.</div><div class="small">Created: February 7, 2006; Last Update: March 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T140-4-18F"><a class="toc-item" href="/books/n/micad/T140-4-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-<span class="small-caps">d</span>-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/T140-4-18F/pdf/">PDF Version</a>]</span><div>4-[<sup>18</sup>F]F-T140</div><div>Kam Leung.</div><div class="small">Created: January 15, 2011; Last Update: March 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_C2A-GST-18F"><a class="toc-item" href="/books/n/micad/C2A-GST-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-C2A domain of synaptotagmin I-glutathione-<i>S</i>-transferase</a><span class="small"> [<a href="/books/n/micad/C2A-GST-18F/pdf/">PDF Version</a>]</span><div>4-[<sup>18</sup>F]FB-C2A-GST</div><div>Kam Leung.</div><div class="small">Created: May 27, 2011; Last Update: August 4, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ET-1-18F"><a class="toc-item" href="/books/n/micad/ET-1-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-endothelin-1</a><span class="small"> [<a href="/books/n/micad/ET-1-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]ET-1</div><div>The MICAD Research Team.</div><div class="small">Created: March 12, 2007; Last Update: April 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25D18F"><a class="toc-item" href="/books/n/micad/Knottin25D18F/">4-[<sup>18</sup>F]Fluorobenzoyl-knottin 2.5D</a><span class="small"> [<a href="/books/n/micad/Knottin25D18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-2.5D</div><div>Kam Leung.</div><div class="small">Created: March 23, 2010; Last Update: September 23, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A20FMDV2-18F"><a class="toc-item" href="/books/n/micad/A20FMDV2-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-NAVPNLRGDLQVLAQKVART </a><span class="small"> [<a href="/books/n/micad/A20FMDV2-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-A20FMDV2</div><div>Kam Leung.</div><div class="small">Created: March 16, 2008; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBA-FALGEA-18F"><a class="toc-item" href="/books/n/micad/FBA-FALGEA-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-Phe-Ala-Leu-Gly-Glu-Ala-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/FBA-FALGEA-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBA-FALGEA-NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: August 26, 2011; Last Update: December 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FB-RMSH-18F"><a class="toc-item" href="/books/n/micad/FB-RMSH-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-rhenium-cyclized-Ac-<span class="small-caps">D</span>-Lys-[Cys<sup>3,4,10</sup>, <span class="small-caps">D</span>-Phe<sup>7</sup>, Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/FB-RMSH-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FB-RMSH</div><div>Kam Leung.</div><div class="small">Created: February 20, 2010; Last Update: April 8, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84Diabody18F"><a class="toc-item" href="/books/n/micad/T84Diabody18F/">4-[<sup>18</sup>F]Fluorobenzoyl-T84.66 diabody</a><span class="small"> [<a href="/books/n/micad/T84Diabody18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-T84.66 diabody</div><div>Kam Leung.</div><div class="small">Created: April 15, 2007; Last Update: February 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDechi-hCit-18F"><a class="toc-item" href="/books/n/micad/RGDechi-hCit-18F/">4-[<sup>18</sup>F]Fluorobenzoyl-ε-Lys<sup>1</sup>-c(KRGDe)MDDPGRNPH<i>hCit</i>GPAT</a><span class="small"> [<a href="/books/n/micad/RGDechi-hCit-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-RGDechi-hCit</div><div>Kam Leung.</div><div class="small">Created: November 26, 2009; Last Update: December 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBnTP18F"><a class="toc-item" href="/books/n/micad/FBnTP18F/">4-[<sup>18</sup>F]Fluorobenzyl-triphenylphosphonium </a><span class="small"> [<a href="/books/n/micad/FBnTP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBnTP</div><div>Kam Leung.</div><div class="small">Created: September 26, 2006; Last Update: January 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMT-4F18"><a class="toc-item" href="/books/n/micad/FMT-4F18/">4-[<sup>18</sup>F]Fluoro-<span class="small-caps">l</span>-<i>m</i>-tyrosine</a><span class="small"> [<a href="/books/n/micad/FMT-4F18/pdf/">PDF Version</a>]</span><div>4-[<sup>18</sup>F]FMT</div><div>The MICAD Research Team.</div><div class="small">Created: October 11, 2006; Last Update: November 9, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FITM-18F"><a class="toc-item" href="/books/n/micad/FITM-18F/">4-[<sup>18</sup>F]Fluoro-<i>N</i>-[4-[6-(isopropylamino)pyrimidin-4-yl]-1,3-thiazol-2-yl]-<i>N</i>-methylbenzamide</a><span class="small"> [<a href="/books/n/micad/FITM-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FITM</div><div>Kam Leung.</div><div class="small">Created: November 5, 2012; Last Update: February 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPAC18F"><a class="toc-item" href="/books/n/micad/FPAC18F/">4-[<sup>18</sup>F]Fluoropaclitaxel</a><span class="small"> [<a href="/books/n/micad/FPAC18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPAC</div><div>Kam Leung.</div><div class="small">Created: January 2, 2006; Last Update: February 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NS10743-18F"><a class="toc-item" href="/books/n/micad/NS10743-18F/">4-[5-(4-[<sup>18</sup>F]Fluoro-phenyl)-[1,3,4]oxadiazol-2-yl]-1,4-diaza-bicyclo[3.2.2]nonane</a><span class="small"> [<a href="/books/n/micad/NS10743-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]NS10743</div><div>Kam Leung.</div><div class="small">Created: December 12, 2010; Last Update: January 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BrFPN"><a class="toc-item" href="/books/n/micad/BrFPN/">4-Bromo-1-(3-[<sup>18</sup>F]fluoropropyl)-2-nitroimidazole</a><span class="small"> [<a href="/books/n/micad/BrFPN/pdf/">PDF Version</a>]</span><div>4-Br[<sup>18</sup>F]FPN</div><div>The MICAD Research Team.</div><div class="small">Created: October 27, 2005; Last Update: December 12, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEHTP18F"><a class="toc-item" href="/books/n/micad/FEHTP18F/"><span class="small-caps">5-(2-</span>[<sup>18</sup>F]Fluoroethoxy)-<span class="small-caps">L</span>-tryphan</a><span class="small"> [<a href="/books/n/micad/FEHTP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-<span class="small-caps">L</span>-FEHTP</div><div>Kam Leung.</div><div class="small">Created: March 3, 2012; Last Update: June 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPHBF-2-18F"><a class="toc-item" href="/books/n/micad/FPHBF-2-18F/">5-(5-(2-(2-(2-[<sup>18</sup>F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-<i>N</i>-methylbenzenamine</a><span class="small"> [<a href="/books/n/micad/FPHBF-2-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FPHBF-2</div><div>Kam Leung.</div><div class="small">Created: June 11, 2011; Last Update: September 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPYBF-2-18F"><a class="toc-item" href="/books/n/micad/FPYBF-2-18F/">5-(5-(2-(2-(2-[<sup>18</sup>F]Fluoroethoxy)ethoxy)ethoxy)benzofuran-2-yl)-<i>N</i>-methylpyridin-2-amine</a><span class="small"> [<a href="/books/n/micad/FPYBF-2-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FPYBF-2</div><div>Kam Leung.</div><div class="small">Created: June 11, 2011; Last Update: September 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_resveratrol18F"><a class="toc-item" href="/books/n/micad/resveratrol18F/">5-[(<i>E</i>)-2-(4-[<sup>18</sup>F]Fluorophenyl)ethenyl]-1,3-benzenediol </a><span class="small"> [<a href="/books/n/micad/resveratrol18F/pdf/">PDF Version</a>]</span><div>3,5-Dihydroxy-4'-[<sup>18</sup>F]fluoro-<i>trans</i>-stilbene</div><div>The MICAD Research Team.</div><div class="small">Created: August 22, 2006; Last Update: September 11, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MK332818F"><a class="toc-item" href="/books/n/micad/MK332818F/">5-[<sup>18</sup>F]Fluoro-2-(1-methyl-1H-pyrrolo[2,3-b]pyridin-5-yl)-oxazolo[5,4-b]pyridine</a><span class="small"> [<a href="/books/n/micad/MK332818F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]MK-3328</div><div>Arvind Chopra.</div><div class="small">Created: December 20, 2011; Last Update: February 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nifrolidine18F"><a class="toc-item" href="/books/n/micad/Nifrolidine18F/">5-3’-[<sup>18</sup>F]Fluoropropyl-3-[2-((<i>S</i>)-pyrrolidinyl)methoxy]pyridine</a><span class="small"> [<a href="/books/n/micad/Nifrolidine18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Nifrolidine</div><div>Kam Leung.</div><div class="small">Created: September 18, 2006; Last Update: April 3, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BF-168F18"><a class="toc-item" href="/books/n/micad/BF-168F18/">6-(2-[<sup>18</sup>F]Fluoroethoxy)-2-[2-(4-methylaminophenyl)ethenyl]benzoxazole </a><span class="small"> [<a href="/books/n/micad/BF-168F18/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]BF-168</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 3, 2006; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPPIP18F"><a class="toc-item" href="/books/n/micad/FPPIP18F/">6-(3'-[<sup>18</sup>F]Fluoropropyl)-2-(4'-dimethylamino)phenylimidazol[1,2-α]pyridine</a><span class="small"> [<a href="/books/n/micad/FPPIP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPPIP</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 3, 2006; Last Update: April 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPTQ-18F"><a class="toc-item" href="/books/n/micad/FPTQ-18F/">6-[1-(2-[<sup>18</sup>F]Fluoro-3-pyridyl)-5-methyl-1<i>H</i>-1,2,3-triazol-4-yl]quinoline</a><span class="small"> [<a href="/books/n/micad/FPTQ-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPTQ</div><div>Kam Leung.</div><div class="small">Created: November 11, 2012; Last Update: March 7, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A85380-6-18F"><a class="toc-item" href="/books/n/micad/A85380-6-18F/">6-[<sup>18</sup>F]Fluoro-3-[2(S)-2-azetidinylmethoxy]pyridine</a><span class="small"> [<a href="/books/n/micad/A85380-6-18F/pdf/">PDF Version</a>]</span><div>6-[<sup>18</sup>F]FA</div><div>Kam Leung.</div><div class="small">Created: June 26, 2006; Last Update: April 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fluorodopamine18F"><a class="toc-item" href="/books/n/micad/Fluorodopamine18F/">6-[<sup>18</sup>F]Fluorodopamine</a><span class="small"> [<a href="/books/n/micad/Fluorodopamine18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDA</div><div>Kam Leung.</div><div class="small">Created: April 6, 2005; Last Update: December 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FMT18F"><a class="toc-item" href="/books/n/micad/FMT18F/">6-[<sup>18</sup>F]Fluoro-<span class="small-caps">l</span>-<i>m</i>-tyrosine</a><span class="small"> [<a href="/books/n/micad/FMT18F/pdf/">PDF Version</a>]</span><div>6-[<sup>18</sup>F]FMT</div><div>The MICAD Research Team.</div><div class="small">Created: May 22, 2006; Last Update: September 6, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDF18F"><a class="toc-item" href="/books/n/micad/FDF18F/">6-Deoxy-6-[<sup>18</sup>F]fluoro<span class="small-caps">-D</span>-fructose</a><span class="small"> [<a href="/books/n/micad/FDF18F/pdf/">PDF Version</a>]</span><div>6-[<sup>18</sup>F]FDF</div><div>Kam Leung.</div><div class="small">Created: July 10, 2011; Last Update: October 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEMIMPY18F"><a class="toc-item" href="/books/n/micad/FEMIMPY18F/">6-Iodo-2-[4'-<i>N</i>-(2-[<sup>18</sup>F]fluoroethyl)methylamino]phenylimidazo[1,2-<i>a</i>]pyridine</a><span class="small"> [<a href="/books/n/micad/FEMIMPY18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEM-IMPY</div><div>The MICAD Research Team.</div><div class="small">Created: December 13, 2006; Last Update: December 31, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDPN18F"><a class="toc-item" href="/books/n/micad/FDPN18F/">6-<i>O</i>-(2-[<sup>18</sup>F]Fluoroethyl)-6-<i>O</i>-desmethyldiprenorphine</a><span class="small"> [<a href="/books/n/micad/FDPN18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDPN</div><div>Kam Leung.</div><div class="small">Created: June 15, 2006; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CPFPX18F"><a class="toc-item" href="/books/n/micad/CPFPX18F/">8-Cyclopentyl-3-(3-[<sup>18</sup>F]fluoropropyl)-1-propylxanthine</a><span class="small"> [<a href="/books/n/micad/CPFPX18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]CPFPX</div><div>Kam Leung.</div><div class="small">Created: February 13, 2006; Last Update: July 8, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_WC59_18F"><a class="toc-item" href="/books/n/micad/WC59_18F/">9-(4-(2-[<sup>18</sup>F]Fluoroethyl)benzyl)-9-azabicyclo[3.3.1]nonan-3-yl-2-methoxy-5-methyl-phenylcarbamate</a><span class="small"> [<a href="/books/n/micad/WC59_18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]WC-59</div><div>Arvind Chopra.</div><div class="small">Created: November 10, 2009; Last Update: December 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FHBG18F"><a class="toc-item" href="/books/n/micad/FHBG18F/">9-(4-[<sup>18</sup>F]Fluoro-3-hydroxymethylbutyl)guanine</a><span class="small"> [<a href="/books/n/micad/FHBG18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FHBG</div><div>Kam Leung.</div><div class="small">Created: January 24, 2005; Last Update: February 23, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AdTSTAsr39tk"><a class="toc-item" href="/books/n/micad/AdTSTAsr39tk/"><i>Ad5</i>-(PSE-BC)-(GAL4-(VP16)<sub>2</sub>)-(GAL4)<sub>5</sub>-sr39<i>tk </i></a><span class="small"> [<a href="/books/n/micad/AdTSTAsr39tk/pdf/">PDF Version</a>]</span><div>AdTSTA-sr39<i>tk</i></div><div>Huiming Zhang.</div><div class="small">Created: December 15, 2008; Last Update: January 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-E-NODAGA-18F"><a class="toc-item" href="/books/n/micad/RGDfK2-E-NODAGA-18F/">Al<sup>18</sup>F-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid<b>-</b>Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-E-NODAGA-18F/pdf/">PDF Version</a>]</span><div>Al<sup>18</sup>F-NODAGA-E-[c(RGDfK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: May 7, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-NOTA-8-Aoc-18F"><a class="toc-item" href="/books/n/micad/BBN-NOTA-8-Aoc-18F/">Al<sup>18</sup>F-1,4,7-Triazacyclononane-1,4,7-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-NOTA-8-Aoc-18F/pdf/">PDF Version</a>]</span><div>Al<sup>18</sup>F-NOTA-8-Aoc-BBN[7-14]NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 26, 2012; Last Update: October 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anti-2-FACBC18F"><a class="toc-item" href="/books/n/micad/Anti-2-FACBC18F/"><i>anti</i>-1-Amino-2-[<sup>18</sup>F]fluorocyclobutane-1-carboxylic acid</a><span class="small"> [<a href="/books/n/micad/Anti-2-FACBC18F/pdf/">PDF Version</a>]</span><div><i>anti</i>-2-[<sup>18</sup>F]FACBC</div><div>Kam Leung.</div><div class="small">Created: November 18, 2010; Last Update: February 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FACBC18F"><a class="toc-item" href="/books/n/micad/FACBC18F/"><i>anti</i>-1-Amino-3-[<sup>18</sup>F]fluorocyclobutane-1-carboxylic acid</a><span class="small"> [<a href="/books/n/micad/FACBC18F/pdf/">PDF Version</a>]</span><div><i>anti</i>-[<sup>18</sup>F]FACBC</div><div>Kam Leung.</div><div class="small">Created: October 18, 2004; Last Update: October 21, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PIPAM818F"><a class="toc-item" href="/books/n/micad/PIPAM818F/">CtPyPyIm-(R)<sup>H</sup><sub>2</sub><sup>N</sup>γ-PyImPyPy-<i>C</i><sub><i>3</i></sub>-<sup>18</sup>F</a><span class="small"> [<a href="/books/n/micad/PIPAM818F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PIPAM8</div><div>Huiming Zhang.</div><div class="small">Created: November 4, 2008; Last Update: December 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGD-galacto18F"><a class="toc-item" href="/books/n/micad/RGD-galacto18F/">Cyclo(-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys(([<sup>18</sup>F]Fluoropropionyl)galacto-amino acid)-)</a><span class="small"> [<a href="/books/n/micad/RGD-galacto18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]Galacto-RGD</div><div>Kam Leung.</div><div class="small">Created: November 18, 2004; Last Update: January 9, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CRPPR-FDP18F-Lips"><a class="toc-item" href="/books/n/micad/CRPPR-FDP18F-Lips/">Cys-Arg-Pro-Pro-Arg-[<sup>18</sup>F]fluorodipalmitin-liposomes</a><span class="small"> [<a href="/books/n/micad/CRPPR-FDP18F-Lips/pdf/">PDF Version</a>]</span><div>CRPPR-[<sup>18</sup>F]FDP-liposomes</div><div>Kam Leung.</div><div class="small">Created: May 12, 2008; Last Update: May 29, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-83-85"><a class="toc-item" href="/books/n/micad/F18-83-85/">Fluoro-pegylated (1E,4E)-1-(4-(dimethylamino)phenyl)-5-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)penta-1,4-dien-3-one and (1E,4E)-1-(4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)phenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one</a><span class="small"> [<a href="/books/n/micad/F18-83-85/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]83, [<sup>18</sup>F]85</div><div>Liang Shan.</div><div class="small">Created: November 30, 2011; Last Update: February 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PIPAM518F"><a class="toc-item" href="/books/n/micad/PIPAM518F/">ImPyβImPyβImβ-<i>C</i><sub><i>3</i></sub>-<sup>18</sup>F</a><span class="small"> [<a href="/books/n/micad/PIPAM518F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PIPAM5</div><div>Huiming Zhang.</div><div class="small">Created: November 4, 2008; Last Update: December 1, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FDOPA"><a class="toc-item" href="/books/n/micad/FDOPA/">L-3,4-Dihydroxy-6-[<sup>18</sup>F]fluorophenylalanine</a><span class="small"> [<a href="/books/n/micad/FDOPA/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FDOPA</div><div>Kam Leung.</div><div class="small">Created: March 21, 2005; Last Update: December 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPHCys18F"><a class="toc-item" href="/books/n/micad/FPHCys18F/">L- and D-<i>S</i>-(3-[<sup>18</sup>F]fluoropropyl)homocysteine</a><span class="small"> [<a href="/books/n/micad/FPHCys18F/pdf/">PDF Version</a>]</span><div><span class="small-caps">l</span>- and <span class="small-caps">d</span>-[<sup>18</sup>F]FPHCys</div><div>Arvind Chopra.</div><div class="small">Created: January 10, 2012; Last Update: February 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CNPFH18F"><a class="toc-item" href="/books/n/micad/CNPFH18F/"><i>m</i>-Cyano-<i>p</i>-[<sup>18</sup>F]fluorohippurate</a><span class="small"> [<a href="/books/n/micad/CNPFH18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-CNPFH</div><div>Arvind Chopra.</div><div class="small">Created: October 24, 2012; Last Update: November 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MFNBMB18F"><a class="toc-item" href="/books/n/micad/MFNBMB18F/">Methyl 2-(2-[<sup>18</sup>F]fluoro-4-nitrobenzamido)-3-methylbutanoate</a><span class="small"> [<a href="/books/n/micad/MFNBMB18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]MFNBMB</div><div>Arvind Chopra.</div><div class="small">Created: August 5, 2009; Last Update: September 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FNBMBA18F"><a class="toc-item" href="/books/n/micad/FNBMBA18F/">Methyl 2-(2-[<sup>18</sup>F]fluoro-4-nitrobenzamido)-3- methylbutanoic acid</a><span class="small"> [<a href="/books/n/micad/FNBMBA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FNBMBA</div><div>Arvind Chopra.</div><div class="small">Created: August 5, 2009; Last Update: September 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEAnGA-Me18F"><a class="toc-item" href="/books/n/micad/FEAnGA-Me18F/">Methyl ester of 1-<i>O</i>-(4-(2-[<sup>18</sup>F]fluoroethyl-carbamoyloxymethyl)-2-nitrophenyl)-<i>O</i>-β-<span class="small-caps">d</span>-glucopyronuronate</a><span class="small"> [<a href="/books/n/micad/FEAnGA-Me18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FEAnGA-Me</div><div>Arvind Chopra.</div><div class="small">Created: April 4, 2012; Last Update: April 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBFNT18F"><a class="toc-item" href="/books/n/micad/FBFNT18F/"><i>N</i>-((<i>E</i>)-4-[<sup>18</sup>F]Fluorobut-2-en-1-yl)-2β-carbomethoxy-3β-(4'-fluorophenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/FBFNT18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FBFNT</div><div>Jeffrey S. Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F6PWAY18F"><a class="toc-item" href="/books/n/micad/F6PWAY18F/"><i>N</i>-(2-(1-(4-(2-Methoxyphenyl)piperazinyl)ethyl))-<i>N</i>-(2-(6-[<sup>18</sup>F]fluoro)-pyridinyl)cyclohexanecarboxamide</a><span class="small"> [<a href="/books/n/micad/F6PWAY18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]6FPWAY</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 29, 2005; Last Update: June 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBEMEM3106B18F"><a class="toc-item" href="/books/n/micad/FBEMEM3106B18F/"><i>N</i>-(2-(2,5-dioxo-2,5-dihydro-1<i>H</i>-pyrrol-1-yl)ethyl)-4-[<sup>18</sup>F]-fluorobenzamide ([<sup>18</sup>F]FBEM) conjugated to EM3106B, an analog of glucagon-like peptide-1</a><span class="small"> [<a href="/books/n/micad/FBEMEM3106B18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FBEM-EM3106B</div><div>Arvind Chopra.</div><div class="small">Created: February 23, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nicotinamide-18F"><a class="toc-item" href="/books/n/micad/Nicotinamide-18F/"><i>N</i>-(2-(Diethylamino)ethyl)-6-[<sup>18</sup>F]fluoronicotinamide</a><span class="small"> [<a href="/books/n/micad/Nicotinamide-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]2</div><div>Kam Leung.</div><div class="small">Created: October 7, 2009; Last Update: February 24, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DAFBA18F"><a class="toc-item" href="/books/n/micad/DAFBA18F/"><i>N</i>-(2-Diethylaminoethyl)-4-[<sup>18</sup>F]fluorobenzamide for imaging melanoma</a><span class="small"> [<a href="/books/n/micad/DAFBA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]-DAFBA</div><div>Liang Shan.</div><div class="small">Created: November 19, 2009; Last Update: December 30, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FP-CIT18F"><a class="toc-item" href="/books/n/micad/FP-CIT18F/"><i>N</i>-(3-[<sup>18</sup>F]Fluoropropyl)-2β-carbomethoxy-3β-(4-iodophenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/FP-CIT18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FP-CIT</div><div>Kam Leung.</div><div class="small">Created: December 15, 2004; Last Update: February 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DRD3-5-18F"><a class="toc-item" href="/books/n/micad/DRD3-5-18F/"><i>N</i>-(4-(4-(2-(2-[<sup>18</sup>F]Fluoroethoxy)phenyl)piperazine-1-yl)butyl)-4-(3-thienyl)benzamide</a><span class="small"> [<a href="/books/n/micad/DRD3-5-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]5</div><div>Kam Leung.</div><div class="small">Created: June 24, 2011; Last Update: October 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PC-10-18F"><a class="toc-item" href="/books/n/micad/PC-10-18F/"><i>N</i>-(4-[<sup>18</sup>F]Fluoro-benzoyl)-<i>N</i>'-{2-[5-(4-fluoro-benzyl)-1-(4-methoxy-benzyl)-4,6-dioxo-1,4,5,6-tetrahydro-[1,3,5]triazin-2-ylamino]-ethyl}-guanidine</a><span class="small"> [<a href="/books/n/micad/PC-10-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]PC-10</div><div>Kam Leung.</div><div class="small">Created: June 29, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PipISB18F"><a class="toc-item" href="/books/n/micad/PipISB18F/"><i>N</i>-(4-[<sup>18</sup>F]Fluorobenzyl)-4-(3-(piperidin-1-yl)indole-1-sulfonyl)benzamide</a><span class="small"> [<a href="/books/n/micad/PipISB18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]PipISB</div><div>Kam Leung and Sean Donohue.</div><div class="small">Created: August 18, 2010; Last Update: October 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEDAA1106-18F"><a class="toc-item" href="/books/n/micad/FEDAA1106-18F/"><i>N</i>-(5-Fluoro-2-phenoxyphenyl)-<i>N</i>-(2-[<sup>18</sup>F]fluoroethyl-5-methoxybenzyl)acetamide</a><span class="small"> [<a href="/books/n/micad/FEDAA1106-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEDAA1106</div><div>Kam Leung.</div><div class="small">Created: March 10, 2006; Last Update: March 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR28F18"><a class="toc-item" href="/books/n/micad/PBR28F18/">N-(6-[<sup>18</sup>F]Fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide</a><span class="small"> [<a href="/books/n/micad/PBR28F18/pdf/">PDF Version</a>]</span><div>6-[<sup>18</sup>F]Fluoro-PBR28</div><div>Arvind Chopra.</div><div class="small">Created: March 26, 2013; Last Update: April 25, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR06-18F"><a class="toc-item" href="/books/n/micad/PBR06-18F/"><i>N</i>-[<sup>18</sup>F]Fluoroacetyl-<i>N</i>-(2,5-dimethoxybenzyl)-2-phenoxyaniline</a><span class="small"> [<a href="/books/n/micad/PBR06-18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]PBR06</div><div>Kam Leung.</div><div class="small">Created: June 6, 2007; Last Update: March 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEP4MA18F"><a class="toc-item" href="/books/n/micad/FEP4MA18F/"><i>N</i>-[<sup>18</sup>F]Fluoroethylpiperidin-4ylmethyl acetate</a><span class="small"> [<a href="/books/n/micad/FEP4MA18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FEP-4MA</div><div>Kam Leung.</div><div class="small">Created: March 17, 2010; Last Update: September 23, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MK947018F"><a class="toc-item" href="/books/n/micad/MK947018F/"><i>N</i>-[2-(3-cyanophenyl)-3-(4-(2-[<sup>18</sup>F]fluorethoxy)phenyl)-1-methylpropyl]-2-(5-methyl-2-pyridyloxy)-2-methylproponamide</a><span class="small"> [<a href="/books/n/micad/MK947018F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]MK-9470</div><div>Arvind Chopra.</div><div class="small">Created: February 28, 2008; Last Update: March 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-FBEM-18F"><a class="toc-item" href="/books/n/micad/Z1907-FBEM-18F/"><i>N</i>-[2-(4-[<sup>18</sup>F]Fluorobenzamido)ethyl]maleimide-Cys-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-FBEM-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBEM-Cys-Z<sub>EGFR:1907</sub></div><div>Kam Leung.</div><div class="small">Created: July 31, 2012; Last Update: November 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBEM-SRGD2F18"><a class="toc-item" href="/books/n/micad/FBEM-SRGD2F18/"><i>N</i>-[2-(4-[<sup>18</sup>F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid dimeric peptide</a><span class="small"> [<a href="/books/n/micad/FBEM-SRGD2F18/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBEM-SRGD2</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 6, 2007; Last Update: February 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBEM-SRGD18F"><a class="toc-item" href="/books/n/micad/FBEM-SRGD18F/"><i>N</i>-[2-(4-[<sup>18</sup>F]Fluorobenzamido)ethyl]maleimide-sulfhydryl-cyclic-arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/FBEM-SRGD18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBEM-SRGD</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 6, 2007; Last Update: February 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_F18-44"><a class="toc-item" href="/books/n/micad/F18-44/"><i>N</i>-[2-[<i>N</i>-Ethyl-<i>N</i>-[2-(2-[<sup>18</sup>F]fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide</a><span class="small"> [<a href="/books/n/micad/F18-44/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]44</div><div>Liang Shan.</div><div class="small">Created: August 5, 2011; Last Update: August 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DCFBC18F"><a class="toc-item" href="/books/n/micad/DCFBC18F/"><i>N</i>-[<i>N</i>-[(<i>S</i>)-1,3-Dicarboxypropyl]carbamoyl]-4-[<sup>18</sup>F]fluorobenzyl-<span class="small-caps">L</span>-cysteine</a><span class="small"> [<a href="/books/n/micad/DCFBC18F/pdf/">PDF Version</a>]</span><div><sup>18</sup>F-DCFBC</div><div>Kam Leung.</div><div class="small">Created: November 1, 2008; Last Update: December 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Mefway18F"><a class="toc-item" href="/books/n/micad/Mefway18F/"><i>N</i>-{2-[4-(2-Methoxyphenyl)piperazinyl]ethyl}-<i>N</i>-(2-pyridyl)-<i>N</i>-(4-[<sup>18</sup>F]-fluoromethylcyclohexane)carboxamide</a><span class="small"> [<a href="/books/n/micad/Mefway18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]MeFWAY</div><div>Kam Leung.</div><div class="small">Created: November 9, 2006; Last Update: April 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBEMcEGF18F"><a class="toc-item" href="/books/n/micad/FBEMcEGF18F/"><i>N</i>-2-(4-[<sup>18</sup>F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/FBEMcEGF18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FBEM-cEGF</div><div>Arvind Chopra.</div><div class="small">Created: January 30, 2012; Last Update: March 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBEMExe4Cys18F"><a class="toc-item" href="/books/n/micad/FBEMExe4Cys18F/"><i>N</i>-2-(4-[<sup>18</sup>F]-Fluorobenzamido)ethylmaleimide coupled to cysteine-tagged on the C- or N-terminal of exendin-4</a><span class="small"> [<a href="/books/n/micad/FBEMExe4Cys18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]FBEM-[Cys<sup>0</sup>]-exendin-4 and [<sup>18</sup>F]FBEM-[Cys<sup>40</sup>]-exendin-4</div><div>Arvind Chopra.</div><div class="small">Created: February 21, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBFPA18F"><a class="toc-item" href="/books/n/micad/FBFPA18F/"><i>N</i>-4'-[<sup>18</sup>F]Fluorobenzylpiperidin-4yl-(2-fluorophenyl)acetamide</a><span class="small"> [<a href="/books/n/micad/FBFPA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FBFPA</div><div>Kam Leung.</div><div class="small">Created: October 6, 2006; Last Update: March 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FB-cRGDyK18F"><a class="toc-item" href="/books/n/micad/FB-cRGDyK18F/"><i>N</i>-4-[<sup>18</sup>F]Fluorobenzoyl-c(RGDyK) </a><span class="small"> [<a href="/books/n/micad/FB-cRGDyK18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: March 6, 2006; Last Update: March 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FB-RGD2-18F"><a class="toc-item" href="/books/n/micad/FB-RGD2-18F/"><i>N</i>-4-[<sup>18</sup>F]Fluorobenzoyl-c[(RGDyK)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/FB-RGD2-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FB-c[(RGDyK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: March 3, 2006; Last Update: March 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PR04MZ18F"><a class="toc-item" href="/books/n/micad/PR04MZ18F/"><i>N</i>-4-[<sup>18</sup>F]Fluorobut-2-yn-1-yl-2β-carbomethoxy-3β-phenyltropane</a><span class="small"> [<a href="/books/n/micad/PR04MZ18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]PR04.MZ</div><div>Kam Leung.</div><div class="small">Created: August 10, 2011; Last Update: November 3, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEPPA18F"><a class="toc-item" href="/books/n/micad/FEPPA18F/"><i>N</i>-Acetyl-<i>N</i>-(2-[<sup>18</sup>F]fluoroethoxybenzyl)-2-phenoxy-5-pyridinamine </a><span class="small"> [<a href="/books/n/micad/FEPPA18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEPPA</div><div>Kam Leung.</div><div class="small">Created: August 12, 2008; Last Update: August 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEAC18F"><a class="toc-item" href="/books/n/micad/FEAC18F/"><i>N</i>-Benzyl-<i>N</i>-ethyl-2-[7,8-dihydro-7-(2-[<sup>18</sup>F]fluoroethyl)-8-oxo-2-phenyl-9<i>H</i>-purin-9-yl]acetamide</a><span class="small"> [<a href="/books/n/micad/FEAC18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEAC</div><div>Kam Leung.</div><div class="small">Created: May 6, 2010; Last Update: August 19, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEDAC18F"><a class="toc-item" href="/books/n/micad/FEDAC18F/"><i>N</i>-Benzyl-<i>N</i>-methyl-2-[7,8-dihydro-7-(2-[<sup>18</sup>F]fluoroethyl)-8-oxo-2-phenyl-9<i>H</i>-purin-9-yl]acetamide</a><span class="small"> [<a href="/books/n/micad/FEDAC18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEDAC</div><div>Kam Leung.</div><div class="small">Created: May 6, 2010; Last Update: August 19, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FET18F"><a class="toc-item" href="/books/n/micad/FET18F/"><i>O</i>-(2-[<sup>18</sup>F]Fluoroethyl)-<span class="small-caps">L</span>-tyrosine</a><span class="small"> [<a href="/books/n/micad/FET18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FET</div><div>Kam Leung.</div><div class="small">Created: September 15, 2005; Last Update: December 6, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FPT18F"><a class="toc-item" href="/books/n/micad/FPT18F/"><i>O</i>-(3-[<sup>18</sup>F]Fluoropropyl)-<span class="small-caps">L</span>-tyrosine</a><span class="small"> [<a href="/books/n/micad/FPT18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FPT</div><div>Kam Leung.</div><div class="small">Created: February 18, 2005; Last Update: December 5, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEP18F"><a class="toc-item" href="/books/n/micad/FEP18F/"><i>p</i>-(2-[<sup>18</sup>F]Fluoroethyl)-<span class="small-caps">l</span>-phenylalanine</a><span class="small"> [<a href="/books/n/micad/FEP18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEP</div><div>Kam Leung.</div><div class="small">Created: February 7, 2011; Last Update: June 16, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AP4A18F"><a class="toc-item" href="/books/n/micad/AP4A18F/">P<sup>2</sup>,P<sup>3</sup>-[<sup>18</sup>F]Monofluoromethylene diadenosine-5’,5’’’-P<sup>1</sup>,P<sup>4</sup>-tetraphosphate</a><span class="small"> [<a href="/books/n/micad/AP4A18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]AppCHFppA</div><div>Huiming Zhang.</div><div class="small">Created: March 20, 2008; Last Update: April 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PFH18F"><a class="toc-item" href="/books/n/micad/PFH18F/"><i>Para</i>-[<sup>18</sup>F]-fluorohippurate</a><span class="small"> [<a href="/books/n/micad/PFH18F/pdf/">PDF Version</a>]</span><div> [<sup>18</sup>F]-PFH</div><div>Hariprasad Gali and Arvind Chopra.</div><div class="small">Created: January 4, 2011; Last Update: February 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FBAPEGA20FMDV2F18"><a class="toc-item" href="/books/n/micad/FBAPEGA20FMDV2F18/">PEGylated 4-[<sup>18</sup>F]fluorobenzoyl-NAVPNLRGDLQVLAQKVART</a><span class="small"> [<a href="/books/n/micad/FBAPEGA20FMDV2F18/pdf/">PDF Version</a>]</span><div>PEGylated [<sup>18</sup>F]FBA-A20FMDV2</div><div>Arvind Chopra.</div><div class="small">Created: July 17, 2009; Last Update: October 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP-PEG-TMR-18F"><a class="toc-item" href="/books/n/micad/MMP-PEG-TMR-18F/">Polyethylene glycol-Cys-Arg-Ser-Gly-Pro-Leu-Gly-Val-Tyr-[<sup>18</sup>F]fluorobenzoyl-Lys-Lys-tetramethylrhodamine</a><span class="small"> [<a href="/books/n/micad/MMP-PEG-TMR-18F/pdf/">PDF Version</a>]</span><div>PEG-peptide-[<sup>18</sup>F]-TMR</div><div>Kam Leung.</div><div class="small">Created: February 6, 2012; Last Update: May 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Syn-3-FACBC18F"><a class="toc-item" href="/books/n/micad/Syn-3-FACBC18F/"><i>syn</i>-1-Amino-3-[<sup>18</sup>F]fluorocyclobutane-1-carboxylic acid</a><span class="small"> [<a href="/books/n/micad/Syn-3-FACBC18F/pdf/">PDF Version</a>]</span><div><i>syn</i>-3-[<sup>18</sup>F]FACBC</div><div>Kam Leung.</div><div class="small">Created: November 18, 2010; Last Update: February 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FEMcN18F"><a class="toc-item" href="/books/n/micad/FEMcN18F/">Trans-1,2,3,5,6,10b-hexahydro-6-[4-([<sup>18</sup>F]fluoroethylthio)-phenyl]pyrrolo-[2,1-a]-isoquinoline</a><span class="small"> [<a href="/books/n/micad/FEMcN18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]FEMcN</div><div>Arvind Chopra.</div><div class="small">Created: May 29, 2007; Last Update: June 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BAY94-9172-18F"><a class="toc-item" href="/books/n/micad/BAY94-9172-18F/">Trans<i>-</i>4-(<i>N</i>-Methylamino)-4´-{2-[2-(2-[<sup>18</sup>F]fluoro-ethoxy)-ethoxy]-ethoxy}-stilbene</a><span class="small"> [<a href="/books/n/micad/BAY94-9172-18F/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F]BAY94-9172</div><div>Kam Leung.</div><div class="small">Created: May 11, 2009; Last Update: June 5, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos44sc"><a class="toc-item" href="/books/n/micad/sos44sc/">44Sc</a><ul id="toc_lst_NBK5330_toc_sos44sc" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Pur44Sc"><a class="toc-item" href="/books/n/micad/Pur44Sc/"><sup>44</sup>Sc-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid–conjugated puromycin</a><span class="small"> [<a href="/books/n/micad/Pur44Sc/pdf/">PDF Version</a>]</span><div> [<sup>44</sup>Sc]-DOTA-Pur</div><div>Arvind Chopra.</div><div class="small">Created: January 28, 2013; Last Update: February 28, 2013.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos6061626467cu"><a class="toc-item" href="/books/n/micad/sos6061626467cu/">60,61,62,64, 67Cu</a><ul id="toc_lst_NBK5330_toc_sos6061626467cu" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-ATSM"><a class="toc-item" href="/books/n/micad/Cu-ATSM/">Copper(II) diacetyl-di(<i>N</i><sup>4</sup>-methylthiosemicarbazone)</a><span class="small"> [<a href="/books/n/micad/Cu-ATSM/pdf/">PDF Version</a>]</span><div>Cu-ATSM</div><div>The MICAD Research Team.</div><div class="small">Created: November 10, 2004; Last Update: July 31, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-PTSM"><a class="toc-item" href="/books/n/micad/Cu-PTSM/">Copper pyruvaldehyde bis(<i>N</i><sup>4</sup>-methylthiosemicarbazone) complex</a><span class="small"> [<a href="/books/n/micad/Cu-PTSM/pdf/">PDF Version</a>]</span><div>Cu-PTSM</div><div>The MICAD Research Team.</div><div class="small">Created: December 3, 2004; Last Update: January 3, 2005.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos64cu"><a class="toc-item" href="/books/n/micad/sos64cu/">64Cu</a><ul id="toc_lst_NBK5330_toc_sos64cu" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiGD2mAb64Cu"><a class="toc-item" href="/books/n/micad/AntiGD2mAb64Cu/">[<sup>64</sup>Cu](1-<i>N</i>-(4-aminobenzyl)-3,6,10,13,16,19-hexaazabicyclo[6.6.6]-eicosane-1,8-diamine)-anti-GD2 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/AntiGD2mAb64Cu/pdf/">PDF Version</a>]</span><div>Arvind Chopra.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25D64Cu"><a class="toc-item" href="/books/n/micad/Knottin25D64Cu/">[<sup>64</sup>Cu]-1,4,7,10-Tetra-azacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid conjugated knottin 2.5D</a><span class="small"> [<a href="/books/n/micad/Knottin25D64Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu] Knottin 2.5D</div><div>Arvind Chopra.</div><div class="small">Created: March 23, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin25F64Cu"><a class="toc-item" href="/books/n/micad/Knottin25F64Cu/">[<sup>64</sup>Cu]-1,4,7,10-Tetra-azacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid conjugated knottin 2.5F</a><span class="small"> [<a href="/books/n/micad/Knottin25F64Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu] Knottin 2.5F</div><div>Arvind Chopra.</div><div class="small">Created: March 25, 2009; Last Update: May 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NAPamide64Cu"><a class="toc-item" href="/books/n/micad/NAPamide64Cu/"><sup>64</sup>Cu-[Ac-NIe-Asp-His-<span class="small-caps">d</span>-Phe-Arg-Trp-Gly-Lys(1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid)-NH<sub>2</sub>]</a><span class="small"> [<a href="/books/n/micad/NAPamide64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-NAPamide</div><div>Kenneth T. Cheng, Sam Gambhir, and Zhen Cheng.</div><div class="small">Created: August 10, 2007; Last Update: December 3, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cFLFLFK64Cu"><a class="toc-item" href="/books/n/micad/cFLFLFK64Cu/"><sup>64</sup>Cu-[cinnamoyl-Phe-D-Leu-Phe-<span class="small-caps">D</span>-Leu-Phe-Lys(PEG-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid)-NH<sub>2</sub>]</a><span class="small"> [<a href="/books/n/micad/cFLFLFK64Cu/pdf/">PDF Version</a>]</span><div>cFLFLFK-PEG-<sup>64</sup>Cu</div><div>Arvind Chopra and Dongfeng Pan.</div><div class="small">Created: November 1, 2007; Last Update: May 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AMD3465-64Cu"><a class="toc-item" href="/books/n/micad/AMD3465-64Cu/"><sup>64</sup>Cu-{<i>N</i>-[1,4,8,11-Tetraazacyclotetradecanyl-1,4-phenylenebis(methylene)]-2-(aminomethyl)pyridine}</a><span class="small"> [<a href="/books/n/micad/AMD3465-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-AMD3465</div><div>Kam Leung.</div><div class="small">Created: September 15, 2011; Last Update: January 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-CBTE2A-64Cu"><a class="toc-item" href="/books/n/micad/ReCCMSH-CBTE2A-64Cu/"><sup>64</sup>Cu-1,4,7,10-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-CBTE2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CBTE2A-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: December 30, 2008; Last Update: May 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGFCu64"><a class="toc-item" href="/books/n/micad/VEGFCu64/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclodecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-vascular endothelial growth factor </a><span class="small"> [<a href="/books/n/micad/VEGFCu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-VEGF</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 19, 2006; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TRC105-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/TRC105-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-CD105 TRC105 chimeric monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/TRC105-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-TRC105</div><div>Kam Leung.</div><div class="small">Created: October 27, 2011; Last Update: January 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NFB-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/NFB-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-<span class="small-caps">d</span>-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/NFB-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-NFB</div><div>Kam Leung.</div><div class="small">Created: November 15, 2011; Last Update: February 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_R01-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/R01-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin α<sub>v</sub>β<sub>6</sub>-binding peptide RSLARTDLDHLRGR</a><span class="small"> [<a href="/books/n/micad/R01-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-R<sub>0</sub>1</div><div>Kam Leung.</div><div class="small">Created: August 16, 2012; Last Update: November 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_R02-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/R02-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Arg-rich Cys knot scaffold grafted with integrin α<sub>v</sub>β<sub>6</sub>-binding peptide RSLARTDLDHLRGR</a><span class="small"> [<a href="/books/n/micad/R02-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-R<sub>0</sub>2</div><div>Kam Leung.</div><div class="small">Created: August 16, 2012; Last Update: November 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DGEA-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/DGEA-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Asp-Gly-Glu-Ala</a><span class="small"> [<a href="/books/n/micad/DGEA-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-DGEA</div><div>Kam Leung.</div><div class="small">Created: January 3, 2012; Last Update: March 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GX1-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/GX1-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-cyclo(CGNSNPKSC)</a><span class="small"> [<a href="/books/n/micad/GX1-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-GX1</div><div>Kam Leung.</div><div class="small">Created: January 30, 2012; Last Update: May 3, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FnE13-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/FnE13-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-epidermal growth factor receptor-binding fibronectin domain E13.4.3'</a><span class="small"> [<a href="/books/n/micad/FnE13-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-Fn<sub>E13.4.3'</sub></div><div>Kam Leung.</div><div class="small">Created: May 3, 2012; Last Update: August 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_S02-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/S02-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ser-rich Cys knot scaffold grafted with integrin α<sub>v</sub>β<sub>6</sub>-binding peptide RSLARTDLDHLRGR</a><span class="small"> [<a href="/books/n/micad/S02-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-S<sub>0</sub>2</div><div>Kam Leung.</div><div class="small">Created: August 16, 2012; Last Update: November 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KCCYSL-DO3A-64Cu"><a class="toc-item" href="/books/n/micad/KCCYSL-DO3A-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu</a><span class="small"> [<a href="/books/n/micad/KCCYSL-DO3A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DO3A-(GSG)-KCCYSL</div><div>Kam Leung.</div><div class="small">Created: April 26, 2012; Last Update: July 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-HSA-DO3A-64Cu"><a class="toc-item" href="/books/n/micad/Z1907-HSA-DO3A-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-HSA-DO3A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DO3A-HSA-Z<sub>EGFR:1907</sub></div><div>Kam Leung.</div><div class="small">Created: June 25, 2012; Last Update: September 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/Z1907-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidethylacetamide-Ac-Cys-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-Z<sub>EGFR:1907</sub></div><div>Kam Leung.</div><div class="small">Created: June 21, 2012; Last Update: September 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-pHLIP64Cu"><a class="toc-item" href="/books/n/micad/DOTA-pHLIP64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-Tris-acetic acid-10-maleimidoethylacetamide-ACEQNPIYWARYADWLFTTPLLLLDLALLVDADEGTG</a><span class="small"> [<a href="/books/n/micad/DOTA-pHLIP64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-pHLIP</div><div>Liang Shan.</div><div class="small">Created: May 29, 2009; Last Update: July 27, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64ZHER2-477-2"><a class="toc-item" href="/books/n/micad/Cu64ZHER2-477-2/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(<i>N</i>-ethylmaleimide amide)-dimeric (Z<sub>HER2:477</sub>)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Cu64ZHER2-477-2/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-(Z<sub>HER2:477</sub>)<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: November 2, 2011; Last Update: November 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64ZHER2-477"><a class="toc-item" href="/books/n/micad/Cu64ZHER2-477/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-1,4,7-β max tris(acetic acid)-10-acetate mono(<i>N</i>-ethylmaleimide amide)-monomeric Z<sub>HER2:477</sub></a><span class="small"> [<a href="/books/n/micad/Cu64ZHER2-477/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-Z<sub>HER2:477</sub></div><div>Liang Shan.</div><div class="small">Created: November 2, 2011; Last Update: November 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-3A12-64Cu"><a class="toc-item" href="/books/n/micad/DOTA-3A12-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-anti-prostate-specific membrane antigen 3/A12 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/DOTA-3A12-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-3/A12</div><div>Kam Leung.</div><div class="small">Created: August 1, 2009; Last Update: September 16, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AE105-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/AE105-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Asp-cyclohexylalanine-Phe-<span class="small-caps">D</span>-Ser-<span class="small-caps">D</span>-Arg-Tyr-Leu-Trp-Ser</a><span class="small"> [<a href="/books/n/micad/AE105-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-AE105</div><div>Kam Leung.</div><div class="small">Created: January 7, 2009; Last Update: March 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AE105-NH2-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/AE105-NH2-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-Asp-cyclohexylalanine-Phe-<span class="small-caps">d</span>-Ser-<span class="small-caps">d</span>-Arg-Tyr-Leu-Trp-Ser-NH<sub>2</sub> (AE105-NH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/AE105-NH2-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-AE105-NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: May 18, 2012; Last Update: August 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cetuximab64Cu"><a class="toc-item" href="/books/n/micad/Cetuximab64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-cetuximab</a><span class="small"> [<a href="/books/n/micad/Cetuximab64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-cetuximab</div><div>Kam Leung.</div><div class="small">Created: February 6, 2007; Last Update: June 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64-DOTA-C-ANF"><a class="toc-item" href="/books/n/micad/Cu64-DOTA-C-ANF/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-C-type atrial natriuretic factor</a><span class="small"> [<a href="/books/n/micad/Cu64-DOTA-C-ANF/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-C-ANF</div><div>Liang Shan.</div><div class="small">Created: July 14, 2010; Last Update: August 24, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDDOTA64Cu"><a class="toc-item" href="/books/n/micad/RGDDOTA64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid- cyclic arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/RGDDOTA64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-c(RGDyK)</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 7, 2007; Last Update: May 20, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDOctameric64Cu"><a class="toc-item" href="/books/n/micad/RGDOctameric64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-E(E{E[c(RGDyK)]<sub>2</sub>}<sub>2</sub>)<sub>2</sub> peptide</a><span class="small"> [<a href="/books/n/micad/RGDOctameric64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-RGD Octamer</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 16, 2007; Last Update: February 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TetramericRGD64Cu"><a class="toc-item" href="/books/n/micad/TetramericRGD64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-E{E[c(RGDfK)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/TetramericRGD64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-E{E[c(RGDfK)]<sub>2</sub>}<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: February 27, 2007; Last Update: February 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK2Cu64"><a class="toc-item" href="/books/n/micad/RGDyK2Cu64/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-E{E[c(RGDyK)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDyK2Cu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-E{E[c(RGDyK)]<sub>2</sub>}<sub>2</sub></div><div>The MICAD Research Team.</div><div class="small">Created: August 10, 2007; Last Update: August 29, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HB22-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/HB22-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-HB22.7</a><span class="small"> [<a href="/books/n/micad/HB22-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-HB22.7</div><div>Kam Leung.</div><div class="small">Created: February 20, 2009; Last Update: May 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-18bp-Fc-DOTA64Cu"><a class="toc-item" href="/books/n/micad/IL-18bp-Fc-DOTA64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-interleukin-18-binding protein-Fc</a><span class="small"> [<a href="/books/n/micad/IL-18bp-Fc-DOTA64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-IL-18bp-Fc</div><div>Kam Leung.</div><div class="small">Created: February 23, 2009; Last Update: May 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Panitumumab64Cu"><a class="toc-item" href="/books/n/micad/Panitumumab64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-panitumumab</a><span class="small"> [<a href="/books/n/micad/Panitumumab64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-Panitumumab</div><div>Kam Leung.</div><div class="small">Created: June 25, 2010; Last Update: September 30, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_K322A-Bn-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/K322A-Bn-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-<i>p</i>-benzyl-NH-hu14.18K322A</a><span class="small"> [<a href="/books/n/micad/K322A-Bn-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-Bn-NH-hu14.18K322A</div><div>Kam Leung.</div><div class="small">Created: December 16, 2012; Last Update: March 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDPEGDOTA64Cu"><a class="toc-item" href="/books/n/micad/RGDPEGDOTA64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-PEGylated cyclic arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/RGDPEGDOTA64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-PEG-c(RGDyK)</div><div>The MICAD Research Team.</div><div class="small">Created: May 10, 2007; Last Update: July 17, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGD2PEGDOTA64Cu"><a class="toc-item" href="/books/n/micad/RGD2PEGDOTA64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-PEGylated dimeric cyclic arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/RGD2PEGDOTA64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-PEG-E[c(RGDyK)]<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: June 1, 2007; Last Update: May 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64PEG12AVP"><a class="toc-item" href="/books/n/micad/Cu64PEG12AVP/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-polyethylene glycol 12 anti–tumor-associated glycoprotein 72 diabody</a><span class="small"> [<a href="/books/n/micad/Cu64PEG12AVP/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-PEG12 AVP04-07</div><div>Liang Shan.</div><div class="small">Created: June 23, 2010; Last Update: September 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64PEG27AVP"><a class="toc-item" href="/books/n/micad/Cu64PEG27AVP/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-polyethylene glycol 27 anti–tumor-associated glycoprotein 72 diabody</a><span class="small"> [<a href="/books/n/micad/Cu64PEG27AVP/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-PEG27 AVP04-07</div><div>Liang Shan.</div><div class="small">Created: June 23, 2010; Last Update: July 19, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-DOTA-Cu64"><a class="toc-item" href="/books/n/micad/scVEGF-DOTA-Cu64/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-DOTA-Cu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-PEG-scVEGF</div><div>Kam Leung.</div><div class="small">Created: February 27, 2008; Last Update: March 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-SWNT-64Cu"><a class="toc-item" href="/books/n/micad/RGDyK-SWNT-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-polyethylene-glycol-single-walled nanotube-c(RGDyK)</a><span class="small"> [<a href="/books/n/micad/RGDyK-SWNT-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-SWNT-PEG-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: October 6, 2008; Last Update: October 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84scFvHSA64Cu"><a class="toc-item" href="/books/n/micad/T84scFvHSA64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-T84.66 scFv-human serum albumin</a><span class="small"> [<a href="/books/n/micad/T84scFvHSA64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-T84.66 scFv-HSA</div><div>Kam Leung.</div><div class="small">Created: July 2, 2008; Last Update: September 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF-DEE64Cu"><a class="toc-item" href="/books/n/micad/VEGF-DEE64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-vascular endothelial growth factor-121(D63AE64AE67A)</a><span class="small"> [<a href="/books/n/micad/VEGF-DEE64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-VEGF<sub>DEE</sub></div><div>Kam Leung.</div><div class="small">Created: September 17, 2007; Last Update: October 22, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/ReCCMSH-DOTA-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: December 30, 2008; Last Update: May 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AgRP-7C-64Cu"><a class="toc-item" href="/books/n/micad/AgRP-7C-64Cu/"><sup>64</sup>Cu-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid agouti-related protein-7C</a><span class="small"> [<a href="/books/n/micad/AgRP-7C-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-AgRP-7C</div><div>Kam Leung.</div><div class="small">Created: May 23, 2010; Last Update: July 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-NODAGA-64Cu"><a class="toc-item" href="/books/n/micad/RGDfK-NODAGA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-NODAGA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NODAGA-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: November 28, 2011; Last Update: February 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-NODAGA-64Cu"><a class="toc-item" href="/books/n/micad/RGDyK-NODAGA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Tyr-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDyK-NODAGA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NODAGA-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: March 28, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LM3-NODAGA-64Cu"><a class="toc-item" href="/books/n/micad/LM3-NODAGA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LM3-NODAGA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NODAGA-LM3</div><div>Kam Leung.</div><div class="small">Created: May 5, 2012; Last Update: August 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NFB-NOTA-64Cu"><a class="toc-item" href="/books/n/micad/NFB-NOTA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-Arg-Arg-Natl-Cys-Tyr-Cit-Lys-<span class="small-caps">d</span>-Lys-Pro-Tyr-Arg-Cit-Cys-Arg-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/NFB-NOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NOTA-NFB</div><div>Kam Leung.</div><div class="small">Created: November 15, 2011; Last Update: February 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ALT-836-NOTA-64Cu"><a class="toc-item" href="/books/n/micad/ALT-836-NOTA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4,7-triacetic acid-<i>p</i>-isothiocyanatobenzyl-ALT-836</a><span class="small"> [<a href="/books/n/micad/ALT-836-NOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NOTA-ALT-836</div><div>Kam Leung.</div><div class="small">Created: December 6, 2012; Last Update: March 21, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-NOTA-64Cu"><a class="toc-item" href="/books/n/micad/BBN-NOTA-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-NOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NOTA-8-Aoc-BBN[7-14]NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 26, 2009; Last Update: July 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN_RGDyK_NOTA_64Cu"><a class="toc-item" href="/books/n/micad/BBN_RGDyK_NOTA_64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]</a><span class="small"> [<a href="/books/n/micad/BBN_RGDyK_NOTA_64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NOTA-RGD-BBN</div><div>Kam Leung.</div><div class="small">Created: October 26, 2009; Last Update: January 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-NO2A-64Cu"><a class="toc-item" href="/books/n/micad/BBN-NO2A-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetate-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-NO2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-8-Aoc-BBN[7-14]NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 26, 2009; Last Update: July 23, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KCCYSL-NO2A-64Cu"><a class="toc-item" href="/books/n/micad/KCCYSL-NO2A-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu</a><span class="small"> [<a href="/books/n/micad/KCCYSL-NO2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-(GSG)-KCCYSL</div><div>Kam Leung.</div><div class="small">Created: April 26, 2012; Last Update: July 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-NO2A-Ahx-BBN"><a class="toc-item" href="/books/n/micad/Cu-NO2A-Ahx-BBN/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-6-aminohexanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Cu-NO2A-Ahx-BBN/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-(6-Ahx)-BBN(7–14)NH<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: January 2, 2011; Last Update: January 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-NO2A-Anc-BBN"><a class="toc-item" href="/books/n/micad/Cu-NO2A-Anc-BBN/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-9-aminonanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Cu-NO2A-Anc-BBN/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-(9-Anc)-BBN(7–14)NH<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: January 2, 2011; Last Update: January 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-RGDyK-NO2A-64Cu"><a class="toc-item" href="/books/n/micad/BBN-RGDyK-NO2A-64Cu/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-c(RGDyK)-Glu-6-aminohexanoic acid-bombesin[7-14]NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-RGDyK-NO2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-RGD-Glu-6-Ahx-BBN</div><div>Kam Leung.</div><div class="small">Created: August 6, 2012; Last Update: November 8, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-NO2A-AMBA-BBN"><a class="toc-item" href="/books/n/micad/Cu-NO2A-AMBA-BBN/"><sup>64</sup>Cu-1,4,7-Triazacyclononane-1,4-diacetic acid-para-aminobenzoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Cu-NO2A-AMBA-BBN/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-NO2A-(AMBA)-BBN(7–14)NH<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: January 2, 2011; Last Update: January 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TETA-Y3-TATE64Cu"><a class="toc-item" href="/books/n/micad/TETA-Y3-TATE64Cu/"><sup>64</sup>Cu-1,4,8,11-Tetraazacyclotetradecane-<i>N</i>,<i>N'</i>,<i>N"</i>,<i>N"'</i>-tetraacetic acid-<span class="small-caps">D</span>-Phe-cyclo(Cys-Tyr-<span class="small-caps">D</span>-Trp-Lys-Thr-Cys)-Thr(OH)</a><span class="small"> [<a href="/books/n/micad/TETA-Y3-TATE64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-TETA-Y3-TATE</div><div>Kam Leung.</div><div class="small">Created: September 1, 2009; Last Update: October 8, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CyclamRAFT-RGD64Cu"><a class="toc-item" href="/books/n/micad/CyclamRAFT-RGD64Cu/"><sup>64</sup>Cu-1,4,8,11-Tetraazacyclotetradecane-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>4</sub></a><span class="small"> [<a href="/books/n/micad/CyclamRAFT-RGD64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-Cyclam-RAFT-c(-RGDfK-)<sub>4</sub></div><div>Kam Leung.</div><div class="small">Created: August 9, 2011; Last Update: December 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDTE2A64Cu"><a class="toc-item" href="/books/n/micad/RGDTE2A64Cu/"><sup>64</sup>Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclic-arginine-glycine-aspartic acid peptide</a><span class="small"> [<a href="/books/n/micad/RGDTE2A64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-c(RGDyK)</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 9, 2007; Last Update: May 20, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CB-TE2A-Y3-TATE64Cu"><a class="toc-item" href="/books/n/micad/CB-TE2A-Y3-TATE64Cu/"><sup>64</sup>Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-D-Phe-cyclo(Cys-Tyr-D-Trp-Lys-Thr-Cys)-Thr(OH)</a><span class="small"> [<a href="/books/n/micad/CB-TE2A-Y3-TATE64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-Y3-TATE</div><div>Kam Leung.</div><div class="small">Created: September 1, 2009; Last Update: October 8, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LLP2A-CB-TE2A-64Cu"><a class="toc-item" href="/books/n/micad/LLP2A-CB-TE2A-64Cu/"><sup>64</sup>Cu-4,11-bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-LLP2A</a><span class="small"> [<a href="/books/n/micad/LLP2A-CB-TE2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-LLP2A</div><div>Kam Leung.</div><div class="small">Created: June 10, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LM3-CB-TE2A-64Cu"><a class="toc-item" href="/books/n/micad/LM3-CB-TE2A-64Cu/"><sup>64</sup>Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-p-Cl-Phe-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LM3-CB-TE2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-LM3</div><div>Kam Leung.</div><div class="small">Created: May 5, 2012; Last Update: August 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SST2-ANT-64Cu"><a class="toc-item" href="/books/n/micad/SST2-ANT-64Cu/"><sup>64</sup>Cu-4,11-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-Phe(4-NO<sub>2</sub>)-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-Trp-Lys-Thr-Cys)-<span class="small-caps">D</span>-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/SST2-ANT-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-sst<sub>2</sub>-ANT</div><div>Kam Leung.</div><div class="small">Created: September 1, 2009; Last Update: October 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LM609Cu64"><a class="toc-item" href="/books/n/micad/LM609Cu64/"><sup>64</sup>Cu-Anti-human integrin α<sub>v</sub>β<sub>3</sub> monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/LM609Cu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-hLM609-II</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 31, 2007; Last Update: February 13, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KCCYSL-CB-TE2A-64Cu"><a class="toc-item" href="/books/n/micad/KCCYSL-CB-TE2A-64Cu/"><sup>64</sup>Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-(Gly-Ser-Gly)-Lys-Cys-Cys-Tyr-Ser-Leu</a><span class="small"> [<a href="/books/n/micad/KCCYSL-CB-TE2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-(GSG)-KCCYSL</div><div>Kam Leung.</div><div class="small">Created: April 26, 2012; Last Update: July 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-CB-TE2A-64Cu"><a class="toc-item" href="/books/n/micad/RGDfK-CB-TE2A-64Cu/"><sup>64</sup>Cu-Bis(carboxymethyl)-1,4,8,11-tetraazabicyclo[6.6.2]hexadecane-cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-CB-TE2A-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-CB-TE2A-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: November 28, 2011; Last Update: February 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64-DTPA-ProT"><a class="toc-item" href="/books/n/micad/Cu64-DTPA-ProT/"><sup>64</sup>Cu-Diethylenetriamine pentaacetic acid-NH-CO-CH<sub>2</sub>-S-CH<sub>2</sub>-Phe-Pro-Arg-CH<sub>2</sub>-prothrombin</a><span class="small"> [<a href="/books/n/micad/Cu64-DTPA-ProT/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DTPA-ProT</div><div>Liang Shan.</div><div class="small">Created: March 15, 2012; Last Update: May 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MP2346Cu64"><a class="toc-item" href="/books/n/micad/MP2346Cu64/"><sup>64</sup>Cu-DOTA-[Pro<sup>1</sup>,Tyr<sup>4</sup>]-Bombesin[1-14]</a><span class="small"> [<a href="/books/n/micad/MP2346Cu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-MP2346</div><div>Kenneth T. Cheng, Jason S. Lewis, and Gráinne B. Biddlecombe.</div><div class="small">Created: August 16, 2007; Last Update: January 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrastFv-FcDM64Cu"><a class="toc-item" href="/books/n/micad/TrastFv-FcDM64Cu/"><sup>64</sup>Cu-DOTA hu4D5v8 (scFv-C<sub>H</sub>2-C<sub>H</sub>3)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/TrastFv-FcDM64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA hu4D5v8 scFv-Fc DM</div><div>Kenneth T. Cheng.</div><div class="small">Created: April 11, 2006; Last Update: April 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64-DOTA-CysDb"><a class="toc-item" href="/books/n/micad/Cu64-DOTA-CysDb/"><sup>64</sup>Cu-Labeled, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-chelated, and cysteine-modified anti-activated leukocyte cell adhesion molecule diabody</a><span class="small"> [<a href="/books/n/micad/Cu64-DOTA-CysDb/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-CysDb</div><div>Liang Shan.</div><div class="small">Created: November 7, 2012; Last Update: November 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AMD3100Cu64"><a class="toc-item" href="/books/n/micad/AMD3100Cu64/"><sup>64</sup>Cu-Labeled 1,1’-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}</a><span class="small"> [<a href="/books/n/micad/AMD3100Cu64/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]-AMD3100</div><div>Arvind Chopra.</div><div class="small">Created: June 8, 2009; Last Update: July 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64-MUT-DS"><a class="toc-item" href="/books/n/micad/Cu64-MUT-DS/"><sup>64</sup>Cu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH<sub>2</sub> with a disulfide bridge between the two homoC</a><span class="small"> [<a href="/books/n/micad/Cu64-MUT-DS/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-MUT-DS</div><div>Liang Shan.</div><div class="small">Created: November 15, 2011; Last Update: December 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu64-VEGF121rGel"><a class="toc-item" href="/books/n/micad/Cu64-VEGF121rGel/"><sup>64</sup>Cu-Labeled 1,4,7,10-Tetraazacyclododedane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid–conjugated vascular endothelial growth factor A isoform 121-gelonin fusion protein</a><span class="small"> [<a href="/books/n/micad/Cu64-VEGF121rGel/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-VEGF<sub>121</sub>/rGel</div><div>Liang Shan.</div><div class="small">Created: July 6, 2011; Last Update: August 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DO3AVSExe464Cu"><a class="toc-item" href="/books/n/micad/DO3AVSExe464Cu/"><sup>64</sup>Cu-Labeled 1,4,7-tris(acetic acid)-10-vinylsulfone-1,4,7,10-tetraazacyclododecane conjugated to Cys<sup>40</sup>-Exendin-4</a><span class="small"> [<a href="/books/n/micad/DO3AVSExe464Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DO3A-VS-Cys<sup>40</sup>-Exendin-4</div><div>Arvind Chopra.</div><div class="small">Created: August 24, 2011; Last Update: March 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABS64Cu"><a class="toc-item" href="/books/n/micad/ABS64Cu/"><sup>64</sup>Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6] icosane-1-ylamino)methyl)benzoic acid (AmBaSar)</a><span class="small"> [<a href="/books/n/micad/ABS64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-AmBaSar</div><div>Arvind Chopra.</div><div class="small">Created: September 23, 2010; Last Update: October 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABSRGD64Cu"><a class="toc-item" href="/books/n/micad/ABSRGD64Cu/"><sup>64</sup>Cu-Labeled 4-((8-amino-3,6,10,13,16,19-hexaazabicyclo [6.6.6]
|
|
icosane-1-ylamino)methyl)benzoic acid (AmBaSar) conjugated to cyclic
|
|
arginine-glycine-aspartic acid (RGD) peptide</a><span class="small"> [<a href="/books/n/micad/ABSRGD64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-AmBaSar-RGD</div><div>Arvind Chopra.</div><div class="small">Created: September 20, 2010; Last Update: October 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fab12A864Cu"><a class="toc-item" href="/books/n/micad/Fab12A864Cu/"><sup>64</sup>Cu-Labeled anti-c-kit monoclonal antibody 12A8 Fab fragment</a><span class="small"> [<a href="/books/n/micad/Fab12A864Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]12A8 Fab</div><div>Arvind Chopra.</div><div class="small">Created: June 9, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Hypericin64Cu"><a class="toc-item" href="/books/n/micad/Hypericin64Cu/"><sup>64</sup>Cu-Labeled bis-1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>,<i>N</i>'-tetraacetic acid conjugated hypericin</a><span class="small"> [<a href="/books/n/micad/Hypericin64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-bis DOTA-hypericin</div><div>Arvind Chopra.</div><div class="small">Created: May 3, 2011; Last Update: May 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CysdEGF64Cu"><a class="toc-item" href="/books/n/micad/CysdEGF64Cu/"><sup>64</sup>Cu-Labeled cysteine–tagged dimeric epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/CysdEGF64Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]Cys-dEGF</div><div>Arvind Chopra.</div><div class="small">Created: May 18, 2009; Last Update: July 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CysEGF64Cu"><a class="toc-item" href="/books/n/micad/CysEGF64Cu/"><sup>64</sup>Cu-Labeled cysteine–tagged epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/CysEGF64Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]Cys-EGF</div><div>Arvind Chopra.</div><div class="small">Created: May 18, 2009; Last Update: July 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anti-EMP2-64Cu"><a class="toc-item" href="/books/n/micad/Anti-EMP2-64Cu/"><sup>64</sup>Cu-Labeled DOTA conjugated anti-epithelial membrane protein 2 minibody KS83</a><span class="small"> [<a href="/books/n/micad/Anti-EMP2-64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-DOTA-KS83</div><div>Arvind Chopra.</div><div class="small">Created: February 20, 2013; Last Update: February 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rituximab64Cu"><a class="toc-item" href="/books/n/micad/Rituximab64Cu/"><sup>64</sup>Cu-Labeled DOTA-conjugated rituximab, a chimeric murine/human anti-CD20 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Rituximab64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-DOTA-Rituximab</div><div>Arvind Chopra.</div><div class="small">Created: September 20, 2012; Last Update: October 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HER2342HSA64Cu"><a class="toc-item" href="/books/n/micad/HER2342HSA64Cu/"><sup>64</sup>Cu-Labeled human serum albumin–conjugated Affibody <i>Z</i><sub><i>HER2:342</i></sub> that targets the human epidermal growth factor receptor 2 (HER2)</a><span class="small"> [<a href="/books/n/micad/HER2342HSA64Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]-DOTA-HSA-<i>Z</i><sub><i>HER2:342</i></sub></div><div>Arvind Chopra.</div><div class="small">Created: May 19, 2011; Last Update: June 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HisCu64"><a class="toc-item" href="/books/n/micad/HisCu64/"><sup>64</sup>Cu-Labeled <span class="small-caps">l</span>-histidine</a><span class="small"> [<a href="/books/n/micad/HisCu64/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-His</div><div>Arvind Chopra.</div><div class="small">Created: June 14, 2012; Last Update: July 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTAExe64Cu"><a class="toc-item" href="/books/n/micad/DOTAExe64Cu/"><sup>64</sup>Cu-Labeled Lys<sup>40</sup>(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid)NH<sub>2</sub>–conjugated exendin-4</a><span class="small"> [<a href="/books/n/micad/DOTAExe64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu](Lys<sup>40</sup>(DOTA)NH<sub>2</sub>)Exendin-4</div><div>Arvind Chopra.</div><div class="small">Created: January 25, 2012; Last Update: February 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrasBFCs64Cu"><a class="toc-item" href="/books/n/micad/TrasBFCs64Cu/"><sup>64</sup>Cu-Labeled Oxo-DO3A-conjugated trastuzumab and PCTA-conjugated trastuzumab</a><span class="small"> [<a href="/books/n/micad/TrasBFCs64Cu/pdf/">PDF Version</a>]</span><div> [<sup>64</sup>Cu]-Oxo-DO3A-trastuzumab and [<sup>64</sup>Cu]-PCTA-trastuzumab</div><div>Arvind Chopra.</div><div class="small">Created: July 24, 2012; Last Update: August 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOGOTRC10564Cu"><a class="toc-item" href="/books/n/micad/NOGOTRC10564Cu/"><sup>64</sup>Cu-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105</a><span class="small"> [<a href="/books/n/micad/NOGOTRC10564Cu/pdf/">PDF Version</a>]</span><div>[<sup>64</sup>Cu]-NOTA-GO-TRC105</div><div>Arvind Chopra.</div><div class="small">Created: May 17, 2012; Last Update: June 28, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PNAKRAS64Cu"><a class="toc-item" href="/books/n/micad/PNAKRAS64Cu/"><sup>64</sup>Cu-<i>N</i>,<i>N'</i>-Bis(<i>S</i>-benzoyl-thioglycoloyl)diaminopropanoate-<i>KRAS</i>-PNA-<span class="small-caps">d</span>(Cys-Ser-Lys-Cys)</a><span class="small"> [<a href="/books/n/micad/PNAKRAS64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-WT4351</div><div>Kenneth T. Cheng, Atis Chakrabart, Mohan R. Aruva, Mathew L. Thakur, and Eric Wickstrom.</div><div class="small">Created: August 10, 2007; Last Update: January 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEI-64Cu"><a class="toc-item" href="/books/n/micad/PEI-64Cu/"><sup>64</sup>Cu-Polyethylenimine</a><span class="small"> [<a href="/books/n/micad/PEI-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-PEI</div><div>Kam Leung.</div><div class="small">Created: April 16, 2010; Last Update: July 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Conatumumab64Cu"><a class="toc-item" href="/books/n/micad/Conatumumab64Cu/"><sup>64</sup>Cu-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-conatumumab</a><span class="small"> [<a href="/books/n/micad/Conatumumab64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-conatumumab</div><div>Kam Leung.</div><div class="small">Created: October 8, 2011; Last Update: December 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MEDI-522-64Cu"><a class="toc-item" href="/books/n/micad/MEDI-522-64Cu/"><sup>64</sup>Cu-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-MEDI-522</a><span class="small"> [<a href="/books/n/micad/MEDI-522-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-MEDI-522</div><div>Kam Leung.</div><div class="small">Created: June 8, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TNYL-RAW-DOTA-64Cu"><a class="toc-item" href="/books/n/micad/TNYL-RAW-DOTA-64Cu/"><sup>64</sup>Cu-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-TNYLFSPNGPIARAW (TNYL-RAW)</a><span class="small"> [<a href="/books/n/micad/TNYL-RAW-DOTA-64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-DOTA-TNYL-RAW</div><div>Kam Leung.</div><div class="small">Created: September 10, 2011; Last Update: December 15, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DGEA-Z-E-Ahx64Cu"><a class="toc-item" href="/books/n/micad/DGEA-Z-E-Ahx64Cu/"><sup>64</sup>Cu-Z-E-(1,8-Diamino-3,6,10,13,16,19-hexaazabicyclo(6,6,6)eicosane)-aminohexanoyl-Asp-Gly-Glu-Ala</a><span class="small"> [<a href="/books/n/micad/DGEA-Z-E-Ahx64Cu/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-Z-E(diamsar)-Ahx-DGEA</div><div>Kam Leung.</div><div class="small">Created: January 3, 2012; Last Update: March 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-TETA-OC"><a class="toc-item" href="/books/n/micad/Cu-TETA-OC/">Copper 1,4,8,11-tetraazacyclotetradecane-<i>N,N',N'',N'''</i>-tetraacetic acid-octreotide </a><span class="small"> [<a href="/books/n/micad/Cu-TETA-OC/pdf/">PDF Version</a>]</span><div>Cu-TETA-OC</div><div>The MICAD Research Team.</div><div class="small">Created: December 20, 2004; Last Update: March 14, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TP3939Cu64"><a class="toc-item" href="/books/n/micad/TP3939Cu64/">HSDAVFTDNYTKLRKQ-NIe-AVKK-(3-OCH3,4-OH)-FLNSSV-GABA-L-(Dap-(BMA)<sub>2</sub>)-<sup>64</sup>Cu</a><span class="small"> [<a href="/books/n/micad/TP3939Cu64/pdf/">PDF Version</a>]</span><div><sup>64</sup>Cu-TP3939</div><div>Kenneth T. Cheng and Mathew L. Thakur.</div><div class="small">Created: March 17, 2008; Last Update: June 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cu-DOTA-biotin"><a class="toc-item" href="/books/n/micad/Cu-DOTA-biotin/">NR-LU-10/streptavidin-copper 64-(1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>′,<i>N</i>′′,<i>N</i>′′′-tetraacetic acid)-biotin</a><span class="small"> [<a href="/books/n/micad/Cu-DOTA-biotin/pdf/">PDF Version</a>]</span><div>NR-LU-10/SA-<sup>64</sup>Cu-DOTA-biotin</div><div>The MICAD Research Team.</div><div class="small">Created: February 15, 2005; Last Update: May 25, 2005.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos66ga"><a class="toc-item" href="/books/n/micad/sos66ga/">66Ga</a><ul id="toc_lst_NBK5330_toc_sos66ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOTATRC10566Ga"><a class="toc-item" href="/books/n/micad/NOTATRC10566Ga/"><sup>66</sup>Ga-Labeled NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/NOTATRC10566Ga/pdf/">PDF Version</a>]</span><div>[<sup>66</sup>Ga]-NOTA-TRC105</div><div>Arvind Chopra.</div><div class="small">Created: May 10, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOGOTRC10566Ga"><a class="toc-item" href="/books/n/micad/NOGOTRC10566Ga/"><sup>66</sup>Ga-Labeled PEGylated nano-graphene oxide (GO) covalently linked to NOTA-conjugated anti-CD105 (endoglin) chimeric monoclonal antibody TRC105</a><span class="small"> [<a href="/books/n/micad/NOGOTRC10566Ga/pdf/">PDF Version</a>]</span><div>[<sup>66</sup>Ga]-NOTA-GO-TRC105</div><div>Arvind Chopra.</div><div class="small">Created: May 14, 2012; Last Update: June 28, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos68ga"><a class="toc-item" href="/books/n/micad/sos68ga/">68Ga</a><ul id="toc_lst_NBK5330_toc_sos68ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_P3026-68Ga"><a class="toc-item" href="/books/n/micad/P3026-68Ga/"><sup>67/68</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-1,2-diaminoethane-γ-folate</a><span class="small"> [<a href="/books/n/micad/P3026-68Ga/pdf/">PDF Version</a>]</span><div><sup>67/68</sup>Ga-P3026</div><div>Kam Leung.</div><div class="small">Created: February 14, 2011; Last Update: May 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JR11-DOTA-68Ga"><a class="toc-item" href="/books/n/micad/JR11-DOTA-68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Cpa-cyclo(<span class="small-caps">d</span>-Cys-amino-Phe-hydroorotic acid-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH<sub>2</sub> (JR11)</a><span class="small"> [<a href="/books/n/micad/JR11-DOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-JR11</div><div>Kam Leung.</div><div class="small">Created: October 7, 2012; Last Update: January 3, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LM3-DOTA-68Ga"><a class="toc-item" href="/books/n/micad/LM3-DOTA-68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-p-Cl-Phe-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LM3-DOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-LM3</div><div>Kam Leung.</div><div class="small">Created: May 5, 2012; Last Update: November 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-4-DOTA-68Ga"><a class="toc-item" href="/books/n/micad/Exendin-4-DOTA-68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-aminohexanoic acid-Lys<sup>40</sup>-exendin-4</a><span class="small"> [<a href="/books/n/micad/Exendin-4-DOTA-68Ga/pdf/">PDF Version</a>]</span><div>[Lys<sup>40</sup>(Ahx-DOTA-<sup>68</sup>Ga)NH<sub>2</sub>]-exendin-4</div><div>Kam Leung.</div><div class="small">Created: January 30, 2012; Last Update: April 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK_DOTAGa68"><a class="toc-item" href="/books/n/micad/RGDfK_DOTAGa68/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-cyclo(Arg-Gly-Asp-D-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK_DOTAGa68/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: October 9, 2007; Last Update: December 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGF68Ga"><a class="toc-item" href="/books/n/micad/EGF68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-N,N',N'',N'''-tetraacetic acid-Epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/EGF68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-EGF</div><div>Kam Leung.</div><div class="small">Created: July 25, 2006; Last Update: April 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VAP-P1-DOTA68Ga"><a class="toc-item" href="/books/n/micad/VAP-P1-DOTA68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N,N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-Gly-Gly-Gly-Gly-Lys-Gly-Gly-Gly-Gly</a><span class="small"> [<a href="/books/n/micad/VAP-P1-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-VAP-P1</div><div>Kam Leung.</div><div class="small">Created: March 1, 2008; Last Update: May 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHER2-2891-DOTA68Ga"><a class="toc-item" href="/books/n/micad/ZHER2-2891-DOTA68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-HER2-specific Affibody Z<sub>HER2:2891</sub></a><span class="small"> [<a href="/books/n/micad/ZHER2-2891-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-Z<sub>HER2:2891</sub></div><div>Kam Leung.</div><div class="small">Created: August 26, 2012; Last Update: December 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-3-DOTA68Ga"><a class="toc-item" href="/books/n/micad/Exendin-3-DOTA68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-Lys<sup>40</sup>-exendin-3</a><span class="small"> [<a href="/books/n/micad/Exendin-3-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-Lys<sup>40</sup>-exendin-3</div><div>Kam Leung.</div><div class="small">Created: August 20, 2010; Last Update: November 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHER2342-DOTA68Ga"><a class="toc-item" href="/books/n/micad/ZHER2342-DOTA68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-synthetic HER2 specific Affibody Z<sub>HER2:342-pep2</sub></a><span class="small"> [<a href="/books/n/micad/ZHER2342-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-Z<sub>HER2:342-pep2</sub></div><div>Kam Leung.</div><div class="small">Created: August 26, 2010; Last Update: November 10, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-DOTA-68Ga"><a class="toc-item" href="/books/n/micad/ReCCMSH-DOTA-68Ga/"><sup>68</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-1,4,7,10-tetraacetic acid-rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-DOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: January 30, 2009; Last Update: May 11, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P3238-68Ga"><a class="toc-item" href="/books/n/micad/P3238-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-5,8-dideazfolic acid (P3238)</a><span class="small"> [<a href="/books/n/micad/P3238-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-P3238</div><div>Kam Leung.</div><div class="small">Created: June 14, 2012; Last Update: September 20, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P3246-68Ga"><a class="toc-item" href="/books/n/micad/P3246-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-1,2-diaminoethane-γ-folate (P3246)</a><span class="small"> [<a href="/books/n/micad/P3246-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-P3246</div><div>Kam Leung.</div><div class="small">Created: June 14, 2012; Last Update: September 20, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AE105-NODAGA-68Ga"><a class="toc-item" href="/books/n/micad/AE105-NODAGA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Asp-cyclohexylalanine-Phe-<span class="small-caps">d</span>-Ser-<span class="small-caps">d</span>-Arg-Tyr-Leu-Trp-Ser-NH<sub>2</sub> (AE105-NH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/AE105-NODAGA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NODAGA-AE105-NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: May 20, 2012; Last Update: August 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_JR11-NODAGA-68Ga"><a class="toc-item" href="/books/n/micad/JR11-NODAGA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-Cpa-cyclo(<span class="small-caps">d</span>-Cys-amino-Phe-hydroorotic acid-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)-D-Tyr-NH<sub>2</sub> (JR11)</a><span class="small"> [<a href="/books/n/micad/JR11-NODAGA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NODAGA-JR11</div><div>Kam Leung.</div><div class="small">Created: October 5, 2012; Last Update: January 3, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-NODAGA-68Ga"><a class="toc-item" href="/books/n/micad/RGDfK-NODAGA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-NODAGA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NODAGA-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: August 26, 2011; Last Update: November 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LM3-NODAGA-68Ga"><a class="toc-item" href="/books/n/micad/LM3-NODAGA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-p-Cl-Phe-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-4-amino-Phe(carbamoyl)-Lys-Thr-Cys)D-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LM3-NODAGA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NODAGA-LM3</div><div>Kam Leung.</div><div class="small">Created: May 5, 2012; Last Update: November 1, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOTA-2-NI-68Ga"><a class="toc-item" href="/books/n/micad/NOTA-2-NI-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-2-nitroimidazole-<i>N</i>-ethylamine</a><span class="small"> [<a href="/books/n/micad/NOTA-2-NI-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-NI</div><div>Kam Leung.</div><div class="small">Created: January 19, 2011; Last Update: March 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGD-HSA-TIMP2-68Ga"><a class="toc-item" href="/books/n/micad/RGD-HSA-TIMP2-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein</a><span class="small"> [<a href="/books/n/micad/RGD-HSA-TIMP2-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-RGD-HSA-TIMP2</div><div>Kam Leung.</div><div class="small">Created: February 14, 2012; Last Update: May 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cRGDyK-PLHSpT-68Ga"><a class="toc-item" href="/books/n/micad/cRGDyK-PLHSpT-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-c(RGDyK)-S-S-CPLHSpT</a><span class="small"> [<a href="/books/n/micad/cRGDyK-PLHSpT-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-cRGDyK-CPLHSpT</div><div>Kam Leung.</div><div class="small">Created: August 14, 2012; Last Update: October 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/VEGF-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-<i>p</i>-isothiocyanatobenzyl-vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/VEGF-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-VEGF<sub>121</sub></div><div>Kam Leung.</div><div class="small">Created: April 7, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/scVEGF-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4,7-triacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-PEG-scVEGF</div><div>Kam Leung.</div><div class="small">Created: November 17, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-P4-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/RGDfK2-P4-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[15-amino-4,7,10,13-tetraoxapentadecanoic acid-c(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-P4-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-P<sub>4</sub>-RGD2</div><div>Kam Leung.</div><div class="small">Created: October 26, 2009; Last Update: December 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK2-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/RGDyK2-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[c(Arg-Gly-Asp-<span class="small-caps">D</span>-Tyr-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDyK2-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-RGD2</div><div>Kam Leung.</div><div class="small">Created: October 26, 2009; Last Update: December 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-G3-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/RGDfK2-G3-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-[Gly-Gly-Gly-c(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-G3-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-G<sub>3</sub>-RGD2</div><div>Kam Leung.</div><div class="small">Created: October 26, 2009; Last Update: December 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN_RGDyK_NOTA_68Ga"><a class="toc-item" href="/books/n/micad/BBN_RGDyK_NOTA_68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-Glu-c(RGDyK)-bombesin[7-14]</a><span class="small"> [<a href="/books/n/micad/BBN_RGDyK_NOTA_68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-RGD-BBN</div><div>Kam Leung.</div><div class="small">Created: January 2, 2010; Last Update: January 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-NOTA-68Ga"><a class="toc-item" href="/books/n/micad/RGDyK-NOTA-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-7-triacetic acid-isothiocyanatobenzyl-c(Arg-Gly-Asp-<span class="small-caps">d</span>-Tyr-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDyK-NOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-RGD</div><div>Kam Leung.</div><div class="small">Created: January 26, 2011; Last Update: April 7, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-NOTA-8-Aoc-68Ga"><a class="toc-item" href="/books/n/micad/BBN-NOTA-8-Aoc-68Ga/"><sup>68</sup>Ga-1,4,7-Triazacyclononane-1,4-diacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-NOTA-8-Aoc-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-NOTA-8-Aoc-BBN[7-14]NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 26, 2012; Last Update: October 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-CHX-68Ga"><a class="toc-item" href="/books/n/micad/ReCCMSH-CHX-68Ga/"><sup>68</sup>Ga-CHX-A”-Rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-CHX-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-CHX-A”-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: August 20, 2009; Last Update: September 8, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Df-Bz-7D12-68Ga"><a class="toc-item" href="/books/n/micad/Df-Bz-7D12-68Ga/"><sup>68</sup>Ga-Desferrioxamine <i>p</i>-isothiocyanatobenzyl-anti-EGFR nanobody 7D12</a><span class="small"> [<a href="/books/n/micad/Df-Bz-7D12-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-Df-Bz-NCS-7D12</div><div>Kam Leung.</div><div class="small">Created: March 21, 2012; Last Update: June 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RM2-68Ga"><a class="toc-item" href="/books/n/micad/RM2-68Ga/"><sup>68</sup>Ga-DOTA-4-amino-1-carboxymethyl-piperidine-<span class="small-caps">D</span>-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RM2-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-RM2</div><div>Kam Leung.</div><div class="small">Created: February 5, 2011; Last Update: May 4, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GAPEDLGa68"><a class="toc-item" href="/books/n/micad/GAPEDLGa68/"><sup>68</sup>Ga-Glutamate peptide-3 aminoethyl estradiol</a><span class="small"> [<a href="/books/n/micad/GAPEDLGa68/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-GAP-EDL</div><div>Arvind Chopra.</div><div class="small">Created: August 23, 2007; Last Update: June 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-Bz-2-NI-68Ga"><a class="toc-item" href="/books/n/micad/DOTA-Bz-2-NI-68Ga/"><sup>68</sup>Ga-Isothiocyanatobenzyl-tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine</a><span class="small"> [<a href="/books/n/micad/DOTA-Bz-2-NI-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-SCN-Bz-DOTA-NI</div><div>Kam Leung.</div><div class="small">Created: May 19, 2011; Last Update: September 22, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOC68Ga"><a class="toc-item" href="/books/n/micad/NOC68Ga/"><sup>68</sup>Ga-Labeled (1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid)-1-NaI3-octreotide</a><span class="small"> [<a href="/books/n/micad/NOC68Ga/pdf/">PDF Version</a>]</span><div>[<sup>68</sup>Ga]-DOTA-NOC</div><div>Arvind Chopra.</div><div class="small">Created: May 12, 2009; Last Update: June 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BPAMD68Ga"><a class="toc-item" href="/books/n/micad/BPAMD68Ga/"><sup>68</sup>Ga-Labeled (4-{[(bis(phosphonomethyl))carbamoyl]methyl}-7,10-bis(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl)acetic acid (BPAMD)</a><span class="small"> [<a href="/books/n/micad/BPAMD68Ga/pdf/">PDF Version</a>]</span><div> [<sup>68</sup>Ga]BPAMD</div><div>Arvind Chopra.</div><div class="small">Created: September 18, 2012; Last Update: November 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-AM3"><a class="toc-item" href="/books/n/micad/Ga68-AM3/"><sup>68</sup>Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-<span class="small-caps">d</span>-Trp-Lys-Thr-Cys))</a><span class="small"> [<a href="/books/n/micad/Ga68-AM3/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-AM3</div><div>Liang Shan.</div><div class="small">Created: December 10, 2010; Last Update: January 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-MUT-DS"><a class="toc-item" href="/books/n/micad/Ga68-MUT-DS/"><sup>68</sup>Ga-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH<sub>2</sub> with a disulfide bridge between the two homoC</a><span class="small"> [<a href="/books/n/micad/Ga68-MUT-DS/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-MUT-DS</div><div>Liang Shan.</div><div class="small">Created: November 15, 2011; Last Update: January 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PSMA68Ga6"><a class="toc-item" href="/books/n/micad/PSMA68Ga6/"><sup>68</sup>Ga-Labeled 2-[3-(1-carboxy-5-{7-[5-carboxy-5-(3-phenyl-2-{3-phenyl-2-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]propionylamino}propionylamino)pentylcarbamoyl]heptanoylamino}pentyl)ureido]pentanedioic acid</a><span class="small"> [<a href="/books/n/micad/PSMA68Ga6/pdf/">PDF Version</a>]</span><div>[<sup>68</sup>Ga]6</div><div>Arvind Chopra.</div><div class="small">Created: September 27, 2010; Last Update: December 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NOTABP68Ga"><a class="toc-item" href="/books/n/micad/NOTABP68Ga/"><sup>68</sup>Ga-Labeled 2-[4,7-di(carboxymethyl)-1,4,7-triazonan-1-yl]-5-[(4-hydroxy-4,4-diphosphonobutyl)amino]-5-oxopentanoic acid (NOTA-bisphosphonate (BP))</a><span class="small"> [<a href="/books/n/micad/NOTABP68Ga/pdf/">PDF Version</a>]</span><div> [<sup>68</sup>Ga]-NOTA-BP</div><div>Arvind Chopra.</div><div class="small">Created: December 7, 2011; Last Update: December 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PSMA68Ga3"><a class="toc-item" href="/books/n/micad/PSMA68Ga3/"><sup>68</sup>Ga-Labeled 2-{3-[5-(7-{1-benzyloxycarbonyl-5-[2-(4,7,10-tris-carboxymethyl-1,4,7,10-tetraazacyclododec-1-l)acetylamino]pentylcarbamoyl}-heptanoylamino)-1-carboxypentyl]ureido}pentanedioic acid</a><span class="small"> [<a href="/books/n/micad/PSMA68Ga3/pdf/">PDF Version</a>]</span><div> [<sup>68</sup>Ga]3</div><div>Arvind Chopra.</div><div class="small">Created: September 28, 2010; Last Update: December 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-21-22"><a class="toc-item" href="/books/n/micad/Ga68-21-22/"><sup>68</sup>Ga-Labeled alanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid</a><span class="small"> [<a href="/books/n/micad/Ga68-21-22/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-21, <sup>68</sup>Ga-22</div><div>Liang Shan.</div><div class="small">Created: August 29, 2011; Last Update: October 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EpCAM68Ga"><a class="toc-item" href="/books/n/micad/EpCAM68Ga/"><sup>68</sup>Ga-Labeled anti-EpCAM diabody against epithelial cell adhesion molecule</a><span class="small"> [<a href="/books/n/micad/EpCAM68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-HBED-CC-anti-EpCAM diabody</div><div>Kam Leung.</div><div class="small">Created: August 6, 2010; Last Update: November 19, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sCCK8Der68Ga"><a class="toc-item" href="/books/n/micad/sCCK8Der68Ga/"><sup>68</sup>Ga-Labeled DOTA-conjugated sCCK8[Phe<sup>2</sup>(<i>p</i>-CH<sub>2</sub>SO<sub>3</sub>H),Nle<sup>3,6</sup>], a sulfated cholecystokinin 8 (sCCK8) peptide derivative</a><span class="small"> [<a href="/books/n/micad/sCCK8Der68Ga/pdf/">PDF Version</a>]</span><div> [<sup>68</sup>Ga]sCCK8[Phe<sup>2</sup>(<i>p</i>-CH<sub>2</sub>SO<sub>3</sub>H),Nle<sup>3,6</sup></div><div>Arvind Chopra.</div><div class="small">Created: January 10, 2013; Last Update: January 31, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-23-24"><a class="toc-item" href="/books/n/micad/Ga68-23-24/"><sup>68</sup>Ga-Labeled homoalanine derivatives of 1,4,7,10-tetraazacyclododecane-1,7-diacetic acid and 1,4,7,10-tetraazacyclododecane-1,4,7,-triacetic acid</a><span class="small"> [<a href="/books/n/micad/Ga68-23-24/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-23, <sup>68</sup>Ga-24</div><div>Liang Shan.</div><div class="small">Created: August 29, 2011; Last Update: October 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GhrelinDer68Ga"><a class="toc-item" href="/books/n/micad/GhrelinDer68Ga/"><sup>68</sup>Ga-Labeled NODAGA-conjugated ghrelin receptor agonists and inverse agonists</a><span class="small"> [<a href="/books/n/micad/GhrelinDer68Ga/pdf/">PDF Version</a>]</span><div> [<sup>68</sup>Ga]-NODAGA-ghrelin derivatives</div><div>Arvind Chopra.</div><div class="small">Created: June 10, 2012; Last Update: July 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-2a-c"><a class="toc-item" href="/books/n/micad/Ga68-2a-c/"><sup>68</sup>Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid</a><span class="small"> [<a href="/books/n/micad/Ga68-2a-c/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-2a-c</div><div>Liang Shan.</div><div class="small">Created: August 29, 2011; Last Update: October 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-1a-c"><a class="toc-item" href="/books/n/micad/Ga68-1a-c/"><sup>68</sup>Ga-Labeled β-aminoalanine, γ-aminohomoalanine, and ε-aminolysine conjugates of 1,4,7-triazacyclononane-1,4,7-triacetic acid</a><span class="small"> [<a href="/books/n/micad/Ga68-1a-c/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-1a-c</div><div>Liang Shan.</div><div class="small">Created: August 29, 2011; Last Update: October 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-HBED-68Ga"><a class="toc-item" href="/books/n/micad/scVEGF-HBED-68Ga/"><sup>68</sup>Ga-<i>N,N’</i>-bis[2-Hydroxy-5-(carboxyethyl)benzyl]ethylenediamine-<i>N,N’</i>-diacetic acid-polyethylene glycol-single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-HBED-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-HBED-CC-PEG-scVEGF</div><div>Kam Leung.</div><div class="small">Created: December 18, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-2-NI-68Ga"><a class="toc-item" href="/books/n/micad/DOTA-2-NI-68Ga/"><sup>68</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-2-(2-nitroimidazolyl)ethylamine</a><span class="small"> [<a href="/books/n/micad/DOTA-2-NI-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-NI</div><div>Kam Leung.</div><div class="small">Created: May 19, 2011; Last Update: July 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-E-DOTA68Ga"><a class="toc-item" href="/books/n/micad/RGDfK2-E-DOTA68Ga/"><sup>68</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-E-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-E-[c(RGDfK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: February 20, 2011; Last Update: May 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK4-E-DOTA68Ga"><a class="toc-item" href="/books/n/micad/RGDfK4-E-DOTA68Ga/"><sup>68</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK4-E-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-E-{E-[c(RGDfK)]<sub>2</sub>}<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: February 19, 2011; Last Update: May 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-E-DOTA68Ga"><a class="toc-item" href="/books/n/micad/RGDfK-E-DOTA68Ga/"><sup>68</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-E-DOTA68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-E-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: February 6, 2011; Last Update: May 12, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-MG0-68Ga"><a class="toc-item" href="/books/n/micad/DOTA-MG0-68Ga/"><sup>68</sup>Ga-Tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid-<span class="small-caps">d</span>-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/DOTA-MG0-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-MG0</div><div>Kam Leung.</div><div class="small">Created: August 15, 2011; Last Update: November 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrastFabGa68"><a class="toc-item" href="/books/n/micad/TrastFabGa68/"><sup>68</sup>Ga-Trastuzumab F(ab’) fragment</a><span class="small"> [<a href="/books/n/micad/TrastFabGa68/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DCHF</div><div>The MICAD Research Team.</div><div class="small">Created: May 18, 2007; Last Update: June 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-Cys165-AnxA5"><a class="toc-item" href="/books/n/micad/Ga68-Cys165-AnxA5/">Gallium-68-dotamaleimide-Cys165-annexin A5</a><span class="small"> [<a href="/books/n/micad/Ga68-Cys165-AnxA5/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-Cys165-AnxA5</div><div>Liang Shan.</div><div class="small">Created: June 28, 2011; Last Update: August 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ga68-Cys2-AnxA5"><a class="toc-item" href="/books/n/micad/Ga68-Cys2-AnxA5/">Gallium-68-dotamaleimide-Cys2-annexin A5</a><span class="small"> [<a href="/books/n/micad/Ga68-Cys2-AnxA5/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-Cys2-AnxA5</div><div>Liang Shan.</div><div class="small">Created: June 28, 2011; Last Update: August 10, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TCTP-1-DOTA-68Ga"><a class="toc-item" href="/books/n/micad/TCTP-1-DOTA-68Ga/">Gly-Ala-Cys-Leu-Arg-Ser-Gly-Arg-Gly-Cys-Gly-(PEG)<sub>3</sub>-DOTA-<sup>68</sup>Ga</a><span class="small"> [<a href="/books/n/micad/TCTP-1-DOTA-68Ga/pdf/">PDF Version</a>]</span><div><sup>68</sup>Ga-DOTA-TCTP-1</div><div>Kam Leung.</div><div class="small">Created: December 20, 2010; Last Update: April 7, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos74as"><a class="toc-item" href="/books/n/micad/sos74as/">74As</a><ul id="toc_lst_NBK5330_toc_sos74as" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bavituximab74As"><a class="toc-item" href="/books/n/micad/Bavituximab74As/">[<sup>74</sup>As]-Labeled monoclonal antibody against anionic phospholipids</a><span class="small"> [<a href="/books/n/micad/Bavituximab74As/pdf/">PDF Version</a>]</span><div>Arvind Chopra.</div><div class="small">Created: April 14, 2008; Last Update: May 27, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos76br"><a class="toc-item" href="/books/n/micad/sos76br/">76Br</a><ul id="toc_lst_NBK5330_toc_sos76br" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_SSR180711-76Br"><a class="toc-item" href="/books/n/micad/SSR180711-76Br/">4-[<sup>76</sup>Br]Bromophenyl-1,4-diazabicyclo(3.2.2) nonane-4-carboxylate</a><span class="small"> [<a href="/books/n/micad/SSR180711-76Br/pdf/">PDF Version</a>]</span><div>[<sup>76</sup>Br]SSR180711</div><div>Kam Leung.</div><div class="small">Created: December 12, 2008; Last Update: February 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RHM-4-76Br"><a class="toc-item" href="/books/n/micad/RHM-4-76Br/">5-[<sup>76</sup>Br]-<i>N</i>-(4-(3,4-Dihydro-6,7-dimethoxyisoquinolin-2(1<i>H</i>)-yl)butyl)-2,3-dimethoxybenzamide</a><span class="small"> [<a href="/books/n/micad/RHM-4-76Br/pdf/">PDF Version</a>]</span><div> [<sup>76</sup>Br]RHM-4</div><div>Kam Leung.</div><div class="small">Created: October 5, 2006; Last Update: April 3, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L19SIP76Br"><a class="toc-item" href="/books/n/micad/L19SIP76Br/"><sup>76</sup>Br-Human recombinant anti-ED-B fibronectin L19-small immunoprotein</a><span class="small"> [<a href="/books/n/micad/L19SIP76Br/pdf/">PDF Version</a>]</span><div><sup>76</sup>Br-L19-SIP</div><div>The MICAD Research Team.</div><div class="small">Created: August 4, 2007; Last Update: August 27, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos86y"><a class="toc-item" href="/books/n/micad/sos86y/">86Y</a><ul id="toc_lst_NBK5330_toc_sos86y" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bevacizumab86Y"><a class="toc-item" href="/books/n/micad/Bevacizumab86Y/"><sup>86</sup>Y-CHX-A''-Diethylenetriamine pentaacetic acid-bevacizumab</a><span class="small"> [<a href="/books/n/micad/Bevacizumab86Y/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-CHX-A''-DTPA-bevacizumab</div><div>Kam Leung.</div><div class="small">Created: December 17, 2010; Last Update: March 16, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cetuximab-CHX86Y"><a class="toc-item" href="/books/n/micad/Cetuximab-CHX86Y/"><sup>86</sup>Y-CHX-A''-Diethylenetriamine pentaacetic acid-cetuximab</a><span class="small"> [<a href="/books/n/micad/Cetuximab-CHX86Y/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-CHX-A''-DTPA-cetuximab</div><div>Kam Leung.</div><div class="small">Created: August 15, 2010; Last Update: November 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Panitumumab86Y"><a class="toc-item" href="/books/n/micad/Panitumumab86Y/"><sup>86</sup>Y-CHX-A''-diethylenetriamine pentaacetic acid-panitumumab</a><span class="small"> [<a href="/books/n/micad/Panitumumab86Y/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-CHX-A''-DTPA-Panitumumab</div><div>Kam Leung.</div><div class="small">Created: August 25, 2011; Last Update: December 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-CHX-86Y"><a class="toc-item" href="/books/n/micad/ReCCMSH-CHX-86Y/"><sup>86</sup>Y-CHX-A”-Rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-CHX-86Y/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-CHX-A”-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: August 20, 2009; Last Update: September 8, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MP2346Y86"><a class="toc-item" href="/books/n/micad/MP2346Y86/"><sup>86</sup>Y-DOTA-[Pro<sup>1</sup>,Tyr<sup>4</sup>]-Bombesin[1-14]</a><span class="small"> [<a href="/books/n/micad/MP2346Y86/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-MP2346</div><div>Kenneth T. Cheng, Jason S. Lewis, and Gráinne B. Biddlecombe.</div><div class="small">Created: August 6, 2007; Last Update: January 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-DOTA-86Y"><a class="toc-item" href="/books/n/micad/ReCCMSH-DOTA-86Y/"><sup>86</sup>Y-DOTA-rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-DOTA-86Y/pdf/">PDF Version</a>]</span><div><sup>86</sup>Y-DOTA-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: May 30, 2009; Last Update: July 14, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos89zr"><a class="toc-item" href="/books/n/micad/sos89zr/">89Zr</a><ul id="toc_lst_NBK5330_toc_sos89zr" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TRC105-Df-89Zr"><a class="toc-item" href="/books/n/micad/TRC105-Df-89Zr/"><sup>89</sup>Zr-Desferrioxamine-anti-CD105 TRC105 chimeric monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/TRC105-Df-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df-TRC105</div><div>Kam Leung.</div><div class="small">Created: November 1, 2011; Last Update: January 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hRS7-Df-89Zr"><a class="toc-item" href="/books/n/micad/hRS7-Df-89Zr/"><sup>89</sup>Zr-Desferrioxamine-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/hRS7-Df-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df-hRS7</div><div>Kam Leung.</div><div class="small">Created: January 15, 2012; Last Update: April 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DFO-7E11-89Zr"><a class="toc-item" href="/books/n/micad/DFO-7E11-89Zr/"><sup>89</sup>Zr-Desferrioxamine B-7E11 anti-prostate-specific membrane antigen monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/DFO-7E11-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-DFO-7E11</div><div>Kam Leung.</div><div class="small">Created: November 22, 2011; Last Update: February 23, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_J591-DFO-89Zr"><a class="toc-item" href="/books/n/micad/J591-DFO-89Zr/"><sup>89</sup>Zr-Desferrioxamine B-J591 anti-prostate-specific membrane antigen monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/J591-DFO-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-DFO-J591</div><div>Kam Leung.</div><div class="small">Created: September 12, 2010; Last Update: November 18, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Transferrin-89Zr"><a class="toc-item" href="/books/n/micad/Transferrin-89Zr/"><sup>89</sup>Zr-Desferrioxamine B-Transferrin</a><span class="small"> [<a href="/books/n/micad/Transferrin-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-DFO-Transferrin</div><div>Kam Leung.</div><div class="small">Created: April 1, 2013; Last Update: June 6, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Df-Bz-7D12-89Zr"><a class="toc-item" href="/books/n/micad/Df-Bz-7D12-89Zr/"><sup>89</sup>Zr-Desferrioxamine <i>p</i>-isothiocyanatobenzyl-anti-EGFR nanobody 7D12</a><span class="small"> [<a href="/books/n/micad/Df-Bz-7D12-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df-Bz-NCS-7D12</div><div>Kam Leung.</div><div class="small">Created: March 21, 2012; Last Update: June 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Df-Bz-1E2-Alb8-89Zr"><a class="toc-item" href="/books/n/micad/Df-Bz-1E2-Alb8-89Zr/"><sup>89</sup>Zr-Desferrioxamine <i>p</i>-isothiocyanatobenzyl-anti-hepatocyte growth factor nanobody 1E2 fused to albumin-binding nanobody Alb8</a><span class="small"> [<a href="/books/n/micad/Df-Bz-1E2-Alb8-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df-Bz-NCS-1E2-Alb8</div><div>Kam Leung.</div><div class="small">Created: May 17, 2012; Last Update: August 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Onartuzumab-Df-89Zr"><a class="toc-item" href="/books/n/micad/Onartuzumab-Df-89Zr/"><sup>89</sup>Zr-Desferrioxamine <i>p</i>-isothiocyanatobenzyl-anti-hepatocyte growth factor receptor 1-armed antibody onartuzumab</a><span class="small"> [<a href="/books/n/micad/Onartuzumab-Df-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df-Onartuzumab</div><div>Kam Leung.</div><div class="small">Created: December 1, 2012; Last Update: March 14, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fresolimumab89Zr"><a class="toc-item" href="/books/n/micad/Fresolimumab89Zr/"><sup>89</sup>Zr-Labeled fresolimumab (human anti-transforming growth factor-β monoclonal antibody)</a><span class="small"> [<a href="/books/n/micad/Fresolimumab89Zr/pdf/">PDF Version</a>]</span><div> [<sup>89</sup>Zr]-Fresolimumab</div><div>Arvind Chopra.</div><div class="small">Created: December 13, 2011; Last Update: January 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rzumab89Zr"><a class="toc-item" href="/books/n/micad/Rzumab89Zr/"><sup>89</sup>Zr-Labeled <i>N</i>-succinyldesferrioxamine-ranibizumab</a><span class="small"> [<a href="/books/n/micad/Rzumab89Zr/pdf/">PDF Version</a>]</span><div> [<sup>89</sup>Zr]-Ranibizumab</div><div>Arvind Chopra.</div><div class="small">Created: January 26, 2011; Last Update: February 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250-Fab2-89Zr"><a class="toc-item" href="/books/n/micad/cG250-Fab2-89Zr/"><sup>89</sup>Zr-Labeled <i>N</i>-suc-desferrioxamine-conjugated anti-carbonic anhydrase IX chimeric monoclonal antibody cG250-F(ab’)<sub>2</sub> fragments</a><span class="small"> [<a href="/books/n/micad/cG250-Fab2-89Zr/pdf/">PDF Version</a>]</span><div>[<sup>89</sup>Zr]-cG250-F(ab')<sub>2</sub></div><div>Arvind Chopra.</div><div class="small">Created: August 2, 2010; Last Update: October 14, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Panitumumab89Zr"><a class="toc-item" href="/books/n/micad/Panitumumab89Zr/"><sup>89</sup>Zr-Labeled <i>p</i>-isothiocyanatobenzyl-desferrioxamine B (Df-Bz-NCS)–conjugated panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/Panitumumab89Zr/pdf/">PDF Version</a>]</span><div>[<sup>89</sup>Zr]-Panitumumab</div><div>Arvind Chopra.</div><div class="small">Created: May 4, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tras89Zr"><a class="toc-item" href="/books/n/micad/Tras89Zr/"><sup>89</sup>Zr-Labeled trastuzumab, a humanized monoclonal antibody against epidermal growth factor receptor 2</a><span class="small"> [<a href="/books/n/micad/Tras89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Trastuzumab</div><div>Arvind Chopra.</div><div class="small">Created: January 5, 2010; Last Update: March 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_U36-89Zr"><a class="toc-item" href="/books/n/micad/U36-89Zr/"><sup>89</sup>Zr-<i>N</i>-Succinyldesferal-anti-CD44v6 chimeric monoclonal antibody U36</a><span class="small"> [<a href="/books/n/micad/U36-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-<i>N</i>-SucDf-cMAb U36</div><div>Kam Leung.</div><div class="small">Created: March 25, 2010; Last Update: April 22, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250-89Zr"><a class="toc-item" href="/books/n/micad/cG250-89Zr/"><sup>89</sup>Zr-<i>N</i>-Succinyldesferal-chimeric monoclonal antibody G250</a><span class="small"> [<a href="/books/n/micad/cG250-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Df<i>-</i>cG250</div><div>Kam Leung.</div><div class="small">Created: April 22, 2010; Last Update: May 27, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_R1507-Df-89Zr"><a class="toc-item" href="/books/n/micad/R1507-Df-89Zr/"><sup>89</sup>Zr-<i>N</i>-Succinyldesferal-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507</a><span class="small"> [<a href="/books/n/micad/R1507-Df-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-R1507</div><div>Kam Leung.</div><div class="small">Created: December 20, 2010; Last Update: February 3, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bevacizumab89Zr"><a class="toc-item" href="/books/n/micad/Bevacizumab89Zr/"><sup>89</sup>Zr-<i>N</i>-Succinyldesferrioxamine-bevacizumab</a><span class="small"> [<a href="/books/n/micad/Bevacizumab89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-Bevacizumab</div><div>Kam Leung.</div><div class="small">Created: October 17, 2008; Last Update: December 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DN30-89Zr"><a class="toc-item" href="/books/n/micad/DN30-89Zr/"><sup>89</sup>Zr-<i>N</i>-Succinyldesferrioxamine-DN30</a><span class="small"> [<a href="/books/n/micad/DN30-89Zr/pdf/">PDF Version</a>]</span><div><sup>89</sup>Zr-DN30</div><div>Kam Leung.</div><div class="small">Created: November 17, 2007; Last Update: March 12, 2012.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_spect"><a class="toc-item" href="/books/n/micad/spect/">SPECT</a><ul id="toc_lst_NBK5330_toc_spect" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos111in"><a class="toc-item" href="/books/n/micad/sos111in/">111In</a><ul id="toc_lst_NBK5330_toc_sos111in" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Biotin111In"><a class="toc-item" href="/books/n/micad/Biotin111In/">[<sup>111</sup>In]5-[(3aR,6S,6aS)-2-Oxo-1,3,3a,4,6,6a-hexahydrothieno[3,4-d]imidazol-6-yl]pentanoic acid</a><span class="small"> [<a href="/books/n/micad/Biotin111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]Biotin</div><div>Arvind Chopra.</div><div class="small">Created: May 1, 2008; Last Update: May 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bomproamide111In"><a class="toc-item" href="/books/n/micad/Bomproamide111In/">[<sup>111</sup>In]-DOTA-Aminohexanoyl-[<i>D</i>-Phe<sup>6</sup>,Leu-NHCH<sub>2</sub>CH<sub>2</sub>CH<sub>3</sub><sup>13</sup>,desMet<sup>14</sup>] BBN[6-14]</a><span class="small"> [<a href="/books/n/micad/Bomproamide111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]Bomproamide</div><div>Arvind Chopra.</div><div class="small">Created: May 20, 2010; Last Update: July 8, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECAPT111In"><a class="toc-item" href="/books/n/micad/ECAPT111In/">[<sup>111</sup>In]-Ethylenedicysteine-murine anti-phosphotyrosine antibody</a><span class="small"> [<a href="/books/n/micad/ECAPT111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-EC-APT</div><div>Arvind Chopra.</div><div class="small">Created: March 12, 2009; Last Update: April 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiuPARpep111In"><a class="toc-item" href="/books/n/micad/AntiuPARpep111In/">[<sup>111</sup>In]Labeled-(NAc-dD-CHA-F-dS-dR-Y-L-W-S-βAla)<sub>2</sub>-K-K(DOTA)</a><span class="small"> [<a href="/books/n/micad/AntiuPARpep111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]Anti-uPA peptide</div><div>Arvind Chopra.</div><div class="small">Created: April 1, 2010; Last Update: May 27, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Enterotoxin111In"><a class="toc-item" href="/books/n/micad/Enterotoxin111In/">[<sup>111</sup>In]-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-heat-stable human <i>Escherichia coli</i> enterotoxin </a><span class="small"> [<a href="/books/n/micad/Enterotoxin111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]DOTA-F<sup>19</sup>-ST<sub>h</sub>(1-19)</div><div>Arvind Chopra.</div><div class="small">Created: May 16, 2008; Last Update: June 10, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250In111"><a class="toc-item" href="/books/n/micad/cG250In111/">[<sup>111</sup>In]-Labeled chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX</a><span class="small"> [<a href="/books/n/micad/cG250In111/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-DOTA-cG250</div><div>Arvind Chopra.</div><div class="small">Created: August 6, 2010; Last Update: September 2, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250-Fab2-In111"><a class="toc-item" href="/books/n/micad/cG250-Fab2-In111/">[<sup>111</sup>In]-Labeled divalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX</a><span class="small"> [<a href="/books/n/micad/cG250-Fab2-In111/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-DOTA-F(ab’)<sub>2</sub>-cG250</div><div>Arvind Chopra.</div><div class="small">Created: August 11, 2010; Last Update: September 2, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cG250-Fab-In111"><a class="toc-item" href="/books/n/micad/cG250-Fab-In111/">[<sup>111</sup>In]-Labeled monovalent Fab fragment of chimeric monoclonal antibody cG250 directed against carbonic anhydrase IX</a><span class="small"> [<a href="/books/n/micad/cG250-Fab-In111/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-DOTA-Fab-cG250</div><div>Arvind Chopra.</div><div class="small">Created: August 11, 2010; Last Update: September 2, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BNDOTA111In"><a class="toc-item" href="/books/n/micad/BNDOTA111In/">[<sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-Pro<sup>1</sup>,Tyr<sup>4</sup>]Bombesin</a><span class="small"> [<a href="/books/n/micad/BNDOTA111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In-DOTA-Pro<sup>1</sup>,Tyr<sup>4</sup>]BN</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 23, 2007; Last Update: November 13, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z2395-NODAGA-111In"><a class="toc-item" href="/books/n/micad/Z2395-NODAGA-111In/">[<sup>111</sup>In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid-10-maleimidoethylacetamide-Cys<sup>61</sup>]-Affibody Z<sub>HER2:2395</sub></a><span class="small"> [<a href="/books/n/micad/Z2395-NODAGA-111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In-MMA-NODAGA-Cys<sup>61</sup>]-Z<sub>HER2:2395</sub></div><div>Kam Leung.</div><div class="small">Created: May 20, 2012; Last Update: September 13, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ACMpip111In"><a class="toc-item" href="/books/n/micad/ACMpip111In/">[<sup>111</sup>In-Diethylenetriamine pentaacetic acid-ACMpip<sup>5</sup>,Tha<sup>6</sup>,βAla<sup>11</sup>,Tha<sup>13</sup>,NIe<sup>14</sup>]bombesin(5-14)</a><span class="small"> [<a href="/books/n/micad/ACMpip111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In-DTPA-ACMpip<sup>5</sup>,Tha<sup>6</sup>,βAla<sup>11</sup>,Tha<sup>13</sup>,NIe<sup>14</sup>]BN(5-14)</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 18, 2007; Last Update: January 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BNDTPA111In"><a class="toc-item" href="/books/n/micad/BNDTPA111In/">[<sup>111</sup>In-Diethylenetriaminepentaacetic acid-Pro<sup>1</sup>,Tyr<sup>4</sup>]bombesin</a><span class="small"> [<a href="/books/n/micad/BNDTPA111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In-DTPA-Pro<sup>1</sup>,Tyr<sup>4</sup>]BN</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 10, 2007; Last Update: November 7, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hPAM4InI"><a class="toc-item" href="/books/n/micad/hPAM4InI/"><sup>111</sup>In/<sup>125/131</sup>I-Labeled anti-mucin-1 murine, chimeric or humanized antibody hPAM4</a><span class="small"> [<a href="/books/n/micad/hPAM4InI/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In/<sup>125/131</sup>I]-hPAM4</div><div>Arvind Chopra.</div><div class="small">Created: June 16, 2011; Last Update: July 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HE3H6Zher2342InTcI"><a class="toc-item" href="/books/n/micad/HE3H6Zher2342InTcI/"><sup>111</sup>In/<sup>125</sup>I/<sup>99m</sup>Tc-Labeled N-terminus tri-(histidine-glutamate) (HE)<sub>3</sub>-tagged and N- or C-terminus hexahistidine (H6)-tagged anti-epidermal growth factor receptor Affibody Z<sub>HER2:342</sub>-C</a><span class="small"> [<a href="/books/n/micad/HE3H6Zher2342InTcI/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In/<sup>125</sup>I/<sup>99m</sup>Tc]-(HE)<sub>3</sub>-Z<sub>HER2:342</sub>-C, [<sup>111</sup>In/<sup>125</sup>I/<sup>99m</sup>Tc]-H<sub>6</sub>-Z<sub>HER2:342</sub>-C, and [<sup>111</sup>In/<sup>125</sup>I/<sup>99m</sup>Tc]-Z<sub>HER2:342</sub>-H<sub>6</sub>-C</div><div>Arvind Chopra.</div><div class="small">Created: July 16, 2012; Last Update: August 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PaniMabFab111In"><a class="toc-item" href="/books/n/micad/PaniMabFab111In/"><sup>111</sup>In/<sup>86</sup>Y-Labeled F(ab')<sub>2</sub> fragment of panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/PaniMabFab111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In/<sup>86</sup>Y]-CHX-A''-Panitumumab F(ab')<sub>2</sub></div><div>Arvind Chopra.</div><div class="small">Created: April 30, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HuCC49CH2In111"><a class="toc-item" href="/books/n/micad/HuCC49CH2In111/"><sup>111</sup>In-(1-isothiocyanatobenzyl-3-methyldiethylenetriaminepentaaetic acid)-anti–TAG-72 humanized C<sub>H</sub>2 domain-deleted antibody </a><span class="small"> [<a href="/books/n/micad/HuCC49CH2In111/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-(Mx-DTPA)-HuCC49ΔC<sub>H</sub>2 Ab</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 17, 2007; Last Update: February 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FibPep-DOTA-111In"><a class="toc-item" href="/books/n/micad/FibPep-DOTA-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-Ac-RWQPCPAESWT-Cha-CWDPGGGK-NH<sub>2</sub> (FibPep)</a><span class="small"> [<a href="/books/n/micad/FibPep-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-FibPep</div><div>Kam Leung.</div><div class="small">Created: May 7, 2013; Last Update: May 30, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-4551-DOTA-111In"><a class="toc-item" href="/books/n/micad/Z-4551-DOTA-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-tetraacetic acid-anti-insulin-like growth factor 1 receptor Affibody Z<sub>IGF1R:4551</sub></a><span class="small"> [<a href="/books/n/micad/Z-4551-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-Z<sub>IGF1R:4551</sub></div><div>Kam Leung.</div><div class="small">Created: January 20, 2012; Last Update: March 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-DOTA-8-Aoc111In"><a class="toc-item" href="/books/n/micad/BBN-DOTA-8-Aoc111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-1,4,7,10-triacetic acid-8-aminooctanoic acid-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-DOTA-8-Aoc111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-8-Aoc-BBN[7-14]NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 20, 2012; Last Update: October 4, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H-DO3A-111In"><a class="toc-item" href="/books/n/micad/H-DO3A-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-<span class="small-caps">L</span>-homoalanine</a><span class="small"> [<a href="/books/n/micad/H-DO3A-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DO3A-H</div><div>Kam Leung.</div><div class="small">Created: January 12, 2013; Last Update: March 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-2395-DOTA-111In"><a class="toc-item" href="/books/n/micad/Z-2395-DOTA-111In/"><sup>111</sup>In-1,4,7,10-tetraazacyclododecane-1,4,7-tris-acetic acid-10-maleimidoethylacetamide-Affibody Z<sub>HER2:2395</sub>-Cys</a><span class="small"> [<a href="/books/n/micad/Z-2395-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-[MMA-DOTA-Cys<sup>61</sup>]-Z<sub>2395</sub>-C</div><div>Kam Leung.</div><div class="small">Created: August 16, 2009; Last Update: November 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AB-Fab4D5-111In"><a class="toc-item" href="/books/n/micad/AB-Fab4D5-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-AB.Fab4D5 </a><span class="small"> [<a href="/books/n/micad/AB-Fab4D5-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-AB.Fab4D5</div><div>Kam Leung.</div><div class="small">Created: April 16, 2007; Last Update: November 8, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-DOTA111In"><a class="toc-item" href="/books/n/micad/Z-DOTA111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid- Affibody Z<sub>HER2:342-pep2</sub></a><span class="small"> [<a href="/books/n/micad/Z-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-Z<sub>HER2:342-pep2</sub></div><div>Kam Leung.</div><div class="small">Created: April 16, 2007; Last Update: June 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KE88-111In"><a class="toc-item" href="/books/n/micad/KE88-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N,N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-cyclo(<span class="small-caps">D</span>-diaminobutyric acid-Arg-Phe-Phe-<span class="small-caps">D</span>-Trp-Lys-Thr-Phe)</a><span class="small"> [<a href="/books/n/micad/KE88-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-KE88</div><div>Kam Leung.</div><div class="small">Created: September 1, 2009; Last Update: October 8, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LLP2A-DOTA-111In"><a class="toc-item" href="/books/n/micad/LLP2A-DOTA-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-LLP2A</a><span class="small"> [<a href="/books/n/micad/LLP2A-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-LLP2A</div><div>Kam Leung.</div><div class="small">Created: June 10, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84Diabody111In"><a class="toc-item" href="/books/n/micad/T84Diabody111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-T84.66 diabody</a><span class="small"> [<a href="/books/n/micad/T84Diabody111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-T84.66 diabody</div><div>Kam Leung.</div><div class="small">Created: February 2, 2008; Last Update: March 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84minibody111In"><a class="toc-item" href="/books/n/micad/T84minibody111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-T84.66 minibody</a><span class="small"> [<a href="/books/n/micad/T84minibody111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-T84.66 minibody</div><div>Kam Leung.</div><div class="small">Created: February 2, 2008; Last Update: March 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84scFvHSA111In"><a class="toc-item" href="/books/n/micad/T84scFvHSA111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid-T84.66 scFv-human serum albumin</a><span class="small"> [<a href="/books/n/micad/T84scFvHSA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-T84.66 scFv-HSA</div><div>Kam Leung.</div><div class="small">Created: July 2, 2008; Last Update: September 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_UroguanylinE3-111In"><a class="toc-item" href="/books/n/micad/UroguanylinE3-111In/"><sup>111</sup>In-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-NDECELCVNVACTGCL</a><span class="small"> [<a href="/books/n/micad/UroguanylinE3-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-E<sup>3</sup>-uroguanylin</div><div>Kam Leung.</div><div class="small">Created: April 16, 2010; Last Update: June 25, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-NODAGA-111In"><a class="toc-item" href="/books/n/micad/RGDfK2-NODAGA-111In/"><sup>111</sup>In-1,4,7-Triazacyclononane,1-glutaric acid-4,7-acetic acid<b>-</b>Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-NODAGA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-NODAGA-E-[c(RGDfK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: May 5, 2013; Last Update: June 13, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast-DOTAGA-111In"><a class="toc-item" href="/books/n/micad/Trast-DOTAGA-111In/"><sup>111</sup>In-2-(4,7,10-Tris(carboxymethyl)-1,4,7,10-tetracyclododecan-1-yl)pentanedioic acid-Trastuzumab</a><span class="small"> [<a href="/books/n/micad/Trast-DOTAGA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTAGA-Trastuzumab</div><div>Kam Leung.</div><div class="small">Created: May 23, 2012; Last Update: September 13, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast1B4M111In"><a class="toc-item" href="/books/n/micad/Trast1B4M111In/"><sup>111</sup>In-2-(<i>p</i>-isothiocyanatobenzyl)-6-methyl-diethylenetriamine-<i>N</i>,<i>N</i>,<i>N</i>´,<i>N</i>´´,<i>N</i>´´-pentaacetic acid-trastuzumab</a><span class="small"> [<a href="/books/n/micad/Trast1B4M111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-1B4M-DTPA-humAb4D5-8</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 1, 2008; Last Update: June 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiCD105111In"><a class="toc-item" href="/books/n/micad/AntiCD105111In/"><sup>111</sup>In-Anti-CD105 MJ7/18 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/AntiCD105111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-MJ7/18 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 4, 2006; Last Update: December 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AMB8LK-DTPA111In"><a class="toc-item" href="/books/n/micad/AMB8LK-DTPA111In/"><sup>111</sup>In-Benzyl-diethylenetriamine pentaacetic acid-AMB8LK </a><span class="small"> [<a href="/books/n/micad/AMB8LK-DTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-AMB8LK</div><div>Kam Leung.</div><div class="small">Created: May 24, 2007; Last Update: February 1, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-benzyl-DPTA111In"><a class="toc-item" href="/books/n/micad/Z-benzyl-DPTA111In/"><sup>111</sup>In-Benzyl-diethylenetriaminepentaacetic acid-Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-benzyl-DPTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-Benzyl-DTPA-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: April 6, 2008; Last Update: May 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-benzyl-DOTA111In"><a class="toc-item" href="/books/n/micad/Z-benzyl-DOTA111In/"><sup>111</sup>In-Benzyl-tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-benzyl-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-Benzyl-DOTA-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: April 6, 2008; Last Update: May 29, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-BZ-DPTA111In"><a class="toc-item" href="/books/n/micad/Z1907-BZ-DPTA111In/"><sup>111</sup>In-BZ-Diethylenetriaminepentaacetic acid-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-BZ-DPTA111In/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: April 6, 2009; Last Update: June 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Capromab111In"><a class="toc-item" href="/books/n/micad/Capromab111In/"><sup>111</sup>In-Capromab pendetide </a><span class="small"> [<a href="/books/n/micad/Capromab111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-CYT-356</div><div>Kam Leung.</div><div class="small">Created: October 5, 2005; Last Update: May 24, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Mindin19G9-111In"><a class="toc-item" href="/books/n/micad/Mindin19G9-111In/"><sup>111</sup>In-CHX-A''-DTPA-anti-mindin/RG-1 monoclonal antibody 19G9</a><span class="small"> [<a href="/books/n/micad/Mindin19G9-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-CHX-A''-DTPA-19G9</div><div>Kam Leung.</div><div class="small">Created: November 16, 2009; Last Update: December 3, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-2395-CHX-A-111In"><a class="toc-item" href="/books/n/micad/Z-2395-CHX-A-111In/"><sup>111</sup>In-CHX-A”-diethylenepentaacetic acid-Affibody Z<sub>HER2:2395</sub>-Cys</a><span class="small"> [<a href="/books/n/micad/Z-2395-CHX-A-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-CHX-A’’-DTPA-Z<sub>2395</sub>-C</div><div>Kam Leung.</div><div class="small">Created: August 16, 2009; Last Update: November 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZEGFR955-111In"><a class="toc-item" href="/books/n/micad/ZEGFR955-111In/"><sup>111</sup>In-CHX-A”-Diethylenetriamine pentaacetic acid-(Z<sub>EGFR:955</sub>)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/ZEGFR955-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-CHX-A”-DTPA-(Z<sub>EGFR:955</sub>)<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: June 6, 2008; Last Update: July 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ReCCMSH-CHX-111In"><a class="toc-item" href="/books/n/micad/ReCCMSH-CHX-111In/"><sup>111</sup>In-CHX-A”-Rhenium-cyclized-[Cys<sup>3,4,10</sup>,D-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/ReCCMSH-CHX-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-CHX-A”-ReCCMSH(Arg<sup>11</sup>)</div><div>Kam Leung.</div><div class="small">Created: August 20, 2009; Last Update: May 9, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGF111In"><a class="toc-item" href="/books/n/micad/EGF111In/"><sup>111</sup>In conjugated to benzyl-diethylenetriaminepentaacetic acid-human epidermal growth factor </a><span class="small"> [<a href="/books/n/micad/EGF111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]Bz-DTPA-hEGF</div><div>Arvind Chopra.</div><div class="small">Created: February 4, 2009; Last Update: February 25, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DTPA-B3-111In"><a class="toc-item" href="/books/n/micad/DTPA-B3-111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-2-(<i>p</i>-isothiocyanatobenzyl)-6-methyl-B3 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/DTPA-B3-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-1B4M-B3</div><div>Kam Leung.</div><div class="small">Created: March 17, 2009; Last Update: May 13, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DTPA-2C5-111In"><a class="toc-item" href="/books/n/micad/DTPA-2C5-111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-2C5 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/DTPA-2C5-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-2C5</div><div>Kam Leung.</div><div class="small">Created: May 17, 2009; Last Update: June 6, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-4-DTPA111In"><a class="toc-item" href="/books/n/micad/Exendin-4-DTPA111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-aminohexanoic acid-Lys<sup>40</sup>-exendin-4</a><span class="small"> [<a href="/books/n/micad/Exendin-4-DTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-Ahx-Lys<sup>40</sup>-exendin-4</div><div>Kam Leung.</div><div class="small">Created: January 17, 2007; Last Update: January 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hRS7-DTPA-111In"><a class="toc-item" href="/books/n/micad/hRS7-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-anti-epithelial glycoprotein-1 hRS7 humanized monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/hRS7-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-hRS7</div><div>Kam Leung.</div><div class="small">Created: January 12, 2012; Last Update: April 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LIBS-DTPA-111In"><a class="toc-item" href="/books/n/micad/LIBS-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-Anti-ligand–induced binding sites (LIBS) single-chain (scFv) antibody</a><span class="small"> [<a href="/books/n/micad/LIBS-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-LIBS-scFv</div><div>Kam Leung.</div><div class="small">Created: November 23, 2012; Last Update: January 31, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bevacizumab111In"><a class="toc-item" href="/books/n/micad/Bevacizumab111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-bevacizumab</a><span class="small"> [<a href="/books/n/micad/Bevacizumab111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-bevacizumab</div><div>Kam Leung.</div><div class="small">Created: October 17, 2008; Last Update: December 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CTT-DTPA111In"><a class="toc-item" href="/books/n/micad/CTT-DTPA111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-cyclo(CTTHWGFTLC)</a><span class="small"> [<a href="/books/n/micad/CTT-DTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-CTT</div><div>Kam Leung.</div><div class="small">Created: January 17, 2007; Last Update: April 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_R1507-DTPA111In"><a class="toc-item" href="/books/n/micad/R1507-DTPA111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-human anti-insulin-like growth factor 1 receptor monoclonal antibody R1507</a><span class="small"> [<a href="/books/n/micad/R1507-DTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-R1507</div><div>Kam Leung.</div><div class="small">Created: December 20, 2010; Last Update: February 3, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hEGFDTPA111In"><a class="toc-item" href="/books/n/micad/hEGFDTPA111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-human epidermal growth factor </a><span class="small"> [<a href="/books/n/micad/hEGFDTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-hEGF</div><div>Arvind Chopra.</div><div class="small">Created: December 4, 2007; Last Update: January 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IC2-DTPA-111In"><a class="toc-item" href="/books/n/micad/IC2-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-IC2 rat monoclonal autoantibody to pancreatic β-cell surface antigen</a><span class="small"> [<a href="/books/n/micad/IC2-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-IC2</div><div>Kam Leung.</div><div class="small">Created: November 3, 2011; Last Update: February 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-3-DTPA111In"><a class="toc-item" href="/books/n/micad/Exendin-3-DTPA111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-Lys<sup>40</sup>-exendin-3</a><span class="small"> [<a href="/books/n/micad/Exendin-3-DTPA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-Lys<sup>40</sup>-exendin-3</div><div>Kam Leung.</div><div class="small">Created: August 20, 2010; Last Update: November 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A20FMDV2-DTPA-111In"><a class="toc-item" href="/books/n/micad/A20FMDV2-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-NAVPNLRGDLQVLAQKVART</a><span class="small"> [<a href="/books/n/micad/A20FMDV2-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-A20FMDV2</div><div>Kam Leung.</div><div class="small">Created: September 6, 2012; Last Update: November 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Pertuzumab111In"><a class="toc-item" href="/books/n/micad/Pertuzumab111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-pertuzumab</a><span class="small"> [<a href="/books/n/micad/Pertuzumab111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-pertuzumab</div><div>Kam Leung.</div><div class="small">Created: December 6, 2009; Last Update: January 21, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx5In111"><a class="toc-item" href="/books/n/micad/Anx5In111/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-polyethylene glycol-annexin V</a><span class="small"> [<a href="/books/n/micad/Anx5In111/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-PEG-Anx5</div><div>Kenneth T. Cheng.</div><div class="small">Created: September 28, 2006; Last Update: January 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-DTPA-111In"><a class="toc-item" href="/books/n/micad/BBN-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine
|
|
pentaacetic acid-QKYGNQWAVGHLM-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-[DTPA<sup>1</sup>-Lys<sup>3</sup>,Tyr<sup>4</sup>]-BN</div><div>Kam Leung.</div><div class="small">Created: April 21, 2010; Last Update: June 25, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SWNT-DTPA-111In"><a class="toc-item" href="/books/n/micad/SWNT-DTPA-111In/"><sup>111</sup>In-Diethylenetriamine pentaacetic acid-single-walled nanotubes</a><span class="small"> [<a href="/books/n/micad/SWNT-DTPA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-SWNTs</div><div>Kam Leung.</div><div class="small">Created: September 26, 2008; Last Update: November 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Trast111In"><a class="toc-item" href="/books/n/micad/Trast111In/"><sup>111</sup>In-Diethylenetriaminepentaacetic acid-trastuzumab</a><span class="small"> [<a href="/books/n/micad/Trast111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-humAb4D5-8</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 1, 2006; Last Update: June 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In-DTPA-OC"><a class="toc-item" href="/books/n/micad/In-DTPA-OC/"><sup>111</sup>Indium-diethylenetriaminepentaacetic acid-<span class="small-caps">d</span>-phenylalanine-octreotide</a><span class="small"> [<a href="/books/n/micad/In-DTPA-OC/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-OC</div><div>The MICAD Research Team.</div><div class="small">Created: January 23, 2005; Last Update: August 25, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DTPA-folate-111In"><a class="toc-item" href="/books/n/micad/DTPA-folate-111In/"><sup>111</sup>Indium-diethylenetriaminepentaacetic acid-folate</a><span class="small"> [<a href="/books/n/micad/DTPA-folate-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-folate</div><div>Kam Leung.</div><div class="small">Created: April 1, 2005; Last Update: January 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RM2-111In"><a class="toc-item" href="/books/n/micad/RM2-111In/"><sup>111</sup>In-DOTA-4-amino-1-carboxymethyl-piperidine-<span class="small-caps">D</span>-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RM2-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-RM2</div><div>Kam Leung.</div><div class="small">Created: February 5, 2011; Last Update: May 4, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RM1-DOTA-111In"><a class="toc-item" href="/books/n/micad/RM1-DOTA-111In/"><sup>111</sup>In-DOTA-Gly-benzoyl-<span class="small-caps">D</span>-Phe-Gln-Trp-Ala-Val-Gly-His-Sta-Leu-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RM1-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-RM1</div><div>Kam Leung.</div><div class="small">Created: November 5, 2009; Last Update: January 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CCMSH111In"><a class="toc-item" href="/books/n/micad/CCMSH111In/"><sup>111</sup>In-DOTA-Re(Cys<sup>3,4,10</sup>,<span class="small-caps">d</span>-Phe<sup>7</sup>,Arg<sup>11</sup>)αMSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/CCMSH111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-Re(Arg<sup>11</sup>)CCMSH</div><div>Kenneth T. Cheng, Zhen Cheng, and Thomas P. Quinn.</div><div class="small">Created: September 1, 2007; Last Update: December 17, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPC11870In111"><a class="toc-item" href="/books/n/micad/DPC11870In111/"><sup>111</sup>In-DPC11870</a><span class="small"> [<a href="/books/n/micad/DPC11870In111/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DPC11870</div><div>Arvind Chopra.</div><div class="small">Created: March 7, 2007; Last Update: December 19, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_D-PEGantiEGFRC225"><a class="toc-item" href="/books/n/micad/D-PEGantiEGFRC225/"><sup>111</sup>In-DTPA-Poly(ethylene glycol)-anti-epidermal growth factor receptor antibody C225 </a><span class="small"> [<a href="/books/n/micad/D-PEGantiEGFRC225/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DTPA-PEG-C225</div><div>The MICAD Research Team.</div><div class="small">Created: June 7, 2007; Last Update: July 2, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ibritumomab"><a class="toc-item" href="/books/n/micad/Ibritumomab/"><sup>111</sup>In-Ibritumomab tiuxetan</a><span class="small"> [<a href="/books/n/micad/Ibritumomab/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-2B8 MAb</div><div>The MICAD Research Team.</div><div class="small">Created: November 22, 2005; Last Update: September 26, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-3"><a class="toc-item" href="/books/n/micad/In111-3/"><sup>111</sup>In-Labeled (7<i>S</i>)-26-(4-((1-((1-carboxy-5-(2-(4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododecan-1-yl)acetamido)pentyl)amino)-1-oxo-6-(1-((7<i>S</i>)-1,3,7,22-tetracarboxy-5,13,20-trioxo-4,6,12,21-tetraazahexacosan-26-yl)-1<i>H</i>-1,2,3-triazole-4-carboxamido)hexan-2-yl)carbamoyl)-1<i>H</i>-1,2,3-triazol-5-yl)-5,13,20-trioxo-4,6,12,21-tetraazahexacosane-1,3,7,22-tetracarboxylic acid</a><span class="small"> [<a href="/books/n/micad/In111-3/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]3</div><div>Liang Shan.</div><div class="small">Created: October 31, 2012; Last Update: December 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-D-octreo"><a class="toc-item" href="/books/n/micad/In111-D-octreo/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated dimeric [Tyr<sup>3</sup>]octreotide</a><span class="small"> [<a href="/books/n/micad/In111-D-octreo/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-Dimeric [Tyr<sup>3</sup>]octreotide</div><div>Liang Shan.</div><div class="small">Created: November 14, 2010; Last Update: December 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-M-octreo"><a class="toc-item" href="/books/n/micad/In111-M-octreo/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-conjugated monomeric [Tyr<sup>3</sup>]octreotide</a><span class="small"> [<a href="/books/n/micad/In111-M-octreo/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-Monomeric [Tyr<sup>3</sup>]octreotide</div><div>Liang Shan.</div><div class="small">Created: November 14, 2010; Last Update: December 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-RAFT-RGD"><a class="toc-item" href="/books/n/micad/In111-RAFT-RGD/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>4</sub></a><span class="small"> [<a href="/books/n/micad/In111-RAFT-RGD/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-RAFT-RGD</div><div>Liang Shan.</div><div class="small">Created: July 17, 2012; Last Update: August 29, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-MUT-DS"><a class="toc-item" href="/books/n/micad/In111-MUT-DS/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-VENK[homoC]NKEMRNRYWEAALDPNLNNQQKRAKIRSIYDDP[homoC]-NH<sub>2</sub> with a disulfide bridge between the two homoC</a><span class="small"> [<a href="/books/n/micad/In111-MUT-DS/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-MUT-DS</div><div>Liang Shan.</div><div class="small">Created: November 15, 2011; Last Update: December 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-2P4G-RGD4"><a class="toc-item" href="/books/n/micad/In111-2P4G-RGD4/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG<sub>4</sub>-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp<span class="small-caps">-d-</span>Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp<span class="small-caps">-d-</span>Phe)}-{PEG<sub>4</sub>-Glu[cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp<span class="small-caps">-d-</span>Phe)]-cyclo(Lys(Gly-Gly-Gly)-Arg-Gly-Asp<span class="small-caps">-d-</span>Phe)} (PEG<sub>4</sub> = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)</a><span class="small"> [<a href="/books/n/micad/In111-2P4G-RGD4/pdf/">PDF Version</a>]</span><div><sup>111</sup>In(DOTA-2P4G-RGD<sub>4</sub>)</div><div>Liang Shan.</div><div class="small">Created: February 23, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-6P-RGD4"><a class="toc-item" href="/books/n/micad/In111-6P-RGD4/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG<sub>4</sub>-Glu[cyclo(Lys(PEG<sub>4</sub>)-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)]-cyclo(Lys(PEG<sub>4</sub>)-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)}-{PEG<sub>4</sub>-Glu[cyclo(Lys(PEG<sub>4</sub>)-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)]-cyclo(Lys(PEG<sub>4</sub>)-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)} (PEG<sub>4</sub> = 15 amino-4,7,10,13-tetraoxapentadecanoic acid)</a><span class="small"> [<a href="/books/n/micad/In111-6P-RGD4/pdf/">PDF Version</a>]</span><div><sup>111</sup>In(DOTA-6P-RGD<sub>4</sub>)</div><div>Liang Shan.</div><div class="small">Created: February 23, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_In111-2P-RGD4"><a class="toc-item" href="/books/n/micad/In111-2P-RGD4/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid-Glu{PEG<sub>4</sub>-Glu[cyclo(Lys-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)]-cyclo(Lys-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)}-{PEG<sub>4</sub>-Glu[cyclo(Lys-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)]-cyclo(Lys-Arg-Gly-Asp-<span class="small-caps">d</span>-Phe)} (PEG<sub>4</sub> = 15 amino-4,710,13-tetraoxapentadecanoic acid)</a><span class="small"> [<a href="/books/n/micad/In111-2P-RGD4/pdf/">PDF Version</a>]</span><div><sup>111</sup>In(DOTA-2P-RGD<sub>4</sub>)</div><div>Liang Shan.</div><div class="small">Created: February 23, 2012; Last Update: March 22, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMP288111In"><a class="toc-item" href="/books/n/micad/IMP288111In/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N</i>',<i>N</i>'',<i>N</i>'''-tetraacetic acid (DOTA)-<span class="small-caps">d</span>-Tyr-<span class="small-caps">d</span>-Lys(HSG)-<span class="small-caps">d</span>-Glu-<span class="small-caps">d</span>-Lys(HSG)-NH<sub>2</sub> (IMP-288)</a><span class="small"> [<a href="/books/n/micad/IMP288111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-IMP-288</div><div>Arvind Chopra.</div><div class="small">Created: June 29, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MGD5111In"><a class="toc-item" href="/books/n/micad/MGD5111In/"><sup>111</sup>In-Labeled 1,4,7,10-tetraazacyclododecane-<i>N,N’,N”,N’”-</i>tetraacetic acid-GSC(succinimidopropionyl-EAYGWNleDF-NH<sub>2</sub>)-EAYGWNleDF-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/MGD5111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-MGD5</div><div>Arvind Chopra.</div><div class="small">Created: January 8, 2010; Last Update: February 18, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMP156111In"><a class="toc-item" href="/books/n/micad/IMP156111In/"><sup>111</sup>In-Labeled Ac-Phe-Lys(DTPA)-Tyr-Lys(DTPA)-NH<sub>2</sub> (IMP-156)</a><span class="small"> [<a href="/books/n/micad/IMP156111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-IMP-156</div><div>Arvind Chopra.</div><div class="small">Created: June 27, 2011; Last Update: July 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABY025-111In"><a class="toc-item" href="/books/n/micad/ABY025-111In/"><sup>111</sup>In-Labeled affibody ABY-025 targeting epidermal growth factor receptor 2</a><span class="small"> [<a href="/books/n/micad/ABY025-111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-ABY-025</div><div>Arvind Chopra.</div><div class="small">Created: July 27, 2010; Last Update: August 27, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAbU36111In"><a class="toc-item" href="/books/n/micad/MAbU36111In/"><sup>111</sup>In-Labeled anti-CD44v6 chimeric monoclonal antibody U36 </a><span class="small"> [<a href="/books/n/micad/MAbU36111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-cMAb U36</div><div>Arvind Chopra.</div><div class="small">Created: July 22, 2008; Last Update: August 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEP09239-111In"><a class="toc-item" href="/books/n/micad/PEP09239-111In/"><sup>111</sup>In-Labeled anti-epidermal growth factor receptor Affibody PEP09239</a><span class="small"> [<a href="/books/n/micad/PEP09239-111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]PEP09239</div><div>Arvind Chopra.</div><div class="small">Created: March 28, 2013; Last Update: May 2, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mAb048-006111In"><a class="toc-item" href="/books/n/micad/mAb048-006111In/"><sup>111</sup>In-Labeled anti-epidermal growth factor receptor human monoclonal antibody 048-006</a><span class="small"> [<a href="/books/n/micad/mAb048-006111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-048-006</div><div>Arvind Chopra.</div><div class="small">Created: October 10, 2012; Last Update: November 8, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ch806-111In"><a class="toc-item" href="/books/n/micad/ch806-111In/"><sup>111</sup>In-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/ch806-111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-ch806</div><div>Arvind Chopra.</div><div class="small">Created: July 6, 2010; Last Update: August 26, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MORAb009111In"><a class="toc-item" href="/books/n/micad/MORAb009111In/"><sup>111</sup>In-Labeled CHX-A''-DTPA–conjugated MORAb-009, a chimeric monoclonal antibody directed against mesothelin</a><span class="small"> [<a href="/books/n/micad/MORAb009111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]MORAb-009</div><div>Arvind Chopra.</div><div class="small">Created: January 10, 2012; Last Update: February 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mAb806-111In"><a class="toc-item" href="/books/n/micad/mAb806-111In/"><sup>111</sup>In-Labeled CHX-A”-DTPA conjugated monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/mAb806-111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-mAb806</div><div>Arvind Chopra.</div><div class="small">Created: July 1, 2010; Last Update: August 5, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AcTZ14011-111In"><a class="toc-item" href="/books/n/micad/AcTZ14011-111In/"><sup>111</sup>In-Labeled diethylenetriamine-pentaacetic acid-Ac-TZ14011</a><span class="small"> [<a href="/books/n/micad/AcTZ14011-111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]Ac-TZ14011</div><div>Arvind Chopra.</div><div class="small">Created: June 10, 2009; Last Update: July 7, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABY003111In"><a class="toc-item" href="/books/n/micad/ABY003111In/"><sup>111</sup>In-Labeled DOTA-conjugated 6-aminohexanoic linker-containing variant of anti-epidermal growth factor receptor 2 Affibody Z<sub>HER2:342</sub> (ABY-003)</a><span class="small"> [<a href="/books/n/micad/ABY003111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-ABY-003</div><div>Arvind Chopra.</div><div class="small">Created: July 8, 2011; Last Update: August 23, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sCCK8Der111In"><a class="toc-item" href="/books/n/micad/sCCK8Der111In/"><sup>111</sup>In-Labeled DOTA-conjugated sCCK8[Phe<sup>2</sup>(<i>p</i>-CH<sub>2</sub>SO<sub>3</sub>H),Nle<sup>3,6</sup>], a sulfated cholecystokinin 8 (sCCK8) peptide derivative</a><span class="small"> [<a href="/books/n/micad/sCCK8Der111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]sCCK8[Phe<sup>2</sup>(<i>p</i>-CH<sub>2</sub>SO<sub>3</sub>H),Nle<sup>3,6</sup></div><div>Arvind Chopra.</div><div class="small">Created: January 7, 2013; Last Update: January 31, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fab12A8111In"><a class="toc-item" href="/books/n/micad/Fab12A8111In/"><sup>111</sup>In-Labeled DTPA conjugated anti-c-kit monoclonal antibody 12A8 Fab fragment</a><span class="small"> [<a href="/books/n/micad/Fab12A8111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]12A8 Fab</div><div>Arvind Chopra.</div><div class="small">Created: June 9, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IgG12A8111In"><a class="toc-item" href="/books/n/micad/IgG12A8111In/"><sup>111</sup>In-Labeled DTPA conjugated monoclonal antibody 12A8 that targets the c-kit receptor</a><span class="small"> [<a href="/books/n/micad/IgG12A8111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]12A8</div><div>Arvind Chopra.</div><div class="small">Created: June 9, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H2AXTat111In"><a class="toc-item" href="/books/n/micad/H2AXTat111In/"><sup>111</sup>In-Labeled DTPA-conjugated Tat-linked anti-phosphorylated histone protein H2AX antibody</a><span class="small"> [<a href="/books/n/micad/H2AXTat111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-DTPA-anti-γH2AX-Tat</div><div>Arvind Chopra.</div><div class="small">Created: July 28, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HER2342HSA111In"><a class="toc-item" href="/books/n/micad/HER2342HSA111In/"><sup>111</sup>In-Labeled human serum albumin–conjugated Affibody <i>Z</i><sub><i>HER2:342</i></sub> that targets the human epidermal growth factor receptor 2 (HER2)</a><span class="small"> [<a href="/books/n/micad/HER2342HSA111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-DOTA-HSA-<i>Z</i><sub><i>HER2:342</i></sub></div><div>Arvind Chopra.</div><div class="small">Created: May 19, 2011; Last Update: June 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECHGSETR2111In"><a class="toc-item" href="/books/n/micad/ECHGSETR2111In/"><sup>111</sup>In-Labeled lexatumumab</a><span class="small"> [<a href="/books/n/micad/ECHGSETR2111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>ln-EC-HGS-ETR2</div><div>Arvind Chopra.</div><div class="small">Created: March 19, 2009; Last Update: May 20, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECHGSETR1111In"><a class="toc-item" href="/books/n/micad/ECHGSETR1111In/"><sup>111</sup>In-Labeled mapatumumab</a><span class="small"> [<a href="/books/n/micad/ECHGSETR1111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-EC-HGS-ETR1</div><div>Arvind Chopra.</div><div class="small">Created: March 16, 2009; Last Update: May 20, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MLS128-111In"><a class="toc-item" href="/books/n/micad/MLS128-111In/"><sup>111</sup>In-Labeled MLS128 anti-Tn murine monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MLS128-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-MLS128</div><div>Liang Shan.</div><div class="small">Created: July 21, 2009; Last Update: August 25, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Panitumumab111In"><a class="toc-item" href="/books/n/micad/Panitumumab111In/"><sup>111</sup>In-Labeled panitumumab, a fully human monoclonal antibody directed against the extracellular domain III of the epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/Panitumumab111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]-Panitumumab</div><div>Arvind Chopra.</div><div class="small">Created: April 24, 2012; Last Update: June 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_rGelBLyS111In"><a class="toc-item" href="/books/n/micad/rGelBLyS111In/"><sup>111</sup>In-Labeled recombinant gelonin toxin-B lymphocyte stimulator protein fusion protein</a><span class="small"> [<a href="/books/n/micad/rGelBLyS111In/pdf/">PDF Version</a>]</span><div> [<sup>111</sup>In]-DTPA-rGel/BLyS</div><div>Arvind Chopra.</div><div class="small">Created: February 22, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAb14C5-DOTA-111In"><a class="toc-item" href="/books/n/micad/MAb14C5-DOTA-111In/"><sup>111</sup>In-<i>p</i>-Benzyl isothiocyanate-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-14C5 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MAb14C5-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-p-SCN-Bz-DOTA-14C5</div><div>Kam Leung.</div><div class="small">Created: April 20, 2013; Last Update: May 16, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSHSA111In"><a class="toc-item" href="/books/n/micad/MSHSA111In/"><sup>111</sup>In-Streptavidin-biotinylated α-melanocyte-stimulating hormone 2.0 bacteriophage</a><span class="small"> [<a href="/books/n/micad/MSHSA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-SA-α-MSH2.0 phage</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 28, 2007; Last Update: May 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TA138-111In"><a class="toc-item" href="/books/n/micad/TA138-111In/"><sup>111</sup>In-TA138</a><span class="small"> [<a href="/books/n/micad/TA138-111In/pdf/">PDF Version</a>]</span><div>RP748</div><div>Kam Leung.</div><div class="small">Created: October 17, 2005; Last Update: March 11, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SST3-ODN-8-111In"><a class="toc-item" href="/books/n/micad/SST3-ODN-8-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-c(D-Cys-Phe-Tyr-D-AgI<sup>8</sup>(Me,2-naphthoyl)-Lys-Thr-Phe-Cys)-OH</a><span class="small"> [<a href="/books/n/micad/SST3-ODN-8-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-sst<sub>3</sub>-ODN-8</div><div>Kam Leung.</div><div class="small">Created: August 5, 2009; Last Update: October 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-DOTA111In"><a class="toc-item" href="/books/n/micad/RGDfK2-DOTA111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-E-[c(RGDfK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: August 20, 2007; Last Update: September 15, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK4-DOTA111In"><a class="toc-item" href="/books/n/micad/RGDfK4-DOTA111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK4-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-E-{E-[c(RGDfK)]<sub>2</sub>}<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: August 19, 2007; Last Update: September 15, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-DOTA111In"><a class="toc-item" href="/books/n/micad/RGDfK-DOTA111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-Glu-cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys) </a><span class="small"> [<a href="/books/n/micad/RGDfK-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-E-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: August 6, 2007; Last Update: September 17, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MEDI-522-111In"><a class="toc-item" href="/books/n/micad/MEDI-522-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-MEDI-522</a><span class="small"> [<a href="/books/n/micad/MEDI-522-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-MEDI-522</div><div>Kam Leung.</div><div class="small">Created: June 6, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SST2-ANT-DOTA111In"><a class="toc-item" href="/books/n/micad/SST2-ANT-DOTA111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-Phe(4-NO<sub>2</sub>)-cyclo(<span class="small-caps">D</span>-Cys-Tyr-<span class="small-caps">D</span>-Trp-Lys-Thr-Cys)-<span class="small-caps">D</span>-Tyr-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/SST2-ANT-DOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-sst<sub>2</sub>-ANT</div><div>Kam Leung.</div><div class="small">Created: September 5, 2009; Last Update: October 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_G3-C13-DOTA-111In"><a class="toc-item" href="/books/n/micad/G3-C13-DOTA-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-(GSG)-ANTPCGPYTHDCPVKR</a><span class="small"> [<a href="/books/n/micad/G3-C13-DOTA-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA(GSG)-G3-C12</div><div>Kam Leung.</div><div class="small">Created: April 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-sCCK8-111In"><a class="toc-item" href="/books/n/micad/DOTA-sCCK8-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-Asp–Tyr(SO<sub>3</sub>H)–Met–Gly–Trp–Met–Asp–Phe–<span class="small-caps">NH</span><sub>2</sub></a><span class="small"> [<a href="/books/n/micad/DOTA-sCCK8-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-sCCK8</div><div>Kam Leung.</div><div class="small">Created: December 17, 2007; Last Update: February 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTA-MG0-111In"><a class="toc-item" href="/books/n/micad/DOTA-MG0-111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid- <span class="small-caps">d</span>-Glu-Glu-Glu-Glu-Glu-Glu-Ala-Tyr-Gly-Trp-Met-Asp-Phe-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/DOTA-MG0-111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-minigastrin</div><div>Kam Leung.</div><div class="small">Created: February 17, 2008; Last Update: May 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H2Nle111In"><a class="toc-item" href="/books/n/micad/H2Nle111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-dihistidine-norleucine peptide analog </a><span class="small"> [<a href="/books/n/micad/H2Nle111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-H2-Nle</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 8, 2007; Last Update: December 11, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H2Met111In"><a class="toc-item" href="/books/n/micad/H2Met111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-HHEAYGWMDF-NH<sub>2</sub> peptide </a><span class="small"> [<a href="/books/n/micad/H2Met111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-H2-Met</div><div>Kenneth T. Cheng.</div><div class="small">Created: April 23, 2007; Last Update: April 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H6Met111In"><a class="toc-item" href="/books/n/micad/H6Met111In/"><sup>111</sup>In-Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid-HHHHHH-EAYGWMDF-NH<sub>2</sub> peptide </a><span class="small"> [<a href="/books/n/micad/H6Met111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-H6-Met</div><div>Kenneth T. Cheng.</div><div class="small">Created: April 23, 2007; Last Update: April 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_tPTP111In"><a class="toc-item" href="/books/n/micad/tPTP111In/"><sup>111</sup>In-Tetrameric Plectin-1 targeting peptide (4(βAKTLLPTP-GGS(PEG5000))KKK-<sup>111</sup>In-DOTA-βA-NH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/tPTP111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-tPTP</div><div>Kam Leung.</div><div class="small">Created: January 28, 2011; Last Update: April 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TrastFab111In"><a class="toc-item" href="/books/n/micad/TrastFab111In/"><sup>111</sup>In-Trastuzumab Fab</a><span class="small"> [<a href="/books/n/micad/TrastFab111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-humAb4D5-8 Fab</div><div>The MICAD Research Team.</div><div class="small">Created: March 13, 2006; Last Update: April 18, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IAC111In"><a class="toc-item" href="/books/n/micad/IAC111In/">4-[2-(3,4,5,6-Tetrahydropyrimidin-2-ylamino)ethyloxy]benzoyl-2-(<i>S</i>)-[<i>N</i>-3-amino-(SCN-Bz-DOTA-<sup>111</sup>In)-neopenta-1-carbamyl)]-aminoethylsulfonylamino-β-alanine</a><span class="small"> [<a href="/books/n/micad/IAC111In/pdf/">PDF Version</a>]</span><div>IAC-SCN-Bz-DOTA-<sup>111</sup>In</div><div>Kenneth T. Cheng, Chang H. Paik, and Narasimhan Danthi.</div><div class="small">Created: July 9, 2007; Last Update: December 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mIgGtat111In"><a class="toc-item" href="/books/n/micad/mIgGtat111In/">Anti-mouse monoclonal antibody immunoglobulin G conjugated to GRKKRRQRRRPPQGYG-diethylenetriamine pentaacetic acid-[<sup>111</sup>In]</a><span class="small"> [<a href="/books/n/micad/mIgGtat111In/pdf/">PDF Version</a>]</span><div>[<sup>111</sup>In]mIgG-tat peptide</div><div>Arvind Chopra.</div><div class="small">Created: January 16, 2008; Last Update: February 20, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MLS128-SA-biotin"><a class="toc-item" href="/books/n/micad/MLS128-SA-biotin/">Biotinylated anti-Tn MLS128 monoclonal antibody-streptavidin-<sup>111</sup>In-DTPA-biotin</a><span class="small"> [<a href="/books/n/micad/MLS128-SA-biotin/pdf/">PDF Version</a>]</span><div>Bt-MLS128-SA-<sup>111</sup>In-biotin</div><div>Liang Shan.</div><div class="small">Created: July 21, 2009; Last Update: September 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_KCCYSLDOTA111In"><a class="toc-item" href="/books/n/micad/KCCYSLDOTA111In/">Lys-cys-cys-tyr-ser-leu-(gly-ser-gly)-1,4,7,10-tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-<sup>111</sup>In</a><span class="small"> [<a href="/books/n/micad/KCCYSLDOTA111In/pdf/">PDF Version</a>]</span><div><sup>111</sup>In-DOTA-(GSG)-KCCYSL</div><div>Arvind Chopra.</div><div class="small">Created: November 8, 2007; Last Update: December 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CNT-rituximab111In"><a class="toc-item" href="/books/n/micad/CNT-rituximab111In/">Single-walled carbon nanotubes-<sup>111</sup>In-1,4,7,10-tetraazacyclododecane-<i>N</i>,<i>N'</i>,<i>N''</i>,<i>N'''</i>-tetraacetic acid-rituximab </a><span class="small"> [<a href="/books/n/micad/CNT-rituximab111In/pdf/">PDF Version</a>]</span><div>CNT-([<sup>111</sup>In]DOTA)(Rituximab)</div><div>Kenneth T. Cheng, Michael R. McDevitt, and David A. Scheinberg.</div><div class="small">Created: August 21, 2007; Last Update: December 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IntegrinNP111In"><a class="toc-item" href="/books/n/micad/IntegrinNP111In/">TA138-conjugated <sup>111</sup>In nanoparticles</a><span class="small"> [<a href="/books/n/micad/IntegrinNP111In/pdf/">PDF Version</a>]</span><div>α<sub>v</sub>β<sub>3</sub>-targeted <sup>111</sup>In/NP</div><div>Arvind Chopra.</div><div class="small">Created: October 22, 2007; Last Update: November 13, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos123i"><a class="toc-item" href="/books/n/micad/sos123i/">123I</a><ul id="toc_lst_NBK5330_toc_sos123i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_SB207710-123I"><a class="toc-item" href="/books/n/micad/SB207710-123I/">(1-Butyl-4-piperidinylmethyl)-8-amino-7-[<sup>123</sup>I]iodo-1,4-benzodioxan-5-carboxylate</a><span class="small"> [<a href="/books/n/micad/SB207710-123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]SB207710</div><div>Kam Leung.</div><div class="small">Created: April 22, 2009; Last Update: June 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Phe123I"><a class="toc-item" href="/books/n/micad/Phe123I/">[<sup>123</sup>I]-2-Iodo-2-amino-3-phenylpropanoic acid</a><span class="small"> [<a href="/books/n/micad/Phe123I/pdf/">PDF Version</a>]</span><div>2-[<sup>123</sup>I]I-L-PA</div><div>Arvind Chopra.</div><div class="small">Created: June 3, 2008; Last Update: July 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Iomazenil"><a class="toc-item" href="/books/n/micad/Iomazenil/">[<sup>123</sup>I]Iomazenil</a><span class="small"> [<a href="/books/n/micad/Iomazenil/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]IMZ</div><div>The MICAD Research Team.</div><div class="small">Created: March 22, 2005; Last Update: October 5, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF"><a class="toc-item" href="/books/n/micad/VEGF/">[<sup>123</sup>I]Vascular endothelial growth factor </a><span class="small"> [<a href="/books/n/micad/VEGF/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]VEGF<sub>165</sub></div><div>Kam Leung.</div><div class="small">Created: April 18, 2005; Last Update: August 16, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BMIPP123I"><a class="toc-item" href="/books/n/micad/BMIPP123I/">[<sup>123</sup>I]-β-Methyl iodophenyl-pentadecanoic acid </a><span class="small"> [<a href="/books/n/micad/BMIPP123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]-BMIPP</div><div>Arvind Chopra.</div><div class="small">Created: February 12, 2008; Last Update: December 19, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Me2Pyr123I"><a class="toc-item" href="/books/n/micad/Me2Pyr123I/">1-(2,4-Dichlorophenyl)-5-(4-[<sup>123</sup>I]iodophenyl)-4-methyl-1<i>H</i>-pyrazole-3-carboxylic acid <i>N</i>',<i>N</i>'-dimethyl-hydrazide</a><span class="small"> [<a href="/books/n/micad/Me2Pyr123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]Me<sub>2</sub>Pyr</div><div>Kam Leung.</div><div class="small">Created: March 5, 2007; Last Update: March 13, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TPCNE123I"><a class="toc-item" href="/books/n/micad/TPCNE123I/">1(<i>trans</i>-[<sup>123</sup>I]Iodopropen-2-yl)-4-[(4-cyanophenoxy)methyl]piperidine </a><span class="small"> [<a href="/books/n/micad/TPCNE123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]TPCNE</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 5, 2007; Last Update: June 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fab14C5-123I"><a class="toc-item" href="/books/n/micad/Fab14C5-123I/"><sup>123/131</sup>I-Fab and F(ab')<sub>2</sub> fragments of anti-integrin α<sub>v</sub>β<sub>5</sub> monoclonal antibody 14C5</a><span class="small"> [<a href="/books/n/micad/Fab14C5-123I/pdf/">PDF Version</a>]</span><div><sup>123/131</sup>I-Fab/F(ab')<sub>2</sub>-14C5</div><div>Kam Leung.</div><div class="small">Created: March 20, 2013; Last Update: May 23, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anx5I123"><a class="toc-item" href="/books/n/micad/Anx5I123/"><sup>123</sup>I-Annexin V</a><span class="small"> [<a href="/books/n/micad/Anx5I123/pdf/">PDF Version</a>]</span><div><sup>123</sup>I-Anx5</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 15, 2006; Last Update: December 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAb-5F10-123I"><a class="toc-item" href="/books/n/micad/MAb-5F10-123I/"><sup>123</sup>I-Anti-vascular cell adhesion molecule monoclonal antibody 5F10</a><span class="small"> [<a href="/books/n/micad/MAb-5F10-123I/pdf/">PDF Version</a>]</span><div><sup>123</sup>I-5F10</div><div>Kam Leung.</div><div class="small">Created: September 27, 2007; Last Update: October 29, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_B2702-p123I"><a class="toc-item" href="/books/n/micad/B2702-p123I/"><sup>123</sup>I-Arg-Glu-Asn-Leu-Arg-Ile-Ala-Leu-Arg-Tyr</a><span class="small"> [<a href="/books/n/micad/B2702-p123I/pdf/">PDF Version</a>]</span><div><sup>123</sup>I-B2702-p</div><div>Kam Leung.</div><div class="small">Created: September 6, 2007; Last Update: November 15, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGD-HSA-TIMP2-123I"><a class="toc-item" href="/books/n/micad/RGD-HSA-TIMP2-123I/"><sup>123</sup>I-c(RGDfK)-human serum albumin-tissue inhibitor of matrix metalloproteinase 2 fusion protein</a><span class="small"> [<a href="/books/n/micad/RGD-HSA-TIMP2-123I/pdf/">PDF Version</a>]</span><div><sup>123</sup>I-RGD-HSA-TIMP2</div><div>Kam Leung.</div><div class="small">Created: February 10, 2012; Last Update: May 24, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-2-123I"><a class="toc-item" href="/books/n/micad/IL-2-123I/"><sup>123</sup>I-Interleukin-2 </a><span class="small"> [<a href="/books/n/micad/IL-2-123I/pdf/">PDF Version</a>]</span><div><sup>123</sup>I-IL-2</div><div>Kam Leung.</div><div class="small">Created: April 29, 2005; Last Update: August 16, 2005.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MIP1095-123I"><a class="toc-item" href="/books/n/micad/MIP1095-123I/"><sup>123</sup>I-Labeled (S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl) ureido)pentyl)ureido)pentanedoic acid</a><span class="small"> [<a href="/books/n/micad/MIP1095-123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]MIP-1095</div><div>Arvind Chopra.</div><div class="small">Created: September 29, 2009; Last Update: November 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MIP1072-123I"><a class="toc-item" href="/books/n/micad/MIP1072-123I/"><sup>123</sup>I-Labeled (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedoic acid</a><span class="small"> [<a href="/books/n/micad/MIP1072-123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]MIP-1072</div><div>Arvind Chopra.</div><div class="small">Created: September 29, 2009; Last Update: November 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MEL037I123"><a class="toc-item" href="/books/n/micad/MEL037I123/">2-(2-(4-(4-[<sup>123</sup>I]Iodobenzyl)piperazin-1-yl)-2-oxoethyl)isoindoline-1,3-dione</a><span class="small"> [<a href="/books/n/micad/MEL037I123/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]MEL037</div><div>Kenneth T. Cheng and Andrew Katsifis.</div><div class="small">Created: July 31, 2007; Last Update: January 31, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_pZIENT123I"><a class="toc-item" href="/books/n/micad/pZIENT123I/">2β-Carbomethoxy-3β-(4´-((<i>Z</i>)-2-[<sup>123</sup>I]iodoethenyl)phenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/pZIENT123I/pdf/">PDF Version</a>]</span><div> [<sup>123</sup>I]<i>p</i>ZIENT</div><div>Jeffrey Stehouwer and Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A85380-5-123I"><a class="toc-item" href="/books/n/micad/A85380-5-123I/">5-[<sup>123</sup>I]Iodo-3-[2(S)-2-azetidinylmethoxy]pyridine </a><span class="small"> [<a href="/books/n/micad/A85380-5-123I/pdf/">PDF Version</a>]</span><div>5-[<sup>123</sup>I]IA</div><div>Kam Leung.</div><div class="small">Created: July 7, 2006; Last Update: July 24, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CLINDE123I"><a class="toc-item" href="/books/n/micad/CLINDE123I/">6-Chloro-2-(4'-[<sup>123</sup>I]iodophenyl)-3-(<i>N</i>,<i>N</i>-diethyl)imidazo[1,2-<i>a</i>]pyridine-3-acetamide </a><span class="small"> [<a href="/books/n/micad/CLINDE123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]CLINDE</div><div>Kam Leung.</div><div class="small">Created: January 12, 2008; Last Update: February 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MNI-420-123I"><a class="toc-item" href="/books/n/micad/MNI-420-123I/">7-(2-(4-(2-Fluoro-4-[<sup>123</sup>I]iodophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidin-5-amine</a><span class="small"> [<a href="/books/n/micad/MNI-420-123I/pdf/">PDF Version</a>]</span><div> [<sup>123</sup>I]MNI-420</div><div>Arvind Chopra.</div><div class="small">Created: April 22, 2013; Last Update: June 27, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ITIC123I"><a class="toc-item" href="/books/n/micad/ITIC123I/">8-[<sup>123</sup>I]Iodo-<span class="small-caps">L</span>-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid</a><span class="small"> [<a href="/books/n/micad/ITIC123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]ITIC</div><div>Kam Leung.</div><div class="small">Created: February 22, 2007; Last Update: May 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MIH123I"><a class="toc-item" href="/books/n/micad/MIH123I/">Mono-[<sup>123</sup>I]Iodohypericin</a><span class="small"> [<a href="/books/n/micad/MIH123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]MIH</div><div>Arvind Chopra.</div><div class="small">Created: February 6, 2008; Last Update: March 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MIHA123I"><a class="toc-item" href="/books/n/micad/MIHA123I/">Mono-[<sup>123</sup>I]iodohypericine monocarboxylic acid </a><span class="small"> [<a href="/books/n/micad/MIHA123I/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I]MIHA</div><div>Arvind Chopra.</div><div class="small">Created: February 21, 2008; Last Update: June 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nicotinamide-123I"><a class="toc-item" href="/books/n/micad/Nicotinamide-123I/"><i>N</i>-(2-(Diethylamino)ethyl)-5-[<sup>123</sup>I]iodonicotinamide</a><span class="small"> [<a href="/books/n/micad/Nicotinamide-123I/pdf/">PDF Version</a>]</span><div> [<sup>123</sup>I]MEL008</div><div>Kam Leung.</div><div class="small">Created: October 7, 2009; Last Update: March 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_FP-CIT123I"><a class="toc-item" href="/books/n/micad/FP-CIT123I/"><i>N</i>-(3-Fluoropropyl)-2β-carbomethoxy-3β-(4-[<sup>123</sup>I]iodophenyl)nortropane</a><span class="small"> [<a href="/books/n/micad/FP-CIT123I/pdf/">PDF Version</a>]</span><div> [<sup>123</sup>I]FP-CIT</div><div>Kam Leung.</div><div class="small">Created: December 16, 2004; Last Update: February 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AM281-123I"><a class="toc-item" href="/books/n/micad/AM281-123I/"><i>N</i>-(Morpholin-4-yl)-5-(4-[<sup>123</sup>I]iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1<i>H</i>-pyrazole-3-carboxamide</a><span class="small"> [<a href="/books/n/micad/AM281-123I/pdf/">PDF Version</a>]</span><div> [<sup>123</sup>I]AM281</div><div>Kam Leung.</div><div class="small">Created: December 5, 2006; Last Update: January 31, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos123i125i"><a class="toc-item" href="/books/n/micad/sos123i125i/">123I,125I</a><ul id="toc_lst_NBK5330_toc_sos123i125i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMPY"><a class="toc-item" href="/books/n/micad/IMPY/">[<sup>123</sup>I/<sup>125</sup>I]6-Iodo-2-(4´-dimethylamino)-phenyl-imidazo[1,2-<i>a</i>]pyridine</a><span class="small"> [<a href="/books/n/micad/IMPY/pdf/">PDF Version</a>]</span><div>[<sup>123,125</sup>I]IMPY</div><div>The MICAD Research Team.</div><div class="small">Created: April 18, 2005; Last Update: May 12, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ch806-125I"><a class="toc-item" href="/books/n/micad/ch806-125I/"><sup>125</sup>I-Labeled chimeric monoclonal antibody, ch806, targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/ch806-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-ch806</div><div>Arvind Chopra.</div><div class="small">Created: July 6, 2010; Last Update: August 26, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_mAb806-125I"><a class="toc-item" href="/books/n/micad/mAb806-125I/"><sup>125</sup>I-Labeled monoclonal antibody (mAb) 806 targeting the epidermal growth factor receptor deletion variant de2-7 (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/mAb806-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-mAb806</div><div>Arvind Chopra.</div><div class="small">Created: July 1, 2010; Last Update: August 5, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ADAM123I"><a class="toc-item" href="/books/n/micad/ADAM123I/">2-((2-((Dimethylamino)methyl)phenyl)thio)-5-[<sup>123</sup>I]iodophenylamine </a><span class="small"> [<a href="/books/n/micad/ADAM123I/pdf/">PDF Version</a>]</span><div>Radioiodinated ADAM</div><div>The MICAD Research Team.</div><div class="small">Created: August 6, 2007; Last Update: September 6, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ICF01012"><a class="toc-item" href="/books/n/micad/ICF01012/">Radioiodinated <i>N</i>-(2-diethylaminoethyl)-6-iodoquinoxaline-2-carboxamide dihydrochloride salt</a><span class="small"> [<a href="/books/n/micad/ICF01012/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]ICF01012</div><div>Liang Shan.</div><div class="small">Created: August 5, 2011; Last Update: September 28, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos123i131i"><a class="toc-item" href="/books/n/micad/sos123i131i/">123I, 131I</a><ul id="toc_lst_NBK5330_toc_sos123i131i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAb14C5-123I"><a class="toc-item" href="/books/n/micad/MAb14C5-123I/"><sup>123/131</sup>I-Anti-cellular adhesion molecule monoclonal antibody 14C5</a><span class="small"> [<a href="/books/n/micad/MAb14C5-123I/pdf/">PDF Version</a>]</span><div><sup>123/131</sup>I-mAb 14C5</div><div>Kam Leung.</div><div class="small">Created: June 11, 2007; Last Update: February 20, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RRL-131I"><a class="toc-item" href="/books/n/micad/RRL-131I/"><sup>131</sup>I-Labeled arginine-arginine-leucine (RRL)-containing cyclic peptide (YCGGRRLGGC) for imaging prostate carcinoma</a><span class="small"> [<a href="/books/n/micad/RRL-131I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-Labeled RRL peptide</div><div>Liang Shan.</div><div class="small">Created: January 6, 2010; Last Update: February 16, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos123i125i131i"><a class="toc-item" href="/books/n/micad/sos123i125i131i/">123I/125I/131I</a><ul id="toc_lst_NBK5330_toc_sos123i125i131i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Iodinated-MIBG"><a class="toc-item" href="/books/n/micad/Iodinated-MIBG/">Meta-[radioiodinated]iodobenzylguanidine</a><span class="small"> [<a href="/books/n/micad/Iodinated-MIBG/pdf/">PDF Version</a>]</span><div>[<sup>123</sup>I/<sup>125</sup>I/<sup>131</sup>I]MIBG</div><div>The MICAD Research Team.</div><div class="small">Created: May 3, 2007; Last Update: July 3, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos125i"><a class="toc-item" href="/books/n/micad/sos125i/">125I</a><ul id="toc_lst_NBK5330_toc_sos125i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IPBM-125I"><a class="toc-item" href="/books/n/micad/IPBM-125I/">(2S,αS)-2-(α-(2-[<sup>125</sup>I]Iodophenoxy)benzyl)morpholine</a><span class="small"> [<a href="/books/n/micad/IPBM-125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]IPBM</div><div>Kam Leung.</div><div class="small">Created: February 19, 2009; Last Update: May 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-E1"><a class="toc-item" href="/books/n/micad/I125-E1/">[<sup>125</sup>I](<i>E</i>)-<i>N</i>-1-(3'-iodoallyl)-<i>N</i>'-4-(3'',4''-dimethoxyphenethyl)-piperazine</a><span class="small"> [<a href="/books/n/micad/I125-E1/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]<i>E</i>-1</div><div>Liang Shan.</div><div class="small">Created: August 16, 2012; Last Update: September 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-5"><a class="toc-item" href="/books/n/micad/I125-5/">[<sup>125</sup>I]2-Iodo-<i>N</i>-[(<i>S</i>)-{(<i>S</i>)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide</a><span class="small"> [<a href="/books/n/micad/I125-5/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]5</div><div>Liang Shan.</div><div class="small">Created: April 10, 2012; Last Update: May 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Claudin125I"><a class="toc-item" href="/books/n/micad/Claudin125I/">[<sup>125</sup>I]Anti-claudin 4 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Claudin125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]Anti-claudin 4</div><div>The MICAD Research Team.</div><div class="small">Created: June 28, 2007; Last Update: August 2, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiPSCA125I"><a class="toc-item" href="/books/n/micad/AntiPSCA125I/">[<sup>125</sup>I]Anti-prostate stem cell antigen antibody</a><span class="small"> [<a href="/books/n/micad/AntiPSCA125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]Anti-PSCA antibody</div><div>The MICAD Research Team.</div><div class="small">Created: June 29, 2007; Last Update: August 2, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SGMIBL8A4125I"><a class="toc-item" href="/books/n/micad/SGMIBL8A4125I/">[<sup>125</sup>I]-Labeled monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/SGMIBL8A4125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]SGMIB-L8A4</div><div>Arvind Chopra.</div><div class="small">Created: December 24, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-BZ18"><a class="toc-item" href="/books/n/micad/I125-BZ18/">[<sup>125</sup>I]<i>N</i>-(4-Dipropylaminobutyl)-4-iodobenzamide</a><span class="small"> [<a href="/books/n/micad/I125-BZ18/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]BZ18</div><div>Liang Shan.</div><div class="small">Created: August 5, 2011; Last Update: August 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-56"><a class="toc-item" href="/books/n/micad/I125-56/">[<sup>125</sup>I]<i>N</i>-[2-[<i>N</i>-Ethyl-<i>N</i>-[2-(2-fluoropyridin-3-yloxy)ethyl]amino]ethyl]-6-iodoquinoxaline-2-carboxamide dihydrochloride salt</a><span class="small"> [<a href="/books/n/micad/I125-56/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]56</div><div>Liang Shan.</div><div class="small">Created: August 5, 2011; Last Update: August 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDA2-125I"><a class="toc-item" href="/books/n/micad/MDA2-125I/"><sup>125</sup>I-Anti-malondialdehyde-modified low-density lipoprotein monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MDA2-125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-MDA2</div><div>Kam Leung.</div><div class="small">Created: August 15, 2009; Last Update: October 22, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SWNTols-125I"><a class="toc-item" href="/books/n/micad/SWNTols-125I/"><sup>125</sup>I-Hydroxylated-single-walled nanotubes</a><span class="small"> [<a href="/books/n/micad/SWNTols-125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-SWNTols</div><div>Kam Leung.</div><div class="small">Created: September 26, 2008; Last Update: November 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGFR-Fab125I"><a class="toc-item" href="/books/n/micad/EGFR-Fab125I/"><sup>125</sup>I-Labeled anti-epidermal growth factor receptor human Fab antibody fragment</a><span class="small"> [<a href="/books/n/micad/EGFR-Fab125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-Fab</div><div>Kam Leung.</div><div class="small">Created: April 6, 2010; Last Update: June 18, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_bsPAM4125I"><a class="toc-item" href="/books/n/micad/bsPAM4125I/"><sup>125</sup>I-Labeled anti-mucin 1 bispecific antibody bsPAM4</a><span class="small"> [<a href="/books/n/micad/bsPAM4125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-bsPAM4</div><div>Arvind Chopra.</div><div class="small">Created: June 22, 2011; Last Update: July 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Peptides125I"><a class="toc-item" href="/books/n/micad/Peptides125I/"><sup>125</sup>I-Labeled heparin-binding peptides that target heparan sulfate proteoglycans for the <i>in vivo</i> imaging of peripheral amyloidosis</a><span class="small"> [<a href="/books/n/micad/Peptides125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-Peptides</div><div>Arvind Chopra.</div><div class="small">Created: November 2, 2011; Last Update: December 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMBP125I"><a class="toc-item" href="/books/n/micad/cMBP125I/"><sup>125</sup>I Labeled-mesenchymal-epithelial transition factor binding peptide</a><span class="small"> [<a href="/books/n/micad/cMBP125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]-cMBP</div><div>Arvind Chopra.</div><div class="small">Created: July 28, 2009; Last Update: September 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMBPAOC125I"><a class="toc-item" href="/books/n/micad/cMBPAOC125I/"><sup>125</sup>I-Labeled mesenchymal-epithelial transition factor binding peptide-8-aminooctanoic acid</a><span class="small"> [<a href="/books/n/micad/cMBPAOC125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]-cMBP-AOC</div><div>Arvind Chopra.</div><div class="small">Created: July 30, 2009; Last Update: September 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cMBPGGG125I"><a class="toc-item" href="/books/n/micad/cMBPGGG125I/"><sup>125</sup>I-Labeled mesenchymal-epithelial transition factor binding peptide-Gly-Gly-Gly</a><span class="small"> [<a href="/books/n/micad/cMBPGGG125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]cMBP-GGG</div><div>Arvind Chopra.</div><div class="small">Created: July 30, 2009; Last Update: September 10, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RM2-125I"><a class="toc-item" href="/books/n/micad/RM2-125I/"><sup>125</sup>I-Labeled monoclonal antibody, mAb RM2, targeting the RM2 antigen</a><span class="small"> [<a href="/books/n/micad/RM2-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-mAb RM2</div><div>Arvind Chopra.</div><div class="small">Created: September 12, 2012; Last Update: October 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-PSA30"><a class="toc-item" href="/books/n/micad/I125-PSA30/"><sup>125</sup>I-Labeled monoclonal antibody PSA30</a><span class="small"> [<a href="/books/n/micad/I125-PSA30/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-PSA30</div><div>Liang Shan.</div><div class="small">Created: November 9, 2012; Last Update: December 5, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125MAb"><a class="toc-item" href="/books/n/micad/I125MAb/"><sup>125</sup>I-Labeled mouse anti-human carbonic anhydrase IX monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/I125MAb/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-MAb</div><div>Liang Shan.</div><div class="small">Created: May 3, 2012; Last Update: May 30, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SIBNuB2-125I"><a class="toc-item" href="/books/n/micad/SIBNuB2-125I/"><sup>125</sup>I-Labeled murine anti-CD20 antigen monoclonal antibody NuB2 conjugated to one or three octaarginine (maleimide-(6-aminocaproic acid)<sub>2</sub>-(D-Arg)<sub>8</sub>-(D-Tyr)) peptide chains</a><span class="small"> [<a href="/books/n/micad/SIBNuB2-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]SIB-NuB2<span class="small-caps">i</span> and [<sup>125</sup>I]SIB-NuB2<span class="small-caps">iii</span></div><div>Arvind Chopra.</div><div class="small">Created: December 8, 2010; Last Update: December 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NS4F5125I"><a class="toc-item" href="/books/n/micad/NS4F5125I/"><sup>125</sup>I-Labeled single-chain monoclonal antibody, NS4F5, that targets the GlcNS6S-IdoA2S motif of heparan sulfate proteoglycans for the <i>in vivo</i> imaging of peripheral amyloidosis</a><span class="small"> [<a href="/books/n/micad/NS4F5125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-NS4F5</div><div>Arvind Chopra.</div><div class="small">Created: November 4, 2011; Last Update: December 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TF10125I"><a class="toc-item" href="/books/n/micad/TF10125I/">125I-Labeled trivalent, bispecific monoclonal antibody construct TF10 that targets mucin-1 and is reactive against a histamine-succinyl-glycine hapten IMP-288</a><span class="small"> [<a href="/books/n/micad/TF10125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-TP10</div><div>Arvind Chopra.</div><div class="small">Created: June 29, 2011; Last Update: August 25, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-4"><a class="toc-item" href="/books/n/micad/I125-4/"><sup>125</sup>I-Radioiodinated tyrosine-folate and tyrosine-click-folate</a><span class="small"> [<a href="/books/n/micad/I125-4/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]-2 and [<sup>125</sup>I]-4</div><div>Liang Shan.</div><div class="small">Created: May 20, 2012; Last Update: June 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SCA-B1-125I"><a class="toc-item" href="/books/n/micad/SCA-B1-125I/"><sup>125</sup>I-Single-chain antibody B1 targeting a pancreatic β-cell surface antigen</a><span class="small"> [<a href="/books/n/micad/SCA-B1-125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-SCA B1</div><div>Kam Leung.</div><div class="small">Created: February 2, 2012; Last Update: May 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SCA-B5-125I"><a class="toc-item" href="/books/n/micad/SCA-B5-125I/"><sup>125</sup>I-Single-chain antibody B5 targeting a pancreatic β-cell surface antigen</a><span class="small"> [<a href="/books/n/micad/SCA-B5-125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-SCA B5</div><div>Kam Leung.</div><div class="small">Created: February 2, 2012; Last Update: May 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_T84scFvHSA125I"><a class="toc-item" href="/books/n/micad/T84scFvHSA125I/"><sup>125</sup>I-T84.66 scFv-human serum albumin</a><span class="small"> [<a href="/books/n/micad/T84scFvHSA125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-T84.66 scFv-HSA</div><div>Kam Leung.</div><div class="small">Created: July 2, 2008; Last Update: September 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGF121-125I"><a class="toc-item" href="/books/n/micad/VEGF121-125I/"><sup>125</sup>I-Vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/VEGF121-125I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-VEGF<sub>121</sub></div><div>Kam Leung.</div><div class="small">Created: June 6, 2007; Last Update: July 6, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TZDM125I"><a class="toc-item" href="/books/n/micad/TZDM125I/">2-(4'-Dimethylaminophenyl)-6-[<sup>125</sup>I]iodobenzothiazole </a><span class="small"> [<a href="/books/n/micad/TZDM125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]TZDM</div><div>The MICAD Research Team.</div><div class="small">Created: January 8, 2007; Last Update: January 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-8"><a class="toc-item" href="/books/n/micad/I125-8/">2-{[4-(4-[<sup>125</sup>I]Iodobenzyl)piperidin-1-yl]methyl}benzimidazol-5-ol</a><span class="small"> [<a href="/books/n/micad/I125-8/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]8</div><div>Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin-BH-125I"><a class="toc-item" href="/books/n/micad/Exendin-BH-125I/">3-(4-Hydroxy-3-[<sup>125</sup>I]iodophenyl)propionate-exendin(9-39)</a><span class="small"> [<a href="/books/n/micad/Exendin-BH-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-BH-Exendin(9-39)</div><div>Kam Leung.</div><div class="small">Created: April 6, 2010; Last Update: June 18, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MLS128-125I-SA"><a class="toc-item" href="/books/n/micad/MLS128-125I-SA/">Biotinylated anti-Tn MLS128 monoclonal antibody-<sup>125</sup>I-streptavidin</a><span class="small"> [<a href="/books/n/micad/MLS128-125I-SA/pdf/">PDF Version</a>]</span><div>Bt-MLS128-<sup>125</sup>I-SA</div><div>Liang Shan.</div><div class="small">Created: July 21, 2009; Last Update: September 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125F183"><a class="toc-item" href="/books/n/micad/I125F183/">Fluorinated and iodinated (<i>Z</i>)-2-(4-(2-fluoroethoxy)benzylidene)-5-iodobenzofuran-3(2<i>H</i>)-one</a><span class="small"> [<a href="/books/n/micad/I125F183/pdf/">PDF Version</a>]</span><div>[<sup>18</sup>F/<sup>125</sup>I]3</div><div>Liang Shan.</div><div class="small">Created: November 30, 2011; Last Update: December 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IodoDPA-713-125I"><a class="toc-item" href="/books/n/micad/IodoDPA-713-125I/"><i>N</i>,<i>N</i>-Diethyl-2-(2-(3-[<sup>125</sup>I]iodo-4-methyoxyphenyl)-5,7-dimethyl-pyrazolo(1,5-<i>a</i>)pyrimidin-3-yl)-acetamide</a><span class="small"> [<a href="/books/n/micad/IodoDPA-713-125I/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]-IodoDPA-713</div><div>Kam Leung.</div><div class="small">Created: April 16, 2010; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-9"><a class="toc-item" href="/books/n/micad/I125-9/"><i>N</i>-{2-[4-(4-[<sup>125</sup>I]Iodobenzyl)-piperidin-1-ylmethyl]benzoimidazol-5-yl}-methanesulfonamide</a><span class="small"> [<a href="/books/n/micad/I125-9/pdf/">PDF Version</a>]</span><div> [<sup>125</sup>I]9</div><div>Arvind Chopra.</div><div class="small">Created: January 31, 2011; Last Update: March 31, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125IQ"><a class="toc-item" href="/books/n/micad/I125IQ/">N<sup>1</sup>,N<sup>1</sup>-diethyl-N<sup>4</sup>-(7-[<sup>125</sup>I]iodoquinolin-4-yl)pentane-1,4-diamine</a><span class="small"> [<a href="/books/n/micad/I125IQ/pdf/">PDF Version</a>]</span><div><sup>125</sup>I IQ</div><div>Liang Shan.</div><div class="small">Created: March 19, 2012; Last Update: May 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-70-71"><a class="toc-item" href="/books/n/micad/I125-70-71/">Radioiodinated (1<i>E</i>,4<i>E</i>)-1-(4-aminophenyl)-5-(4-iodophenyl)penta-1,4-dien-3-one and (1<i>E</i>,4<i>E</i>)-1-(4-iodophenyl)-5-(4-(methylamino)phenyl)penta-1,4-dien-3-one</a><span class="small"> [<a href="/books/n/micad/I125-70-71/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]70, [<sup>125</sup>I]71</div><div>Liang Shan.</div><div class="small">Created: December 12, 2011; Last Update: February 7, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_I125-15"><a class="toc-item" href="/books/n/micad/I125-15/">Radioiodinated (<i>Z</i>)-2-(4-(2-hydroxyethoxy)benzylidene)-5-iodobenzofuran-3(2<i>H</i>)-one</a><span class="small"> [<a href="/books/n/micad/I125-15/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]15</div><div>Liang Shan.</div><div class="small">Created: November 30, 2011; Last Update: December 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Anti-CD105I125"><a class="toc-item" href="/books/n/micad/Anti-CD105I125/">Radioiodinated anti-CD105 MAEND3 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Anti-CD105I125/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-MAEND3 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: April 5, 2006; Last Update: January 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49FabI"><a class="toc-item" href="/books/n/micad/CC49FabI/">Radioiodinated anti–TAG-72 CC49 Fab’ antibody fragment</a><span class="small"> [<a href="/books/n/micad/CC49FabI/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-CC49 Fab’</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 10, 2008; Last Update: April 9, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49scFv2I"><a class="toc-item" href="/books/n/micad/CC49scFv2I/">Radioiodinated-anti–TAG-72 covalently linked CC49 divalent single-chain Fv antibody</a><span class="small"> [<a href="/books/n/micad/CC49scFv2I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I-CC49 sc(Fv)<sub>2</sub> Ab</div><div>Kenneth T. Cheng.</div><div class="small">Created: September 25, 2007; Last Update: October 30, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BZA5analog125I"><a class="toc-item" href="/books/n/micad/BZA5analog125I/">Radiolabeled (hetero)aromatic analogs of <i>N</i>-(2-diethylaminoethyl)-4-iodobenzamide for imaging and therapy of melanoma</a><span class="small"> [<a href="/books/n/micad/BZA5analog125I/pdf/">PDF Version</a>]</span><div>[<sup>125</sup>I]5a-I</div><div>Liang Shan.</div><div class="small">Created: November 19, 2009; Last Update: December 30, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos125i131i"><a class="toc-item" href="/books/n/micad/sos125i131i/">125I/131I</a><ul id="toc_lst_NBK5330_toc_sos125i131i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49scFv4I"><a class="toc-item" href="/books/n/micad/CC49scFv4I/">Radioiodinated anti-TAG-72 CC49 tetravalent single-chain Fv antibody</a><span class="small"> [<a href="/books/n/micad/CC49scFv4I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I/<sup>131</sup>I-CC49 [sc(Fv)<sub>2</sub>]<sub>2</sub> Ab</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 23, 2007; Last Update: January 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HuCC49CH2I"><a class="toc-item" href="/books/n/micad/HuCC49CH2I/">Radioiodinated anti-TAG-72 humanized C<sub>H</sub>2 domain-deleted antibody </a><span class="small"> [<a href="/books/n/micad/HuCC49CH2I/pdf/">PDF Version</a>]</span><div>Radioiodinated HuCC49ΔC<sub>H</sub>2 Ab</div><div>Kenneth T. Cheng.</div><div class="small">Created: August 30, 2007; Last Update: November 14, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49ncscFv2I"><a class="toc-item" href="/books/n/micad/CC49ncscFv2I/">Radioiodinated anti–TAG-72 non-covalently linked CC49 divalent single-chain Fv antibody</a><span class="small"> [<a href="/books/n/micad/CC49ncscFv2I/pdf/">PDF Version</a>]</span><div><sup>125</sup>I/<sup>131</sup>I-CC49 (scFv)<sub>2</sub> Ab</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 5, 2007; Last Update: January 7, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IodinatedhuA33"><a class="toc-item" href="/books/n/micad/IodinatedhuA33/">Radioiodinated humanized monoclonal antibody A33</a><span class="small"> [<a href="/books/n/micad/IodinatedhuA33/pdf/">PDF Version</a>]</span><div>Radioiodinated-huA33 mAb</div><div>Arvind Chopra.</div><div class="small">Created: September 16, 2007; Last Update: October 22, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MLS128-125I-131I"><a class="toc-item" href="/books/n/micad/MLS128-125I-131I/">Radioiodinated MLS128 anti-Tn murine monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MLS128-125I-131I/pdf/">PDF Version</a>]</span><div>Radioiodinated-MLS128</div><div>Liang Shan.</div><div class="small">Created: July 21, 2009; Last Update: August 25, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos125mTe"><a class="toc-item" href="/books/n/micad/sos125mTe/">125mTe</a><ul id="toc_lst_NBK5330_toc_sos125mTe" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Cd-125mTe-Zn-201B"><a class="toc-item" href="/books/n/micad/Cd-125mTe-Zn-201B/">Cd<sup>125m</sup>Te/ZnS Nanoparticles coupled with anti-thrombomodulin monoclonal antibody 201B</a><span class="small"> [<a href="/books/n/micad/Cd-125mTe-Zn-201B/pdf/">PDF Version</a>]</span><div>Cd<sup>125m</sup>Te/ZnS-201B</div><div>Kam Leung.</div><div class="small">Created: September 26, 2009; Last Update: December 24, 2009.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos131i"><a class="toc-item" href="/books/n/micad/sos131i/">131I</a><ul id="toc_lst_NBK5330_toc_sos131i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_IPCbetaAL3131I"><a class="toc-item" href="/books/n/micad/IPCbetaAL3131I/">[<sup>131</sup>I]<i>N</i>-(6-amino-2,2,4-trimethylhexyl)-2-[(5-iodo(3-pyridyl))carbonylamino]-3-(2-napthyl)propanamide</a><span class="small"> [<a href="/books/n/micad/IPCbetaAL3131I/pdf/">PDF Version</a>]</span><div>[<sup>131</sup>I]IPC-β-AL3</div><div>Arvind Chopra.</div><div class="small">Created: June 22, 2009; Last Update: August 4, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Chlorotoxin131I"><a class="toc-item" href="/books/n/micad/Chlorotoxin131I/"><sup>131</sup>I-Chlorotoxin</a><span class="small"> [<a href="/books/n/micad/Chlorotoxin131I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-TM-601</div><div>The MICAD Research Team.</div><div class="small">Created: July 17, 2007; Last Update: August 8, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L19-SIP131I"><a class="toc-item" href="/books/n/micad/L19-SIP131I/"><sup>131</sup>I-Human recombinant anti-ED-B fibronectin antibody small immunoprotein</a><span class="small"> [<a href="/books/n/micad/L19-SIP131I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-L19-SIP</div><div>Kam Leung.</div><div class="small">Created: April 17, 2007; Last Update: July 6, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TAM131I"><a class="toc-item" href="/books/n/micad/TAM131I/"><sup>131</sup>I-Labeled [<i>Z</i>]-2-[4-(1,2-diphenyl-1-di-butenyl)-phenoxy]-<i>N</i>,<i>N</i>-dimethylethanamine</a><span class="small"> [<a href="/books/n/micad/TAM131I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-TAM</div><div>Liang Shan.</div><div class="small">Created: July 6, 2009; Last Update: August 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AFRADFM53131I"><a class="toc-item" href="/books/n/micad/AFRADFM53131I/"><sup>131</sup>I-Labeled anti-α folate receptor human antibody fragment AFRA-DMF5.3 dimer</a><span class="small"> [<a href="/books/n/micad/AFRADFM53131I/pdf/">PDF Version</a>]</span><div> [<sup>131</sup>I]-AFRA-DFM5.3</div><div>Arvind Chopra.</div><div class="small">Created: December 9, 2011; Last Update: December 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_A33scFvCDy131I"><a class="toc-item" href="/books/n/micad/A33scFvCDy131I/"><sup>131</sup>I-Labeled recombinant anti-glycoprotein A33 antibody single chain variable fragment fused to cytosine deaminase</a><span class="small"> [<a href="/books/n/micad/A33scFvCDy131I/pdf/">PDF Version</a>]</span><div>[<sup>131</sup>I]A33scFv::CDy</div><div>Arvind Chopra.</div><div class="small">Created: July 8, 2009; Last Update: August 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NP4MAB131I"><a class="toc-item" href="/books/n/micad/NP4MAB131I/"><sup>131</sup>I-NP-4 anti-CEA monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/NP4MAB131I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-NP-4 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 27, 2005; Last Update: March 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tositumomab"><a class="toc-item" href="/books/n/micad/Tositumomab/"><sup>131</sup>I-Tositumomab</a><span class="small"> [<a href="/books/n/micad/Tositumomab/pdf/">PDF Version</a>]</span><div><sup>131</sup>I-B1 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 19, 2005; Last Update: June 2, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IV-14-131I"><a class="toc-item" href="/books/n/micad/IV-14-131I/">3'-(<i>E</i>)-(2-[<sup>123/131</sup>I]Iodovinyl)uridine</a><span class="small"> [<a href="/books/n/micad/IV-14-131I/pdf/">PDF Version</a>]</span><div>[<sup>123/131</sup>I]IV-14</div><div>Kam Leung.</div><div class="small">Created: March 17, 2010; Last Update: April 22, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PBR3a-131I"><a class="toc-item" href="/books/n/micad/PBR3a-131I/"><i>N</i>-(5-Fluoro-2-phenoxyphenyl)-<i>N</i>-(2-[<sup>131</sup>I]iodo-5-methoxybenzyl)acetamide </a><span class="small"> [<a href="/books/n/micad/PBR3a-131I/pdf/">PDF Version</a>]</span><div>[<sup>131</sup>I]PBR3a</div><div>Kam Leung.</div><div class="small">Created: August 6, 2007; Last Update: September 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nb5F7GGC-IB-131I"><a class="toc-item" href="/books/n/micad/Nb5F7GGC-IB-131I/">N(ε)-(3-[<sup>131</sup>I]Iodobenzoyl)-Lys<sup>5</sup>-N(α)-maleimido-Gly<sup>1</sup>-GEEEK-anti-HER2 nanobody 5F7GGC</a><span class="small"> [<a href="/books/n/micad/Nb5F7GGC-IB-131I/pdf/">PDF Version</a>]</span><div>[<sup>131</sup>I]IB-Mal-<span class="small-caps">D</span>-GEEEK-Nb</div><div>Kam Leung.</div><div class="small">Created: January 15, 2013; Last Update: March 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AM2233-131I"><a class="toc-item" href="/books/n/micad/AM2233-131I/"><i>R</i>-2-[<sup>131</sup>I]Iodophenyl-(1-(1-methylpiperidin-2-ylmethyl)-1<i>H</i>-indol-3-yl)methanone</a><span class="small"> [<a href="/books/n/micad/AM2233-131I/pdf/">PDF Version</a>]</span><div><i>R</i>-[<sup>131</sup>I]AM2233</div><div>Kam Leung.</div><div class="small">Created: December 12, 2006; Last Update: February 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_chTNT-1B"><a class="toc-item" href="/books/n/micad/chTNT-1B/">Radioiodinated anti-DNA-histone 1 complex chimeric tumor necrosis therapy (TNT) monoclonal antibody 1</a><span class="small"> [<a href="/books/n/micad/chTNT-1B/pdf/">PDF Version</a>]</span><div> [<sup>125/131</sup>I]-chTNT-1/B</div><div>Arvind Chopra.</div><div class="small">Created: September 17, 2011; Last Update: December 1, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos131i123i125i"><a class="toc-item" href="/books/n/micad/sos131i123i125i/">131I, 123I, 125I</a><ul id="toc_lst_NBK5330_toc_sos131i123i125i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_INP4MAbF"><a class="toc-item" href="/books/n/micad/INP4MAbF/">Radioiodinated anti-CEA monoclonal antibody NP-4 F(ab´)<sub>2</sub> fragment</a><span class="small"> [<a href="/books/n/micad/INP4MAbF/pdf/">PDF Version</a>]</span><div><sup>123</sup>I/<sup>131</sup>I/<sup>125</sup>I-NP-4 F(ab´)<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: March 23, 2006; Last Update: April 10, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos131i125i"><a class="toc-item" href="/books/n/micad/sos131i125i/">131I, 125I</a><ul id="toc_lst_NBK5330_toc_sos131i125i" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49Fab2I"><a class="toc-item" href="/books/n/micad/CC49Fab2I/">Radioiodinated anti–TAG-72 CC49 (Fab’)<sub>2</sub> antibody fragment</a><span class="small"> [<a href="/books/n/micad/CC49Fab2I/pdf/">PDF Version</a>]</span><div><sup>131</sup>I/<sup>125</sup>I-CC49 (Fab’)<sub>2</sub></div><div>Kenneth T. Cheng.</div><div class="small">Created: November 5, 2007; Last Update: January 9, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos170tm"><a class="toc-item" href="/books/n/micad/sos170tm/">170Tm</a><ul id="toc_lst_NBK5330_toc_sos170tm" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_EDTMP170Tm"><a class="toc-item" href="/books/n/micad/EDTMP170Tm/">[<sup>170</sup>Tm]-Labeled ethylenediamine tetramethylene phosphonic acid</a><span class="small"> [<a href="/books/n/micad/EDTMP170Tm/pdf/">PDF Version</a>]</span><div>[<sup>170</sup>Tm]-EDTMP</div><div>Arvind Chopra.</div><div class="small">Created: April 27, 2011; Last Update: May 26, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos177lu"><a class="toc-item" href="/books/n/micad/sos177lu/">177Lu</a><ul id="toc_lst_NBK5330_toc_sos177lu" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CDOTAL8A4177Lu"><a class="toc-item" href="/books/n/micad/CDOTAL8A4177Lu/">[<sup>177</sup>Lu]-Labeled (S-2-(4-isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane-tetraacetic acid (C-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/CDOTAL8A4177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]C-DOTA-L8A4</div><div>Arvind Chopra.</div><div class="small">Created: December 24, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CDTPAL8A4177Lu"><a class="toc-item" href="/books/n/micad/CDTPAL8A4177Lu/">[<sup>177</sup>Lu]-Labeled [(<i>R</i>)-2-amino-3-(4-isothiocyanatophenyl)propyl]-trans-(<i>S,S</i>)-cyclohexane-1,2-diamine-pentaacetic acid (CHX-A″-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/CDTPAL8A4177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]CHX-A''-DTPA-L8A4</div><div>Arvind Chopra.</div><div class="small">Created: December 24, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BMDTPAL8A4177Lu"><a class="toc-item" href="/books/n/micad/BMDTPAL8A4177Lu/">[<sup>177</sup>Lu]-Labeled 2-(4-isothiocyanatobenzyl)-6-methyldiethylene-triaminepentaacetic acid (1B4M-DTPA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/BMDTPAL8A4177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]1B4M-DTPA-L8A4</div><div>Arvind Chopra.</div><div class="small">Created: December 24, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MeDOTAL8A4177Lu"><a class="toc-item" href="/books/n/micad/MeDOTAL8A4177Lu/">[<sup>177</sup>Lu]-Labeled α-(5-isothiocyanato-2-methoxyphenyl)-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (MeO-DOTA) conjugated monoclonal antibody L8A4 against epidermal growth factor receptor variant III (EGFRvIII)</a><span class="small"> [<a href="/books/n/micad/MeDOTAL8A4177Lu/pdf/">PDF Version</a>]</span><div>[<sup>177</sup>Lu]MeO-DOTA-L8A4</div><div>Arvind Chopra.</div><div class="small">Created: December 24, 2010; Last Update: February 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z1907-HSA-DO3A177Lu"><a class="toc-item" href="/books/n/micad/Z1907-HSA-DO3A177Lu/"><sup>177</sup>Lu-1,4,7,10-Tetraazacyclododecane-1,4,7-triacetic acid-human serum albumin-Ac-Cys-Z<sub>EGFR:1907</sub></a><span class="small"> [<a href="/books/n/micad/Z1907-HSA-DO3A177Lu/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-DO3A-HSA-Z<sub>EGFR:1907</sub></div><div>Kam Leung.</div><div class="small">Created: June 25, 2012; Last Update: November 15, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SIP_A3_177Lu"><a class="toc-item" href="/books/n/micad/SIP_A3_177Lu/"><sup>177</sup>Lu-Benzyl-diethylenetriamine pentaacetic acid-anti-carbonic anhydrase IX small immunoprotein A3</a><span class="small"> [<a href="/books/n/micad/SIP_A3_177Lu/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-Bn-DTPA-SIP-A3</div><div>Kam Leung.</div><div class="small">Created: December 2, 2009; Last Update: January 12, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LuABDZ"><a class="toc-item" href="/books/n/micad/LuABDZ/"><sup>177</sup>Lu-CHX-A''-DTPA-ABD-Affibody (Z<sub>HER2:342</sub>)<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LuABDZ/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-ABD-(Z<sub>HER2:342</sub>)<sub>2</sub></div><div>Huiming Zhang.</div><div class="small">Created: July 25, 2008; Last Update: August 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LuAMBA"><a class="toc-item" href="/books/n/micad/LuAMBA/"><sup>177</sup>Lu-DOTA-Gly-4-aminobenzoyl-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/LuAMBA/pdf/">PDF Version</a>]</span><div>[<sup>177</sup>Lu]-AMBA</div><div>Huiming Zhang.</div><div class="small">Created: October 1, 2008; Last Update: November 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lu177-AM3"><a class="toc-item" href="/books/n/micad/Lu177-AM3/"><sup>177</sup>Lu-Labeled 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-Tyr-cyclo(DAB-Arg-cyclo(Cys-Phe-<span class="small-caps">d</span>-Trp-Lys-Thr-Cys))</a><span class="small"> [<a href="/books/n/micad/Lu177-AM3/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-AM3</div><div>Liang Shan.</div><div class="small">Created: December 10, 2010; Last Update: January 18, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_chCE7agl177Lu"><a class="toc-item" href="/books/n/micad/chCE7agl177Lu/"><sup>177</sup>Lu-Labeled aglycosylated anti-L1-CAM monoclonal antibody chCE7</a><span class="small"> [<a href="/books/n/micad/chCE7agl177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]-chCE7agl</div><div>Arvind Chopra.</div><div class="small">Created: June 26, 2012; Last Update: July 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AE105DOTA177Lu"><a class="toc-item" href="/books/n/micad/AE105DOTA177Lu/"><sup>177</sup>Lu-Labeled DOTA-conjugated AE105 peptide (Asp-Cha-Phe-(<span class="small-caps">d</span>)Ser-(<span class="small-caps">d</span>)Arg-Tyr-Leu-Trp-Ser-CONH<sub>2</sub>)</a><span class="small"> [<a href="/books/n/micad/AE105DOTA177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]-DOTA-AE105</div><div>Arvind Chopra.</div><div class="small">Created: September 13, 2012; Last Update: November 8, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EDTMP177Lu"><a class="toc-item" href="/books/n/micad/EDTMP177Lu/"><sup>177</sup>Lu-Labeled ethylenediamine tetramethylene phosphonic acid</a><span class="small"> [<a href="/books/n/micad/EDTMP177Lu/pdf/">PDF Version</a>]</span><div>[<sup>177</sup>Lu]-EDTMP</div><div>Arvind Chopra.</div><div class="small">Created: April 28, 2011; Last Update: May 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nimomab177Lu"><a class="toc-item" href="/books/n/micad/Nimomab177Lu/"><sup>177</sup>Lu-Labeled h-R3 (nimotuzumab), a humanized monoclonal antibody targeting the external domain of the epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/Nimomab177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]-h-R3</div><div>Arvind Chopra.</div><div class="small">Created: January 4, 2012; Last Update: February 2, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Pertuzumab177Lu"><a class="toc-item" href="/books/n/micad/Pertuzumab177Lu/"><sup>177</sup>Lu-Labeled humanized monoclonal antibody against human epidermal growth factor receptor 2</a><span class="small"> [<a href="/books/n/micad/Pertuzumab177Lu/pdf/">PDF Version</a>]</span><div>[<sup>177</sup>Lu]Pertuzumab</div><div>Arvind Chopra.</div><div class="small">Created: November 17, 2008; Last Update: December 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDP177Lu"><a class="toc-item" href="/books/n/micad/MDP177Lu/"><sup>177</sup>Lu-Labeled methylene diphosphonate</a><span class="small"> [<a href="/books/n/micad/MDP177Lu/pdf/">PDF Version</a>]</span><div> [<sup>177</sup>Lu]-MDP</div><div>Arvind Chopra.</div><div class="small">Created: May 24, 2011; Last Update: June 30, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lu177-PYP"><a class="toc-item" href="/books/n/micad/Lu177-PYP/"><sup>177</sup>Lu-Labeled sodium pyrophosphate</a><span class="small"> [<a href="/books/n/micad/Lu177-PYP/pdf/">PDF Version</a>]</span><div><sup>177</sup>Lu-PYP</div><div>Liang Shan.</div><div class="small">Created: November 27, 2012; Last Update: December 19, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos186re"><a class="toc-item" href="/books/n/micad/sos186re/">186Re</a><ul id="toc_lst_NBK5330_toc_sos186re" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAMABP186Re"><a class="toc-item" href="/books/n/micad/MAMABP186Re/"><sup>186</sup>Re-Labeled [<i>N</i>-[2[[3-(3,3-diphosphonopropylcarbamoyl)propyl]-2-thioethylamino]acetyl]-2-aminoethylenethiolate] oxorhenium (V)</a><span class="small"> [<a href="/books/n/micad/MAMABP186Re/pdf/">PDF Version</a>]</span><div> [<sup>186</sup>Re]MAMA-BP</div><div>Arvind Chopra.</div><div class="small">Created: November 6, 2009; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAMAHBP186Re"><a class="toc-item" href="/books/n/micad/MAMAHBP186Re/"><sup>186</sup>Re-Labeled [<i>N</i>-[2-[[4-[(4-hydroxy-4,4-diphosphonobutyl)amino]-4-oxobutyl]-2-thioethylamino]acetyl]-2-aminoethanethiolate] oxorhenium (V)</a><span class="small"> [<a href="/books/n/micad/MAMAHBP186Re/pdf/">PDF Version</a>]</span><div> [<sup>186</sup>Re]MAMA-HBP</div><div>Arvind Chopra.</div><div class="small">Created: November 6, 2009; Last Update: June 3, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos188re"><a class="toc-item" href="/books/n/micad/sos188re/">188Re</a><ul id="toc_lst_NBK5330_toc_sos188re" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Nimotuzumab188Re"><a class="toc-item" href="/books/n/micad/Nimotuzumab188Re/"><sup>188</sup>Re-Labeled humanized monoclonal anti-epidermal growth factor receptor antibody </a><span class="small"> [<a href="/books/n/micad/Nimotuzumab188Re/pdf/">PDF Version</a>]</span><div><sup>188</sup>Re-Nimotuzumab</div><div>Arvind Chopra.</div><div class="small">Created: August 4, 2008; Last Update: September 2, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos211at"><a class="toc-item" href="/books/n/micad/sos211at/">211At</a><ul id="toc_lst_NBK5330_toc_sos211at" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MX35213Bi-211At"><a class="toc-item" href="/books/n/micad/MX35213Bi-211At/"><sup>213</sup>Bi/<sup>211</sup>At-Labeled MX35, an anti–sodium-dependent phosphate transport protein 2b (NaPi2b) murine monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MX35213Bi-211At/pdf/">PDF Version</a>]</span><div> [<sup>213</sup>Bi]MX35 and [<sup>211</sup>At]MX35</div><div>Arvind Chopra.</div><div class="small">Created: February 27, 2012; Last Update: May 31, 2012.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos67ga"><a class="toc-item" href="/books/n/micad/sos67ga/">67Ga</a><ul id="toc_lst_NBK5330_toc_sos67ga" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_CycMSH-DOTA-67Ga"><a class="toc-item" href="/books/n/micad/CycMSH-DOTA-67Ga/"><sup>67</sup>Ga-1,4,7,10-Tetraazacyclododecane-<i>N</i>,<i>N</i>’,<i>N</i>’’,<i>N</i>’’’-tetraacetic acid-Gly-Glu-c[Lys-Nlc-Glu-His-<span class="small-caps">d</span>-Phe-Arg-Trp-Gly-Arg-Pro-Val-Asp]</a><span class="small"> [<a href="/books/n/micad/CycMSH-DOTA-67Ga/pdf/">PDF Version</a>]</span><div><sup>67</sup>Ga-DOTA-GlyGlu-CycMSH</div><div>Kam Leung.</div><div class="small">Created: April 28, 2010; Last Update: June 3, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Insulin67Ga"><a class="toc-item" href="/books/n/micad/Insulin67Ga/"><sup>67</sup>Ga labeled cyclic diethylenetriamine pentaacetic acid Insulin </a><span class="small"> [<a href="/books/n/micad/Insulin67Ga/pdf/">PDF Version</a>]</span><div>[<sup>67</sup>Ga]-insulin</div><div>Arvind Chopra.</div><div class="small">Created: May 22, 2008; Last Update: July 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P1254-67Ga"><a class="toc-item" href="/books/n/micad/P1254-67Ga/"><sup>67</sup>Ga-Tetraazacyclododecane-<i>N,N',N'',N'''</i>-tetraacetic acid-3-{2-[2-(3-amino-propoxy)-ethoxy]-ethoxy}-propylamine-γ-folate</a><span class="small"> [<a href="/books/n/micad/P1254-67Ga/pdf/">PDF Version</a>]</span><div><sup>67</sup>Ga-P1254</div><div>Kam Leung.</div><div class="small">Created: February 14, 2011; Last Update: May 26, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sos99mtc"><a class="toc-item" href="/books/n/micad/sos99mtc/">99mTc</a><ul id="toc_lst_NBK5330_toc_sos99mtc" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_TRODAT-1Tc99m"><a class="toc-item" href="/books/n/micad/TRODAT-1Tc99m/">[2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-<i>N2,N2’,S2,S2</i>]oxo-[1R-exo-exo)])- [<sup>99m</sup>Tc]-technetium</a><span class="small"> [<a href="/books/n/micad/TRODAT-1Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-TRODAT-1</div><div>Arvind Chopra.</div><div class="small">Created: April 24, 2007; Last Update: December 20, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTAPhAlior99mTc"><a class="toc-item" href="/books/n/micad/DOTAPhAlior99mTc/">[<sup>99m</sup>Tc/<sup>90</sup>Y]-1,4,7,10 Tetraazacyclododecane-<i>N</i>,<i>N’</i>,<i>N’’</i>,<i>N’’’</i>-tetraacetic acid phenylalanine derivative conjugated to anti-epidermal growth factor receptor antibody ior egf/r3</a><span class="small"> [<a href="/books/n/micad/DOTAPhAlior99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc/<sup>90</sup>Y]DOTA-Ph-Al-ior egf/r3</div><div>Puja Panwar, Normando Iznaga-Escobar, Pushpa Mishra, Vibha Srivastava, Rakesh Sharma, Ramesh Chandra, Anil Mishra, and Arvind Chopra.</div><div class="small">Created: August 27, 2009; Last Update: October 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ZHER2342H6-99mTc"><a class="toc-item" href="/books/n/micad/ZHER2342H6-99mTc/">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled anti-epidermal growth
|
|
factor receptor (HER2) affibody Z<sub>HER2:342</sub> with a hexa-histidine tag
|
|
(H<sub>6</sub>) on the C-terminal</a><span class="small"> [<a href="/books/n/micad/ZHER2342H6-99mTc/pdf/">PDF Version</a>]</span><div>
|
|
[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Z<sub>HER2:342</sub>-H<sub>6</sub></div><div>Arvind Chopra.</div><div class="small">Created: December 20, 2010; Last Update: January 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_H6ZHER2342-99mTc"><a class="toc-item" href="/books/n/micad/H6ZHER2342-99mTc/">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled anti-epidermal growth
|
|
factor receptor (HER2) affibody Z<sub>HER2:342</sub> with a hexa-histidine tag
|
|
(H<sub>6</sub>) on the N-terminal</a><span class="small"> [<a href="/books/n/micad/H6ZHER2342-99mTc/pdf/">PDF Version</a>]</span><div>
|
|
[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-H<sub>6</sub>-Z<sub>HER2:342</sub></div><div>Arvind Chopra.</div><div class="small">Created: December 16, 2010; Last Update: January 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HE3ZHER2342-99mTc"><a class="toc-item" href="/books/n/micad/HE3ZHER2342-99mTc/">[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-Labeled anti-epidermal growth
|
|
factor receptor (HER2) affibody Z<sub>HER2:342</sub> with a
|
|
tri-(histidine-glutamate) peptide tag (HE)<sub>3</sub> on the N-terminal</a><span class="small"> [<a href="/books/n/micad/HE3ZHER2342-99mTc/pdf/">PDF Version</a>]</span><div>
|
|
[<sup>99m</sup>Tc(CO)<sub>3</sub>]<sup>+</sup>-(HE)<sub>3</sub>-Z<sub>HER2:342</sub></div><div>Arvind Chopra.</div><div class="small">Created: December 21, 2010; Last Update: January 20, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PNP3Tc99m"><a class="toc-item" href="/books/n/micad/PNP3Tc99m/">[<sup>99m</sup>Tc(N)(NS-Cys-Gly-CCK-8)(PNP3)]<sup>+</sup></a><span class="small"> [<a href="/books/n/micad/PNP3Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(N)(PNP3)-CCK-8</div><div>The MICAD Research Team.</div><div class="small">Created: April 30, 2007; Last Update: May 30, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Sulfonamide99mTc"><a class="toc-item" href="/books/n/micad/Sulfonamide99mTc/">[<sup>99m</sup>Tc](CO)<sub>3</sub><i>N</i>-(pyridin-2-yl-methyl)-<i>N</i>[2-(4-sulfamoylphenyl)-ethyl]aminoethyl acetate</a><span class="small"> [<a href="/books/n/micad/Sulfonamide99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]5</div><div>Arvind Chopra.</div><div class="small">Created: August 25, 2010; Last Update: October 28, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMP24599mTc"><a class="toc-item" href="/books/n/micad/IMP24599mTc/">[<sup>99m</sup>Tc]1,4,7,10-tetraazacyclododecane-<i>N, N’, N’’, N’’’</i>-tetraacetic acid-Phe-Lys-histamine-succinyl-Gly-D-Tyr-Lys- histamine-succinyl-Gly-thiosemicarbazonyl-glyoxyl-cysteine </a><span class="small"> [<a href="/books/n/micad/IMP24599mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]IMP-245</div><div>Arvind Chopra.</div><div class="small">Created: March 13, 2008; Last Update: May 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DOTMP99mTc"><a class="toc-item" href="/books/n/micad/DOTMP99mTc/">[<sup>99m</sup>Tc]-1,4,7,10-Tetraazacyclododecane tetramethylenephosphonic acid</a><span class="small"> [<a href="/books/n/micad/DOTMP99mTc/pdf/">PDF Version</a>]</span><div>Anupama Datta, Puja Panwar, Krishna Chuttani, Anil Kumar Mishra, and Arvind Chopra.</div><div class="small">Created: March 31, 2009; Last Update: June 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NPNP99mTc"><a class="toc-item" href="/books/n/micad/NPNP99mTc/">[<sup>99m</sup>Tc]4-Dithiocarbamato-N-benzylpiperidine </a><span class="small"> [<a href="/books/n/micad/NPNP99mTc/pdf/">PDF Version</a>]</span><div>[[<sup>99m</sup>Tc]N(PNP)Pip-DTC]+</div><div>Drishty Satpati, Ketaki Bapat, Haladhar Deb Sarma, Kanchan Kothari, Meera Venkatesh, Sharmila Banerjee, and Arvind Chopra.</div><div class="small">Created: April 3, 2008; Last Update: May 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P1827DS99mTc"><a class="toc-item" href="/books/n/micad/P1827DS99mTc/">[<sup>99m</sup>Tc]-Acetyl-arg-arg-arg-arg-arg-cys-gly-cys-gly-gly-pro-leu-tyr-arg-arg-ile-ile-arg-arg-leu-leu-glu-ser-dermatan sulfate </a><span class="small"> [<a href="/books/n/micad/P1827DS99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-P1827DS</div><div>Arvind Chopra.</div><div class="small">Created: November 19, 2007; Last Update: December 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiCD399mTc"><a class="toc-item" href="/books/n/micad/AntiCD399mTc/">[<sup>99m</sup>Tc]Anti-CD3 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/AntiCD399mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Anti-CD3 mAb</div><div>Arvind Chopra.</div><div class="small">Created: January 28, 2008; Last Update: March 10, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Depreotide99mTc"><a class="toc-item" href="/books/n/micad/Depreotide99mTc/">[<sup>99m</sup>Tc]Cyclo(L-homocysteinyl-N-methyl-L-phenylalanyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl), (1‡1´)-sulfide with 3-[(mercaptoacetyl)amino]-L-alanyl-L-lysyl-L-cysteinyl-L-lysinamide</a><span class="small"> [<a href="/books/n/micad/Depreotide99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Depreotide</div><div>Arvind Chopra.</div><div class="small">Created: March 27, 2008; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GSATc99m"><a class="toc-item" href="/books/n/micad/GSATc99m/">[<sup>99m</sup>Tc]-diethylenetriaminepentaacetic acid-galactosyl human serum albumin</a><span class="small"> [<a href="/books/n/micad/GSATc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-GSA</div><div>Arvind Chopra.</div><div class="small">Created: April 24, 2007; Last Update: June 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EGFRnAb99mTc"><a class="toc-item" href="/books/n/micad/EGFRnAb99mTc/">[<sup>99m</sup>Tc]Epidermal growth factor receptor–specific nanobody </a><span class="small"> [<a href="/books/n/micad/EGFRnAb99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]EGFR nanobody</div><div>Arvind Chopra.</div><div class="small">Created: April 22, 2008; Last Update: May 13, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAG3ASON99mTc"><a class="toc-item" href="/books/n/micad/MAG3ASON99mTc/">[<sup>99m</sup>Tc]Human telomerase reverse-transcriptase antisense mRNA oligonucleotide</a><span class="small"> [<a href="/books/n/micad/MAG3ASON99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]MAG3-ASON</div><div>Arvind Chopra.</div><div class="small">Created: May 7, 2008; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Hypericin99mTc"><a class="toc-item" href="/books/n/micad/Hypericin99mTc/">[<sup>99m</sup>Tc]-Mercaptoacetyldiglycyl-1,5-diaminopentylene hypericincarboxamide</a><span class="small"> [<a href="/books/n/micad/Hypericin99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]-Hypericin</div><div>Arvind Chopra.</div><div class="small">Created: February 26, 2008; Last Update: March 25, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DMSA99mTc"><a class="toc-item" href="/books/n/micad/DMSA99mTc/">[<sup>99m</sup>Tc]-Pentavalent dimercaptosuccinic acid</a><span class="small"> [<a href="/books/n/micad/DMSA99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-(V)DMSA</div><div>Arvind Chopra.</div><div class="small">Created: June 11, 2010; Last Update: July 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TP365499mTc"><a class="toc-item" href="/books/n/micad/TP365499mTc/">[<sup>99m</sup>Tc]Vasoactive intestinal peptide-aminobutyric acid-Gly-Gly-(D)-Ala-Gly </a><span class="small"> [<a href="/books/n/micad/TP365499mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]TP3654</div><div>Arvind Chopra.</div><div class="small">Created: March 7, 2008; Last Update: April 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-Orn3-CGG99mTc"><a class="toc-item" href="/books/n/micad/RGDfK-Orn3-CGG99mTc/">[<sup>99m</sup>Tc-Gly-Gly-Cys]-Ornithine-ornithine-ornithine-cyclo(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)</a><span class="small"> [<a href="/books/n/micad/RGDfK-Orn3-CGG99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc-GGC]-(Orn)<sub>3</sub>-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: February 16, 2013; Last Update: April 18, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Demobesin1-99mTc"><a class="toc-item" href="/books/n/micad/Demobesin1-99mTc/">[<sup>99m</sup>Tc-N<sub>4</sub><sup>0-1</sup>-bzlg<sup>0</sup>,D-Phe<sup>6</sup>,Leu-NHEt<sup>13</sup>,<i>des</i>-Met<sup>14</sup>]Bombesin(6–14)</a><span class="small"> [<a href="/books/n/micad/Demobesin1-99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Demobesin 1</div><div>Liang Shan.</div><div class="small">Created: August 30, 2009; Last Update: October 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DSPL-99mTc-111In"><a class="toc-item" href="/books/n/micad/DSPL-99mTc-111In/"><sup>99m</sup>Tc/<sup>111</sup>In-Labeled DTPA-succinyl polylysine</a><span class="small"> [<a href="/books/n/micad/DSPL-99mTc-111In/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc/<sup>111</sup>In]-DSPL</div><div>Arvind Chopra.</div><div class="small">Created: October 16, 2012; Last Update: November 21, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DPAAlate99mTc"><a class="toc-item" href="/books/n/micad/DPAAlate99mTc/"><sup>99m</sup>Tc/<sup>188</sup>Re-Labeled dipicolylamine-alendronate</a><span class="small"> [<a href="/books/n/micad/DPAAlate99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc/<sup>188</sup>Re]DPA-alendronate</div><div>Arvind Chopra.</div><div class="small">Created: April 21, 2010; Last Update: May 24, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TOR99mTc"><a class="toc-item" href="/books/n/micad/TOR99mTc/"><sup>99m</sup>Tc-(3Z)-4-{4-[2-(Dimethylamino)ethoxy]phenyl}-3,4-diphenylbut-3-en-1-yl<i>N</i>,<i>N</i>-bis[2-(2,6-dioxomorpholin-4-yl)ethyl]glycinate</a><span class="small"> [<a href="/books/n/micad/TOR99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-DTPA-TOR</div><div>Kam Leung.</div><div class="small">Created: May 25, 2010; Last Update: July 7, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NAPamide-NSN-99mTc"><a class="toc-item" href="/books/n/micad/NAPamide-NSN-99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-((S-Pyridin-2-ylmethyl)-Cys)-Nle-Asp-His-<span class="small-caps">d</span>-Phe-Arg-Trp-Gly-Lys-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/NAPamide-NSN-99mTc/pdf/">PDF Version</a>]</span><div>Kam Leung.</div><div class="small">Created: January 28, 2013; Last Update: April 18, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cAbCEA5graft-99mTc"><a class="toc-item" href="/books/n/micad/cAbCEA5graft-99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-Anti-carcinoembryonic antigen (CEA) humanized CEA5 graft nanobody</a><span class="small"> [<a href="/books/n/micad/cAbCEA5graft-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Humanized CEA5 graft</div><div>Kam Leung.</div><div class="small">Created: April 11, 2012; Last Update: July 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cAbHER1-8B6-99mTc"><a class="toc-item" href="/books/n/micad/cAbHER1-8B6-99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-Anti-epidermal growth factor receptor nanobody 8B6</a><span class="small"> [<a href="/books/n/micad/cAbHER1-8B6-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(CO)<sub>3</sub>-8B6</div><div>Kam Leung.</div><div class="small">Created: April 11, 2012; Last Update: July 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_cAbVCAM1-5-99mTc"><a class="toc-item" href="/books/n/micad/cAbVCAM1-5-99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-Anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5</a><span class="small"> [<a href="/books/n/micad/cAbVCAM1-5-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-cAbVCAM1-5</div><div>Kam Leung.</div><div class="small">Created: April 5, 2012; Last Update: July 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BPy-cRGDyK99mTc"><a class="toc-item" href="/books/n/micad/BPy-cRGDyK99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-Bipyridine-cyclo-(Arg-Gly-Asp-<span class="small-caps">D</span>-Tyr-Lys)</a><span class="small"> [<a href="/books/n/micad/BPy-cRGDyK99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(CO)<sub>3</sub>-BPy-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: June 14, 2007; Last Update: August 14, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-PZ99mTc"><a class="toc-item" href="/books/n/micad/RGDyK-PZ99mTc/"><sup>99m</sup>Tc(CO)<sub>3</sub>-Pyrazolyl-cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Tyr-Lys) </a><span class="small"> [<a href="/books/n/micad/RGDyK-PZ99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(CO)<sub>3</sub>-PZ-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: July 9, 2007; Last Update: August 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Duramycin-99mTc"><a class="toc-item" href="/books/n/micad/Duramycin-99mTc/"><sup>99m</sup>Tc-(Hydrazinonicotinic acid-duramycin)(tricine)(TPPTS)</a><span class="small"> [<a href="/books/n/micad/Duramycin-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Duramycin</div><div>Kam Leung.</div><div class="small">Created: October 25, 2008; Last Update: January 2, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ABN-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/ABN-HYNIC-99mTc/"><sup>99m</sup>Tc-(Hydrazinonicotinic acid-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub>)(tricine)(TPPTS)</a><span class="small"> [<a href="/books/n/micad/ABN-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-(HYNIC-ABN)(tricine)(TPPTS)</div><div>Kam Leung.</div><div class="small">Created: October 25, 2008; Last Update: December 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NT-XIX-99mTc"><a class="toc-item" href="/books/n/micad/NT-XIX-99mTc/"><sup>99m</sup>Tc-(<i>N</i><sup><i>α</i></sup><i>His</i>)Ac-(Arg-<i>N</i>-CH<sub>3</sub>)-Arg-Pro-(dimethyl-Tyr)-(tertary-Leu)-Leu</a><span class="small"> [<a href="/books/n/micad/NT-XIX-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NT-XIX</div><div>Kam Leung.</div><div class="small">Created: August 5, 2009; Last Update: September 18, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HMPAO99Tc"><a class="toc-item" href="/books/n/micad/HMPAO99Tc/"><sup>99m</sup>Tc-(RR,SS)-4,8-diaza-3,6,6,9-tetramethylundecane-2,10-dione bisoxime</a><span class="small"> [<a href="/books/n/micad/HMPAO99Tc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HMPAO</div><div>Arvind Chopra.</div><div class="small">Created: May 14, 2007; Last Update: June 5, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_N3S-X-BN-99mTc"><a class="toc-item" href="/books/n/micad/N3S-X-BN-99mTc/"><sup>99m</sup>Tc<sup>(v)</sup>O-Gly-Gly-Cys-Orn-Orn-Orn-Bombesin[2-14]</a><span class="small"> [<a href="/books/n/micad/N3S-X-BN-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-N<sub>3</sub>S-X-BN[2-14]</div><div>Liang Shan.</div><div class="small">Created: August 19, 2009; Last Update: September 23, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CCMSH99mTc"><a class="toc-item" href="/books/n/micad/CCMSH99mTc/"><sup>99m</sup>Tc-[Ac-CCEHdFRWCKPV-NH<sub>2</sub>]</a><span class="small"> [<a href="/books/n/micad/CCMSH99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-CCMSH</div><div>Kenneth T Cheng.</div><div class="small">Created: April 7, 2008; Last Update: April 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSH99mTc"><a class="toc-item" href="/books/n/micad/MSH99mTc/"><sup>99m</sup>Tc-[Cys<sup>3,4,10</sup>,<span class="small-caps">d</span>-Phe<sup>7</sup>,Arg<sup>11</sup>]α-MSH<sub>3-13</sub></a><span class="small"> [<a href="/books/n/micad/MSH99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-(Arg<sup>11</sup>)CCMSH</div><div>Kenneth T Cheng and Thomas P Quinn.</div><div class="small">Created: January 26, 2007; Last Update: January 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Folate-DO3A-EA99mTc"><a class="toc-item" href="/books/n/micad/Folate-DO3A-EA99mTc/"><sup>99m</sup>Tc-1,4,7-Tris(carboxymethyl)-10-(4-aminoethyl)-1,4,7,10-tetraazacyclododecane-Folate</a><span class="small"> [<a href="/books/n/micad/Folate-DO3A-EA99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-DO3A-EA-Folate</div><div>Kam Leung.</div><div class="small">Created: November 22, 2012; Last Update: January 31, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-NS3M1"><a class="toc-item" href="/books/n/micad/Tc99m-NS3M1/"><sup>99m</sup>Tc-2-[Bis-(2-mercaptoethyl)]aminoethanethiol-4-isocyano-<i>N</i>-[2-(2-methyl-5-nitro-1<i>H</i>-imidazol-1-yl)ethyl]butanamide</a><span class="small"> [<a href="/books/n/micad/Tc99m-NS3M1/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NS<sub>3</sub>M1</div><div>Liang Shan.</div><div class="small">Created: May 16, 2012; Last Update: July 10, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MIBI99mtc"><a class="toc-item" href="/books/n/micad/MIBI99mtc/"><sup>99m</sup>Tc-2-Methoxyisobutylisonitrile</a><span class="small"> [<a href="/books/n/micad/MIBI99mtc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MIBI</div><div>Kam Leung.</div><div class="small">Created: October 5, 2004; Last Update: December 8, 2004.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NC100668-99mTc"><a class="toc-item" href="/books/n/micad/NC100668-99mTc/"><sup>99m</sup>Tc-Acetyl-Asn-Gln-Glu-Gln-Val-Ser-Pro-3-iodo-Tyr-Thr-Leu-Leu-Lys-Gly-NC100194</a><span class="small"> [<a href="/books/n/micad/NC100668-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NC100668</div><div>Kam Leung.</div><div class="small">Created: May 7, 2007; Last Update: February 11, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IMP19299mTc"><a class="toc-item" href="/books/n/micad/IMP19299mTc/"><sup>99m</sup>Tc-Ac-Lys(DTPA)-Tyr-Lys(DTPA)-Lys(thiosemicarbazonyl-glyoxyl-cysteinyl-)-NH2 (IMP-192)</a><span class="small"> [<a href="/books/n/micad/IMP19299mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-IMP-192</div><div>Arvind Chopra.</div><div class="small">Created: June 27, 2011; Last Update: July 26, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-2395-99mTc"><a class="toc-item" href="/books/n/micad/Z-2395-99mTc/"><sup>99m</sup>Tc-Affibody Z<sub>HER2:2395</sub>-Cys</a><span class="small"> [<a href="/books/n/micad/Z-2395-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Z<sub>2395</sub>-C</div><div>Kam Leung.</div><div class="small">Created: September 16, 2009; Last Update: November 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_E9MAb99mTc"><a class="toc-item" href="/books/n/micad/E9MAb99mTc/"><sup>99m</sup>Tc-Anti-CD105 E9 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/E9MAb99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-CD105 E9 MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 14, 2007; Last Update: December 10, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AP39Tc99m"><a class="toc-item" href="/books/n/micad/AP39Tc99m/"><sup>99m</sup>Tc-Anti-ED-B fibronectin L19-(Gy)<sub>3</sub>-Cys-Ala scFv antibody fragment</a><span class="small"> [<a href="/books/n/micad/AP39Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-AP39</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 6, 2007; Last Update: January 14, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L19-Hi20Tc99m"><a class="toc-item" href="/books/n/micad/L19-Hi20Tc99m/"><sup>99m</sup>Tc-Anti-ED-B fibronectin single-chain antibody fragment L19-Hi20</a><span class="small"> [<a href="/books/n/micad/L19-Hi20Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-L19-Hi20</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 26, 2007; Last Update: January 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_L19-His-99mTc"><a class="toc-item" href="/books/n/micad/L19-His-99mTc/"><sup>99m</sup>Tc-Anti-ED-B fibronectin single-chain antibody fragment L19-His</a><span class="small"> [<a href="/books/n/micad/L19-His-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-L19-His</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 12, 2007; Last Update: January 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_hR3Tc99m"><a class="toc-item" href="/books/n/micad/hR3Tc99m/"><sup>99m</sup>Tc- anti-EGFR monoclonal antibody h-R3</a><span class="small"> [<a href="/books/n/micad/hR3Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-hR3</div><div>The MICAD Research Team.</div><div class="small">Created: May 22, 2007; Last Update: June 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Arcitumomab"><a class="toc-item" href="/books/n/micad/Arcitumomab/"><sup>99m</sup>Tc-Arcitumomab </a><span class="small"> [<a href="/books/n/micad/Arcitumomab/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-IMMU-4</div><div>Kenneth T. Cheng.</div><div class="small">Created: December 11, 2005; Last Update: March 17, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BAT-FL-AR99mTc"><a class="toc-item" href="/books/n/micad/BAT-FL-AR99mTc/"><sup>99m</sup>Tc-Bis-amino-bis-thiol-conjugated 6-(3-bromopropoxy)-2-(4-(dimethylamino)phenyl)-4<i>H</i>-chromen-4-one and (<i>Z</i>)-5-(3-bromopropoxy)-2-(4-(dimethylamino)benzylidene)benzofuran-3(2<i>H</i>)-one</a><span class="small"> [<a href="/books/n/micad/BAT-FL-AR99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]BAT-FL, [<sup>99m</sup>Tc]BAT-AR</div><div>Liang Shan.</div><div class="small">Created: November 30, 2011; Last Update: December 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PNA99mTc"><a class="toc-item" href="/books/n/micad/PNA99mTc/"><sup>99m</sup>Tc-CCND1-PNA-IGF1 Chimeras</a><span class="small"> [<a href="/books/n/micad/PNA99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-WT4185</div><div>Kenneth T Cheng, Eric Wickstrom, Xiaobing Tian, Mohan R Aruva, Wenyi Qin, Weizhu Zhu, Kevin T Duffy, Edward R Sauter, and Mathew L Thakur.</div><div class="small">Created: November 1, 2006; Last Update: January 16, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-CGG-99mTc"><a class="toc-item" href="/books/n/micad/Z-CGG-99mTc/"><sup>99m</sup>Tc-Cys-Gly-Gly-Affibody Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-CGG-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-CGG-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: February 16, 2008; Last Update: April 7, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NC100692-99mTc"><a class="toc-item" href="/books/n/micad/NC100692-99mTc/"><sup>99m</sup>Tc-Diamine dioxime-Lys-Cys-Arg-Gly-Asp-Cyc-Phe-Cys-polyethylene glycol</a><span class="small"> [<a href="/books/n/micad/NC100692-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-<span class="small-caps">NC100692</span></div><div>Kam Leung.</div><div class="small">Created: April 9, 2010; Last Update: May 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DG99mTc"><a class="toc-item" href="/books/n/micad/DG99mTc/"><sup>99m</sup>Tc-Diethylenetriaminepentaacetate-deoxyglucose </a><span class="small"> [<a href="/books/n/micad/DG99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-DTPA-DG</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 6, 2007; Last Update: March 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LACTAL99mTc"><a class="toc-item" href="/books/n/micad/LACTAL99mTc/"><sup>99m</sup>Tc-Diethylenetriamine pentaacetic acid–lactosyl human serum albumin</a><span class="small"> [<a href="/books/n/micad/LACTAL99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-LACTAL</div><div>Liang Shan.</div><div class="small">Created: August 23, 2010; Last Update: October 1, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Lymphoseek"><a class="toc-item" href="/books/n/micad/Lymphoseek/"><sup>99m</sup>Tc-Diethylenetriaminepentaacetic acid-mannosyl-dextran</a><span class="small"> [<a href="/books/n/micad/Lymphoseek/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-DTPA-Mannosyl-dextran</div><div>Kenneth T. Cheng, David R. Vera, Anne M. Wallace, Carl K Hoh, Jeanette Mendez, and Kam Leung.</div><div class="small">Created: October 23, 2007; Last Update: March 2, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LBA-SPION-99mTc"><a class="toc-item" href="/books/n/micad/LBA-SPION-99mTc/"><sup>99m</sup>Tc-Diethylenetriamine pentaacetic acid superparamagnetic iron oxide nanoparticles conjugated with lactobionic acid</a><span class="small"> [<a href="/books/n/micad/LBA-SPION-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-DTPA-SPION-LBA</div><div>Kam Leung.</div><div class="small">Created: April 28, 2010; Last Update: May 20, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICMG0Tc99m"><a class="toc-item" href="/books/n/micad/HYNICMG0Tc99m/"><sup>99m</sup>Tc-Ethylenediaminediacetic acid/hydrazinonicotinamide-[<span class="small-caps">d</span>Glu<sup>1</sup>]minigastrin</a><span class="small"> [<a href="/books/n/micad/HYNICMG0Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EDDA/HYNIC-MG0</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 2, 2007; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICMG11Tc99m"><a class="toc-item" href="/books/n/micad/HYNICMG11Tc99m/"><sup>99m</sup>Tc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-[<span class="small-caps">d</span>Glu<sup>1</sup>, desGlu<sup>2–6</sup>]minigastrin</a><span class="small"> [<a href="/books/n/micad/HYNICMG11Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EDDA/HYNIC-MG11</div><div>The MICAD Research Team.</div><div class="small">Created: May 4, 2007; Last Update: June 7, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDyK-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/RGDyK-HYNIC-99mTc/"><sup>99m</sup>Tc-Ethylenediaminediacetic acid/hydrazinonicotinic acid-cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Try-Lys) </a><span class="small"> [<a href="/books/n/micad/RGDyK-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EDDA/HYNIC-c(RGDyK)</div><div>Kam Leung.</div><div class="small">Created: July 15, 2007; Last Update: August 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICTOC99mTc"><a class="toc-item" href="/books/n/micad/HYNICTOC99mTc/"><sup>99m</sup>Tc-ethylenediamine <i>N,N’</i>-diacetic acid/hydrazinonicotinamide-Tyr<sup>3</sup>-octreotide</a><span class="small"> [<a href="/books/n/micad/HYNICTOC99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-TOC</div><div>Arvind Chopra.</div><div class="small">Created: October 12, 2007; Last Update: November 7, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EC-C225-99mtc"><a class="toc-item" href="/books/n/micad/EC-C225-99mtc/"><sup>99m</sup>Tc-Ethylenedicysteine-C225</a><span class="small"> [<a href="/books/n/micad/EC-C225-99mtc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-C225</div><div>Kam Leung.</div><div class="small">Created: April 22, 2005; Last Update: December 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EC-DG-99mTc"><a class="toc-item" href="/books/n/micad/EC-DG-99mTc/"><sup>99m</sup>Tc-Ethylenedicysteine-deoxyglucose</a><span class="small"> [<a href="/books/n/micad/EC-DG-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-DG</div><div>Kam Leung.</div><div class="small">Created: October 17, 2009; Last Update: February 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Endostatin-EC-99mTc"><a class="toc-item" href="/books/n/micad/Endostatin-EC-99mTc/"><sup>99m</sup>Tc-Ethylenedicysteine-endostatin</a><span class="small"> [<a href="/books/n/micad/Endostatin-EC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-endostatin</div><div>Kam Leung.</div><div class="small">Created: March 3, 2005; Last Update: December 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EC-folate-99mTc"><a class="toc-item" href="/books/n/micad/EC-folate-99mTc/"><sup>99m</sup>Tc-Ethylenedicysteine-folate</a><span class="small"> [<a href="/books/n/micad/EC-folate-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-folate</div><div>Kam Leung.</div><div class="small">Created: April 18, 2005; Last Update: January 9, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECGuan99mTc"><a class="toc-item" href="/books/n/micad/ECGuan99mTc/"><sup>99m</sup>Tc-Ethylenedicysteine-guanine</a><span class="small"> [<a href="/books/n/micad/ECGuan99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-Guan</div><div>The MICAD Research Team.</div><div class="small">Created: August 17, 2007; Last Update: September 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICBN99mTc"><a class="toc-item" href="/books/n/micad/HYNICBN99mTc/"><sup>99m</sup>Tc-Ethylenenediamine-<i>N</i>,<i>N</i>'-diacetic acid/hydrazinonicotinamide[Lys<sup>3</sup>]-bombesin</a><span class="small"> [<a href="/books/n/micad/HYNICBN99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EDDA/HYNIC-[Lys<sup>3</sup>]-BN</div><div>Kenneth T. Cheng, Guillermina Ferro-Flores, and Consuelo Arteaga de Murphy.</div><div class="small">Created: August 15, 2007; Last Update: September 19, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fucoidan-99mTc"><a class="toc-item" href="/books/n/micad/Fucoidan-99mTc/"><sup>99m</sup>Tc-Fucoidan, a polysaccharidic ligand of P-selectin</a><span class="small"> [<a href="/books/n/micad/Fucoidan-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Fucoidan</div><div>Kam Leung.</div><div class="small">Created: January 18, 2012; Last Update: April 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GMC-99mTc"><a class="toc-item" href="/books/n/micad/GMC-99mTc/"><sup>99m</sup>Tc-Galactosyl-methylated chitosan</a><span class="small"> [<a href="/books/n/micad/GMC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-GMC</div><div>Kam Leung.</div><div class="small">Created: September 15, 2009; Last Update: December 2, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MWNT-G99mTc"><a class="toc-item" href="/books/n/micad/MWNT-G99mTc/"><sup>99m</sup>Tc-Glucosamine-multiwall carbon nanotubes</a><span class="small"> [<a href="/books/n/micad/MWNT-G99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MWNT-G</div><div>Kenneth T. Cheng, Jinxue. Guo, and Xiao Zhang.</div><div class="small">Created: October 2, 2007; Last Update: November 5, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK-D-99mTc"><a class="toc-item" href="/books/n/micad/RGDfK-D-99mTc/"><sup>99m</sup>Tc-Glucosamino-Asp-cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys) </a><span class="small"> [<a href="/books/n/micad/RGDfK-D-99mTc/pdf/">PDF Version</a>]</span><div>Glucosamino <sup>99m</sup>Tc-D-c(RGDfK)</div><div>Kam Leung.</div><div class="small">Created: August 15, 2007; Last Update: September 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_GAPEDLTc99m"><a class="toc-item" href="/books/n/micad/GAPEDLTc99m/"><sup>99m</sup>Tc-glutamate peptide 3-aminoethyl estradiol</a><span class="small"> [<a href="/books/n/micad/GAPEDLTc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-GAP-EDL</div><div>Arvind Chopra.</div><div class="small">Created: August 27, 2007; Last Update: September 24, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-BN-A"><a class="toc-item" href="/books/n/micad/Tc99m-BN-A/"><sup>99m</sup>Tc-Gly-Gly-Cys-(Arg)<sub>3</sub>-bombesin(2-14)-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Tc99m-BN-A/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-BN-A</div><div>Liang Shan.</div><div class="small">Created: December 6, 2012; Last Update: January 29, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TcBBL"><a class="toc-item" href="/books/n/micad/TcBBL/"><sup>99m</sup>Tc-Hexamethylpropyleneamine oxime-blue-biotin-liposomes</a><span class="small"> [<a href="/books/n/micad/TcBBL/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HMPAO-BBL</div><div>Huiming Zhang.</div><div class="small">Created: March 11, 2008; Last Update: April 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SpHL99mTc"><a class="toc-item" href="/books/n/micad/SpHL99mTc/"><sup>99m</sup>Tc-Hexamethylpropyleneamine oxime pH-sensitive liposomes</a><span class="small"> [<a href="/books/n/micad/SpHL99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-SpHL</div><div>Vildete Carmo, Mônica De Oliveira, Valbert Cardoso, and Arvind Chopra.</div><div class="small">Created: July 2, 2008; Last Update: August 7, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Defensin3-99mTc"><a class="toc-item" href="/books/n/micad/Defensin3-99mTc/"><sup>99m</sup>Tc-Human β-defensin-3</a><span class="small"> [<a href="/books/n/micad/Defensin3-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HBD-3</div><div>Kam Leung.</div><div class="small">Created: August 25, 2009; Last Update: November 19, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RNAHYNIC99mTc"><a class="toc-item" href="/books/n/micad/RNAHYNIC99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide/tricine-eighteen-nucleotide RIα mRNA antisense small interfering oligoribonucleotides </a><span class="small"> [<a href="/books/n/micad/RNAHYNIC99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC/tricine-18-nt-RIα-mRNA-AS siRNAs</div><div>Kenneth T. Cheng.</div><div class="small">Created: September 21, 2007; Last Update: October 23, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Exendin4HYNIC99mTc"><a class="toc-item" href="/books/n/micad/Exendin4HYNIC99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-aminohexanoic acid-Lys<sup>40</sup>-exendin-4</a><span class="small"> [<a href="/books/n/micad/Exendin4HYNIC99mTc/pdf/">PDF Version</a>]</span><div>[Lys<sup>40</sup>(Ahx-HYNIC-<sup>99m</sup>Tc)NH<sub>2</sub>]-exendin-4</div><div>Kam Leung.</div><div class="small">Created: January 20, 2012; Last Update: April 26, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Annexin-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/Annexin-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-annexin V</a><span class="small"> [<a href="/books/n/micad/Annexin-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-annexin V</div><div>Kam Leung.</div><div class="small">Created: February 28, 2006; Last Update: April 6, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49ScFv2Tc99m"><a class="toc-item" href="/books/n/micad/CC49ScFv2Tc99m/"><sup>99m</sup>Tc-Hydrazinonicotinamide-anti-TAG-72 CC49 divalent single-chain Fv monoclonal antibody </a><span class="small"> [<a href="/books/n/micad/CC49ScFv2Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-CC49 sc(Fv)<sub>2</sub> MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: June 19, 2007; Last Update: January 28, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CC49ScFv4Tc99m"><a class="toc-item" href="/books/n/micad/CC49ScFv4Tc99m/"><sup>99m</sup>Tc-Hydrazinonicotinamide-anti-TAG-72 CC49 tetravalent single-chain Fv monoclonal antibody </a><span class="small"> [<a href="/books/n/micad/CC49ScFv4Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-CC49 [sc(Fv)<sub>2</sub>]<sub>2</sub> MAb</div><div>Kenneth T. Cheng.</div><div class="small">Created: June 26, 2007; Last Update: December 28, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DC101-HYNIC99mTc"><a class="toc-item" href="/books/n/micad/DC101-HYNIC99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-chitosan-anti-vascular endothelial growth factor receptor 2 monoclonal antibody DC101</a><span class="small"> [<a href="/books/n/micad/DC101-HYNIC99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-chitosan-DC101</div><div>Kam Leung.</div><div class="small">Created: September 15, 2009; Last Update: December 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNIC-EGF-99mTc"><a class="toc-item" href="/books/n/micad/HYNIC-EGF-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/HYNIC-EGF-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-EGF</div><div>Kam Leung.</div><div class="small">Created: June 3, 2005; Last Update: January 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HGC-HYNIC99mTc"><a class="toc-item" href="/books/n/micad/HGC-HYNIC99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-galactosyl-chitosan</a><span class="small"> [<a href="/books/n/micad/HGC-HYNIC99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HGC</div><div>Kam Leung.</div><div class="small">Created: September 15, 2009; Last Update: December 2, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-8-99mTc"><a class="toc-item" href="/books/n/micad/IL-8-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinamide-interleukin-8</a><span class="small"> [<a href="/books/n/micad/IL-8-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-IL-8</div><div>Kam Leung.</div><div class="small">Created: March 9, 2007; Last Update: March 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Bitistatin99mTc"><a class="toc-item" href="/books/n/micad/Bitistatin99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinic acid-bitistatin</a><span class="small"> [<a href="/books/n/micad/Bitistatin99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-bitistatin</div><div>Kam Leung.</div><div class="small">Created: July 7, 2007; Last Update: April 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MG1-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/MG1-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinic acid-cyclo[γ-<span class="small-caps">d</span>-Glu-Ala-Tyr-<span class="small-caps">d</span>-Lys]-Trp-Met-Phe-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/MG1-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-cyclo-MG1</div><div>Kam Leung.</div><div class="small">Created: February 17, 2010; Last Update: March 25, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK2-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/RGDfK2-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinic acid-Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK2-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-E-[c(RGDfK)]<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: August 15, 2007; Last Update: September 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDfK4-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/RGDfK4-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinic acid-Glu-{Glu-[cyclo(Arg-Gly-Asp-<span class="small-caps">D</span>-Phe-Lys)]<sub>2</sub>}<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/RGDfK4-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-E{E[c(RGDfK)]<sub>2</sub>}<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: July 15, 2007; Last Update: August 31, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/scVEGF-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinic acid-single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-scVEGF<sub>121</sub></div><div>Kam Leung.</div><div class="small">Created: February 17, 2008; Last Update: March 31, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-RGD-HYNIC-99mTc"><a class="toc-item" href="/books/n/micad/BBN-RGD-HYNIC-99mTc/"><sup>99m</sup>Tc-Hydrazinonicotinyl(tricine)(TPPTS)-Glu-c(RGDyK)-bombesin[7-14]NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-RGD-HYNIC-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-RGD-BBN</div><div>Kam Leung.</div><div class="small">Created: August 16, 2012; Last Update: November 8, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL18bpFcIL1ra99mTc"><a class="toc-item" href="/books/n/micad/IL18bpFcIL1ra99mTc/"><sup>99m</sup>Tc-Interleukin-18-binding protein-Fc-interlukin-1 receptor antagonist</a><span class="small"> [<a href="/books/n/micad/IL18bpFcIL1ra99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-IL-18bp-Fc-IL-1ra</div><div>Kam Leung.</div><div class="small">Created: May 2, 2013; Last Update: May 30, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL-2-99mTc"><a class="toc-item" href="/books/n/micad/IL-2-99mTc/"><sup>99m</sup>Tc-Interleukin-2 </a><span class="small"> [<a href="/books/n/micad/IL-2-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-IL-2</div><div>Kam Leung.</div><div class="small">Created: September 15, 2006; Last Update: October 12, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-PEG-Lys-BN"><a class="toc-item" href="/books/n/micad/Tc99m-PEG-Lys-BN/"><sup>99m</sup>Tc-Labeled, PEGylated (N<sup>α</sup>His)Ac-β<sup>3</sup>hLys-βAla-βAla-Gln<sup>7</sup>-Trp<sup>8</sup>-Ala<sup>9</sup>-Val<sup>10</sup>-Gly<sup>11</sup>-His<sup>12</sup>-Cha<sup>13</sup>-Nle<sup>14</sup>-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/Tc99m-PEG-Lys-BN/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-PEG<sub>x</sub>-Lys-BN</div><div>Liang Shan.</div><div class="small">Created: March 12, 2012; Last Update: April 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Drubicin99mTc"><a class="toc-item" href="/books/n/micad/Drubicin99mTc/"><sup>99m</sup>Tc-Labeled (1S,3S)-3-acetyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-α-<span class="small-caps">l</span>-lyxo-hexopyranoside</a><span class="small"> [<a href="/books/n/micad/Drubicin99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]Daunorubicin</div><div>Arvind Chopra.</div><div class="small">Created: February 1, 2013; Last Update: February 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Demobesin3-99mTc"><a class="toc-item" href="/books/n/micad/Demobesin3-99mTc/"><sup>99m</sup>Tc-labeled [N<sub>4</sub><sup>0</sup>,Pro<sup>1</sup>,Tyr<sup>4</sup>]bombesin</a><span class="small"> [<a href="/books/n/micad/Demobesin3-99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Demobesin 3</div><div>Liang Shan.</div><div class="small">Created: September 20, 2009; Last Update: October 28, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Apcitide99mTc"><a class="toc-item" href="/books/n/micad/Apcitide99mTc/"><sup>99m</sup>Tc-Labeled 13,13’[oxybis[methylene(2,5-dioxo-1,3-pyrrolidinediyl)]]bis[<i>N</i>-(mercaptoacetyl)-D-tyrosyl-S-(3-aminopropyl)-L-cysteinylglycyl-L-α-aspartyl-L-cysteinylglycylglycyl-S-[(acetylamino)methyl]-L-cysteinylglycyl-S-[(acetylamino)methyl-L-cysteinylglycylglycyl-L-cysteinamide],cyclic(1→5),(1’→5’),-bis(sulfide)</a><span class="small"> [<a href="/books/n/micad/Apcitide99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-apcitide</div><div>Arvind Chopra.</div><div class="small">Created: December 19, 2008; Last Update: January 14, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EMIDP99mTc"><a class="toc-item" href="/books/n/micad/EMIDP99mTc/"><sup>99m</sup>Tc-Labeled 1-hydroxy-2-(2-ethyl-4-methyl-1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid</a><span class="small"> [<a href="/books/n/micad/EMIDP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-EMIDP</div><div>Arvind Chopra.</div><div class="small">Created: July 13, 2010; Last Update: July 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_iPIDP99mTc"><a class="toc-item" href="/books/n/micad/iPIDP99mTc/"><sup>99m</sup>Tc-Labeled 1-hydroxy-2-(2-isopropyl-1H-imidazole-1-yl)ethylidene-1,1-bisphosphonic acid</a><span class="small"> [<a href="/books/n/micad/iPIDP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-iPIDP</div><div>Arvind Chopra.</div><div class="small">Created: October 24, 2011; Last Update: November 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IPrDP99mTc"><a class="toc-item" href="/books/n/micad/IPrDP99mTc/"><sup>99m</sup>Tc-Labeled 1-hydroxy-3-(1H-imidazol-1-yl)propane-1,1-diyldiphosphonic acid (IPrDP)</a><span class="small"> [<a href="/books/n/micad/IPrDP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-IPrDP</div><div>Arvind Chopra.</div><div class="small">Created: July 7, 2011; Last Update: September 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IPTMP99mTc"><a class="toc-item" href="/books/n/micad/IPTMP99mTc/"><sup>99m</sup>Tc-Labeled 5-amino-1,3-bis(ethylamine-(<i>N,N</i>-dimethyl diphosphonic acid)acetamido)benzene</a><span class="small"> [<a href="/books/n/micad/IPTMP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]IPTMP</div><div>Puja Panwar, Sweta Singh, Nitin Kumar, Harish Rawat, Anil Kumar Mishra, and Arvind Chopra.</div><div class="small">Created: July 10, 2009; Last Update: October 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICPR8199mTc"><a class="toc-item" href="/books/n/micad/HYNICPR8199mTc/"><sup>99m</sup>Tc-Labeled 6-hydrazinopyridine-3-carboxylic acid (HYNIC)–conjugated murine anti-MUC1 monoclonal antibody PR81</a><span class="small"> [<a href="/books/n/micad/HYNICPR8199mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]-PR81</div><div>Arvind Chopra.</div><div class="small">Created: May 26, 2010; Last Update: June 29, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNIC-HBP99mTc"><a class="toc-item" href="/books/n/micad/HYNIC-HBP99mTc/"><sup>99m</sup>Tc-Labeled 6-hydrazinopyridine-3-carboxylic acid conjugated to hydroxy-bisphosphonate</a><span class="small"> [<a href="/books/n/micad/HYNIC-HBP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]HYNIC-HBP</div><div>Arvind Chopra.</div><div class="small">Created: November 6, 2009; Last Update: December 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc-Ac-FA"><a class="toc-item" href="/books/n/micad/Tc-Ac-FA/"><sup>99m</sup>Tc-Labeled acetylated dendrimer poly(amido)-amine generation 5-folic acid-2-(<i>p</i>-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate</a><span class="small"> [<a href="/books/n/micad/Tc-Ac-FA/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-G5-Ac-FA-DTPA</div><div>Liang Shan.</div><div class="small">Created: March 15, 2011; Last Update: April 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc-Ac-pegFA"><a class="toc-item" href="/books/n/micad/Tc-Ac-pegFA/"><sup>99m</sup>Tc-Labeled acetylated dendrimer poly(amido)-amine generation 5-PEGylated folic acid-2-(<i>p</i>-isothiocyanatobenzyl)-6-methyl-diethylenetriamine pentaacetic acid conjugate</a><span class="small"> [<a href="/books/n/micad/Tc-Ac-pegFA/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-G5-Ac-pegFA-DTPA</div><div>Liang Shan.</div><div class="small">Created: March 15, 2011; Last Update: April 21, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AntiCEA99mTcCL58"><a class="toc-item" href="/books/n/micad/AntiCEA99mTcCL58/"><sup>99m</sup>Tc-Labeled anti-carcinoembryonic antigen monoclonal antibody CL-58</a><span class="small"> [<a href="/books/n/micad/AntiCEA99mTcCL58/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Anti-CEA CL-58</div><div>Arvind Chopra.</div><div class="small">Created: July 28, 2008; Last Update: August 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMRNb99mTc"><a class="toc-item" href="/books/n/micad/MMRNb99mTc/"><sup>99m</sup>Tc-Labeled anti-macrophage mannose receptor (MMR; CD206) nanobody</a><span class="small"> [<a href="/books/n/micad/MMRNb99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]MMR Nb</div><div>Arvind Chopra.</div><div class="small">Created: September 4, 2012; Last Update: September 27, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99mRAGEmFab"><a class="toc-item" href="/books/n/micad/Tc99mRAGEmFab/"><sup>99m</sup>Tc-Labeled anti-receptor for advanced glycation endproducts monoclonal antibody F(ab’)<sub>2</sub> fragments</a><span class="small"> [<a href="/books/n/micad/Tc99mRAGEmFab/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-anti-RAGE mF(ab’)<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: July 16, 2010; Last Update: August 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99mRAGEpFab"><a class="toc-item" href="/books/n/micad/Tc99mRAGEpFab/"><sup>99m</sup>Tc-Labeled anti-receptor for advanced glycation endproducts polyclonal antibody F(ab’)<sub>2</sub> fragments</a><span class="small"> [<a href="/books/n/micad/Tc99mRAGEpFab/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-anti-RAGE pF(ab’)<sub>2</sub></div><div>Liang Shan.</div><div class="small">Created: July 16, 2010; Last Update: August 16, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Infliximab99mTc"><a class="toc-item" href="/books/n/micad/Infliximab99mTc/"><sup>99m</sup>Tc-labeled anti-tumor necrosis factor-alpha monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Infliximab99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-anti-TNF-α mAb</div><div>Arvind Chopra.</div><div class="small">Created: September 25, 2007; Last Update: October 22, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc-citro-folate"><a class="toc-item" href="/books/n/micad/Tc-citro-folate/"><sup>99m</sup>Tc-Labeled citric acid-folate conjugate</a><span class="small"> [<a href="/books/n/micad/Tc-citro-folate/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Citro-folate</div><div>Liang Shan.</div><div class="small">Created: March 15, 2011; Last Update: April 19, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CysdEGF99mTc"><a class="toc-item" href="/books/n/micad/CysdEGF99mTc/"><sup>99m</sup>Tc-Labeled cysteine-tagged dimeric epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/CysdEGF99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Cys-dEGF</div><div>Arvind Chopra.</div><div class="small">Created: May 18, 2009; Last Update: July 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CysEGF99mTc"><a class="toc-item" href="/books/n/micad/CysEGF99mTc/"><sup>99m</sup>Tc-Labeled cysteine-tagged epidermal growth factor</a><span class="small"> [<a href="/books/n/micad/CysEGF99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Cys-EGF</div><div>Arvind Chopra.</div><div class="small">Created: May 18, 2009; Last Update: July 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-doxorubicin"><a class="toc-item" href="/books/n/micad/Tc99m-doxorubicin/"><sup>99m</sup>Tc-Labeled doxorubicin</a><span class="small"> [<a href="/books/n/micad/Tc99m-doxorubicin/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-doxorubicin</div><div>Liang Shan.</div><div class="small">Created: December 3, 2012; Last Update: January 2, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICcysAnnaV599mTc"><a class="toc-item" href="/books/n/micad/HYNICcysAnnaV599mTc/"><sup>99m</sup>Tc-Labeled hydrazinonicotinamide-cysteine-annexin A5</a><span class="small"> [<a href="/books/n/micad/HYNICcysAnnaV599mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-HYNIC-<i>cys</i>-Annexin A5</div><div>Arvind Chopra.</div><div class="small">Created: January 13, 2010; Last Update: March 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Complex799mTc"><a class="toc-item" href="/books/n/micad/Complex799mTc/"><sup>99m</sup>Tc-Labeled imine 6-(pyridine-2-methylimine)-4-[(3-bromophenyl)amino]quinazoline</a><span class="small"> [<a href="/books/n/micad/Complex799mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc]Complex 7</div><div>Arvind Chopra.</div><div class="small">Created: June 18, 2009; Last Update: August 4, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ioregfrMAb99mTc"><a class="toc-item" href="/books/n/micad/ioregfrMAb99mTc/"><sup>99m</sup>Tc-labeled ior-egf/r3 monoclonal antibody against epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/ioregfrMAb99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-ior-egf/r3 MAb</div><div>Arvind Chopra.</div><div class="small">Created: June 11, 2007; Last Update: December 19, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECHGSETR299mTc"><a class="toc-item" href="/books/n/micad/ECHGSETR299mTc/"><sup>99m</sup>Tc-Labeled lexatumumab</a><span class="small"> [<a href="/books/n/micad/ECHGSETR299mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-HGS-ETR2</div><div>Arvind Chopra.</div><div class="small">Created: March 19, 2009; Last Update: May 20, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-DCM20"><a class="toc-item" href="/books/n/micad/Tc99m-DCM20/"><sup>99m</sup>Tc-Labeled mannosylated dextran DCM20</a><span class="small"> [<a href="/books/n/micad/Tc99m-DCM20/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(CO)<sub>3</sub>-DCM20</div><div>Liang Shan.</div><div class="small">Created: May 16, 2012; Last Update: July 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ECHGSETR199mTc"><a class="toc-item" href="/books/n/micad/ECHGSETR199mTc/"><sup>99m</sup>Tc-Labeled mapatumumab</a><span class="small"> [<a href="/books/n/micad/ECHGSETR199mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC-HGS-ETR1</div><div>Arvind Chopra.</div><div class="small">Created: March 16, 2009; Last Update: May 20, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MAG3-HBP99mTc"><a class="toc-item" href="/books/n/micad/MAG3-HBP99mTc/"><sup>99m</sup>Tc-Labeled mercaptoacetylglycylglycylglycine conjugated to hydroxy-bisphosphonate</a><span class="small"> [<a href="/books/n/micad/MAG3-HBP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]MAG3-HBP</div><div>Arvind Chopra.</div><div class="small">Created: November 6, 2009; Last Update: December 9, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Fanolesomab99mTc"><a class="toc-item" href="/books/n/micad/Fanolesomab99mTc/"><sup>99m</sup>Tc-Labeled murine IgM monoclonal antibody, fanolesomab, that targets the CD15 glycoprotein antigen</a><span class="small"> [<a href="/books/n/micad/Fanolesomab99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Fanolesomab</div><div>Arvind Chopra.</div><div class="small">Created: September 19, 2011; Last Update: October 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NTP15_599mTc"><a class="toc-item" href="/books/n/micad/NTP15_599mTc/"><sup>99m</sup>Tc-Labeled <i>N</i>-(triethylammonium)-3-propyl-[15]ane-N5</a><span class="small"> [<a href="/books/n/micad/NTP15_599mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]NTP 15-5</div><div>Arvind Chopra.</div><div class="small">Created: September 18, 2009; Last Update: December 17, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_K49maDABHERTc99m"><a class="toc-item" href="/books/n/micad/K49maDABHERTc99m/"><sup>99m</sup>Tc-Labeled N<sup>ε49</sup> mercaptoacetyl derivatives of affibody Z<sub>HER2:342</sub> targeting the human epidermal growth factor receptor</a><span class="small"> [<a href="/books/n/micad/K49maDABHERTc99m/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-N<sup>ε49</sup>-maGGG-Z<sub>HER2:342</sub>; [<sup>99m</sup>Tc]-N<sup>ε49</sup>-maSSS-Z<sub>HER2:342</sub>; [<sup>99m</sup>Tc]-N<sup>ε49</sup>-maESE-Z<sub>HER2:342</sub></div><div>Arvind Chopra.</div><div class="small">Created: January 19, 2010; Last Update: March 4, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_N4AMT99mTc"><a class="toc-item" href="/books/n/micad/N4AMT99mTc/"><sup>99m</sup>Tc-Labeled O-[3-(1,4,8,11-tetraazabicyclohexadecane)-propyl]-α-methyl tyrosine</a><span class="small"> [<a href="/books/n/micad/N4AMT99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-N4-AMT</div><div>Arvind Chopra.</div><div class="small">Created: October 26, 2011; Last Update: December 1, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_EC2099mTc"><a class="toc-item" href="/books/n/micad/EC2099mTc/"><sup>99m</sup>Tc-Labeled peptide derivative of folic acid</a><span class="small"> [<a href="/books/n/micad/EC2099mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-EC20</div><div>Arvind Chopra.</div><div class="small">Created: September 11, 2009; Last Update: November 12, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PN2SPEGUBI99mTc"><a class="toc-item" href="/books/n/micad/PN2SPEGUBI99mTc/"><sup>99m</sup>Tc-Labeled poly(ethyleneglycol)–<i>N</i>-(<i>N</i>-(3-diphenylphosphinopropionyl)glycyl)-<i>S</i>-tritylcysteine (PEG-PN<sub>2</sub>S)-linked ubiquicidin (UBI)</a><span class="small"> [<a href="/books/n/micad/PN2SPEGUBI99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-PEG-PN<sub>2</sub>S-UBI<sub>29-41</sub></div><div>Arvind Chopra.</div><div class="small">Created: September 26, 2011; Last Update: October 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BATbp99mTc"><a class="toc-item" href="/books/n/micad/BATbp99mTc/"><sup>99m</sup>Tc-Labeled pyridyl benzofuran derivatives to target β-amyloid plaques</a><span class="small"> [<a href="/books/n/micad/BATbp99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]BAT-bp-1, [<sup>99m</sup>Tc]BAT-bp-2, and [<sup>99m</sup>Tc]BAT-bp-3</div><div>Arvind Chopra.</div><div class="small">Created: July 11, 2012; Last Update: August 16, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Rituximab99mTc"><a class="toc-item" href="/books/n/micad/Rituximab99mTc/"><sup>99m</sup>Tc-Labeled rituximab, a chimeric murine/human anti-CD20 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/Rituximab99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]Rituximab</div><div>Arvind Chopra.</div><div class="small">Created: September 20, 2012; Last Update: October 25, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SBzMAG3Ga99mTc"><a class="toc-item" href="/books/n/micad/SBzMAG3Ga99mTc/"><sup>99m</sup>Tc-Labeled <i>S</i>-benzoylmercaptoacetyl triglycine <span class="small-caps">d</span>-galactose</a><span class="small"> [<a href="/books/n/micad/SBzMAG3Ga99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]SBz-MAG<sub>3</sub>-Ga</div><div>Arvind Chopra.</div><div class="small">Created: April 21, 2010; Last Update: May 11, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SBzMAG3Gl99mTc"><a class="toc-item" href="/books/n/micad/SBzMAG3Gl99mTc/"><sup>99m</sup>Tc-Labeled <i>S</i>-benzoylmercaptoacetyl triglycine <span class="small-caps">d</span>-glucose</a><span class="small"> [<a href="/books/n/micad/SBzMAG3Gl99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]SBz-MAG<sub>3</sub>-Gl</div><div>Arvind Chopra.</div><div class="small">Created: April 21, 2010; Last Update: May 13, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SBzMAG3NG99mTc"><a class="toc-item" href="/books/n/micad/SBzMAG3NG99mTc/"><sup>99m</sup>Tc-Labeled <i>S</i>-benzoylmercaptoacetyl triglycine <span class="small-caps">n</span>-acetylglucosamine</a><span class="small"> [<a href="/books/n/micad/SBzMAG3NG99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]SBz-MAG<sub>3</sub>-NG</div><div>Arvind Chopra.</div><div class="small">Created: April 21, 2010; Last Update: May 13, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Visilizumab99mTc"><a class="toc-item" href="/books/n/micad/Visilizumab99mTc/"><sup>99m</sup>Tc-Labeled succinimidyl-6-hydrazinonicotinate hydrochloride (SHNH)-conjugated visilizumab</a><span class="small"> [<a href="/books/n/micad/Visilizumab99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-SHNH-visilizumab</div><div>Liang Shan.</div><div class="small">Created: December 7, 2009; Last Update: January 12, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TEPAfolate99mTc"><a class="toc-item" href="/books/n/micad/TEPAfolate99mTc/"><sup>99m</sup>Tc-Labeled tetraethylenepentamine-folate</a><span class="small"> [<a href="/books/n/micad/TEPAfolate99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-TEPA-Folate</div><div>Puja Panwar, Vibha Srivastava, Vibha Tandon, Pushpa Mishra, Krishna Chuttani, Rakesh Sharma, Ramesh Chandra, Anil Mishra, and Arvind Chopra.</div><div class="small">Created: August 25, 2009; Last Update: October 1, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CDTMP99mTc"><a class="toc-item" href="/books/n/micad/CDTMP99mTc/"><sup>99m</sup>Tc-Labeled <i>trans</i>-1,2-cyclohexyldinitrilo tetramethylene phosphonic acid</a><span class="small"> [<a href="/books/n/micad/CDTMP99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]CDTMP</div><div>Puja Panwar, Krishna Chuttani, Pushpa Mishra, Rajnish Sharma, Anupam Mondal, Anil Kumar Mishra, and Arvind Chopra.</div><div class="small">Created: August 19, 2009; Last Update: October 15, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TAGpepI99mTc"><a class="toc-item" href="/books/n/micad/TAGpepI99mTc/"><sup>99m</sup>Tc-Labeled tumor-associated glycoprotein 72 binding peptides A2-6 and A3-10</a><span class="small"> [<a href="/books/n/micad/TAGpepI99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-A2-6 and [<sup>99m</sup>Tc]-A3-10</div><div>Arvind Chopra.</div><div class="small">Created: September 13, 2011; Last Update: October 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TAGpepII99mTc"><a class="toc-item" href="/books/n/micad/TAGpepII99mTc/"><sup>99m</sup>Tc-Labeled tumor-associated glycoprotein 72 binding peptides G3-15 and T3-15</a><span class="small"> [<a href="/books/n/micad/TAGpepII99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc]-G3-15 and [<sup>99m</sup>Tc]-T3-15</div><div>Arvind Chopra.</div><div class="small">Created: September 13, 2011; Last Update: October 27, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TcTTA1"><a class="toc-item" href="/books/n/micad/TcTTA1/"><sup>99m</sup>Tc-Mercaptoacetyl-Glu-Glu-aptamer specific for tenascin-C </a><span class="small"> [<a href="/books/n/micad/TcTTA1/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-TTA1</div><div>Huiming Zhang.</div><div class="small">Created: July 17, 2008; Last Update: August 12, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-MaEEE-99mTc"><a class="toc-item" href="/books/n/micad/Z-MaEEE-99mTc/"><sup>99m</sup>Tc-Mercaptoacetyl-Glu-Glu-Glu-Affibody Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-MaEEE-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MaEEE-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: March 16, 2008; Last Update: April 7, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-MAG3-99mTc"><a class="toc-item" href="/books/n/micad/Z-MAG3-99mTc/"><sup>99m</sup>Tc-Mercaptoacetyl-Gly-Gly-Gly-Affibody Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-MAG3-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MAG3-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: January 6, 2008; Last Update: April 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PAP-1-MAG3-99mTc"><a class="toc-item" href="/books/n/micad/PAP-1-MAG3-99mTc/"><sup>99m</sup>Tc-Mercaptoacetyl-Gly-Gly-Gly-PAP-1</a><span class="small"> [<a href="/books/n/micad/PAP-1-MAG3-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MAG3-PAP-1</div><div>Kam Leung.</div><div class="small">Created: August 8, 2008; Last Update: August 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Z-MaSSS-99mTc"><a class="toc-item" href="/books/n/micad/Z-MaSSS-99mTc/"><sup>99m</sup>Tc-Mercaptoacetyl-Ser-Ser-Ser-Affibody Z<sub>HER2:342</sub></a><span class="small"> [<a href="/books/n/micad/Z-MaSSS-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MaSSS-Z<sub>HER2:342</sub></div><div>Kam Leung.</div><div class="small">Created: March 11, 2008; Last Update: May 5, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MDP99mTc"><a class="toc-item" href="/books/n/micad/MDP99mTc/"><sup>99m</sup>Tc-Methyl diphosphonate</a><span class="small"> [<a href="/books/n/micad/MDP99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MDP</div><div>Arvind Chopra.</div><div class="small">Created: March 29, 2007; Last Update: August 24, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MCP-1Tc99m"><a class="toc-item" href="/books/n/micad/MCP-1Tc99m/"><sup>99m</sup>Tc-Monocyte chemoattractant protein-1 </a><span class="small"> [<a href="/books/n/micad/MCP-1Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MCP-1</div><div>Dagmar Hartung, Artiom Petrov, Kenneth T. Cheng, and Jagat Narula.</div><div class="small">Created: February 2, 2008; Last Update: March 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PNAKRAS99mTc"><a class="toc-item" href="/books/n/micad/PNAKRAS99mTc/"><sup>99m</sup>Tc-<i>N</i>,<i>N'</i>-Bis(<i>S</i>-benzoyl-thioglycoloyl)diamidopropanoyl-KRAS-PNA-<span class="small-caps">d</span>(Cys-Ser-Lys-Cys)</a><span class="small"> [<a href="/books/n/micad/PNAKRAS99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-WT4351</div><div>Kenneth T. Cheng, Atis Chakrabarti, Mohan R. Aruva, Mathew L. Thakur, and Eric Wickstrom.</div><div class="small">Created: August 9, 2007; Last Update: January 3, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tat-BN-99mTc"><a class="toc-item" href="/books/n/micad/Tat-BN-99mTc/"><sup>99m</sup>Tc-N<sub>2</sub>S<sub>2</sub>-Tat(49-57)-Lys<sup>3</sup>-bombesin</a><span class="small"> [<a href="/books/n/micad/Tat-BN-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Tat-BN</div><div>Liang Shan.</div><div class="small">Created: August 10, 2009; Last Update: September 23, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICnsCCK8Tc99m"><a class="toc-item" href="/books/n/micad/HYNICnsCCK8Tc99m/"><sup>99m</sup>Tc-Nicotinic acid/tricine/hydrazinonicotinamide-nonsulfated cholecystokinin-8</a><span class="small"> [<a href="/books/n/micad/HYNICnsCCK8Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NA/tricine/HYNIC-nsCCK-8</div><div>Kenneth T. Cheng and Peter Laverman.</div><div class="small">Created: August 31, 2007; Last Update: September 25, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_HYNICsCCK8Tc99m"><a class="toc-item" href="/books/n/micad/HYNICsCCK8Tc99m/"><sup>99m</sup>Tc-Nicotinic acid/tricine/hydrazinonicotinamide-sulfated cholecystokinin-8</a><span class="small"> [<a href="/books/n/micad/HYNICsCCK8Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NA/tricine/HYNIC-sCCK-8</div><div>Kenneth T. Cheng and Peter Laverman.</div><div class="small">Created: August 18, 2007; Last Update: September 13, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Probestin-99mTc"><a class="toc-item" href="/books/n/micad/Probestin-99mTc/"><sup>99m</sup>TcO-<i>N</i>,<i>N</i>-Dimethylglycyl-<span class="small-caps">l</span>-lysinyl-<span class="small-caps">l</span>-cysteinylamide-8-amino-3,6-dioxaoctanoic-probestin</a><span class="small"> [<a href="/books/n/micad/Probestin-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>TcO-N<sub>3</sub>S-PEG<sub>2</sub>-probestin</div><div>Kam Leung.</div><div class="small">Created: January 15, 2012; Last Update: April 12, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Litorin99mTc"><a class="toc-item" href="/books/n/micad/Litorin99mTc/"><sup>99m</sup>Tc-pGlu-Gln-Trp-Ala-Val-Gly-His-Phe-Met-NH2 </a><span class="small"> [<a href="/books/n/micad/Litorin99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-Litorin</div><div>Kam Leung.</div><div class="small">Created: October 1, 2007; Last Update: December 24, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RAFT-RGD99mTc"><a class="toc-item" href="/books/n/micad/RAFT-RGD99mTc/"><sup>99m</sup>Tc-Regioselectively addressable functionalized template-[cyclo-(Arg-Gly-Asp-<span class="small-caps">d</span>-Phe-Lys)]<sub>4</sub></a><span class="small"> [<a href="/books/n/micad/RAFT-RGD99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-RAFT-c(-RGDfK-)<sub>4</sub></div><div>Kam Leung.</div><div class="small">Created: February 9, 2008; Last Update: May 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SDF1alpha99mTc"><a class="toc-item" href="/books/n/micad/SDF1alpha99mTc/"><sup>99m</sup>Tc-S-acetylmercaptoacetyltriserine-stromal-derived factor 1α </a><span class="small"> [<a href="/books/n/micad/SDF1alpha99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-MAS<sub>3</sub>-SDF-1α</div><div>Arvind Chopra.</div><div class="small">Created: June 11, 2008; Last Update: July 22, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IL1299mTc"><a class="toc-item" href="/books/n/micad/IL1299mTc/"><sup>99m</sup>Tc-succinimidyl-6-hydrazinopyridine-3-carboxylate-interleukin 12</a><span class="small"> [<a href="/books/n/micad/IL1299mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-IL-12</div><div>Arvind Chopra.</div><div class="small">Created: October 5, 2007; Last Update: November 13, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_AnxA5-His-99mTc"><a class="toc-item" href="/books/n/micad/AnxA5-His-99mTc/"><sup>99m</sup>Tc-Tricarbonyl-His<sub>6</sub>-annexin A5</a><span class="small"> [<a href="/books/n/micad/AnxA5-His-99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc(CO)<sub>3</sub>-His-A5</div><div>Kam Leung.</div><div class="small">Created: April 19, 2012; Last Update: July 19, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_CCK8KHKH99mTc"><a class="toc-item" href="/books/n/micad/CCK8KHKH99mTc/"><sup>99m</sup>Tc-Tricarbonyl-K-H-K-H-cholecystokinin 8</a><span class="small"> [<a href="/books/n/micad/CCK8KHKH99mTc/pdf/">PDF Version</a>]</span><div>[<sup>99m</sup>Tc](KH)<sub>2</sub>CCK8</div><div>Arvind Chopra.</div><div class="small">Created: July 14, 2008; Last Update: August 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ASMA99mTc"><a class="toc-item" href="/books/n/micad/ASMA99mTc/"><sup>99m</sup>Tc-Tricarbonyl–labeled aspartic-<i>N</i>-monoacetic acid (ASMA)</a><span class="small"> [<a href="/books/n/micad/ASMA99mTc/pdf/">PDF Version</a>]</span><div> [<sup>99m</sup>Tc](CO)<sub>3</sub>(ASMA)</div><div>Arvind Chopra.</div><div class="small">Created: August 2, 2012; Last Update: September 13, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_TNFR2FcIL1ra99mTc"><a class="toc-item" href="/books/n/micad/TNFR2FcIL1ra99mTc/"><sup>99m</sup>Tc-Type II tumor necrosis receptor-Fc-interlukin-1 receptor antagonist fusion protein</a><span class="small"> [<a href="/books/n/micad/TNFR2FcIL1ra99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-TNFR2-Fc-IL-1ra</div><div>Kam Leung.</div><div class="small">Created: May 1, 2013; Last Update: May 30, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_UBI29-41Tc99m"><a class="toc-item" href="/books/n/micad/UBI29-41Tc99m/"><sup>99m</sup>Tc-Ubiquicidin<sub>29-41</sub></a><span class="small"> [<a href="/books/n/micad/UBI29-41Tc99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-UBI<sub>29-41</sub></div><div>The MICAD Research Team.</div><div class="small">Created: July 31, 2007; Last Update: September 6, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BBN-NitridoPNP6-99m"><a class="toc-item" href="/books/n/micad/BBN-NitridoPNP6-99m/"><sup>99m</sup>Tc≡Nitrido(diphosphine)-Cys-β-Ala-Gln-Trp-Ala-Val-Gly-His-Leu-Met-NH<sub>2</sub></a><span class="small"> [<a href="/books/n/micad/BBN-NitridoPNP6-99m/pdf/">PDF Version</a>]</span><div><sup>99m</sup>TcN(PNP6)-Cys-β-Ala-BBN(7-14)NH<sub>2</sub></div><div>Kam Leung.</div><div class="small">Created: December 5, 2008; Last Update: January 16, 2009.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_P483H99mTc"><a class="toc-item" href="/books/n/micad/P483H99mTc/">Acetyl-lys-lys-lys-lys-lys-cys-gly-cys-gly-gly-pro-leu-tyr-lys-lys-ile-ile-lys-lys-leu-leu-glu-ser-heparin-[<sup>99m</sup>Tc] </a><span class="small"> [<a href="/books/n/micad/P483H99mTc/pdf/">PDF Version</a>]</span><div>P483H-<sup>99m</sup>Tc</div><div>Arvind Chopra.</div><div class="small">Created: November 14, 2007; Last Update: December 20, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-NCAM"><a class="toc-item" href="/books/n/micad/Tc99m-NCAM/"><i>N</i>-[2-(<i>N</i>-(2-mercaptoethyl)) amino ethyl]-<i>N</i>-(2-mercaptoethyl)-3,5-dimethylacetamide amantadine-technetium</a><span class="small"> [<a href="/books/n/micad/Tc99m-NCAM/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-NCAM</div><div>Liang Shan.</div><div class="small">Created: June 12, 2012; Last Update: July 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LisnprilCx99mTc"><a class="toc-item" href="/books/n/micad/LisnprilCx99mTc/">Tricarbonyl[<sup>99m</sup>Tc]technetium(I)-((S)-6-(8-(bis(pyridin-2-ylmethyl)amino)octanamido)-2-((S)-1-carboxy-3-phenylpropylamino)hexanoyl)pyrrolidine-2-carboxylic acid </a><span class="small"> [<a href="/books/n/micad/LisnprilCx99mTc/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-(CO)<sub>3</sub>D(C<sub>8</sub>)lisinopril</div><div>Arvind Chopra.</div><div class="small">Created: June 25, 2008; Last Update: July 29, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Tc99m-TMEOP"><a class="toc-item" href="/books/n/micad/Tc99m-TMEOP/">Tri-methoxy-tris-pyrazolyl-<sup>99m</sup>Tc-(CO)<sub>3</sub></a><span class="small"> [<a href="/books/n/micad/Tc99m-TMEOP/pdf/">PDF Version</a>]</span><div><sup>99m</sup>Tc-TMEOP</div><div>Liang Shan.</div><div class="small">Created: March 27, 2012; Last Update: April 25, 2012.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_ultrasound"><a class="toc-item" href="/books/n/micad/ultrasound/">Ultrasound</a><ul id="toc_lst_NBK5330_toc_ultrasound" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosdye"><a class="toc-item" href="/books/n/micad/sosdye/">Dye</a><ul id="toc_lst_NBK5330_toc_sosdye" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_MetBlu"><a class="toc-item" href="/books/n/micad/MetBlu/">3,7-bis(dimethylamino)-phenothiazin-5-ium chloride</a><span class="small"> [<a href="/books/n/micad/MetBlu/pdf/">PDF Version</a>]</span><div>Methylene blue</div><div>Arvind Chopra.</div><div class="small">Created: April 5, 2011; Last Update: April 29, 2011.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosgold"><a class="toc-item" href="/books/n/micad/sosgold/">Gold</a><ul id="toc_lst_NBK5330_toc_sosgold" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-nanocages"><a class="toc-item" href="/books/n/micad/Au-nanocages/">Gold nanocages</a><span class="small"> [<a href="/books/n/micad/Au-nanocages/pdf/">PDF Version</a>]</span><div>Au nanocages</div><div>Kam Leung.</div><div class="small">Created: March 19, 2011; Last Update: June 2, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-PEG-nanocages"><a class="toc-item" href="/books/n/micad/Au-PEG-nanocages/">Poly(ethylene glycol)-coated gold nanocages</a><span class="small"> [<a href="/books/n/micad/Au-PEG-nanocages/pdf/">PDF Version</a>]</span><div>PEG-AuNCs</div><div>Kam Leung.</div><div class="small">Created: March 19, 2011; Last Update: June 2, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MSH-AuNCs"><a class="toc-item" href="/books/n/micad/MSH-AuNCs/">Poly(ethylene glycol)-coated gold nanocages bioconjugated with [Nle<sup>4</sup>,<span class="small-caps">d</span>-Phe<sup>7</sup>]-α-melanotropin-stimulating hormone</a><span class="small"> [<a href="/books/n/micad/MSH-AuNCs/pdf/">PDF Version</a>]</span><div>[Nle<sup>4</sup>,<span class="small-caps">d</span>-Phe<sup>7</sup>]-α-MSH-PEG-AuNCs</div><div>Kam Leung.</div><div class="small">Created: May 29, 2011; Last Update: July 14, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_PEG-gold-NP"><a class="toc-item" href="/books/n/micad/PEG-gold-NP/">Polyethylene glycol–coated (PEG5000) gold nanoparticles</a><span class="small"> [<a href="/books/n/micad/PEG-gold-NP/pdf/">PDF Version</a>]</span><div>PEGylated gold nanoparticles</div><div>Liang Shan.</div><div class="small">Created: June 17, 2010; Last Update: November 17, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosicg"><a class="toc-item" href="/books/n/micad/sosicg/">ICG</a><ul id="toc_lst_NBK5330_toc_sosicg" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_SWNT-ICG-RGD"><a class="toc-item" href="/books/n/micad/SWNT-ICG-RGD/">Indocyanine green–enhanced, cyclic Arg-Gly-Asp–conjugated, PEGylated single-walled carbon nanotubes</a><span class="small"> [<a href="/books/n/micad/SWNT-ICG-RGD/pdf/">PDF Version</a>]</span><div>SWNT-ICG-RGD</div><div>Liang Shan.</div><div class="small">Created: June 2, 2010; Last Update: July 12, 2010.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosmicrobubbles"><a class="toc-item" href="/books/n/micad/sosmicrobubbles/">Microbubbles</a><ul id="toc_lst_NBK5330_toc_sosmicrobubbles" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Abciximab-MS"><a class="toc-item" href="/books/n/micad/Abciximab-MS/">Abciximab microbubbles</a><span class="small"> [<a href="/books/n/micad/Abciximab-MS/pdf/">PDF Version</a>]</span><div>MB<sub>Abc</sub></div><div>Kam Leung.</div><div class="small">Created: April 26, 2007; Last Update: February 26, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Quantison"><a class="toc-item" href="/books/n/micad/Quantison/">Air-filled, cross-linked, human serum albumin microcapsules</a><span class="small"> [<a href="/books/n/micad/Quantison/pdf/">PDF Version</a>]</span><div>Air-filled HSA microcapsules</div><div>Kenneth T. Cheng.</div><div class="small">Created: July 6, 2006; Last Update: May 8, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_LIBS-scFv-MB"><a class="toc-item" href="/books/n/micad/LIBS-scFv-MB/">Anti-ligand–induced binding sites (LIBS) single-chain antibody conjugated to microbubbles</a><span class="small"> [<a href="/books/n/micad/LIBS-scFv-MB/pdf/">PDF Version</a>]</span><div>LIBS-MBs</div><div>Kam Leung.</div><div class="small">Created: October 21, 2012; Last Update: February 28, 2013.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MB-VCAM-1"><a class="toc-item" href="/books/n/micad/MB-VCAM-1/">Anti-vascular cell adhesion molecule-1 monoclonal antibody M/K-2.7 microbubbles</a><span class="small"> [<a href="/books/n/micad/MB-VCAM-1/pdf/">PDF Version</a>]</span><div>MB<sub>VCAM-1</sub></div><div>Kam Leung.</div><div class="small">Created: November 20, 2007; Last Update: January 15, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RGDMB"><a class="toc-item" href="/books/n/micad/RGDMB/">Buried cyclo(Arg-Gly-Tyr(Me)-Lys-Glu) microbubbles</a><span class="small"> [<a href="/books/n/micad/RGDMB/pdf/">PDF Version</a>]</span><div>bRGD-MBs</div><div>Huiming Zhang.</div><div class="small">Created: June 2, 2008; Last Update: July 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MBm-VCAM-1-mAb429"><a class="toc-item" href="/books/n/micad/MBm-VCAM-1-mAb429/">Magnetic microbubbles conjugated with anti-vascular cell adhesion molecule-1 monoclonal antibody 429</a><span class="small"> [<a href="/books/n/micad/MBm-VCAM-1-mAb429/pdf/">PDF Version</a>]</span><div>MBvM</div><div>Kam Leung.</div><div class="small">Created: February 27, 2012; Last Update: June 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_BR55"><a class="toc-item" href="/books/n/micad/BR55/">Microbubble-conjugated vascular endothelial growth factor receptor 2 binding peptide</a><span class="small"> [<a href="/books/n/micad/BR55/pdf/">PDF Version</a>]</span><div>BR55</div><div>Adrian Nunn, Sibylle Pochon, Isabelle Tardy, Francois Tranquart, and Arvind Chopra.</div><div class="small">Created: February 14, 2012; Last Update: July 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_VEGFR2MB"><a class="toc-item" href="/books/n/micad/VEGFR2MB/">Microbubble-conjugated vascular endothelial growth factor receptor 2 monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/VEGFR2MB/pdf/">PDF Version</a>]</span><div>Arvind Chopra.</div><div class="small">Created: November 5, 2007; Last Update: December 12, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MB-ICAM-1"><a class="toc-item" href="/books/n/micad/MB-ICAM-1/">Microbubbles coated with antibody to intracellular adhesion molecule-1</a><span class="small"> [<a href="/books/n/micad/MB-ICAM-1/pdf/">PDF Version</a>]</span><div>MB<sub>ICAM-1</sub></div><div>Kam Leung.</div><div class="small">Created: December 21, 2006; Last Update: April 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MB-MAdCAM-1"><a class="toc-item" href="/books/n/micad/MB-MAdCAM-1/">Microbubbles coated with antibody to mucosal addressin cellular adhesion molecule-1</a><span class="small"> [<a href="/books/n/micad/MB-MAdCAM-1/pdf/">PDF Version</a>]</span><div>MB<sub>MAdCAM-1</sub></div><div>Kam Leung.</div><div class="small">Created: February 9, 2007; Last Update: February 27, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MB-RB40"><a class="toc-item" href="/books/n/micad/MB-RB40/">Microbubbles coated with anti-P-selectin antibody RB40.34</a><span class="small"> [<a href="/books/n/micad/MB-RB40/pdf/">PDF Version</a>]</span><div>MB-RB40.34</div><div>Kam Leung.</div><div class="small">Created: December 21, 2006; Last Update: April 17, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MBendo"><a class="toc-item" href="/books/n/micad/MBendo/">Microbubbles coated with biotinylated rabbit anti-mouse endoglin monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MBendo/pdf/">PDF Version</a>]</span><div>MB<sub>endoglin</sub></div><div>Arvind Chopra.</div><div class="small">Created: September 6, 2011; Last Update: September 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MBVEGFR2"><a class="toc-item" href="/books/n/micad/MBVEGFR2/">Microbubbles coated with biotinylated rabbit anti-mouse vascular endothelial growth factor receptor 2 (VEGFR-2) monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MBVEGFR2/pdf/">PDF Version</a>]</span><div>MB<sub>vegfr2</sub></div><div>Arvind Chopra.</div><div class="small">Created: September 12, 2011; Last Update: September 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MBInt"><a class="toc-item" href="/books/n/micad/MBInt/">Microbubbles coated with biotinylated rabbit anti-mouse α<sub>V</sub>β<sub>3</sub> integrin monoclonal antibody</a><span class="small"> [<a href="/books/n/micad/MBInt/pdf/">PDF Version</a>]</span><div>MB<sub>integrin</sub></div><div>Arvind Chopra.</div><div class="small">Created: September 12, 2011; Last Update: September 29, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MMP2-MB"><a class="toc-item" href="/books/n/micad/MMP2-MB/">Microbubbles conjugated with anti-matrix metalloproteinase 2 mouse monoclonal antibody sc-13595</a><span class="small"> [<a href="/books/n/micad/MMP2-MB/pdf/">PDF Version</a>]</span><div>MMP2-MBs</div><div>Kam Leung.</div><div class="small">Created: August 15, 2011; Last Update: November 17, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MB-cAbVCAM1-5"><a class="toc-item" href="/books/n/micad/MB-cAbVCAM1-5/">Microbubbles conjugated with anti-vascular cell adhesion molecule-1 nanobody cAbVCAM1-5</a><span class="small"> [<a href="/books/n/micad/MB-cAbVCAM1-5/pdf/">PDF Version</a>]</span><div>MB-cAbVCAM1-5</div><div>Kam Leung.</div><div class="small">Created: March 3, 2012; Last Update: June 14, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_RRL-MB"><a class="toc-item" href="/books/n/micad/RRL-MB/">Microbubbles conjugated with cyclo(CGGRRLGGC)</a><span class="small"> [<a href="/books/n/micad/RRL-MB/pdf/">PDF Version</a>]</span><div>MB<sub>RRL</sub></div><div>Kam Leung.</div><div class="small">Created: June 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Knottin-MB"><a class="toc-item" href="/books/n/micad/Knottin-MB/">Microbubbles conjugated with knottin 2.5D</a><span class="small"> [<a href="/books/n/micad/Knottin-MB/pdf/">PDF Version</a>]</span><div>MB<sub>Knottin</sub></div><div>Kam Leung.</div><div class="small">Created: October 20, 2010; Last Update: December 9, 2010.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_scVEGF-MB"><a class="toc-item" href="/books/n/micad/scVEGF-MB/">Microbubbles conjugated with single-chain Cys-tagged vascular endothelial growth factor-121</a><span class="small"> [<a href="/books/n/micad/scVEGF-MB/pdf/">PDF Version</a>]</span><div>scVEGF-MBs</div><div>Kam Leung.</div><div class="small">Created: December 15, 2010; Last Update: February 24, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Echistatin-mb"><a class="toc-item" href="/books/n/micad/Echistatin-mb/">Microbubbles-echistatin</a><span class="small"> [<a href="/books/n/micad/Echistatin-mb/pdf/">PDF Version</a>]</span><div>MB<sub>E</sub></div><div>Kam Leung.</div><div class="small">Created: February 18, 2005; Last Update: January 11, 2012.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_MBPDPcRGD"><a class="toc-item" href="/books/n/micad/MBPDPcRGD/">Microbubbles with a disteroylphosphatidylcholine, disteroylphosphatidylethanolamine-polyethyleneglycol (PEG) 2000-pyridyldithio propionate-PEG 40 stearate shell conjugated to cyclic arginine-glycine-aspartic acid-d-tyrosine-lysine (cRGD) pentapeptide</a><span class="small"> [<a href="/books/n/micad/MBPDPcRGD/pdf/">PDF Version</a>]</span><div>cRGD-MB</div><div>Arvind Chopra.</div><div class="small">Created: March 28, 2011; Last Update: April 28, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Perflexane"><a class="toc-item" href="/books/n/micad/Perflexane/">Perflexane-Lipid Microspheres</a><span class="small"> [<a href="/books/n/micad/Perflexane/pdf/">PDF Version</a>]</span><div>AFO150</div><div>Kenneth T. Cheng.</div><div class="small">Created: November 1, 2005; Last Update: May 13, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_perflutren-ms"><a class="toc-item" href="/books/n/micad/perflutren-ms/">Perflutren lipid microspheres</a><span class="small"> [<a href="/books/n/micad/perflutren-ms/pdf/">PDF Version</a>]</span><div>DMP 115</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 24, 2006; Last Update: November 21, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SonicatedHSM"><a class="toc-item" href="/books/n/micad/SonicatedHSM/">Sonicated human serum microspheres</a><span class="small"> [<a href="/books/n/micad/SonicatedHSM/pdf/">PDF Version</a>]</span><div>Sonicated HSM</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 20, 2006; Last Update: May 27, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_SonoVue"><a class="toc-item" href="/books/n/micad/SonoVue/">Stabilized sulfur hexafluoride microbubbles</a><span class="small"> [<a href="/books/n/micad/SonoVue/pdf/">PDF Version</a>]</span><div>SF<sub>6</sub> Microbubbles</div><div>Kenneth T. Cheng.</div><div class="small">Created: September 21, 2006; Last Update: February 25, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosnanobubbles"><a class="toc-item" href="/books/n/micad/sosnanobubbles/">Nanobubbles</a><ul id="toc_lst_NBK5330_toc_sosnanobubbles" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_PFC-SP-NB"><a class="toc-item" href="/books/n/micad/PFC-SP-NB/">Perfluoropropane-filled, sorbitan monostearate– and polyoxyethylene 40 stearate–shelled nanobubbles</a><span class="small"> [<a href="/books/n/micad/PFC-SP-NB/pdf/">PDF Version</a>]</span><div>PFC-S60-PEG40S-NB</div><div>Liang Shan.</div><div class="small">Created: August 2, 2010; Last Update: September 1, 2010.</div></li></ul></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_xrayct"><a class="toc-item" href="/books/n/micad/xrayct/">X-Ray, CT</a><ul id="toc_lst_NBK5330_toc_xrayct" class="simple-list toc bktoc_lst_exp"><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosau"><a class="toc-item" href="/books/n/micad/sosau/">Au</a><ul id="toc_lst_NBK5330_toc_sosau" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_AuNP"><a class="toc-item" href="/books/n/micad/AuNP/">Gold nanoparticles</a><span class="small"> [<a href="/books/n/micad/AuNP/pdf/">PDF Version</a>]</span><div>AuNPs</div><div>Kam Leung.</div><div class="small">Created: October 26, 2006; Last Update: March 8, 2011.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Au-PEG-NP"><a class="toc-item" href="/books/n/micad/Au-PEG-NP/">Polyethylene glycol-gold nanoparticles</a><span class="small"> [<a href="/books/n/micad/Au-PEG-NP/pdf/">PDF Version</a>]</span><div>PEG-AuNPs</div><div>Kam Leung.</div><div class="small">Created: May 26, 2008; Last Update: June 9, 2008.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosbi"><a class="toc-item" href="/books/n/micad/sosbi/">Bi</a><ul id="toc_lst_NBK5330_toc_sosbi" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_BPNP"><a class="toc-item" href="/books/n/micad/BPNP/">Bismuth sulphide polyvinylpyrrolidone nanoparticles</a><span class="small"> [<a href="/books/n/micad/BPNP/pdf/">PDF Version</a>]</span><div>BPNPs</div><div>Kam Leung.</div><div class="small">Created: October 26, 2006; Last Update: November 11, 2007.</div></li></ul></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_sosiodine"><a class="toc-item" href="/books/n/micad/sosiodine/">Iodine</a><ul id="toc_lst_NBK5330_toc_sosiodine" class="simple-list toc bktoc_lst_clps"><li class="half_rhythm" id="toc_itm_NBK5330_toc_Iopamidol"><a class="toc-item" href="/books/n/micad/Iopamidol/">(S)-<i>N</i>,<i>N</i>’-bis[2-hydroxy-1-(hydroxymethyl)-ethyl-2,4,6-triiodo-5-lactamidoisophthalamide</a><span class="small"> [<a href="/books/n/micad/Iopamidol/pdf/">PDF Version</a>]</span><div>Iopamidol</div><div>The MICAD Research Team.</div><div class="small">Created: April 3, 2007; Last Update: April 17, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_DHOG"><a class="toc-item" href="/books/n/micad/DHOG/">1,3-Bis-[7-(3-amino-2,4,6-triiodophenyl)-heptanoyl]-2-oleoyl glycerol</a><span class="small"> [<a href="/books/n/micad/DHOG/pdf/">PDF Version</a>]</span><div>DHOG</div><div>Cynthia Burrascano, William C. Dow, and Arvind Chopra.</div><div class="small">Created: August 29, 2007; Last Update: December 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Iobitridol"><a class="toc-item" href="/books/n/micad/Iobitridol/">5-[3-Hydroxy-2-hydroxymethyl-propionamido)-<i>N</i>,<i>N</i>´-dimethyl-<i>N</i>,<i>N</i>´-bis-(2,3-dihydroxypropyl)-2,4,6-triiodoisophthalamide</a><span class="small"> [<a href="/books/n/micad/Iobitridol/pdf/">PDF Version</a>]</span><div>Iobitridol</div><div>Kenneth T. Cheng.</div><div class="small">Created: May 16, 2006; Last Update: April 21, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_N1177"><a class="toc-item" href="/books/n/micad/N1177/">Ethyl-3,5-bis(acetylamino)-2,4,6-triiodobenzoate nanoparticles</a><span class="small"> [<a href="/books/n/micad/N1177/pdf/">PDF Version</a>]</span><div>N1177</div><div>Huiming Zhang.</div><div class="small">Created: June 10, 2008; Last Update: July 30, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_IX-C"><a class="toc-item" href="/books/n/micad/IX-C/">Ioxilan carbonate particles</a><span class="small"> [<a href="/books/n/micad/IX-C/pdf/">PDF Version</a>]</span><div>IX-C particles</div><div>Kenneth T. Cheng.</div><div class="small">Created: September 1, 2007; Last Update: December 18, 2007.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_NPlipiodol"><a class="toc-item" href="/books/n/micad/NPlipiodol/">Lipiodol-loaded poly(oxyethylene)-<i>block</i>-poly(oxypropylene)-<i>block</i>-poly(oxyethylene) triblock copolymers/polyethylene glycol-nanoparticles</a><span class="small"> [<a href="/books/n/micad/NPlipiodol/pdf/">PDF Version</a>]</span><div>LPNCs</div><div>Kenneth T. Cheng.</div><div class="small">Created: January 9, 2008; Last Update: February 18, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ioversol"><a class="toc-item" href="/books/n/micad/Ioversol/"><i>N,N´-</i>Bis(2,3-dihydroxypropyl)-5-[<i>N</i>-(2-hydroxyethyl)-glycolamidol]-2,4,6-triiodoisophthalamide</a><span class="small"> [<a href="/books/n/micad/Ioversol/pdf/">PDF Version</a>]</span><div>Ioversol</div><div>Kenneth T. Cheng.</div><div class="small">Created: February 7, 2006; Last Update: February 7, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Iopentol"><a class="toc-item" href="/books/n/micad/Iopentol/"><i>N</i>,<i>N</i>´-Bis(2,3-dihydroxypropyl)-5-[<i>N</i>-(2-hydroxyethyl-3-methoxypropyl)-acetamidol]-2,4,6-triiodoisophthalamide</a><span class="small"> [<a href="/books/n/micad/Iopentol/pdf/">PDF Version</a>]</span><div>Iopentol</div><div>Kenneth T. Cheng.</div><div class="small">Created: March 6, 2006; Last Update: March 4, 2008.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_Ioxilan"><a class="toc-item" href="/books/n/micad/Ioxilan/"><i>N</i>-(2,3-Dihydroxypropyl)-<i>N</i>´-(2-hydroxyethyl)-5-[<i>N</i>-(2,3-dihydroxypropyl)acetamido]-2,4,6-triiodoisophthalamide</a><span class="small"> [<a href="/books/n/micad/Ioxilan/pdf/">PDF Version</a>]</span><div>Ioxilan</div><div>The MICAD Research Team.</div><div class="small">Created: July 12, 2006; Last Update: August 9, 2006.</div></li><li class="half_rhythm" id="toc_itm_NBK5330_toc_tyropanoatesodium"><a class="toc-item" href="/books/n/micad/tyropanoatesodium/">Sodium-2-[(3-butanoylamino-2,4,6-triiodo-phenyl)methyl]butanoate</a><span class="small"> [<a href="/books/n/micad/tyropanoatesodium/pdf/">PDF Version</a>]</span><div>Tyropanoate Sodium</div><div>Kenneth T. Cheng.</div><div class="small">Created: October 5, 2005; Last Update: June 30, 2008.</div></li></ul></li></ul></li></ul><div class="bktoc_all_cntnr align_right" style="display:none"><ul class="inline_list_right"><li><a class="bktoc_all_exp" href="#">Expand All</a></li><li style="margin-left:.8em"><a class="bktoc_all_clps" href="#">Collapse All</a></li></ul></div></div></div></div>
|
|
<div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright Notice</a></div><div class="small"><span class="label">Bookshelf ID: NBK5330</span><span class="label">PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/20641179" title="PubMed record of this title" ref="pagearea=meta&targetsite=entrez&targetcat=link&targettype=pubmed">20641179</a></span></div><div style="margin-top:2em" class="bk_noprnt"><div class="pagination bk_noprnt"><span class="inactive page_link prev">< Prev</span><a class="active page_link next" href="/books/n/micad/micad_book_info/" title="Next page in this title">Next ></a></div></div></div></div>
|
|
|
|
</div>
|
|
|
|
<!-- Custom content below content -->
|
|
<div class="col4">
|
|
|
|
</div>
|
|
|
|
|
|
<!-- Book content -->
|
|
|
|
<!-- Custom contetnt below bottom nav -->
|
|
<div class="col5">
|
|
|
|
</div>
|
|
</div>
|
|
|
|
<div id="rightcolumn" class="four_col col last">
|
|
<!-- Custom content above discovery portlets -->
|
|
<div class="col6">
|
|
<div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK5330&db=books">Share</a></div>
|
|
|
|
</div>
|
|
<div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK5330/?report=reader">PubReader</a></li><li><a href="/books/NBK5330/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK5330" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK5330" style="display:none" title="Cite this Page"><div class="bk_tt">Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004-2013. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK5330/bin/micad.csv">MICAD summary (CSV file)</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Search MICAD</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-application" id="Shutter"></a></div><div class="portlet_content"><form xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" name="frmSearch" method="get" action="/books/NBK5330/" id="frmSearch"><script type="text/javascript" src="/corehtml/pmc//js/bookshelf/micad.js">/**/</script><label class="offscreen_noflow" for="txtfield">Search term</label><input id="txtfield" type="text" name="f1_term" size="22" onKeyPress="KeyPress('micad',event,'/books/NBK5330/','')" /><button name="f1_search" type="submit">Go</button><button onclick="this.form.reset();" type="reset">Clear</button><p><b>Limit my Search:</b></p><div class="clearfix"><label for="detection">Method of detection:</label><div class="right"><select name="detection" id="detection" style="width:200px"><option value="" selected="selected">Any</option><option value="(MRI OR "Magnetic resonance imaging" OR MRS)">MRI</option><option value="Multimodal">Multimodal imaging</option><option value="Optical">Optical imaging</option><option value="PET">PET</option><option value="Photoacoustic">Photoacoustic imaging</option><option value="(SPECT OR planar)">SPECT</option><option value="Ultrasound">Ultrasound</option><option value="(x-ray OR ct)">X-ray, CT</option></select></div></div><div class="clearfix"><label for="signal">Source of signal/contrast:</label><div class="right"><select name="signal" id="signal" style="width:200px"><option value="" selected="selected">Any</option><optgroup label="MRI agents"><option value="(Copper OR Cu)">Copper</option><option value="(Europium OR Eu3+)">Europium</option><option value="(Fluorine OR 19F)">Fluorine</option><option value="(Gadolinium OR Gd3+)">Gadolinium</option><option value=""Hyperpolarized 13C"">Hyperpolarized 13C</option><option value=""Iron oxide"">Iron oxide</option><option value=""Nitroxide radicals"">Nitroxide radicals</option><option value="(Oxygen OR 17O)">Oxygen</option><option value="Thulium">Thulium</option></optgroup><optgroup label="Multimodal agents"><option value="((Gadolinium OR Gd3+) AND Optical)">Gadolinium and optical</option><option value="((Gadolinium OR Gd3+) AND (Gold OR Au))">Gadolinium and Gold</option><option value="("Iron oxide" AND (64Cu OR 124I OR 111In))">Iron oxide and
|
|
radionuclides</option><option value="("Iron oxide" AND Optical)">Gadolinium and optical</option><option value="(Optical AND (64Cu OR 111In OR 177Lu))">Optical and
|
|
radionuclides</option><option value="(Perfluorocarbon AND (Europium OR Eu3+))">Perfluorocarbon and
|
|
europium</option><option value="(166Ho OR 67Ga OR 68Ga OR 123I OR 124I OR 125I)">Radionuclides</option></optgroup><optgroup label="Optical agents"><option value="("Fluorescent dyes" OR protein)">Fluorescent dyes or proteins</option><option value=""Luminescent agents"">Luminescent agents</option><option value="(Metals OR Metal OR Gold OR Au)">Metals (Au)</option><option value="Nanotubes">Nanotubes</option><option value=""Quantum dots"">Quantum dots</option></optgroup><optgroup label="PET radionuclides"><option value="("Arsenic 74" OR 74As)">Arsenic-74</option><option value="("Bromine 76" OR 76Br)">Bromine-76</option><option value="("Carbon 11" OR 11C)">Carbon-11</option><option value="(Copper-60 OR Copper-61 OR Copper-62 OR Copper-64 OR 60Cu OR 61Cu OR 62Cu OR 64Cu)">Copper-60, 61, 62, 64</option><option value="("Fluorine 18" OR 18F)">Fluorine-18</option><option value="(Gallium-68 OR 68Ga)">Gallium-68</option><option value="("Iodine 124" OR 124I)">Iodine-124</option><option value="("Nitrogen 13" OR 13N)">Nitrogen-13</option><option value="("Yttrium 86" OR 86Y)">Yttrium-86</option><option value="("Zirconium 89" OR 89Zr)">Zirconium-89</option></optgroup><optgroup label="Photoacoustic agents"><option value="(Gold OR Au)">Gold</option><option value="("Indocyanine green" OR ICG)">Indocyanine green</option></optgroup><optgroup label="SPECT radionuclides"><option value="(Gallium-67 OR 67Ga)">Gallium-67</option><option value="("Indium 111" OR 111In)">Indium-111</option><option value="("Iodine 123" OR "Iodine 125" OR "Iodine 131" OR 123I OR 125I OR 131I)">Iodine-123, 125, 131</option><option value="("Lutetium 177" OR 177Lu)">Lutetium-177</option><option value="(Rhenium OR 186Re OR 188Re)">Rhenium</option><option value="("Technetium 99m" OR 99mTc)">Technetium-99m</option><option value="("Tellurium 125m" OR 125mTe)">Tellurium-125m</option></optgroup><optgroup label="Ultrasound agents"><option value="Microbubbles">Microbubbles</option><option value="Nanobubbles">Nanobubbles</option></optgroup><optgroup label="X-ray and CT agents"><option value="(Bismuth OR Bi)">Bismuth</option><option value="(Gold OR Au)">Gold</option><option value="Iodine">Iodine</option></optgroup></select></div></div><div class="clearfix"><label for="agent">Agent Category:</label><div class="right"><select name="agent" id="agent" style="width:200px"><option value="" selected="selected">Any</option><option value="(antibody OR trastuzumab OR immunoglobulin)">Antibodies</option><option value="(bacteria OR bacteriophage OR coli)">Bacteria</option><option value="cell">Cells</option><option value="(compound OR "amino acid" OR "folic acid" OR "cage molecule" OR carbohydrate OR copolymers OR polymer OR "small molecule" OR macromolecule OR triiodobenzoate OR estradiol OR glycosaminoglycan)">Compounds</option><option value="ligand">Ligands</option><option value="(lipid OR liposome OR liposomes">Lipids</option><option value="metal">Metal</option><option value="(nanoparticle OR nanoparticles OR nanotubes OR "iron oxide")">Nanoparticles</option><option value="(siRNA OR "nucleic acid" OR oligonucleotide)">Nucleic acids</option><option value="peptide">Peptides</option><option value="polyeptide">Polyeptides</option><option value="(protein OR albumin OR chemokin OR immunoprotein OR luciferase OR albumin)">Proteins</option><option value="(virus OR adenovirus)">Viruses</option></select></div></div><div class="clearfix"><label for="target">Target Category:</label><div class="right"><select name="target" id="target" style="width:200px"><option value="" selected="selected">Any</option><option value="acceptor">Acceptors</option><option value=""adhesion molecule"">Adhesion molecules</option><option value="(antigen OR antibody-antigen)">Antigens</option><option value="(enzyme OR enzymes OR enzyme-substrate)">Enzymes</option><option value="(lipids OR lipophilic cation)">Lipids</option><option value="(receptor OR receptors OR receptor-ligand OR receptor-antibody OR antibody-receptor)">Receptors</option><option value="transporter">Transporters</option><option value="non-targeted">Non-targeted</option><option value=""nucleic acid"">Nucleic acids</option><option value="(non-targeted OR "unknown binding site")">Others</option></select></div></div><div><input id="__micad_btn_1" type="radio" name="stage" value="vitro" /><label for="__micad_btn_1"><i>In vitro</i></label><input id="__micad_btn_2" type="radio" name="stage" value="rodents" /><label for="__micad_btn_2">Rodents</label><input id="__micad_btn_3" type="radio" name="stage" value="mammals" /><label for="__micad_btn_3">Non-primate non-rodent mammals</label><br /><input id="__micad_btn_4" type="radio" name="stage" value="primates" /><label for="__micad_btn_4">Non-human primates</label><input id="__micad_btn_5" type="radio" name="stage" value="humans" /><label for="__micad_btn_5">Humans</label><input id="__micad_btn_6" type="radio" name="stage" value="any" checked="checked" /><label for="__micad_btn_6">Any</label></div></form><form xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" name="frmGo" method="get" action="javascript:alert('frmGo:_@action_was_not_set')" id="frmGo"><input name="term" value="." type="hidden" /></form></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=nlmcatalog&DbFrom=books&Cmd=Link&LinkName=books_nlmcatalog&IdsFromResult=1502792" ref="log$=recordlinks">NLM Catalog</a><div class="brieflinkpop offscreen_noflow">Related NLM Catalog Entries</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21989943" ref="ordinalpos=1&linkpos=1&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.</a><span class="source">[Mol Imaging Biol. 2012]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Molecular Imaging and Contrast Agent Database (MICAD): evolution and progress.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Chopra A, Shan L, Eckelman WC, Leung K, Latterner M, Bryant SH, Menkens A. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Mol Imaging Biol. 2012 Feb; 14(1):4-13. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/31670644" ref="ordinalpos=1&linkpos=2&log$=relatedarticles&logdbfrom=pubmed">Imaging tests for the detection of osteomyelitis: a systematic review.</a><span class="source">[Health Technol Assess. 2019]</span><div class="brieflinkpop offscreen_noflow">Imaging tests for the detection of osteomyelitis: a systematic review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Llewellyn A, Jones-Diette J, Kraft J, Holton C, Harden M, Simmonds M. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Health Technol Assess. 2019 Oct; 23(61):1-128. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/28876770" ref="ordinalpos=1&linkpos=3&log$=relatedreviews&logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review</a><span class="source">[ 2008]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Dementia -- Caring, Ethics, Ethnical and Economical Aspects: A Systematic Review<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Swedish Council on Health Technology Assessment. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">2008 Jun</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/33314144" ref="ordinalpos=1&linkpos=4&log$=relatedarticles&logdbfrom=pubmed">Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.</a><span class="source">[Med J Aust. 2020]</span><div class="brieflinkpop offscreen_noflow">Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Med J Aust. 2020 Dec; 213 Suppl 11:S3-S32.e1. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23074411" ref="ordinalpos=1&linkpos=5&log$=relatedarticles&logdbfrom=pubmed">Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.</a><span class="source">[Ont Health Technol Assess Ser....]</span><div class="brieflinkpop offscreen_noflow">Single photon emission computed tomography for the diagnosis of coronary artery disease: an evidence-based analysis.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Medical Advisory Secretariat. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ont Health Technol Assess Ser. 2010; 10(8):1-64. Epub 2010 Jun 1.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed_reviews&uid=20641179" ref="ordinalpos=1&log$=relatedreviews_seeall&logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&cmd=link&linkname=pubmed_pubmed&uid=20641179" ref="ordinalpos=1&log$=relatedarticles_seeall&logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=67c9b3c6a68b6b5afc426dcc">Molecular Imaging and Contrast Agent Database (MICAD)</a><div class="ralinkpop offscreen_noflow">Molecular Imaging and Contrast Agent Database (MICAD)<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=2" href="/portal/utils/pageresolver.fcgi?recordid=67c9b3c3b15b832ebcdf10a6">Enterococci</a><div class="ralinkpop offscreen_noflow">Enterococci<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=3" href="/portal/utils/pageresolver.fcgi?recordid=67c9b3c2a68b6b5afc425350">Baculovirus Molecular Biology</a><div class="ralinkpop offscreen_noflow">Baculovirus Molecular Biology<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=4" href="/portal/utils/pageresolver.fcgi?recordid=67c9b3c1f4a390645e08a886">Assay Guidance Manual</a><div class="ralinkpop offscreen_noflow">Assay Guidance Manual<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&linkpos=5" href="/portal/utils/pageresolver.fcgi?recordid=67c9b3c0a68b6b5afc424028">Bookshelf Conversion Projects - About Bookshelf</a><div class="ralinkpop offscreen_noflow">Bookshelf Conversion Projects - About Bookshelf<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
|
|
|
|
<!-- Custom content below discovery portlets -->
|
|
<div class="col7">
|
|
|
|
</div>
|
|
</div>
|
|
</div>
|
|
|
|
<!-- Custom content after all -->
|
|
<div class="col8">
|
|
|
|
</div>
|
|
<div class="col9">
|
|
|
|
</div>
|
|
|
|
<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
|
|
<script type="text/javascript">
|
|
(function($){
|
|
$('.skiplink').each(function(i, item){
|
|
var href = $($(item).attr('href'));
|
|
href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
|
|
$(item).on('click', function(event){
|
|
event.preventDefault();
|
|
$.scrollTo(href, 0, {
|
|
onAfter: function(){
|
|
href.focus();
|
|
}
|
|
});
|
|
});
|
|
});
|
|
})(jQuery);
|
|
</script>
|
|
</div>
|
|
<div class="bottom">
|
|
|
|
<div id="NCBIFooter_dynamic">
|
|
<!--<component id="Breadcrumbs" label="breadcrumbs"/>
|
|
<component id="Breadcrumbs" label="helpdesk"/>-->
|
|
|
|
</div>
|
|
|
|
<div class="footer" id="footer">
|
|
<section class="icon-section">
|
|
<div id="icon-section-header" class="icon-section_header">Follow NCBI</div>
|
|
<div class="grid-container container">
|
|
<div class="icon-section_container">
|
|
<a class="footer-icon" id="footer_twitter" href="https://twitter.com/ncbi" aria-label="Twitter"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<defs>
|
|
<style>
|
|
.cls-11 {
|
|
fill: #737373;
|
|
}
|
|
</style>
|
|
</defs>
|
|
<title>Twitter</title>
|
|
<path class="cls-11" d="M250.11,105.48c-7,3.14-13,3.25-19.27.14,8.12-4.86,8.49-8.27,11.43-17.46a78.8,78.8,0,0,1-25,9.55,39.35,39.35,0,0,0-67,35.85,111.6,111.6,0,0,1-81-41.08A39.37,39.37,0,0,0,81.47,145a39.08,39.08,0,0,1-17.8-4.92c0,.17,0,.33,0,.5a39.32,39.32,0,0,0,31.53,38.54,39.26,39.26,0,0,1-17.75.68,39.37,39.37,0,0,0,36.72,27.3A79.07,79.07,0,0,1,56,223.34,111.31,111.31,0,0,0,116.22,241c72.3,0,111.83-59.9,111.83-111.84,0-1.71,0-3.4-.1-5.09C235.62,118.54,244.84,113.37,250.11,105.48Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_facebook" href="https://www.facebook.com/ncbi.nlm" aria-label="Facebook"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<title>Facebook</title>
|
|
<path class="cls-11" d="M210.5,115.12H171.74V97.82c0-8.14,5.39-10,9.19-10h27.14V52l-39.32-.12c-35.66,0-42.42,26.68-42.42,43.77v19.48H99.09v36.32h27.24v109h45.41v-109h35Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_linkedin" href="https://www.linkedin.com/company/ncbinlm" aria-label="LinkedIn"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<title>LinkedIn</title>
|
|
<path class="cls-11" d="M101.64,243.37H57.79v-114h43.85Zm-22-131.54h-.26c-13.25,0-21.82-10.36-21.82-21.76,0-11.65,8.84-21.15,22.33-21.15S101.7,78.72,102,90.38C102,101.77,93.4,111.83,79.63,111.83Zm100.93,52.61A17.54,17.54,0,0,0,163,182v61.39H119.18s.51-105.23,0-114H163v13a54.33,54.33,0,0,1,34.54-12.66c26,0,44.39,18.8,44.39,55.29v58.35H198.1V182A17.54,17.54,0,0,0,180.56,164.44Z">
|
|
</path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_github" href="https://github.com/ncbi" aria-label="GitHub"><svg xmlns="http://www.w3.org/2000/svg" data-name="Layer 1" viewBox="0 0 300 300">
|
|
<defs>
|
|
<style>
|
|
.cls-11,
|
|
.cls-12 {
|
|
fill: #737373;
|
|
}
|
|
|
|
.cls-11 {
|
|
fill-rule: evenodd;
|
|
}
|
|
</style>
|
|
</defs>
|
|
<title>GitHub</title>
|
|
<path class="cls-11" d="M151.36,47.28a105.76,105.76,0,0,0-33.43,206.1c5.28,1,7.22-2.3,7.22-5.09,0-2.52-.09-10.85-.14-19.69-29.42,6.4-35.63-12.48-35.63-12.48-4.81-12.22-11.74-15.47-11.74-15.47-9.59-6.56.73-6.43.73-6.43,10.61.75,16.21,10.9,16.21,10.9,9.43,16.17,24.73,11.49,30.77,8.79,1-6.83,3.69-11.5,6.71-14.14C108.57,197.1,83.88,188,83.88,147.51a40.92,40.92,0,0,1,10.9-28.39c-1.1-2.66-4.72-13.42,1-28,0,0,8.88-2.84,29.09,10.84a100.26,100.26,0,0,1,53,0C198,88.3,206.9,91.14,206.9,91.14c5.76,14.56,2.14,25.32,1,28a40.87,40.87,0,0,1,10.89,28.39c0,40.62-24.74,49.56-48.29,52.18,3.79,3.28,7.17,9.71,7.17,19.58,0,14.15-.12,25.54-.12,29,0,2.82,1.9,6.11,7.26,5.07A105.76,105.76,0,0,0,151.36,47.28Z">
|
|
</path>
|
|
<path class="cls-12" d="M85.66,199.12c-.23.52-1.06.68-1.81.32s-1.2-1.06-.95-1.59,1.06-.69,1.82-.33,1.21,1.07.94,1.6Zm-1.3-1">
|
|
</path>
|
|
<path class="cls-12" d="M90,203.89c-.51.47-1.49.25-2.16-.49a1.61,1.61,0,0,1-.31-2.19c.52-.47,1.47-.25,2.17.49s.82,1.72.3,2.19Zm-1-1.08">
|
|
</path>
|
|
<path class="cls-12" d="M94.12,210c-.65.46-1.71,0-2.37-.91s-.64-2.07,0-2.52,1.7,0,2.36.89.65,2.08,0,2.54Zm0,0"></path>
|
|
<path class="cls-12" d="M99.83,215.87c-.58.64-1.82.47-2.72-.41s-1.18-2.06-.6-2.7,1.83-.46,2.74.41,1.2,2.07.58,2.7Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M107.71,219.29c-.26.82-1.45,1.2-2.64.85s-2-1.34-1.74-2.17,1.44-1.23,2.65-.85,2,1.32,1.73,2.17Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M116.36,219.92c0,.87-1,1.59-2.24,1.61s-2.29-.68-2.3-1.54,1-1.59,2.26-1.61,2.28.67,2.28,1.54Zm0,0">
|
|
</path>
|
|
<path class="cls-12" d="M124.42,218.55c.15.85-.73,1.72-2,1.95s-2.37-.3-2.52-1.14.73-1.75,2-2,2.37.29,2.53,1.16Zm0,0"></path>
|
|
</svg></a>
|
|
<a class="footer-icon" id="footer_blog" href="https://ncbiinsights.ncbi.nlm.nih.gov/" aria-label="Blog">
|
|
<svg xmlns="http://www.w3.org/2000/svg" id="Layer_1" data-name="Layer 1" viewBox="0 0 40 40">
|
|
<defs><style>.cls-1{fill:#737373;}</style></defs>
|
|
<title>NCBI Insights Blog</title>
|
|
<path class="cls-1" d="M14,30a4,4,0,1,1-4-4,4,4,0,0,1,4,4Zm11,3A19,19,0,0,0,7.05,15a1,1,0,0,0-1,1v3a1,1,0,0,0,.93,1A14,14,0,0,1,20,33.07,1,1,0,0,0,21,34h3a1,1,0,0,0,1-1Zm9,0A28,28,0,0,0,7,6,1,1,0,0,0,6,7v3a1,1,0,0,0,1,1A23,23,0,0,1,29,33a1,1,0,0,0,1,1h3A1,1,0,0,0,34,33Z"></path>
|
|
</svg>
|
|
</a>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
|
|
<section class="container-fluid bg-primary">
|
|
<div class="container pt-5">
|
|
<div class="row mt-3">
|
|
<div class="col-lg-3 col-12">
|
|
<p><a class="text-white" href="https://www.nlm.nih.gov/socialmedia/index.html">Connect with NLM</a></p>
|
|
<ul class="list-inline social_media">
|
|
<li class="list-inline-item"><a href="https://twitter.com/NLM_NIH" aria-label="Twitter" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<style type="text/css">
|
|
.st20 {
|
|
fill: #FFFFFF;
|
|
}
|
|
|
|
.st30 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
</style>
|
|
<title>Twitter</title>
|
|
<g>
|
|
<g>
|
|
<g>
|
|
<path class="st20" d="M192.9,88.1c-5,2.2-9.2,2.3-13.6,0.1c5.7-3.4,6-5.8,8.1-12.3c-5.4,3.2-11.4,5.5-17.6,6.7 c-10.5-11.2-28.1-11.7-39.2-1.2c-7.2,6.8-10.2,16.9-8,26.5c-22.3-1.1-43.1-11.7-57.2-29C58,91.6,61.8,107.9,74,116 c-4.4-0.1-8.7-1.3-12.6-3.4c0,0.1,0,0.2,0,0.4c0,13.2,9.3,24.6,22.3,27.2c-4.1,1.1-8.4,1.3-12.5,0.5c3.6,11.3,14,19,25.9,19.3 c-11.6,9.1-26.4,13.2-41.1,11.5c12.7,8.1,27.4,12.5,42.5,12.5c51,0,78.9-42.2,78.9-78.9c0-1.2,0-2.4-0.1-3.6 C182.7,97.4,189.2,93.7,192.9,88.1z"></path>
|
|
</g>
|
|
</g>
|
|
<circle class="st30" cx="124.4" cy="128.8" r="108.2"></circle>
|
|
</g>
|
|
</svg></a></li>
|
|
<li class="list-inline-item"><a href="https://www.facebook.com/nationallibraryofmedicine" aria-label="Facebook" rel="noopener noreferrer" target="_blank">
|
|
<svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<style type="text/css">
|
|
.st10 {
|
|
fill: #FFFFFF;
|
|
}
|
|
|
|
.st110 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
</style>
|
|
<title>Facebook</title>
|
|
<g>
|
|
<g>
|
|
<path class="st10" d="M159,99.1h-24V88.4c0-5,3.3-6.2,5.7-6.2h16.8V60l-24.4-0.1c-22.1,0-26.2,16.5-26.2,27.1v12.1H90v22.5h16.9 v67.5H135v-67.5h21.7L159,99.1z"></path>
|
|
</g>
|
|
</g>
|
|
<circle class="st110" cx="123.6" cy="123.2" r="108.2"></circle>
|
|
</svg>
|
|
</a></li>
|
|
<li class="list-inline-item"><a href="https://www.youtube.com/user/NLMNIH" aria-label="Youtube" target="_blank" rel="noopener noreferrer"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" x="0px" y="0px" viewBox="0 0 249 249" style="enable-background:new 0 0 249 249;" xml:space="preserve">
|
|
<title>Youtube</title>
|
|
<style type="text/css">
|
|
.st4 {
|
|
fill: none;
|
|
stroke: #FFFFFF;
|
|
stroke-width: 8;
|
|
stroke-miterlimit: 10;
|
|
}
|
|
|
|
.st5 {
|
|
fill: #FFFFFF;
|
|
}
|
|
</style>
|
|
<circle class="st4" cx="124.2" cy="123.4" r="108.2"></circle>
|
|
<g transform="translate(0,-952.36218)">
|
|
<path class="st5" d="M88.4,1037.4c-10.4,0-18.7,8.3-18.7,18.7v40.1c0,10.4,8.3,18.7,18.7,18.7h72.1c10.4,0,18.7-8.3,18.7-18.7 v-40.1c0-10.4-8.3-18.7-18.7-18.7H88.4z M115.2,1058.8l29.4,17.4l-29.4,17.4V1058.8z"></path>
|
|
</g>
|
|
</svg></a></li>
|
|
</ul>
|
|
</div>
|
|
<div class="col-lg-3 col-12">
|
|
<p class="address_footer text-white">National Library of Medicine<br />
|
|
<a href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/@38.9959508,-77.101021,17z/data=!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb:0x19156f88b27635b8!8m2!3d38.9959508!4d-77.0988323" class="text-white" target="_blank" rel="noopener noreferrer">8600 Rockville Pike<br />
|
|
Bethesda, MD 20894</a></p>
|
|
</div>
|
|
<div class="col-lg-3 col-12 centered-lg">
|
|
<p><a href="https://www.nlm.nih.gov/web_policies.html" class="text-white">Web Policies</a><br />
|
|
<a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="text-white">FOIA</a><br />
|
|
<a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="text-white" id="vdp">HHS Vulnerability Disclosure</a></p>
|
|
</div>
|
|
<div class="col-lg-3 col-12 centered-lg">
|
|
<p><a class="supportLink text-white" href="https://support.nlm.nih.gov/">Help</a><br />
|
|
<a href="https://www.nlm.nih.gov/accessibility.html" class="text-white">Accessibility</a><br />
|
|
<a href="https://www.nlm.nih.gov/careers/careers.html" class="text-white">Careers</a></p>
|
|
</div>
|
|
</div>
|
|
<div class="row">
|
|
<div class="col-lg-12 centered-lg">
|
|
<nav class="bottom-links">
|
|
<ul class="mt-3">
|
|
<li>
|
|
<a class="text-white" href="//www.nlm.nih.gov/">NLM</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.nih.gov/">NIH</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.hhs.gov/">HHS</a>
|
|
</li>
|
|
<li>
|
|
<a class="text-white" href="https://www.usa.gov/">USA.gov</a>
|
|
</li>
|
|
</ul>
|
|
</nav>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
</section>
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>
|
|
<script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
|
|
</div>
|
|
</div>
|
|
</div>
|
|
<!--/.page-->
|
|
</div>
|
|
<!--/.wrap-->
|
|
</div><!-- /.twelve_col -->
|
|
</div>
|
|
<!-- /.grid -->
|
|
|
|
<span class="PAFAppResources"></span>
|
|
|
|
<!-- BESelector tab -->
|
|
|
|
|
|
|
|
<noscript><img alt="statistics" src="/stat?jsdisabled=true&ncbi_db=books&ncbi_pdid=book-toc&ncbi_acc=NBK5330&ncbi_domain=micad&ncbi_report=record&ncbi_type=fulltext&ncbi_objectid=&ncbi_pcid=/NBK5330/&ncbi_pagename=Molecular Imaging and Contrast Agent Database (MICAD) - NCBI Bookshelf&ncbi_bookparttype=toc&ncbi_app=bookshelf" /></noscript>
|
|
|
|
|
|
<!-- usually for JS scripts at page bottom -->
|
|
<!--<component id="PageFixtures" label="styles"></component>-->
|
|
|
|
|
|
<!-- CE8B5AF87C7FFCB1_0191SID /projects/books/PBooks@9.11 portal105 v4.1.r689238 Tue, Oct 22 2024 16:10:51 -->
|
|
<span id="portal-csrf-token" style="display:none" data-token="CE8B5AF87C7FFCB1_0191SID"></span>
|
|
|
|
<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4216699/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4209313/4212053/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
|
|
</html> |